ID,Pathway
AKT3,Signaling by VEGF
AKT3,Negative regulation of the PI3K/AKT network
AKT3,PI3K/AKT Signaling in Cancer
AKT3,G beta:gamma signalling through PI3Kgamma
AKT3,G-protein beta:gamma signalling
AKT3,VEGFA-VEGFR2 Pathway
AKT3,VEGFR2 mediated vascular permeability
AKT3,Constitutive Signaling by AKT1 E17K in Cancer
MED6,Respiratory Syncytial Virus Infection Pathway
MED6,RSV-host interactions
ABI1,Signaling by VEGF
ABI1,VEGFA-VEGFR2 Pathway
ABI1,RHO GTPases Activate WASPs and WAVEs
ABI1,RAC2 GTPase cycle
ABI1,RAC3 GTPase cycle
ABI1,Parasite infection
ABI1,Leishmania phagocytosis
ABI1,FCGR3A-mediated phagocytosis
HDAC6,Signaling by NOTCH1
HDAC6,NOTCH1 Intracellular Domain Regulates Transcription
HDAC6,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC6,Signaling by NOTCH1 in Cancer
HDAC6,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC6,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC6,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HDAC5,Signaling by NOTCH1
HDAC5,NOTCH1 Intracellular Domain Regulates Transcription
HDAC5,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC5,Signaling by NOTCH1 in Cancer
HDAC5,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC5,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC5,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HDAC5,Regulation of PTEN gene transcription
PDCD6IP,Budding and maturation of HIV virion
PDCD6IP,Uptake and actions of bacterial toxins
PDCD6IP,Bacterial Infection Pathways
BCL2L11,NRAGE signals death through JNK
BCL2L11,p75 NTR receptor-mediated signalling
BCL2L11,"Cell death signalling via NRAGE, NRIF and NADE"
BCL2L11,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
BCL2L11,Neurodegenerative Diseases
BCL2L11,Diseases of programmed cell death
BCL2L11,Defective Intrinsic Pathway for Apoptosis
SH2B3,Signaling by SCF-KIT
SH2B3,Regulation of KIT signaling
FRAT1,Degradation of beta-catenin by the destruction complex
FRAT1,Beta-catenin phosphorylation cascade
FRAT1,Disassembly of the destruction complex and recruitment of AXIN to the membrane
MED16,Respiratory Syncytial Virus Infection Pathway
MED16,RSV-host interactions
ARHGEF33,NRAGE signals death through JNK
ARHGEF33,p75 NTR receptor-mediated signalling
ARHGEF33,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF33,G alpha (12/13) signalling events
MAMLD1,Pre-NOTCH Transcription and Translation
MAMLD1,Pre-NOTCH Expression and Processing
MAMLD1,Signaling by NOTCH1
MAMLD1,Signaling by NOTCH2
MAMLD1,NOTCH1 Intracellular Domain Regulates Transcription
MAMLD1,NOTCH2 intracellular domain regulates transcription
MAMLD1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
MAMLD1,Signaling by NOTCH1 in Cancer
MAMLD1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
MAMLD1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
MAMLD1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MAMLD1,Signaling by NOTCH3
MAMLD1,NOTCH3 Intracellular Domain Regulates Transcription
MAMLD1,Signaling by NOTCH4
MAMLD1,NOTCH4 Intracellular Domain Regulates Transcription
RANBP9,Signaling by MET
FNTB,RAS processing
FNTB,Potential therapeutics for SARS
AP1M2,Host Interactions of HIV factors
AP1M2,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP1M2,The role of Nef in HIV-1 replication and disease pathogenesis
BMI1,Regulation of PTEN gene transcription
NR1H3,NR1H2 and NR1H3-mediated signaling
NR1H3,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
MUC12,Diseases of glycosylation
MUC12,Diseases associated with O-glycosylation of proteins
MUC12,Defective GALNT3 causes HFTC
MUC12,Defective GALNT12 causes CRCS1
MUC12,Diseases of metabolism
PTPRU,Signaling by SCF-KIT
ARPC5,RHO GTPases Activate WASPs and WAVEs
ARPC5,Parasite infection
ARPC5,Leishmania phagocytosis
ARPC5,FCGR3A-mediated phagocytosis
ARPC4,RHO GTPases Activate WASPs and WAVEs
ARPC4,Parasite infection
ARPC4,Leishmania phagocytosis
ARPC4,FCGR3A-mediated phagocytosis
ARPC3,RHO GTPases Activate WASPs and WAVEs
ARPC3,Parasite infection
ARPC3,Leishmania phagocytosis
ARPC3,FCGR3A-mediated phagocytosis
ARPC1B,RHO GTPases Activate WASPs and WAVEs
ARPC1B,Parasite infection
ARPC1B,Leishmania phagocytosis
ARPC1B,FCGR3A-mediated phagocytosis
ACTR3,RHO GTPases Activate WASPs and WAVEs
ACTR3,Parasite infection
ACTR3,Leishmania phagocytosis
ACTR3,FCGR3A-mediated phagocytosis
ACTR2,RHO GTPases Activate WASPs and WAVEs
ACTR2,Parasite infection
ACTR2,Leishmania phagocytosis
ACTR2,FCGR3A-mediated phagocytosis
ARPC2,RHO GTPases Activate WASPs and WAVEs
ARPC2,Parasite infection
ARPC2,Leishmania phagocytosis
ARPC2,FCGR3A-mediated phagocytosis
RAD50,Diseases of DNA repair
RAD50,Diseases of DNA Double-Strand Break Repair
RAD50,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RAD50,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
RAD50,Defective homologous recombination repair (HRR) due to PALB2 loss of function
RAD50,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
RAD50,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
RAD50,Impaired BRCA2 binding to RAD51
RAD50,Impaired BRCA2 binding to PALB2
ARL4C,NR1H2 and NR1H3-mediated signaling
ARL4C,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
RASGRP1,Effects of PIP2 hydrolysis
RASGRP1,Integrin signaling
DNAL4,Retrograde neurotrophin signalling
DNAL4,Signaling by NTRK1 (TRKA)
OPTN,TNFR1-induced proapoptotic signaling
OPTN,Regulation of TNFR1 signaling
OPTN,TNFR1-induced NF-kappa-B signaling pathway
OPTN,TNF signaling
BCAP31,RHOA GTPase cycle
BCAP31,Respiratory Syncytial Virus Infection Pathway
BCAP31,RSV-host interactions
G3BP1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
ABI2,Signaling by VEGF
ABI2,VEGFA-VEGFR2 Pathway
ABI2,RHO GTPases Activate WASPs and WAVEs
ABI2,RAC2 GTPase cycle
ABI2,RAC3 GTPase cycle
ABI2,Parasite infection
ABI2,Leishmania phagocytosis
ABI2,FCGR3A-mediated phagocytosis
TRIM28,HCMV Infection
TRIM28,HCMV Early Events
RASA4,Regulation of RAS by GAPs
FARP1,RHOA GTPase cycle
FARP1,RHOF GTPase cycle
LPAR6,P2Y receptors
LPAR6,Nucleotide-like (purinergic) receptors
WASF2,Signaling by VEGF
WASF2,VEGFA-VEGFR2 Pathway
WASF2,RHO GTPases Activate WASPs and WAVEs
WASF2,RAC2 GTPase cycle
WASF2,RAC3 GTPase cycle
WASF2,Parasite infection
WASF2,Leishmania phagocytosis
WASF2,FCGR3A-mediated phagocytosis
CDK2,Signaling by PTK6
CDK2,Signaling by Non-Receptor Tyrosine Kinases
DHRS9,Signaling by Retinoic Acid
DHRS9,RA biosynthesis pathway
CDK4,Signaling by PTK6
CDK4,Signaling by Non-Receptor Tyrosine Kinases
RNF41,Signaling by ERBB2
RNF41,Downregulation of ERBB2 signaling
ADAM10,Signaling by NOTCH1
ADAM10,Signaling by NOTCH2
ADAM10,Activated NOTCH1 Transmits Signal to the Nucleus
ADAM10,Signaling by NOTCH1 PEST Domain Mutants in Cancer
ADAM10,Signaling by NOTCH1 in Cancer
ADAM10,Constitutive Signaling by NOTCH1 PEST Domain Mutants
ADAM10,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
ADAM10,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
ADAM10,NOTCH2 Activation and Transmission of Signal to the Nucleus
ADAM10,Signaling by NOTCH3
ADAM10,NOTCH3 Activation and Transmission of Signal to the Nucleus
ADAM10,Signaling by NOTCH4
CDK5,Opioid Signalling
CDK5,DARPP-32 events
CDK5,Signaling by NTRK1 (TRKA)
CDK5,Nuclear Events (kinase and transcription factor activation)
CDK5,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDK5,Neurodegenerative Diseases
CDK5,Signaling by NTRK2 (TRKB)
CDK5,NGF-stimulated transcription
CDK5,Diseases of programmed cell death
CDK5,Defective Intrinsic Pathway for Apoptosis
CALCRL,Class B/2 (Secretin family receptors)
CALCRL,G alpha (s) signalling events
FLOT1,RHOA GTPase cycle
FLOT1,RHOB GTPase cycle
FLOT1,RHOC GTPase cycle
PSMD14,Host Interactions of HIV factors
PSMD14,Vpu mediated degradation of CD4
PSMD14,Vif-mediated degradation of APOBEC3G
PSMD14,Degradation of beta-catenin by the destruction complex
PSMD14,PCP/CE pathway
PSMD14,Asymmetric localization of PCP proteins
PSMD14,Degradation of AXIN
PSMD14,Degradation of DVL
PSMD14,Hedgehog ligand biogenesis
PSMD14,Hh mutants are degraded by ERAD
PSMD14,Hh mutants abrogate ligand secretion
PSMD14,Degradation of GLI1 by the proteasome
PSMD14,Degradation of GLI2 by the proteasome
PSMD14,GLI3 is processed to GLI3R by the proteasome
PSMD14,Hedgehog 'off' state
PSMD14,ABC transporter disorders
PSMD14,Disorders of transmembrane transporters
PSMD14,Hedgehog 'on' state
PSMD14,Regulation of RAS by GAPs
PSMD14,Defective CFTR causes cystic fibrosis
PSMD14,MAPK6/MAPK4 signaling
PSMD14,Regulation of PTEN stability and activity
PSMD14,Signaling by NOTCH4
PSMD14,Negative regulation of NOTCH4 signaling
CDK7,Formation of HIV elongation complex in the absence of HIV Tat
CDK7,Formation of the HIV-1 Early Elongation Complex
CDK7,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
CDK7,HIV Transcription Initiation
CDK7,RNA Polymerase II HIV Promoter Escape
CDK7,HIV Transcription Elongation
CDK7,Transcription of the HIV genome
CDK7,Formation of HIV-1 elongation complex containing HIV-1 Tat
CDK7,Tat-mediated elongation of the HIV-1 transcript
TRIB1,Signaling by NTRK1 (TRKA)
TRIB1,Nuclear Events (kinase and transcription factor activation)
TRIB1,NGF-stimulated transcription
PLIN3,RHOBTB3 ATPase cycle
RASGRP2,Effects of PIP2 hydrolysis
RASGRP2,Integrin signaling
CDK8,Signaling by TGF-beta Receptor Complex
CDK8,Signaling by NOTCH1
CDK8,NOTCH1 Intracellular Domain Regulates Transcription
CDK8,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
CDK8,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
CDK8,Signaling by NOTCH1 PEST Domain Mutants in Cancer
CDK8,Signaling by NOTCH1 in Cancer
CDK8,Constitutive Signaling by NOTCH1 PEST Domain Mutants
CDK8,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
CDK8,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
CDK8,Respiratory Syncytial Virus Infection Pathway
CDK8,RSV-host interactions
CDK9,Host Interactions of HIV factors
CDK9,Formation of HIV elongation complex in the absence of HIV Tat
CDK9,HIV Transcription Elongation
CDK9,Transcription of the HIV genome
CDK9,Formation of HIV-1 elongation complex containing HIV-1 Tat
CDK9,Pausing and recovery of Tat-mediated HIV elongation
CDK9,Tat-mediated HIV elongation arrest and recovery
CDK9,Tat-mediated elongation of the HIV-1 transcript
CDK9,HIV elongation arrest and recovery
CDK9,Pausing and recovery of HIV elongation
CDK9,Signaling by TGF-beta Receptor Complex
CDK9,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
CDK9,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
CDK9,Estrogen-dependent gene expression
SRRM1,RHOBTB2 GTPase cycle
SRRM1,RHOBTB1 GTPase cycle
SRRM1,RHOBTB GTPase Cycle
SPRY1,Signaling by EGFR
SPRY1,EGFR downregulation
SPRY2,Signaling by EGFR
SPRY2,EGFR downregulation
SPRY2,Signaling by FGFR
SPRY2,Negative regulation of FGFR1 signaling
SPRY2,Negative regulation of FGFR2 signaling
SPRY2,Negative regulation of FGFR3 signaling
SPRY2,Negative regulation of FGFR4 signaling
SPRY2,Signaling by FGFR1
SPRY2,Signaling by FGFR2
SPRY2,Signaling by FGFR3
SPRY2,Signaling by FGFR4
STAM2,Signaling by EGFR
STAM2,EGFR downregulation
STAM2,Signaling by MET
STAM2,Negative regulation of MET activity
STAM2,InlB-mediated entry of Listeria monocytogenes into host cell
STAM2,Listeria monocytogenes entry into host cells
STAM2,RHOU GTPase cycle
STAM2,Bacterial Infection Pathways
CNKSR1,MAP2K and MAPK activation
CNKSR1,Signaling by moderate kinase activity BRAF mutants
CNKSR1,Signaling by high-kinase activity BRAF mutants
CNKSR1,Signaling by RAS mutants
CNKSR1,Signaling by BRAF and RAF1 fusions
CNKSR1,Paradoxical activation of RAF signaling by kinase inactive BRAF
CNKSR1,Oncogenic MAPK signaling
CNKSR1,Signaling downstream of RAS mutants
CNKSR1,Signaling by RAF1 mutants
CDKN1A,AKT phosphorylates targets in the cytosol
CDKN1A,PI3K/AKT Signaling in Cancer
CDKN1A,Constitutive Signaling by AKT1 E17K in Cancer
CDKN1A,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
CDKN1A,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
CDKN1A,Diseases of mitotic cell cycle
CDKN1A,FLT3 signaling in disease
CDKN1A,Aberrant regulation of mitotic cell cycle due to RB1 defects
CDKN1A,Signaling by ALK in cancer
CDKN1A,Signaling by FLT3 ITD and TKD mutants
CDKN1A,Signaling by ALK fusions and activated point mutants
RAMP2,Class B/2 (Secretin family receptors)
RAMP2,G alpha (s) signalling events
RAMP1,Class B/2 (Secretin family receptors)
RAMP1,G alpha (s) signalling events
RAMP3,Class B/2 (Secretin family receptors)
RAMP3,G alpha (s) signalling events
CDKN1B,AKT phosphorylates targets in the cytosol
CDKN1B,PI3K/AKT Signaling in Cancer
CDKN1B,RHO GTPases activate CIT
CDKN1B,Constitutive Signaling by AKT1 E17K in Cancer
CDKN1B,Signaling by PTK6
CDKN1B,Signaling by Non-Receptor Tyrosine Kinases
CDKN1B,Extra-nuclear estrogen signaling
CDKN1B,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
CDKN1B,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
CDKN1B,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
CDKN1B,Diseases of mitotic cell cycle
CDKN1B,Aberrant regulation of mitotic cell cycle due to RB1 defects
FSTL3,Signaling by Activin
STUB1,Signaling by ERBB2
STUB1,Signaling by TGF-beta Receptor Complex
STUB1,Downregulation of TGF-beta receptor signaling
STUB1,TGF-beta receptor signaling activates SMADs
STUB1,Regulation of TNFR1 signaling
STUB1,TNF signaling
STUB1,Downregulation of ERBB2 signaling
STUB1,Regulation of PTEN stability and activity
STAG1,Estrogen-dependent gene expression
NET1,NRAGE signals death through JNK
NET1,p75 NTR receptor-mediated signalling
NET1,"Cell death signalling via NRAGE, NRIF and NADE"
NET1,G alpha (12/13) signalling events
NET1,RHOA GTPase cycle
NET1,RHOB GTPase cycle
CDKN1C,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
CDKN1C,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
CDKN1C,Diseases of mitotic cell cycle
CDKN1C,Aberrant regulation of mitotic cell cycle due to RB1 defects
SIGMAR1,Potential therapeutics for SARS
SAP18,Potential therapeutics for SARS
RGS19,G alpha (z) signalling events
PAK4,Activation of RAC1
PAK4,RAC2 GTPase cycle
PAK4,RHOQ GTPase cycle
PAK4,RHOH GTPase cycle
PAK4,RHOG GTPase cycle
PAK4,RHOJ GTPase cycle
PAK4,RHOU GTPase cycle
PAK4,RAC3 GTPase cycle
PAK4,RHOV GTPase cycle
CDKN2B,Signaling by TGF-beta Receptor Complex
CDKN2B,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
CDKN2B,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
TCIRG1,Signaling by Insulin receptor
TCIRG1,Insulin receptor recycling
LAMC3,Signaling by MET
LAMC3,MET activates PTK2 signaling
LAMC3,MET promotes cell motility
RRAGB,MTOR signalling
RRAGB,mTORC1-mediated signalling
RRAGB,Energy dependent regulation of mTOR by LKB1-AMPK
RRAGB,Regulation of PTEN gene transcription
CLEC4M,Respiratory Syncytial Virus Infection Pathway
CLEC4M,RSV-host interactions
TLR6,Diseases of Immune System
TLR6,Diseases associated with the TLR signaling cascade
TLR6,Respiratory Syncytial Virus Infection Pathway
TLR6,RSV-host interactions
HMG20B,Potential therapeutics for SARS
TUBA1B,Hedgehog 'off' state
TUBA1B,RHO GTPases activate IQGAPs
TUBA1B,RHO GTPases Activate Formins
TUBA1B,RHOH GTPase cycle
TUBA1B,HCMV Infection
TUBA1B,HCMV Early Events
TUBB3,Hedgehog 'off' state
TUBB3,RHO GTPases activate IQGAPs
TUBB3,RHO GTPases Activate Formins
TUBB3,HCMV Infection
TUBB3,HCMV Early Events
MYL12B,RHO GTPases activate PKNs
MYL12B,RHO GTPases activate CIT
MYL12B,RHO GTPases Activate ROCKs
MYL12B,RHO GTPases activate PAKs
NOD1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
ANAPC10,Diseases of mitotic cell cycle
ANAPC10,Aberrant regulation of mitotic exit in cancer due to RB1 defects
ANAPC10,Aberrant regulation of mitotic cell cycle due to RB1 defects
DLC1,RHOA GTPase cycle
DLC1,RHOB GTPase cycle
DLC1,RHOC GTPase cycle
DLC1,RHOQ GTPase cycle
MYL9,RHO GTPases activate PKNs
MYL9,RHO GTPases activate CIT
MYL9,RHO GTPases Activate ROCKs
MYL9,RHO GTPases activate PAKs
ST3GAL6,Pre-NOTCH Processing in Golgi
ST3GAL6,Pre-NOTCH Expression and Processing
BASP1,RHOF GTPase cycle
RAPGEF3,Integrin signaling
YAP1,Signaling by ERBB4
YAP1,Nuclear signaling by ERBB4
YAP1,Signaling by Hippo
PGRMC2,RHOA GTPase cycle
PGRMC2,RAC2 GTPase cycle
PGRMC2,RHOD GTPase cycle
PGRMC2,RHOG GTPase cycle
PGRMC2,RAC3 GTPase cycle
SEC24B,SARS-CoV-2 activates/modulates innate and adaptive immune responses
LYPLA1,RAS processing
CDC42EP2,MAPK6/MAPK4 signaling
CDC42EP2,RHOQ GTPase cycle
VAV3,NRAGE signals death through JNK
VAV3,p75 NTR receptor-mediated signalling
VAV3,Signaling by VEGF
VAV3,"Cell death signalling via NRAGE, NRIF and NADE"
VAV3,G alpha (12/13) signalling events
VAV3,VEGFA-VEGFR2 Pathway
VAV3,RHOA GTPase cycle
VAV3,RAC2 GTPase cycle
VAV3,RHOG GTPase cycle
VAV3,Parasite infection
VAV3,Leishmania phagocytosis
VAV3,FCGR3A-mediated phagocytosis
TAB1,TNFR1-induced NF-kappa-B signaling pathway
TAB1,TNF signaling
TAB1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
GPNMB,Signaling by PTK6
GPNMB,Signaling by Non-Receptor Tyrosine Kinases
BAIAP2,Signaling by VEGF
BAIAP2,VEGFA-VEGFR2 Pathway
BAIAP2,RHO GTPases Activate WASPs and WAVEs
BAIAP2,RAC3 GTPase cycle
BAIAP2,Parasite infection
BAIAP2,Leishmania phagocytosis
BAIAP2,FCGR3A-mediated phagocytosis
TACC3,Signaling by NOTCH3
TACC3,NOTCH3 Activation and Transmission of Signal to the Nucleus
TACC3,Signaling by NOTCH4
TACC3,Negative regulation of NOTCH4 signaling
PPIH,SARS-CoV-1-host interactions
PPIH,SARS-CoV-1 activates/modulates innate immune responses
FST,Signaling by Activin
SEC23A,SARS-CoV-2 activates/modulates innate and adaptive immune responses
LRRC41,RHOBTB3 ATPase cycle
CRHR1,Class B/2 (Secretin family receptors)
CRHR1,G alpha (s) signalling events
CARM1,Estrogen-dependent gene expression
NCOA2,RHO GTPases activate PKNs
NCOA2,Estrogen-dependent gene expression
SEMA4F,RND3 GTPase cycle
CEBPB,Signaling by ALK in cancer
CEBPB,Signaling by ALK fusions and activated point mutants
CEBPB,Nuclear events stimulated by ALK signaling in cancer
CEBPD,HCMV Infection
CEBPD,HCMV Late Events
KAT5,Formation of the beta-catenin:TCF transactivating complex
KAT5,Estrogen-dependent gene expression
KAT5,Diseases of DNA repair
KAT5,Diseases of DNA Double-Strand Break Repair
KAT5,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
KAT5,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
KAT5,Defective homologous recombination repair (HRR) due to PALB2 loss of function
KAT5,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
KAT5,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
KAT5,Impaired BRCA2 binding to RAD51
KAT5,Impaired BRCA2 binding to PALB2
ARPC1A,RHO GTPases Activate WASPs and WAVEs
ARPC1A,Parasite infection
ARPC1A,Leishmania phagocytosis
ARPC1A,FCGR3A-mediated phagocytosis
CXCL13,Peptide ligand-binding receptors
CXCL13,Chemokine receptors bind chemokines
CCT7,RHOBTB2 GTPase cycle
CCT7,RHOBTB1 GTPase cycle
CCT7,RHOBTB GTPase Cycle
CCT2,RHOBTB2 GTPase cycle
CCT2,RHOBTB1 GTPase cycle
CCT2,RHOBTB GTPase Cycle
POMT1,Diseases of glycosylation
POMT1,Diseases associated with O-glycosylation of proteins
POMT1,Diseases of metabolism
DRAP1,Signaling by Activin
CDC42EP3,MAPK6/MAPK4 signaling
CDC42EP3,RHOQ GTPase cycle
SH2B2,Signaling by SCF-KIT
SH2B2,Regulation of KIT signaling
MXD4,Signaling by ERBB4
MXD4,Nuclear signaling by ERBB4
ST6GALNAC2,Translation of Structural Proteins
ST6GALNAC2,Maturation of spike protein
ST6GALNAC2,Late SARS-CoV-2 Infection Events
ERLIN1,ABC transporter disorders
ERLIN1,Disorders of transmembrane transporters
ERLIN1,Defective CFTR causes cystic fibrosis
RBCK1,TNFR1-induced proapoptotic signaling
RBCK1,Regulation of TNFR1 signaling
RBCK1,TNFR1-induced NF-kappa-B signaling pathway
RBCK1,TNF signaling
TXNIP,Purinergic signaling in leishmaniasis infection
TXNIP,Cell recruitment (pro-inflammatory response)
RAD51AP1,Diseases of DNA repair
RAD51AP1,Diseases of DNA Double-Strand Break Repair
RAD51AP1,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RAD51AP1,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
RAD51AP1,Defective homologous recombination repair (HRR) due to PALB2 loss of function
RAD51AP1,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
RAD51AP1,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
RAD51AP1,Impaired BRCA2 binding to PALB2
IGF2BP1,MAPK6/MAPK4 signaling
CAMKK2,Opioid Signalling
CAMKK2,CaMK IV-mediated phosphorylation of CREB
CAMKK2,Calmodulin induced events
CAMKK2,Ca-dependent events
CAMKK2,CaM pathway
CAMKK2,G-protein mediated events
CAMKK2,PLC beta mediated events
CAMKK2,DAG and IP3 signaling
SPINT2,Signaling by MET
KHDRBS1,Signaling by PTK6
KHDRBS1,Signaling by Non-Receptor Tyrosine Kinases
CXCR6,Peptide ligand-binding receptors
CXCR6,Chemokine receptors bind chemokines
RRAGA,MTOR signalling
RRAGA,mTORC1-mediated signalling
RRAGA,Energy dependent regulation of mTOR by LKB1-AMPK
RRAGA,Regulation of PTEN gene transcription
GNA13,NRAGE signals death through JNK
GNA13,p75 NTR receptor-mediated signalling
GNA13,"Cell death signalling via NRAGE, NRIF and NADE"
GNA13,G alpha (12/13) signalling events
GNB5,Opioid Signalling
GNB5,G-protein activation
GNB5,Class B/2 (Secretin family receptors)
GNB5,G beta:gamma signalling through PI3Kgamma
GNB5,G-protein beta:gamma signalling
GNB5,Ca2+ pathway
GNB5,G alpha (12/13) signalling events
GNB5,G beta:gamma signalling through PLC beta
GNB5,G alpha (s) signalling events
GNB5,G alpha (z) signalling events
GNB5,Glucagon-type ligand receptors
GNB5,G beta:gamma signalling through BTK
GNB5,G beta:gamma signalling through CDC42
GNB5,Extra-nuclear estrogen signaling
GNB5,GPER1 signaling
GNB5,ADORA2B mediated anti-inflammatory cytokines production
GNB5,Anti-inflammatory response favouring Leishmania parasite infection
GNB5,Leishmania parasite growth and survival
PAK6,Activation of RAC1
PAK6,RHOD GTPase cycle
PAK6,RHOH GTPase cycle
PAK6,RHOV GTPase cycle
ADCY1,Opioid Signalling
ADCY1,PKA-mediated phosphorylation of CREB
ADCY1,Calmodulin induced events
ADCY1,Ca-dependent events
ADCY1,CaM pathway
ADCY1,G-protein mediated events
ADCY1,PLC beta mediated events
ADCY1,DAG and IP3 signaling
ADCY1,PKA activation
ADCY1,Adenylate cyclase activating pathway
ADCY1,Adenylate cyclase inhibitory pathway
ADCY1,G alpha (s) signalling events
ADCY1,G alpha (z) signalling events
ADCY1,Hedgehog 'off' state
ADCY1,GPER1 signaling
ADCY1,ADORA2B mediated anti-inflammatory cytokines production
ADCY1,Anti-inflammatory response favouring Leishmania parasite infection
ADCY1,FCGR3A-mediated IL10 synthesis
ADCY1,Leishmania parasite growth and survival
CETP,NR1H2 and NR1H3-mediated signaling
CETP,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
NRG3,Signaling by ERBB2
NRG3,Signaling by ERBB2 in Cancer
NRG3,Signaling by ERBB4
NRG3,Nuclear signaling by ERBB4
NRG3,Negative regulation of the PI3K/AKT network
NRG3,PI3K/AKT Signaling in Cancer
NRG3,Constitutive Signaling by Aberrant PI3K in Cancer
NRG3,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
NRG3,Signaling by PTK6
NRG3,Downregulation of ERBB2 signaling
NRG3,Signaling by Non-Receptor Tyrosine Kinases
NRG3,Signaling by ERBB2 KD Mutants
NRG3,Signaling by ERBB2 TMD/JMD mutants
CFL1,RHO GTPases Activate ROCKs
NUDC,RHO GTPases Activate Formins
NUDC,RND2 GTPase cycle
PTGES3,Estrogen-dependent gene expression
PTGES3,Potential therapeutics for SARS
STAG2,Estrogen-dependent gene expression
GRAP,Signaling by SCF-KIT
GIPC1,Signaling by FGFR
GIPC1,Signaling by FGFR1
GIPC1,Signaling by TGFBR3
NUP50,Host Interactions of HIV factors
NUP50,Rev-mediated nuclear export of HIV RNA
NUP50,Transport of Ribonucleoproteins into the Host Nucleus
NUP50,Export of Viral Ribonucleoproteins from Nucleus
NUP50,NS1 Mediated Effects on Host Pathways
NUP50,Viral Messenger RNA Synthesis
NUP50,NEP/NS2 Interacts with the Cellular Export Machinery
NUP50,Interactions of Vpr with host cellular proteins
NUP50,Interactions of Rev with host cellular proteins
NUP50,Nuclear import of Rev protein
NUP50,Vpr-mediated nuclear import of PICs
NUP50,SLC transporter disorders
NUP50,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP50,Disorders of transmembrane transporters
NUP50,HCMV Infection
NUP50,HCMV Early Events
NUP50,HCMV Late Events
NUP50,SARS-CoV-2 activates/modulates innate and adaptive immune responses
AHCYL1,Opioid Signalling
AHCYL1,G-protein mediated events
AHCYL1,PLC beta mediated events
AHCYL1,DAG and IP3 signaling
AHCYL1,Signaling by VEGF
AHCYL1,VEGFA-VEGFR2 Pathway
AHCYL1,VEGFR2 mediated cell proliferation
AHCYL1,Anti-inflammatory response favouring Leishmania parasite infection
AHCYL1,FCGR3A-mediated IL10 synthesis
AHCYL1,Leishmania parasite growth and survival
PLK2,Anti-inflammatory response favouring Leishmania parasite infection
PLK2,Leishmania parasite growth and survival
NCKAP1,Signaling by VEGF
NCKAP1,VEGFA-VEGFR2 Pathway
NCKAP1,RHO GTPases Activate WASPs and WAVEs
NCKAP1,RAC2 GTPase cycle
NCKAP1,RAC3 GTPase cycle
NCKAP1,Parasite infection
NCKAP1,Leishmania phagocytosis
NCKAP1,FCGR3A-mediated phagocytosis
IQGAP2,RHO GTPases activate IQGAPs
IQGAP2,RHOG GTPase cycle
ADCY2,Opioid Signalling
ADCY2,PKA-mediated phosphorylation of CREB
ADCY2,Calmodulin induced events
ADCY2,Ca-dependent events
ADCY2,CaM pathway
ADCY2,G-protein mediated events
ADCY2,PLC beta mediated events
ADCY2,DAG and IP3 signaling
ADCY2,PKA activation
ADCY2,Adenylate cyclase activating pathway
ADCY2,Adenylate cyclase inhibitory pathway
ADCY2,G alpha (s) signalling events
ADCY2,G alpha (z) signalling events
ADCY2,Hedgehog 'off' state
ADCY2,GPER1 signaling
ADCY2,ADORA2B mediated anti-inflammatory cytokines production
ADCY2,Anti-inflammatory response favouring Leishmania parasite infection
ADCY2,FCGR3A-mediated IL10 synthesis
ADCY2,Leishmania parasite growth and survival
CFTR,RHOQ GTPase cycle
CYSLTR1,Eicosanoid ligand-binding receptors
CYSLTR1,Anti-inflammatory response favouring Leishmania parasite infection
CYSLTR1,Leishmania parasite growth and survival
CYSLTR1,Potential therapeutics for SARS
SEC24A,SARS-CoV-2 activates/modulates innate and adaptive immune responses
CCR9,Peptide ligand-binding receptors
CCR9,Chemokine receptors bind chemokines
WASF3,Signaling by VEGF
WASF3,VEGFA-VEGFR2 Pathway
WASF3,RHO GTPases Activate WASPs and WAVEs
WASF3,Parasite infection
WASF3,Leishmania phagocytosis
WASF3,FCGR3A-mediated phagocytosis
NOXA1,RHO GTPases Activate NADPH Oxidases
NOXA1,RAC3 GTPase cycle
FRS3,Signaling by FGFR
FRS3,Downstream signaling of activated FGFR1
FRS3,FRS-mediated FGFR1 signaling
FRS3,Downstream signaling of activated FGFR2
FRS3,FRS-mediated FGFR2 signaling
FRS3,FRS-mediated FGFR3 signaling
FRS3,Downstream signaling of activated FGFR3
FRS3,FRS-mediated FGFR4 signaling
FRS3,Downstream signaling of activated FGFR4
FRS3,Signaling by FGFR1
FRS3,Signaling by FGFR2
FRS3,Signaling by FGFR3
FRS3,Signaling by FGFR4
FRS3,Signaling by NTRK2 (TRKB)
FRS3,RND2 GTPase cycle
FRS3,RND1 GTPase cycle
FRS3,Signaling by ALK in cancer
FRS3,Signaling by ALK fusions and activated point mutants
FRS2,Signaling by FGFR in disease
FRS2,Prolonged ERK activation events
FRS2,Frs2-mediated activation
FRS2,Signaling by NTRK1 (TRKA)
FRS2,Signalling to ERKs
FRS2,Signaling by FGFR
FRS2,Signaling by ALK
FRS2,Downstream signaling of activated FGFR1
FRS2,FRS-mediated FGFR1 signaling
FRS2,Downstream signaling of activated FGFR2
FRS2,FRS-mediated FGFR2 signaling
FRS2,FRS-mediated FGFR3 signaling
FRS2,Downstream signaling of activated FGFR3
FRS2,FRS-mediated FGFR4 signaling
FRS2,Downstream signaling of activated FGFR4
FRS2,Negative regulation of FGFR1 signaling
FRS2,Negative regulation of FGFR2 signaling
FRS2,Negative regulation of FGFR3 signaling
FRS2,Negative regulation of FGFR4 signaling
FRS2,Signaling by FGFR1
FRS2,Signaling by FGFR2
FRS2,Signaling by FGFR3
FRS2,Signaling by FGFR4
FRS2,Signaling by FGFR2 in disease
FRS2,Signaling by FGFR1 in disease
FRS2,Signaling by FGFR3 in disease
FRS2,Signaling by NTRK2 (TRKB)
FRS2,RND2 GTPase cycle
FRS2,RND1 GTPase cycle
FRS2,Signaling by ALK in cancer
FRS2,Signaling by ALK fusions and activated point mutants
CCL27,Peptide ligand-binding receptors
CCL27,Chemokine receptors bind chemokines
CPSF4,NS1 Mediated Effects on Host Pathways
ADCY3,Opioid Signalling
ADCY3,PKA-mediated phosphorylation of CREB
ADCY3,Calmodulin induced events
ADCY3,Ca-dependent events
ADCY3,CaM pathway
ADCY3,G-protein mediated events
ADCY3,PLC beta mediated events
ADCY3,DAG and IP3 signaling
ADCY3,PKA activation
ADCY3,Adenylate cyclase activating pathway
ADCY3,Adenylate cyclase inhibitory pathway
ADCY3,G alpha (s) signalling events
ADCY3,G alpha (z) signalling events
ADCY3,Hedgehog 'off' state
ADCY3,GPER1 signaling
ADCY3,ADORA2B mediated anti-inflammatory cytokines production
ADCY3,Anti-inflammatory response favouring Leishmania parasite infection
ADCY3,FCGR3A-mediated IL10 synthesis
ADCY3,Leishmania parasite growth and survival
DHRS4,Signaling by Retinoic Acid
DHRS4,RA biosynthesis pathway
SUGT1,Purinergic signaling in leishmaniasis infection
SUGT1,Cell recruitment (pro-inflammatory response)
CBX1,HCMV Infection
CBX1,HCMV Early Events
OS9,Hedgehog ligand biogenesis
OS9,Hh mutants are degraded by ERAD
OS9,Hh mutants abrogate ligand secretion
OS9,ABC transporter disorders
OS9,Disorders of transmembrane transporters
OS9,Defective CFTR causes cystic fibrosis
TMED2,Pre-NOTCH Processing in Golgi
TMED2,Pre-NOTCH Expression and Processing
STIP1,RND1 GTPase cycle
CKAP4,RND3 GTPase cycle
CKAP4,RND2 GTPase cycle
YWHAQ,RHO GTPases activate PKNs
YWHAQ,SARS-CoV-1-host interactions
YWHAQ,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
FERMT2,RAC3 GTPase cycle
ADAP1,Signaling by ERBB4
ADAP1,Nuclear signaling by ERBB4
RIPK3,Diseases of programmed cell death
RIPK3,SARS-CoV-1-host interactions
RIPK3,SARS-CoV-1 activates/modulates innate immune responses
RCC1,Host Interactions of HIV factors
RCC1,Rev-mediated nuclear export of HIV RNA
RCC1,Interactions of Rev with host cellular proteins
RCC1,Nuclear import of Rev protein
ADRM1,Host Interactions of HIV factors
ADRM1,Vpu mediated degradation of CD4
ADRM1,Vif-mediated degradation of APOBEC3G
ADRM1,Degradation of beta-catenin by the destruction complex
ADRM1,PCP/CE pathway
ADRM1,Asymmetric localization of PCP proteins
ADRM1,Degradation of AXIN
ADRM1,Degradation of DVL
ADRM1,Hedgehog ligand biogenesis
ADRM1,Hh mutants are degraded by ERAD
ADRM1,Hh mutants abrogate ligand secretion
ADRM1,Degradation of GLI1 by the proteasome
ADRM1,Degradation of GLI2 by the proteasome
ADRM1,GLI3 is processed to GLI3R by the proteasome
ADRM1,Hedgehog 'off' state
ADRM1,ABC transporter disorders
ADRM1,Disorders of transmembrane transporters
ADRM1,Hedgehog 'on' state
ADRM1,Regulation of RAS by GAPs
ADRM1,Defective CFTR causes cystic fibrosis
ADRM1,MAPK6/MAPK4 signaling
ADRM1,Regulation of PTEN stability and activity
ADRM1,Signaling by NOTCH4
ADRM1,Negative regulation of NOTCH4 signaling
CHD1,Estrogen-dependent gene expression
WWP1,Signaling by ERBB4
WWP2,Regulation of PTEN stability and activity
WWP2,Signaling by NOTCH3
WWP2,RHOQ GTPase cycle
WWP2,RHOJ GTPase cycle
WWP2,RHOU GTPase cycle
WWP2,NOTCH3 Activation and Transmission of Signal to the Nucleus
UBE2C,Diseases of mitotic cell cycle
UBE2C,Aberrant regulation of mitotic exit in cancer due to RB1 defects
UBE2C,Aberrant regulation of mitotic cell cycle due to RB1 defects
RAPGEF4,Integrin signaling
CHD3,Regulation of PTEN gene transcription
CHD3,Potential therapeutics for SARS
TOPBP1,Diseases of DNA repair
TOPBP1,Diseases of DNA Double-Strand Break Repair
TOPBP1,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
TOPBP1,Impaired BRCA2 binding to RAD51
STMN2,RND1 GTPase cycle
CHD4,Signaling by NTRK1 (TRKA)
CHD4,Nuclear Events (kinase and transcription factor activation)
CHD4,Regulation of PTEN gene transcription
CHD4,NGF-stimulated transcription
CHD4,Potential therapeutics for SARS
ADCY5,Opioid Signalling
ADCY5,PKA-mediated phosphorylation of CREB
ADCY5,Calmodulin induced events
ADCY5,Ca-dependent events
ADCY5,CaM pathway
ADCY5,G-protein mediated events
ADCY5,PLC beta mediated events
ADCY5,DAG and IP3 signaling
ADCY5,PKA activation
ADCY5,Adenylate cyclase activating pathway
ADCY5,Adenylate cyclase inhibitory pathway
ADCY5,G alpha (s) signalling events
ADCY5,G alpha (z) signalling events
ADCY5,Hedgehog 'off' state
ADCY5,GPER1 signaling
ADCY5,ADORA2B mediated anti-inflammatory cytokines production
ADCY5,Anti-inflammatory response favouring Leishmania parasite infection
ADCY5,FCGR3A-mediated IL10 synthesis
ADCY5,Leishmania parasite growth and survival
PRDM4,p75 NTR receptor-mediated signalling
CHEK1,Signaling by SCF-KIT
CIT,RHO GTPases activate CIT
CIT,RHOA GTPase cycle
CIT,RHOB GTPase cycle
CIT,RHOC GTPase cycle
RCAN3,SARS-CoV-1-host interactions
RCAN3,SARS-CoV-1 activates/modulates innate immune responses
KIF3A,Hedgehog 'off' state
KIF3A,Hedgehog 'on' state
KIF3A,Activation of SMO
CDC42EP1,RAC2 GTPase cycle
CDC42EP1,RHOQ GTPase cycle
CDC42EP1,RHOG GTPase cycle
CDC42EP1,RHOJ GTPase cycle
CDC42EP1,RAC3 GTPase cycle
SLC7A9,SLC transporter disorders
SLC7A9,Disorders of transmembrane transporters
CDC37,Signaling by ERBB2
CDC37,Signaling by ERBB2 in Cancer
CDC37,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
CDC37,Signaling by EGFR in Cancer
CDC37,Constitutive Signaling by EGFRvIII
CDC37,Signaling by EGFRvIII in Cancer
CDC37,Signaling by Ligand-Responsive EGFR Variants in Cancer
CDC37,Downregulation of ERBB2 signaling
CDC37,RHOBTB2 GTPase cycle
CDC37,Signaling by ERBB2 KD Mutants
CDC37,Signaling by ERBB2 ECD mutants
CDC37,Signaling by ERBB2 TMD/JMD mutants
CDC37,RHOBTB GTPase Cycle
CORO1A,Infection with Mycobacterium tuberculosis
CORO1A,Response of Mtb to phagocytosis
CORO1A,Bacterial Infection Pathways
ERLIN2,ABC transporter disorders
ERLIN2,Disorders of transmembrane transporters
ERLIN2,Defective CFTR causes cystic fibrosis
FSTL1,Signaling by BMP
PSIP1,Early Phase of HIV Life Cycle
PSIP1,Host Interactions of HIV factors
PSIP1,Interactions of Vpr with host cellular proteins
PSIP1,Vpr-mediated nuclear import of PICs
STRAP,Signaling by TGF-beta Receptor Complex
STRAP,Downregulation of TGF-beta receptor signaling
STRAP,TGF-beta receptor signaling activates SMADs
WDR6,RHOU GTPase cycle
WDR6,RHOV GTPase cycle
WDR6,RND3 GTPase cycle
WDR6,RND2 GTPase cycle
WDR6,RND1 GTPase cycle
NISCH,RND3 GTPase cycle
NISCH,RND2 GTPase cycle
SUPT16H,Formation of HIV elongation complex in the absence of HIV Tat
SUPT16H,HIV Transcription Elongation
SUPT16H,Transcription of the HIV genome
SUPT16H,Formation of HIV-1 elongation complex containing HIV-1 Tat
SUPT16H,Pausing and recovery of Tat-mediated HIV elongation
SUPT16H,Tat-mediated HIV elongation arrest and recovery
SUPT16H,Tat-mediated elongation of the HIV-1 transcript
SUPT16H,HIV elongation arrest and recovery
SUPT16H,Pausing and recovery of HIV elongation
ADCY6,Opioid Signalling
ADCY6,PKA-mediated phosphorylation of CREB
ADCY6,Calmodulin induced events
ADCY6,Ca-dependent events
ADCY6,CaM pathway
ADCY6,G-protein mediated events
ADCY6,PLC beta mediated events
ADCY6,DAG and IP3 signaling
ADCY6,PKA activation
ADCY6,Adenylate cyclase activating pathway
ADCY6,Adenylate cyclase inhibitory pathway
ADCY6,G alpha (s) signalling events
ADCY6,G alpha (z) signalling events
ADCY6,Hedgehog 'off' state
ADCY6,GPER1 signaling
ADCY6,ADORA2B mediated anti-inflammatory cytokines production
ADCY6,Anti-inflammatory response favouring Leishmania parasite infection
ADCY6,FCGR3A-mediated IL10 synthesis
ADCY6,Leishmania parasite growth and survival
FZD10,Class B/2 (Secretin family receptors)
AKAP13,NRAGE signals death through JNK
AKAP13,p75 NTR receptor-mediated signalling
AKAP13,"Cell death signalling via NRAGE, NRIF and NADE"
AKAP13,G alpha (12/13) signalling events
AKAP13,RHOA GTPase cycle
AKAP13,RHOB GTPase cycle
AKAP13,RHOC GTPase cycle
DDX20,SARS-CoV-2 modulates host translation machinery
DUSP10,RAF-independent MAPK1/3 activation
DUSP10,Negative regulation of MAPK pathway
DUSP10,Oncogenic MAPK signaling
RPL35,Viral mRNA Translation
MAN1B1,Maturation of spike protein
MAN1B1,Translation of Structural Proteins
MAN1B1,Late SARS-CoV-2 Infection Events
HRH3,Amine ligand-binding receptors
SNF8,HCMV Infection
SNF8,HCMV Late Events
TUBA3E,RHO GTPases activate IQGAPs
TUBA3E,RHO GTPases Activate Formins
TUBA3E,HCMV Infection
TUBA3E,HCMV Early Events
RDH13,Signaling by Retinoic Acid
RDH13,RA biosynthesis pathway
IL17F,SARS-CoV-2 activates/modulates innate and adaptive immune responses
STX1B,Neurotoxicity of clostridium toxins
STX1B,Uptake and actions of bacterial toxins
STX1B,Bacterial Infection Pathways
CHRM1,Amine ligand-binding receptors
MGAT4B,Maturation of spike protein
MGAT4B,Translation of Structural Proteins
MGAT4B,Late SARS-CoV-2 Infection Events
CHRM2,Amine ligand-binding receptors
MED8,Respiratory Syncytial Virus Infection Pathway
MED8,RSV-host interactions
ADCY7,Opioid Signalling
ADCY7,PKA-mediated phosphorylation of CREB
ADCY7,Calmodulin induced events
ADCY7,Ca-dependent events
ADCY7,CaM pathway
ADCY7,G-protein mediated events
ADCY7,PLC beta mediated events
ADCY7,DAG and IP3 signaling
ADCY7,PKA activation
ADCY7,Adenylate cyclase activating pathway
ADCY7,Adenylate cyclase inhibitory pathway
ADCY7,G alpha (s) signalling events
ADCY7,G alpha (z) signalling events
ADCY7,Hedgehog 'off' state
ADCY7,GPER1 signaling
ADCY7,ADORA2B mediated anti-inflammatory cytokines production
ADCY7,Anti-inflammatory response favouring Leishmania parasite infection
ADCY7,FCGR3A-mediated IL10 synthesis
ADCY7,Leishmania parasite growth and survival
CHRM3,Amine ligand-binding receptors
VPS45,SARS-CoV-2 modulates autophagy
CHRM4,Amine ligand-binding receptors
STK38,RHOBTB2 GTPase cycle
STK38,RHOBTB1 GTPase cycle
STK38,RHOBTB GTPase Cycle
CHRM5,Amine ligand-binding receptors
MGLL,Effects of PIP2 hydrolysis
TUBA3D,Hedgehog 'off' state
TUBA3D,RHO GTPases activate IQGAPs
TUBA3D,RHO GTPases Activate Formins
TUBA3D,HCMV Infection
TUBA3D,HCMV Early Events
DTX2,Signaling by NOTCH1
DTX2,Activated NOTCH1 Transmits Signal to the Nucleus
ADCY8,Opioid Signalling
ADCY8,PKA-mediated phosphorylation of CREB
ADCY8,Calmodulin induced events
ADCY8,Ca-dependent events
ADCY8,CaM pathway
ADCY8,G-protein mediated events
ADCY8,PLC beta mediated events
ADCY8,DAG and IP3 signaling
ADCY8,PKA activation
ADCY8,Adenylate cyclase activating pathway
ADCY8,Adenylate cyclase inhibitory pathway
ADCY8,G alpha (s) signalling events
ADCY8,G alpha (z) signalling events
ADCY8,Hedgehog 'off' state
ADCY8,GPER1 signaling
ADCY8,ADORA2B mediated anti-inflammatory cytokines production
ADCY8,Anti-inflammatory response favouring Leishmania parasite infection
ADCY8,FCGR3A-mediated IL10 synthesis
ADCY8,Leishmania parasite growth and survival
UCN3,Class B/2 (Secretin family receptors)
NLRP3,Purinergic signaling in leishmaniasis infection
NLRP3,Cell recruitment (pro-inflammatory response)
NLRP3,SARS-CoV-1-host interactions
NLRP3,SARS-CoV-1 activates/modulates innate immune responses
NLRP3,SARS-CoV-2 activates/modulates innate and adaptive immune responses
CHUK,AKT phosphorylates targets in the cytosol
CHUK,PI3K/AKT Signaling in Cancer
CHUK,Diseases of Immune System
CHUK,Regulation of TNFR1 signaling
CHUK,TNFR1-induced NF-kappa-B signaling pathway
CHUK,Diseases associated with the TLR signaling cascade
CHUK,Constitutive Signaling by AKT1 E17K in Cancer
CHUK,TNF signaling
CHUK,SARS-CoV-2 activates/modulates innate and adaptive immune responses
FMNL2,RHO GTPases Activate Formins
FMNL2,RHOC GTPase cycle
OSBPL11,RHOH GTPase cycle
ADCY9,Opioid Signalling
ADCY9,PKA-mediated phosphorylation of CREB
ADCY9,Calmodulin induced events
ADCY9,Ca-dependent events
ADCY9,CaM pathway
ADCY9,G-protein mediated events
ADCY9,PLC beta mediated events
ADCY9,DAG and IP3 signaling
ADCY9,PKA activation
ADCY9,Adenylate cyclase activating pathway
ADCY9,Adenylate cyclase inhibitory pathway
ADCY9,G alpha (s) signalling events
ADCY9,G alpha (z) signalling events
ADCY9,Hedgehog 'off' state
ADCY9,GPER1 signaling
ADCY9,ADORA2B mediated anti-inflammatory cytokines production
ADCY9,Anti-inflammatory response favouring Leishmania parasite infection
ADCY9,FCGR3A-mediated IL10 synthesis
ADCY9,Leishmania parasite growth and survival
CKB,RND3 GTPase cycle
ARHGAP33,RHOQ GTPase cycle
NUS1,Diseases of glycosylation
NUS1,Diseases of metabolism
RPL39L,Viral mRNA Translation
ARAP2,RHOA GTPase cycle
ARAP2,RAC3 GTPase cycle
ARAP1,Signaling by PTK6
ARAP1,RHOA GTPase cycle
ARAP1,Signaling by Non-Receptor Tyrosine Kinases
ADCYAP1R1,Signaling by NTRK1 (TRKA)
ADCYAP1R1,Class B/2 (Secretin family receptors)
ADCYAP1R1,G alpha (s) signalling events
ADCYAP1R1,Glucagon-type ligand receptors
THEM4,PI3K Cascade
THEM4,IRS-mediated signalling
THEM4,Signaling by VEGF
THEM4,Negative regulation of the PI3K/AKT network
THEM4,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
THEM4,IGF1R signaling cascade
THEM4,IRS-related events triggered by IGF1R
THEM4,VEGFA-VEGFR2 Pathway
THEM4,VEGFR2 mediated vascular permeability
THEM4,Insulin receptor signalling cascade
THEM4,Signaling by Insulin receptor
AP2M1,Host Interactions of HIV factors
AP2M1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP2M1,The role of Nef in HIV-1 replication and disease pathogenesis
AP2M1,Retrograde neurotrophin signalling
AP2M1,Signaling by NTRK1 (TRKA)
AP2M1,PCP/CE pathway
AP2M1,WNT5A-dependent internalization of FZD4
AP2M1,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
AP2M1,Potential therapeutics for SARS
AP1S1,Host Interactions of HIV factors
AP1S1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP1S1,The role of Nef in HIV-1 replication and disease pathogenesis
AP2S1,Host Interactions of HIV factors
AP2S1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP2S1,The role of Nef in HIV-1 replication and disease pathogenesis
AP2S1,Retrograde neurotrophin signalling
AP2S1,Signaling by NTRK1 (TRKA)
AP2S1,PCP/CE pathway
AP2S1,WNT5A-dependent internalization of FZD4
AP2S1,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
AP2S1,Potential therapeutics for SARS
MUCL1,Diseases of glycosylation
MUCL1,Diseases associated with O-glycosylation of proteins
MUCL1,Defective GALNT3 causes HFTC
MUCL1,Defective GALNT12 causes CRCS1
MUCL1,Diseases of metabolism
ANAPC16,Diseases of mitotic cell cycle
ANAPC16,Aberrant regulation of mitotic exit in cancer due to RB1 defects
ANAPC16,Aberrant regulation of mitotic cell cycle due to RB1 defects
LRRK2,Signaling by PTK6
LRRK2,Signaling by Non-Receptor Tyrosine Kinases
CLTA,Retrograde neurotrophin signalling
CLTA,Signaling by NTRK1 (TRKA)
CLTA,PCP/CE pathway
CLTA,WNT5A-dependent internalization of FZD4
CLTA,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
CLTB,PCP/CE pathway
CLTB,WNT5A-dependent internalization of FZD4
CLTB,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
CLTC,Retrograde neurotrophin signalling
CLTC,Signaling by NTRK1 (TRKA)
CLTC,PCP/CE pathway
CLTC,WNT5A-dependent internalization of FZD4
CLTC,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
CLTC,RHOU GTPase cycle
CLTC,RHOV GTPase cycle
CMA1,Signaling by SCF-KIT
FGD4,NRAGE signals death through JNK
FGD4,p75 NTR receptor-mediated signalling
FGD4,"Cell death signalling via NRAGE, NRIF and NADE"
FGD4,G alpha (12/13) signalling events
ANO4,Induction of Cell-Cell Fusion
ANO4,Late SARS-CoV-2 Infection Events
CCR1,Peptide ligand-binding receptors
CCR1,Chemokine receptors bind chemokines
LEO1,Formation of the beta-catenin:TCF transactivating complex
CCR3,Peptide ligand-binding receptors
CCR3,Chemokine receptors bind chemokines
CCR4,Peptide ligand-binding receptors
CCR4,Chemokine receptors bind chemokines
CCR5,Early Phase of HIV Life Cycle
CCR5,Peptide ligand-binding receptors
CCR5,Chemokine receptors bind chemokines
CCR6,Peptide ligand-binding receptors
CCR6,Chemokine receptors bind chemokines
CCR7,Peptide ligand-binding receptors
CCR7,Chemokine receptors bind chemokines
CCR8,Peptide ligand-binding receptors
CCR8,Chemokine receptors bind chemokines
WHAMM,RHOD GTPase cycle
ADH1A,Signaling by Retinoic Acid
ADH1A,RA biosynthesis pathway
NOXO1,RHO GTPases Activate NADPH Oxidases
NOXO1,RAC3 GTPase cycle
LTB4R,Eicosanoid ligand-binding receptors
MSI2,RHOBTB2 GTPase cycle
MSI2,RHOBTB GTPase Cycle
ADH1C,Signaling by Retinoic Acid
ADH1C,RA biosynthesis pathway
ADH4,Signaling by Retinoic Acid
ADH4,RA biosynthesis pathway
ATP6V1G3,Signaling by Insulin receptor
ATP6V1G3,Insulin receptor recycling
CNTN1,Signaling by NOTCH1
CNTN1,Signaling by NOTCH2
CNTN1,Activated NOTCH1 Transmits Signal to the Nucleus
CNTN1,NOTCH2 Activation and Transmission of Signal to the Nucleus
COL1A1,Signaling by MET
COL1A1,MET activates PTK2 signaling
COL1A1,MET promotes cell motility
COL1A2,Signaling by MET
COL1A2,MET activates PTK2 signaling
COL1A2,MET promotes cell motility
SYT2,Neurotoxicity of clostridium toxins
SYT2,Uptake and actions of bacterial toxins
SYT2,Bacterial Infection Pathways
UHMK1,Extra-nuclear estrogen signaling
UHMK1,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
COL3A1,Signaling by PDGF
COL3A1,Signaling by MET
COL3A1,MET activates PTK2 signaling
COL3A1,MET promotes cell motility
IQGAP3,RHO GTPases activate IQGAPs
IQGAP3,RHOA GTPase cycle
IQGAP3,RHOB GTPase cycle
IQGAP3,RHOC GTPase cycle
IQGAP3,RHOQ GTPase cycle
IQGAP3,RHOJ GTPase cycle
ARHGEF19,NRAGE signals death through JNK
ARHGEF19,p75 NTR receptor-mediated signalling
ARHGEF19,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF19,G alpha (12/13) signalling events
ARHGEF19,RHOA GTPase cycle
CHMP4B,Budding and maturation of HIV virion
CHMP4B,HCMV Infection
CHMP4B,HCMV Late Events
CHMP4B,Translation of Replicase and Assembly of the Replication Transcription Complex
CHMP4B,Early SARS-CoV-2 Infection Events
COL6A1,Signaling by PDGF
COL6A2,Signaling by PDGF
NUP35,Host Interactions of HIV factors
NUP35,Rev-mediated nuclear export of HIV RNA
NUP35,Transport of Ribonucleoproteins into the Host Nucleus
NUP35,Export of Viral Ribonucleoproteins from Nucleus
NUP35,NS1 Mediated Effects on Host Pathways
NUP35,Viral Messenger RNA Synthesis
NUP35,NEP/NS2 Interacts with the Cellular Export Machinery
NUP35,Interactions of Vpr with host cellular proteins
NUP35,Interactions of Rev with host cellular proteins
NUP35,Nuclear import of Rev protein
NUP35,Vpr-mediated nuclear import of PICs
NUP35,SLC transporter disorders
NUP35,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP35,Disorders of transmembrane transporters
NUP35,HCMV Infection
NUP35,HCMV Early Events
NUP35,HCMV Late Events
NUP35,SARS-CoV-2 activates/modulates innate and adaptive immune responses
COL9A1,Signaling by PDGF
COL9A2,Signaling by PDGF
COL9A3,Signaling by PDGF
AP1S3,Host Interactions of HIV factors
AP1S3,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP1S3,The role of Nef in HIV-1 replication and disease pathogenesis
ACVR1C,Signaling by Activin
COMT,Potential therapeutics for SARS
COL6A6,Signaling by PDGF
EVC2,Hedgehog 'on' state
EVC2,Activation of SMO
ADORA1,Nucleotide-like (purinergic) receptors
TAAR9,Amine ligand-binding receptors
TAAR9,G alpha (s) signalling events
TAAR1,Amine ligand-binding receptors
TAAR1,G alpha (s) signalling events
ADORA2A,Signaling by NTRK1 (TRKA)
ADORA2A,Nucleotide-like (purinergic) receptors
ADORA2A,G alpha (s) signalling events
CP,SLC transporter disorders
CP,Disorders of transmembrane transporters
ADORA2B,Nucleotide-like (purinergic) receptors
ADORA2B,G alpha (s) signalling events
ADORA2B,ADORA2B mediated anti-inflammatory cytokines production
ADORA2B,Anti-inflammatory response favouring Leishmania parasite infection
ADORA2B,Leishmania parasite growth and survival
CPD,RND3 GTPase cycle
CPD,RND1 GTPase cycle
VPS37A,Budding and maturation of HIV virion
VPS37A,Assembly Of The HIV Virion
VPS37A,HCMV Infection
VPS37A,HCMV Late Events
TAF1L,HIV Transcription Initiation
TAF1L,RNA Polymerase II HIV Promoter Escape
TAF1L,Transcription of the HIV genome
CREB1,Opioid Signalling
CREB1,PKA-mediated phosphorylation of CREB
CREB1,CaMK IV-mediated phosphorylation of CREB
CREB1,Calmodulin induced events
CREB1,Ca-dependent events
CREB1,CaM pathway
CREB1,G-protein mediated events
CREB1,PLC beta mediated events
CREB1,DAG and IP3 signaling
CREB1,Signaling by NTRK1 (TRKA)
CREB1,Nuclear Events (kinase and transcription factor activation)
CREB1,PI3K/AKT Signaling in Cancer
CREB1,Constitutive Signaling by AKT1 E17K in Cancer
CREB1,Extra-nuclear estrogen signaling
CREB1,NGF-stimulated transcription
CREB1,HCMV Infection
CREB1,HCMV Early Events
CREB1,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
CREB1,ADORA2B mediated anti-inflammatory cytokines production
CREB1,Anti-inflammatory response favouring Leishmania parasite infection
CREB1,FCGR3A-mediated IL10 synthesis
CREB1,Leishmania parasite growth and survival
CREBBP,Pre-NOTCH Transcription and Translation
CREBBP,Pre-NOTCH Expression and Processing
CREBBP,Signaling by NOTCH1
CREBBP,Formation of the beta-catenin:TCF transactivating complex
CREBBP,NOTCH1 Intracellular Domain Regulates Transcription
CREBBP,Signaling by NOTCH1 PEST Domain Mutants in Cancer
CREBBP,Signaling by NOTCH1 in Cancer
CREBBP,Constitutive Signaling by NOTCH1 PEST Domain Mutants
CREBBP,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
CREBBP,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
CREBBP,Signaling by NOTCH3
CREBBP,NOTCH3 Intracellular Domain Regulates Transcription
CREBBP,Signaling by NOTCH4
CREBBP,NOTCH4 Intracellular Domain Regulates Transcription
CREBBP,Estrogen-dependent gene expression
CREBBP,SARS-CoV-2 activates/modulates innate and adaptive immune responses
CREBBP,Respiratory Syncytial Virus Infection Pathway
CREBBP,Evasion by RSV of host interferon responses
CREBBP,RSV-host interactions
DGKK,Effects of PIP2 hydrolysis
CRH,Class B/2 (Secretin family receptors)
CRH,G alpha (s) signalling events
CRHBP,Class B/2 (Secretin family receptors)
CRK,Prolonged ERK activation events
CRK,Downstream signal transduction
CRK,Signaling by PDGF
CRK,Signaling by NTRK1 (TRKA)
CRK,Signalling to ERKs
CRK,Signaling by VEGF
CRK,Integrin signaling
CRK,p130Cas linkage to MAPK signaling for integrins
CRK,VEGFA-VEGFR2 Pathway
CRK,Signaling by MET
CRK,Signaling by PTK6
CRK,MET promotes cell motility
CRK,Signaling by Non-Receptor Tyrosine Kinases
CRK,Parasite infection
CRK,Leishmania phagocytosis
CRK,FCGR3A-mediated phagocytosis
CRKL,Prolonged ERK activation events
CRKL,Frs2-mediated activation
CRKL,Downstream signal transduction
CRKL,Signaling by PDGF
CRKL,Signaling by NTRK1 (TRKA)
CRKL,Signalling to ERKs
CRKL,Signaling by MET
CRKL,MET promotes cell motility
CRKL,Signaling by Erythropoietin
AAMP,Signaling by EGFR
AAMP,Signaling by VEGF
ADORA3,Nucleotide-like (purinergic) receptors
RPS4Y2,Viral mRNA Translation
RPS4Y2,SARS-CoV-1-host interactions
RPS4Y2,SARS-CoV-1 modulates host translation machinery
RPS4Y2,SARS-CoV-2 modulates host translation machinery
MUC17,Diseases of glycosylation
MUC17,Diseases associated with O-glycosylation of proteins
MUC17,Defective GALNT3 causes HFTC
MUC17,Defective GALNT12 causes CRCS1
MUC17,Diseases of metabolism
DYNLL2,RHO GTPases Activate Formins
DYNLL2,HCMV Infection
DYNLL2,HCMV Early Events
RPL10L,Viral mRNA Translation
PARP1,Signaling by TGF-beta Receptor Complex
PARP1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
PARP1,Downregulation of SMAD2/3:SMAD4 transcriptional activity
MIB2,Signaling by NOTCH1
MIB2,Signaling by NOTCH2
MIB2,Activated NOTCH1 Transmits Signal to the Nucleus
MIB2,Signaling by NOTCH1 PEST Domain Mutants in Cancer
MIB2,Signaling by NOTCH1 in Cancer
MIB2,Constitutive Signaling by NOTCH1 PEST Domain Mutants
MIB2,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
MIB2,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MIB2,NOTCH2 Activation and Transmission of Signal to the Nucleus
MIB2,TNFR1-induced proapoptotic signaling
MIB2,Regulation of TNFR1 signaling
MIB2,TNF signaling
MIB2,Signaling by NOTCH3
MIB2,NOTCH3 Activation and Transmission of Signal to the Nucleus
PARP4,Maturation of nucleoprotein
PARP4,Translation of Structural Proteins
PARP4,Late SARS-CoV-2 Infection Events
MPP7,RAC2 GTPase cycle
MPP7,RHOQ GTPase cycle
MPP7,RHOG GTPase cycle
MPP7,RHOJ GTPase cycle
MPP7,RAC3 GTPase cycle
MAPK14,Signalling to RAS
MAPK14,Signaling by NTRK1 (TRKA)
MAPK14,Signalling to ERKs
MAPK14,Signaling by VEGF
MAPK14,VEGFA-VEGFR2 Pathway
FGFBP3,Signaling by FGFR
FGFBP3,FGFR2 ligand binding and activation
FGFBP3,Signaling by FGFR2
MUC15,Diseases of glycosylation
MUC15,Diseases associated with O-glycosylation of proteins
MUC15,Defective GALNT3 causes HFTC
MUC15,Defective GALNT12 causes CRCS1
MUC15,Diseases of metabolism
CSF2RA,Diseases of metabolism
ARHGAP42,RHOA GTPase cycle
ARHGAP42,RAC2 GTPase cycle
ARHGAP42,RAC3 GTPase cycle
CSF2RB,Diseases of metabolism
PRICKLE1,PCP/CE pathway
PRICKLE1,Asymmetric localization of PCP proteins
CPNE8,RHOD GTPase cycle
CPNE8,RHOQ GTPase cycle
CPNE8,RHOJ GTPase cycle
CSK,Signaling by EGFR
CSK,Integrin signaling
CSK,MAP2K and MAPK activation
CSK,Signaling by moderate kinase activity BRAF mutants
CSK,Signaling by high-kinase activity BRAF mutants
CSK,Signaling by RAS mutants
CSK,Signaling by BRAF and RAF1 fusions
CSK,Paradoxical activation of RAF signaling by kinase inactive BRAF
CSK,Oncogenic MAPK signaling
CSK,RHOH GTPase cycle
CSK,Signaling downstream of RAS mutants
CSK,Signaling by RAF1 mutants
CSN2,Signaling by ERBB4
CSN2,Nuclear signaling by ERBB4
RAD9B,Diseases of DNA repair
RAD9B,Diseases of DNA Double-Strand Break Repair
RAD9B,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RAD9B,Impaired BRCA2 binding to RAD51
CSNK1A1,Degradation of beta-catenin by the destruction complex
CSNK1A1,Beta-catenin phosphorylation cascade
CSNK1A1,Disassembly of the destruction complex and recruitment of AXIN to the membrane
CSNK1A1,Signaling by WNT in cancer
CSNK1A1,Signaling by AXIN mutants
CSNK1A1,Signaling by CTNNB1 phospho-site mutants
CSNK1A1,Signaling by APC mutants
CSNK1A1,Signaling by AMER1 mutants
CSNK1A1,Signaling by GSK3beta mutants
CSNK1A1,CTNNB1 S33 mutants aren't phosphorylated
CSNK1A1,CTNNB1 S37 mutants aren't phosphorylated
CSNK1A1,CTNNB1 S45 mutants aren't phosphorylated
CSNK1A1,CTNNB1 T41 mutants aren't phosphorylated
CSNK1A1,APC truncation mutants have impaired AXIN binding
CSNK1A1,AXIN missense mutants destabilize the destruction complex
CSNK1A1,Truncations of AMER1 destabilize the destruction complex
CSNK1A1,Degradation of GLI2 by the proteasome
CSNK1A1,GLI3 is processed to GLI3R by the proteasome
CSNK1A1,Hedgehog 'off' state
CSNK1A1,Hedgehog 'on' state
CSNK1A1,Activation of SMO
CSNK1A1,Maturation of nucleoprotein
CSNK1A1,Translation of Structural Proteins
CSNK1A1,Late SARS-CoV-2 Infection Events
CSNK1G2,Disassembly of the destruction complex and recruitment of AXIN to the membrane
CSNK2A1,Regulation of PTEN stability and activity
CSNK2A1,Respiratory Syncytial Virus Infection Pathway
CSNK2A1,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
CSNK2A1,Maturation of hRSV A proteins
CSNK2A2,Regulation of PTEN stability and activity
CSNK2A2,Respiratory Syncytial Virus Infection Pathway
CSNK2A2,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
CSNK2A2,Maturation of hRSV A proteins
NRG4,Signaling by ERBB2
NRG4,Signaling by ERBB2 in Cancer
NRG4,Signaling by ERBB4
NRG4,Nuclear signaling by ERBB4
NRG4,Negative regulation of the PI3K/AKT network
NRG4,PI3K/AKT Signaling in Cancer
NRG4,Constitutive Signaling by Aberrant PI3K in Cancer
NRG4,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
NRG4,Signaling by PTK6
NRG4,Downregulation of ERBB2 signaling
NRG4,Signaling by Non-Receptor Tyrosine Kinases
NRG4,Signaling by ERBB2 KD Mutants
NRG4,Signaling by ERBB2 TMD/JMD mutants
ADRA1D,Amine ligand-binding receptors
ADRA1D,G alpha (12/13) signalling events
CSNK2B,Regulation of PTEN stability and activity
CSNK2B,Respiratory Syncytial Virus Infection Pathway
CSNK2B,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
CSNK2B,Maturation of hRSV A proteins
PIK3R6,G beta:gamma signalling through PI3Kgamma
PIK3R6,G-protein beta:gamma signalling
ADRA1B,Amine ligand-binding receptors
ADRA1B,G alpha (12/13) signalling events
NOTUM,Hedgehog ligand biogenesis
WIPF2,RHO GTPases Activate WASPs and WAVEs
WIPF2,RHOJ GTPase cycle
WIPF2,Parasite infection
WIPF2,Leishmania phagocytosis
WIPF2,FCGR3A-mediated phagocytosis
KLC3,RHO GTPases activate KTN1
ADRA1A,Amine ligand-binding receptors
ADRA1A,G alpha (12/13) signalling events
TICAM1,Diseases of Immune System
TICAM1,Diseases associated with the TLR signaling cascade
CDC42EP5,MAPK6/MAPK4 signaling
CTBP1,Degradation of beta-catenin by the destruction complex
CTBP1,Deactivation of the beta-catenin transactivating complex
CTBP1,Repression of WNT target genes
CTBP1,Signaling by WNT in cancer
CTBP2,Degradation of beta-catenin by the destruction complex
CTBP2,Repression of WNT target genes
CTBP2,Signaling by WNT in cancer
CTNNA1,Signaling by VEGF
CTNNA1,VEGFA-VEGFR2 Pathway
CTNNA1,VEGFR2 mediated vascular permeability
CTNNA1,RHO GTPases activate IQGAPs
CTNNB1,Signaling by VEGF
CTNNB1,Degradation of beta-catenin by the destruction complex
CTNNB1,Beta-catenin phosphorylation cascade
CTNNB1,Formation of the beta-catenin:TCF transactivating complex
CTNNB1,Deactivation of the beta-catenin transactivating complex
CTNNB1,Ca2+ pathway
CTNNB1,VEGFA-VEGFR2 Pathway
CTNNB1,Disassembly of the destruction complex and recruitment of AXIN to the membrane
CTNNB1,VEGFR2 mediated vascular permeability
CTNNB1,RHO GTPases activate IQGAPs
CTNNB1,Listeria monocytogenes entry into host cells
CTNNB1,Bacterial Infection Pathways
ADRA2A,Amine ligand-binding receptors
ADRA2A,G alpha (z) signalling events
CTNND1,Signaling by VEGF
CTNND1,VEGFA-VEGFR2 Pathway
CTNND1,VEGFR2 mediated vascular permeability
CTNND1,Listeria monocytogenes entry into host cells
CTNND1,Bacterial Infection Pathways
ADRA2B,Amine ligand-binding receptors
ADRA2B,G alpha (z) signalling events
CTSG,Infection with Mycobacterium tuberculosis
CTSG,Response of Mtb to phagocytosis
CTSG,Purinergic signaling in leishmaniasis infection
CTSG,Cell recruitment (pro-inflammatory response)
CTSG,Bacterial Infection Pathways
ADRA2C,Amine ligand-binding receptors
ADRA2C,G alpha (z) signalling events
CX3CR1,Peptide ligand-binding receptors
CX3CR1,Chemokine receptors bind chemokines
CX3CR1,Respiratory Syncytial Virus Infection Pathway
CX3CR1,RSV-host interactions
PAQR3,Negative regulation of MAPK pathway
KLB,PI3K Cascade
KLB,IRS-mediated signalling
KLB,Signaling by FGFR
KLB,FGFR4 ligand binding and activation
KLB,Negative regulation of the PI3K/AKT network
KLB,PI3K/AKT Signaling in Cancer
KLB,Constitutive Signaling by Aberrant PI3K in Cancer
KLB,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
KLB,IGF1R signaling cascade
KLB,IRS-related events triggered by IGF1R
KLB,Phospholipase C-mediated cascade; FGFR4
KLB,FRS-mediated FGFR4 signaling
KLB,Downstream signaling of activated FGFR4
KLB,SHC-mediated cascade:FGFR4
KLB,PI-3K cascade:FGFR4
KLB,Negative regulation of FGFR4 signaling
KLB,Signaling by FGFR4
KLB,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
KLB,Insulin receptor signalling cascade
KLB,Signaling by Insulin receptor
ADRB1,Amine ligand-binding receptors
ADRB1,G alpha (s) signalling events
DAB2IP,Regulation of RAS by GAPs
SLC38A9,MTOR signalling
SLC38A9,mTORC1-mediated signalling
SLC38A9,Energy dependent regulation of mTOR by LKB1-AMPK
SLC38A9,Regulation of PTEN gene transcription
CYBA,Signaling by VEGF
CYBA,VEGFA-VEGFR2 Pathway
CYBA,RHO GTPases Activate NADPH Oxidases
CYBA,RAC2 GTPase cycle
CYBA,RAC3 GTPase cycle
CYBB,Signaling by VEGF
CYBB,VEGFA-VEGFR2 Pathway
CYBB,RHO GTPases Activate NADPH Oxidases
CYBB,RAC2 GTPase cycle
CYBB,RAC3 GTPase cycle
ADRB2,Amine ligand-binding receptors
ADRB2,G alpha (s) signalling events
CYLD,TNFR1-induced proapoptotic signaling
CYLD,Regulation of TNFR1 signaling
CYLD,TNFR1-induced NF-kappa-B signaling pathway
CYLD,TNF signaling
AMOTL1,Signaling by Hippo
ADRB3,Amine ligand-binding receptors
ADRB3,G alpha (s) signalling events
ATP6V0E2,Signaling by Insulin receptor
ATP6V0E2,Insulin receptor recycling
VPS37D,Budding and maturation of HIV virion
VPS37D,Assembly Of The HIV Virion
VPS37D,HCMV Infection
VPS37D,HCMV Late Events
RDH10,Signaling by Retinoic Acid
RDH10,RA biosynthesis pathway
FAM91A1,RHOH GTPase cycle
MOSPD2,RHOD GTPase cycle
CYP26A1,Signaling by Retinoic Acid
CYP26A1,RA biosynthesis pathway
AP2A1,Host Interactions of HIV factors
AP2A1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP2A1,The role of Nef in HIV-1 replication and disease pathogenesis
AP2A1,Retrograde neurotrophin signalling
AP2A1,Signaling by NTRK1 (TRKA)
AP2A1,PCP/CE pathway
AP2A1,WNT5A-dependent internalization of FZD4
AP2A1,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
AP2A1,Potential therapeutics for SARS
DAD1,Maturation of spike protein
DAD1,Translation of Structural Proteins
DAD1,Late SARS-CoV-2 Infection Events
CD55,Class B/2 (Secretin family receptors)
DGKA,Effects of PIP2 hydrolysis
DGKB,Effects of PIP2 hydrolysis
DGKG,Effects of PIP2 hydrolysis
DGKH,Effects of PIP2 hydrolysis
DGKQ,Effects of PIP2 hydrolysis
DAXX,HCMV Infection
DAXX,HCMV Early Events
DAXX,Diseases of mitotic cell cycle
SPRED1,Signaling by FGFR
SPRED1,Signaling by FGFR1
SPRED1,Regulation of RAS by GAPs
SPRED1,Oncogenic MAPK signaling
AP1B1,Host Interactions of HIV factors
AP1B1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP1B1,The role of Nef in HIV-1 replication and disease pathogenesis
DBN1,RHOD GTPase cycle
DBN1,RHOH GTPase cycle
DBN1,RHOBTB2 GTPase cycle
DBN1,RHOBTB1 GTPase cycle
DBN1,RHOBTB GTPase Cycle
DBT,RHOH GTPase cycle
AP2B1,Host Interactions of HIV factors
AP2B1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP2B1,The role of Nef in HIV-1 replication and disease pathogenesis
AP2B1,Retrograde neurotrophin signalling
AP2B1,Signaling by NTRK1 (TRKA)
AP2B1,PCP/CE pathway
AP2B1,WNT5A-dependent internalization of FZD4
AP2B1,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
AP2B1,Potential therapeutics for SARS
AP1G1,Host Interactions of HIV factors
AP1G1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP1G1,The role of Nef in HIV-1 replication and disease pathogenesis
DDOST,Maturation of spike protein
DDOST,Translation of Structural Proteins
DDOST,Late SARS-CoV-2 Infection Events
OXER1,Eicosanoid ligand-binding receptors
DDX5,Estrogen-dependent gene expression
DDX5,Early SARS-CoV-2 Infection Events
MMAA,Diseases of metabolism
RHOV,RHOV GTPase cycle
PTCRA,Signaling by NOTCH3
PTCRA,NOTCH3 Intracellular Domain Regulates Transcription
DIAPH1,Signaling by ERBB2
DIAPH1,RHO GTPases Activate Formins
DIAPH1,RHOA GTPase cycle
DIAPH1,RHOB GTPase cycle
DIAPH1,RHOC GTPase cycle
DIAPH1,RHOD GTPase cycle
DIAPH1,RHOF GTPase cycle
DIAPH2,RHOF GTPase cycle
DLD,Signaling by Retinoic Acid
DLD,Diseases of metabolism
DLG4,Signaling by ERBB4
DLG4,RHO GTPases activate CIT
DNM1,Retrograde neurotrophin signalling
DNM1,Signaling by NTRK1 (TRKA)
DNA2,Diseases of DNA repair
DNA2,Diseases of DNA Double-Strand Break Repair
DNA2,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
DNA2,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
DNA2,Defective homologous recombination repair (HRR) due to PALB2 loss of function
DNA2,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
DNA2,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
DNA2,Impaired BRCA2 binding to RAD51
DNA2,Impaired BRCA2 binding to PALB2
DYNC1H1,RHO GTPases Activate Formins
DYNC1H1,HCMV Infection
DYNC1H1,HCMV Early Events
DYNC1I1,RHO GTPases Activate Formins
DYNC1I1,HCMV Infection
DYNC1I1,HCMV Early Events
DYNC1I2,RHO GTPases Activate Formins
DYNC1I2,HCMV Infection
DYNC1I2,HCMV Early Events
DYNC1LI2,RHO GTPases Activate Formins
DYNC1LI2,HCMV Infection
DYNC1LI2,HCMV Early Events
DNM2,Retrograde neurotrophin signalling
DNM2,Signaling by NTRK1 (TRKA)
DNM2,Nuclear Events (kinase and transcription factor activation)
DNM2,NGF-stimulated transcription
DNMT1,Signaling by ALK
DNMT1,Diseases of programmed cell death
DNMT1,Signaling by ALK in cancer
DNMT1,STAT3 nuclear events downstream of ALK signaling
DNMT1,Defective pyroptosis
DNMT1,Signaling by ALK fusions and activated point mutants
DNMT1,Nuclear events stimulated by ALK signaling in cancer
DNMT3A,Diseases of programmed cell death
DNMT3A,Defective pyroptosis
DNMT3B,Diseases of programmed cell death
DNMT3B,Defective pyroptosis
DOCK1,Signaling by VEGF
DOCK1,VEGFA-VEGFR2 Pathway
DOCK1,Signaling by PTK6
DOCK1,Signaling by Non-Receptor Tyrosine Kinases
DOCK1,RAC2 GTPase cycle
DOCK1,RHOG GTPase cycle
DOCK1,Parasite infection
DOCK1,Leishmania phagocytosis
DOCK1,FCGR3A-mediated phagocytosis
DOCK2,Host Interactions of HIV factors
DOCK2,The role of Nef in HIV-1 replication and disease pathogenesis
DOCK2,RHOA GTPase cycle
DOCK2,RAC2 GTPase cycle
DOCK2,RHOG GTPase cycle
DOCK3,Signaling by NTRK2 (TRKB)
DOCK3,RAC2 GTPase cycle
DOCK3,RHOG GTPase cycle
DOK1,Signaling by PTK6
DOK1,Signaling by Non-Receptor Tyrosine Kinases
DPEP1,Anti-inflammatory response favouring Leishmania parasite infection
DPEP1,Leishmania parasite growth and survival
DRD1,Amine ligand-binding receptors
DRD1,G alpha (s) signalling events
DRD2,Amine ligand-binding receptors
DRD3,Amine ligand-binding receptors
DRD4,Amine ligand-binding receptors
DRD5,Amine ligand-binding receptors
DRD5,G alpha (s) signalling events
JAG1,Signaling by NOTCH1
JAG1,Signaling by NOTCH2
JAG1,Activated NOTCH1 Transmits Signal to the Nucleus
JAG1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
JAG1,Signaling by NOTCH1 in Cancer
JAG1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
JAG1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
JAG1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
JAG1,NOTCH2 Activation and Transmission of Signal to the Nucleus
JAG1,Signaling by NOTCH3
JAG1,RAC3 GTPase cycle
JAG1,NOTCH3 Activation and Transmission of Signal to the Nucleus
JAG1,Signaling by NOTCH4
ATN1,Regulation of PTEN gene transcription
DSG1,RND3 GTPase cycle
DSG1,RND2 GTPase cycle
DSG2,RAC2 GTPase cycle
DSG2,RHOG GTPase cycle
DSG2,RAC3 GTPase cycle
DSP,RND3 GTPase cycle
DSP,RND1 GTPase cycle
DTX1,Signaling by NOTCH1
DTX1,Activated NOTCH1 Transmits Signal to the Nucleus
DUSP1,RAF-independent MAPK1/3 activation
DUSP1,Negative regulation of MAPK pathway
DUSP2,RAF-independent MAPK1/3 activation
DUSP2,Negative regulation of MAPK pathway
DUSP3,Signaling by NTRK1 (TRKA)
DUSP3,Nuclear Events (kinase and transcription factor activation)
DUSP3,ERK/MAPK targets
DUSP3,ERKs are inactivated
DUSP4,RAF-independent MAPK1/3 activation
DUSP4,Signaling by NTRK1 (TRKA)
DUSP4,Nuclear Events (kinase and transcription factor activation)
DUSP4,ERK/MAPK targets
DUSP4,ERKs are inactivated
DUSP4,Negative regulation of MAPK pathway
DUSP5,RAF-independent MAPK1/3 activation
DUSP5,Negative regulation of MAPK pathway
DUSP6,RAF-independent MAPK1/3 activation
DUSP6,Signaling by NTRK1 (TRKA)
DUSP6,Nuclear Events (kinase and transcription factor activation)
DUSP6,ERK/MAPK targets
DUSP6,ERKs are inactivated
DUSP6,Negative regulation of MAPK pathway
DUSP6,Oncogenic MAPK signaling
DUSP7,RAF-independent MAPK1/3 activation
DUSP7,Signaling by NTRK1 (TRKA)
DUSP7,Nuclear Events (kinase and transcription factor activation)
DUSP7,ERK/MAPK targets
DUSP7,ERKs are inactivated
DUSP7,Negative regulation of MAPK pathway
DUSP7,Oncogenic MAPK signaling
DUSP8,RAF-independent MAPK1/3 activation
DUSP8,Negative regulation of MAPK pathway
DUSP8,Oncogenic MAPK signaling
DUSP9,RAF-independent MAPK1/3 activation
DUSP9,Negative regulation of MAPK pathway
DUSP9,Oncogenic MAPK signaling
DVL1,Degradation of DVL
DVL2,Signaling by Hippo
DVL2,PCP/CE pathway
DVL2,Degradation of DVL
DVL2,WNT5A-dependent internalization of FZD4
DVL3,Degradation of DVL
E2F1,Pre-NOTCH Transcription and Translation
E2F1,Pre-NOTCH Expression and Processing
E2F1,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
E2F1,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
E2F1,Diseases of mitotic cell cycle
E2F1,Aberrant regulation of mitotic cell cycle due to RB1 defects
E2F2,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
E2F2,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
E2F2,Diseases of mitotic cell cycle
E2F2,Aberrant regulation of mitotic cell cycle due to RB1 defects
E2F3,Pre-NOTCH Transcription and Translation
E2F3,Pre-NOTCH Expression and Processing
E2F3,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
E2F3,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
E2F3,Diseases of mitotic cell cycle
E2F3,Aberrant regulation of mitotic cell cycle due to RB1 defects
E2F4,Signaling by TGF-beta Receptor Complex
E2F4,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
E2F4,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
E2F5,Signaling by TGF-beta Receptor Complex
E2F5,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
E2F5,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
ECT2,NRAGE signals death through JNK
ECT2,p75 NTR receptor-mediated signalling
ECT2,"Cell death signalling via NRAGE, NRIF and NADE"
ECT2,G alpha (12/13) signalling events
ECT2,RHOA GTPase cycle
ECT2,RHOB GTPase cycle
ABCA1,NR1H2 and NR1H3-mediated signaling
ABCA1,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
S1PR1,Potential therapeutics for SARS
S1PR3,Extra-nuclear estrogen signaling
PHC1,Regulation of PTEN gene transcription
PHC2,Regulation of PTEN gene transcription
EEF1A1,SARS-CoV-1-host interactions
EEF1A1,SARS-CoV-1 modulates host translation machinery
EEF2,Uptake and actions of bacterial toxins
EEF2,Bacterial Infection Pathways
EGF,Signaling by ERBB2
EGF,Signaling by ERBB2 in Cancer
EGF,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
EGF,Signaling by ERBB4
EGF,Signaling by EGFR in Cancer
EGF,Signaling by EGFR
EGF,EGFR downregulation
EGF,Negative regulation of the PI3K/AKT network
EGF,PI3K/AKT Signaling in Cancer
EGF,Constitutive Signaling by Aberrant PI3K in Cancer
EGF,Constitutive Signaling by EGFRvIII
EGF,Signaling by EGFRvIII in Cancer
EGF,Signaling by Ligand-Responsive EGFR Variants in Cancer
EGF,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
EGF,Signaling by PTK6
EGF,Downregulation of ERBB2 signaling
EGF,Signaling by Non-Receptor Tyrosine Kinases
EGF,Extra-nuclear estrogen signaling
EGF,Signaling by NOTCH3
EGF,NOTCH3 Activation and Transmission of Signal to the Nucleus
EGF,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
EGF,Signaling by ERBB2 KD Mutants
EGF,Signaling by ERBB2 ECD mutants
EGF,Signaling by ERBB2 TMD/JMD mutants
EGFR,Signaling by ERBB2
EGFR,Signaling by ERBB2 in Cancer
EGFR,Signaling by ERBB4
EGFR,Signaling by EGFR in Cancer
EGFR,Signaling by EGFR
EGFR,Signaling by PTK6
EGFR,Signaling by Non-Receptor Tyrosine Kinases
EGFR,HCMV Infection
EGFR,HCMV Early Events
EGFR,Signaling by ERBB2 KD Mutants
EGFR,Signaling by ERBB2 ECD mutants
EGFR,Signaling by ERBB2 TMD/JMD mutants
EGFR,Respiratory Syncytial Virus Infection Pathway
EGR1,Signaling by NTRK1 (TRKA)
EGR1,Nuclear Events (kinase and transcription factor activation)
EGR1,Regulation of PTEN gene transcription
EGR1,NGF-stimulated transcription
EGR2,Signaling by NTRK1 (TRKA)
EGR2,Nuclear Events (kinase and transcription factor activation)
EGR2,NGF-stimulated transcription
EGR3,Signaling by NTRK1 (TRKA)
EGR3,Nuclear Events (kinase and transcription factor activation)
EGR3,NGF-stimulated transcription
EGR4,Signaling by NTRK1 (TRKA)
EGR4,Nuclear Events (kinase and transcription factor activation)
EGR4,NGF-stimulated transcription
ANO6,Induction of Cell-Cell Fusion
ANO6,Late SARS-CoV-2 Infection Events
ADCY4,Opioid Signalling
ADCY4,PKA-mediated phosphorylation of CREB
ADCY4,Calmodulin induced events
ADCY4,Ca-dependent events
ADCY4,CaM pathway
ADCY4,G-protein mediated events
ADCY4,PLC beta mediated events
ADCY4,DAG and IP3 signaling
ADCY4,PKA activation
ADCY4,Adenylate cyclase activating pathway
ADCY4,Adenylate cyclase inhibitory pathway
ADCY4,G alpha (s) signalling events
ADCY4,G alpha (z) signalling events
ADCY4,Hedgehog 'off' state
ADCY4,GPER1 signaling
ADCY4,ADORA2B mediated anti-inflammatory cytokines production
ADCY4,Anti-inflammatory response favouring Leishmania parasite infection
ADCY4,FCGR3A-mediated IL10 synthesis
ADCY4,Leishmania parasite growth and survival
EPHA2,RAC2 GTPase cycle
EPHA2,RHOG GTPase cycle
EPHA2,RHOU GTPase cycle
EPHA2,RAC3 GTPase cycle
EPHA2,RHOV GTPase cycle
EPHA2,RND3 GTPase cycle
EPHA2,RND2 GTPase cycle
EPHA2,RND1 GTPase cycle
MLKL,Diseases of programmed cell death
EIF4B,MTOR signalling
EIF4B,mTORC1-mediated signalling
EIF4E,MTOR signalling
EIF4E,mTORC1-mediated signalling
EIF4EBP1,MTOR signalling
EIF4EBP1,mTORC1-mediated signalling
EIF4G1,MTOR signalling
EIF4G1,mTORC1-mediated signalling
ELF3,Pre-NOTCH Transcription and Translation
ELF3,Pre-NOTCH Expression and Processing
ELK1,Signaling by NTRK1 (TRKA)
ELK1,Nuclear Events (kinase and transcription factor activation)
ELK1,ERK/MAPK targets
ELK1,Extra-nuclear estrogen signaling
ELK1,HCMV Infection
ELK1,HCMV Early Events
ELK1,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
SPRED2,Signaling by FGFR
SPRED2,Signaling by FGFR1
SPRED2,Regulation of RAS by GAPs
SPRED2,Oncogenic MAPK signaling
KCTD6,Estrogen-dependent gene expression
ARL13B,RHOQ GTPase cycle
ARL13B,RHOJ GTPase cycle
RPL22L1,Viral mRNA Translation
MUC20,Diseases of glycosylation
MUC20,Diseases associated with O-glycosylation of proteins
MUC20,Defective GALNT3 causes HFTC
MUC20,Defective GALNT12 causes CRCS1
MUC20,Diseases of metabolism
MUC20,Signaling by MET
EMD,RAC2 GTPase cycle
EMD,RHOD GTPase cycle
EMD,RHOG GTPase cycle
EMD,RAC3 GTPase cycle
CTTN,RHO GTPases activate PAKs
ENO1,Infection with Mycobacterium tuberculosis
ENO1,Response of Mtb to phagocytosis
ENO1,Bacterial Infection Pathways
KHDRBS2,Signaling by PTK6
KHDRBS2,Signaling by Non-Receptor Tyrosine Kinases
TUBB,Potential therapeutics for SARS
EP300,Signaling by TGF-beta Receptor Complex
EP300,Signaling by NTRK1 (TRKA)
EP300,Pre-NOTCH Transcription and Translation
EP300,Pre-NOTCH Expression and Processing
EP300,Signaling by NOTCH1
EP300,Signaling by NOTCH2
EP300,Nuclear Events (kinase and transcription factor activation)
EP300,Signaling by ALK
EP300,Formation of the beta-catenin:TCF transactivating complex
EP300,NOTCH1 Intracellular Domain Regulates Transcription
EP300,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
EP300,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
EP300,NOTCH2 intracellular domain regulates transcription
EP300,Signaling by NOTCH1 PEST Domain Mutants in Cancer
EP300,Signaling by NOTCH1 in Cancer
EP300,Constitutive Signaling by NOTCH1 PEST Domain Mutants
EP300,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
EP300,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
EP300,Signaling by NOTCH3
EP300,NOTCH3 Intracellular Domain Regulates Transcription
EP300,Signaling by NOTCH4
EP300,NOTCH4 Intracellular Domain Regulates Transcription
EP300,Estrogen-dependent gene expression
EP300,NR1H2 and NR1H3-mediated signaling
EP300,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
EP300,NGF-stimulated transcription
EP300,SARS-CoV-1-host interactions
EP300,STAT3 nuclear events downstream of ALK signaling
EP300,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
EP300,Respiratory Syncytial Virus Infection Pathway
EP300,Evasion by RSV of host interferon responses
EP300,RSV-host interactions
EP300,Signaling by TGFBR3
EP300,TGFBR3 expression
EPAS1,Signaling by PTK6
EPAS1,Signaling by Non-Receptor Tyrosine Kinases
ANO5,Induction of Cell-Cell Fusion
ANO5,Late SARS-CoV-2 Infection Events
STOM,RHOA GTPase cycle
STOM,RHOB GTPase cycle
STOM,RHOC GTPase cycle
STOM,RHOQ GTPase cycle
STOM,RHOH GTPase cycle
STOM,RHOJ GTPase cycle
EPO,Signaling by Erythropoietin
EPO,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
EPOR,Signaling by Erythropoietin
EPS15,Signaling by EGFR
EPS15,EGFR downregulation
EPS15,Signaling by MET
EPS15,Negative regulation of MET activity
EPS15,InlB-mediated entry of Listeria monocytogenes into host cell
EPS15,Listeria monocytogenes entry into host cells
EPS15,Bacterial Infection Pathways
ERBB2,Signaling by ERBB2
ERBB2,Signaling by ERBB2 in Cancer
ERBB2,Downregulation of ERBB2 signaling
ERCC2,Formation of HIV elongation complex in the absence of HIV Tat
ERCC2,Formation of the HIV-1 Early Elongation Complex
ERCC2,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
ERCC2,HIV Transcription Initiation
ERCC2,RNA Polymerase II HIV Promoter Escape
ERCC2,HIV Transcription Elongation
ERCC2,Transcription of the HIV genome
ERCC2,Formation of HIV-1 elongation complex containing HIV-1 Tat
ERCC2,Tat-mediated elongation of the HIV-1 transcript
AKT1,Signaling by VEGF
AKT1,Negative regulation of the PI3K/AKT network
AKT1,PI3K/AKT Signaling in Cancer
AKT1,G beta:gamma signalling through PI3Kgamma
AKT1,G-protein beta:gamma signalling
AKT1,VEGFA-VEGFR2 Pathway
AKT1,VEGFR2 mediated vascular permeability
AKT1,Constitutive Signaling by AKT1 E17K in Cancer
AKT1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
AKT1,Signaling by PTK6
AKT1,Signaling by Non-Receptor Tyrosine Kinases
ERCC3,Formation of HIV elongation complex in the absence of HIV Tat
ERCC3,Formation of the HIV-1 Early Elongation Complex
ERCC3,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
ERCC3,HIV Transcription Initiation
ERCC3,RNA Polymerase II HIV Promoter Escape
ERCC3,HIV Transcription Elongation
ERCC3,Transcription of the HIV genome
ERCC3,Formation of HIV-1 elongation complex containing HIV-1 Tat
ERCC3,Tat-mediated elongation of the HIV-1 transcript
AKT2,PI3K Cascade
AKT2,IRS-mediated signalling
AKT2,Signaling by VEGF
AKT2,Negative regulation of the PI3K/AKT network
AKT2,PI3K/AKT Signaling in Cancer
AKT2,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
AKT2,IGF1R signaling cascade
AKT2,IRS-related events triggered by IGF1R
AKT2,G beta:gamma signalling through PI3Kgamma
AKT2,G-protein beta:gamma signalling
AKT2,VEGFA-VEGFR2 Pathway
AKT2,VEGFR2 mediated vascular permeability
AKT2,Constitutive Signaling by AKT1 E17K in Cancer
AKT2,Insulin receptor signalling cascade
AKT2,Signaling by Insulin receptor
ESR1,Signaling by ERBB4
ESR1,Nuclear signaling by ERBB4
ESR1,Negative regulation of the PI3K/AKT network
ESR1,PI3K/AKT Signaling in Cancer
ESR1,Constitutive Signaling by Aberrant PI3K in Cancer
ESR1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
ESR1,Extra-nuclear estrogen signaling
ESR1,Estrogen-dependent gene expression
ESR2,Negative regulation of the PI3K/AKT network
ESR2,PI3K/AKT Signaling in Cancer
ESR2,Constitutive Signaling by Aberrant PI3K in Cancer
ESR2,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
ESR2,Extra-nuclear estrogen signaling
ETV4,MAPK6/MAPK4 signaling
EVC,Hedgehog 'on' state
EVC,Activation of SMO
MECOM,Regulation of PTEN gene transcription
EXT1,Diseases of glycosylation
EXT1,Diseases of metabolism
EXT2,Diseases of glycosylation
EXT2,Diseases of metabolism
EZH2,Regulation of PTEN gene transcription
EZH2,HCMV Infection
EZH2,HCMV Early Events
EZH2,Diseases of programmed cell death
EZH2,Defective pyroptosis
ALDH1A1,Signaling by Retinoic Acid
ALDH1A1,RA biosynthesis pathway
FABP5,Signaling by Retinoic Acid
FABP6,NR1H2 and NR1H3-mediated signaling
FABP7,Signaling by NOTCH3
FABP7,NOTCH3 Intracellular Domain Regulates Transcription
PTK2B,Signaling by VEGF
PTK2B,VEGFA-VEGFR2 Pathway
PTK2B,RHOU GTPase cycle
FASN,NR1H2 and NR1H3-mediated signaling
MED19,Respiratory Syncytial Virus Infection Pathway
MED19,RSV-host interactions
FAU,Viral mRNA Translation
FAU,SARS-CoV-1-host interactions
FAU,SARS-CoV-1 modulates host translation machinery
FAU,SARS-CoV-2 modulates host translation machinery
ALDH1A3,Signaling by Retinoic Acid
ALDH1A3,RA biosynthesis pathway
OTUD1,TNFR1-induced proapoptotic signaling
OTUD1,Regulation of TNFR1 signaling
OTUD1,TNFR1-induced NF-kappa-B signaling pathway
OTUD1,TNF signaling
FCGR1A,Anti-inflammatory response favouring Leishmania parasite infection
FCGR1A,FCGR3A-mediated IL10 synthesis
FCGR1A,Leishmania parasite growth and survival
FCGR3A,Anti-inflammatory response favouring Leishmania parasite infection
FCGR3A,FCGR3A-mediated IL10 synthesis
FCGR3A,Parasite infection
FCGR3A,Leishmania phagocytosis
FCGR3A,FCGR3A-mediated phagocytosis
FCGR3A,Leishmania parasite growth and survival
FGD2,NRAGE signals death through JNK
FGD2,p75 NTR receptor-mediated signalling
FGD2,"Cell death signalling via NRAGE, NRIF and NADE"
FGD2,G alpha (12/13) signalling events
KDM1B,NR1H2 and NR1H3-mediated signaling
KDM1B,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
DAGLB,Effects of PIP2 hydrolysis
GPRC6A,Class C/3 (Metabotropic glutamate/pheromone receptors)
FAM83B,Signaling by EGFR
FAM83B,RND3 GTPase cycle
FAM83B,RND2 GTPase cycle
FAM83B,RND1 GTPase cycle
FDX1,Diseases of metabolism
FDXR,Diseases of metabolism
FEN1,Early Phase of HIV Life Cycle
ALDH3A2,RND2 GTPase cycle
ALDH3A2,RND1 GTPase cycle
FER,Signaling by SCF-KIT
FES,Signaling by SCF-KIT
FGA,Integrin signaling
FGA,p130Cas linkage to MAPK signaling for integrins
FGA,MAP2K and MAPK activation
FGA,Signaling by moderate kinase activity BRAF mutants
FGA,Signaling by high-kinase activity BRAF mutants
FGA,Signaling by RAS mutants
FGA,Signaling by BRAF and RAF1 fusions
FGA,Paradoxical activation of RAF signaling by kinase inactive BRAF
FGA,Oncogenic MAPK signaling
FGA,Signaling downstream of RAS mutants
FGA,Signaling by RAF1 mutants
FGB,Integrin signaling
FGB,p130Cas linkage to MAPK signaling for integrins
FGB,MAP2K and MAPK activation
FGB,Signaling by moderate kinase activity BRAF mutants
FGB,Signaling by high-kinase activity BRAF mutants
FGB,Signaling by RAS mutants
FGB,Signaling by BRAF and RAF1 fusions
FGB,Paradoxical activation of RAF signaling by kinase inactive BRAF
FGB,Oncogenic MAPK signaling
FGB,Signaling downstream of RAS mutants
FGB,Signaling by RAF1 mutants
FGD1,NRAGE signals death through JNK
FGD1,p75 NTR receptor-mediated signalling
FGD1,"Cell death signalling via NRAGE, NRIF and NADE"
FGD1,G alpha (12/13) signalling events
FGF1,PI3K Cascade
FGF1,IRS-mediated signalling
FGF1,Signaling by FGFR in disease
FGF1,FGFR1 mutant receptor activation
FGF1,FGFR2 mutant receptor activation
FGF1,Signaling by FGFR
FGF1,FGFR2 ligand binding and activation
FGF1,FGFR4 ligand binding and activation
FGF1,Negative regulation of the PI3K/AKT network
FGF1,Activated point mutants of FGFR2
FGF1,PI3K/AKT Signaling in Cancer
FGF1,Constitutive Signaling by Aberrant PI3K in Cancer
FGF1,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF1,IGF1R signaling cascade
FGF1,IRS-related events triggered by IGF1R
FGF1,Phospholipase C-mediated cascade; FGFR2
FGF1,Phospholipase C-mediated cascade; FGFR4
FGF1,Downstream signaling of activated FGFR1
FGF1,PI-3K cascade:FGFR1
FGF1,FRS-mediated FGFR1 signaling
FGF1,PI-3K cascade:FGFR2
FGF1,Downstream signaling of activated FGFR2
FGF1,SHC-mediated cascade:FGFR2
FGF1,FRS-mediated FGFR2 signaling
FGF1,FRS-mediated FGFR3 signaling
FGF1,Downstream signaling of activated FGFR3
FGF1,FRS-mediated FGFR4 signaling
FGF1,Downstream signaling of activated FGFR4
FGF1,SHC-mediated cascade:FGFR4
FGF1,PI-3K cascade:FGFR4
FGF1,Negative regulation of FGFR1 signaling
FGF1,Negative regulation of FGFR2 signaling
FGF1,Negative regulation of FGFR3 signaling
FGF1,Negative regulation of FGFR4 signaling
FGF1,Signaling by FGFR1
FGF1,Signaling by FGFR2
FGF1,Signaling by FGFR3
FGF1,Signaling by FGFR4
FGF1,Signaling by FGFR2 in disease
FGF1,Signaling by FGFR1 in disease
FGF1,Signaling by FGFR3 in disease
FGF1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF1,Insulin receptor signalling cascade
FGF1,Signaling by Insulin receptor
FGF1,Signaling by FGFR2 IIIa TM
FGF3,PI3K Cascade
FGF3,IRS-mediated signalling
FGF3,Signaling by FGFR in disease
FGF3,FGFR2 mutant receptor activation
FGF3,Signaling by FGFR
FGF3,FGFR2 ligand binding and activation
FGF3,Negative regulation of the PI3K/AKT network
FGF3,Activated point mutants of FGFR2
FGF3,PI3K/AKT Signaling in Cancer
FGF3,Constitutive Signaling by Aberrant PI3K in Cancer
FGF3,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF3,IGF1R signaling cascade
FGF3,IRS-related events triggered by IGF1R
FGF3,Phospholipase C-mediated cascade; FGFR2
FGF3,Downstream signaling of activated FGFR1
FGF3,PI-3K cascade:FGFR1
FGF3,FRS-mediated FGFR1 signaling
FGF3,PI-3K cascade:FGFR2
FGF3,Downstream signaling of activated FGFR2
FGF3,SHC-mediated cascade:FGFR2
FGF3,FRS-mediated FGFR2 signaling
FGF3,Negative regulation of FGFR1 signaling
FGF3,Negative regulation of FGFR2 signaling
FGF3,Signaling by FGFR1
FGF3,Signaling by FGFR2
FGF3,Signaling by FGFR2 in disease
FGF3,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF3,Insulin receptor signalling cascade
FGF3,Signaling by Insulin receptor
FGF4,PI3K Cascade
FGF4,IRS-mediated signalling
FGF4,Signaling by FGFR in disease
FGF4,FGFR1 mutant receptor activation
FGF4,FGFR2 mutant receptor activation
FGF4,Signaling by FGFR
FGF4,FGFR2 ligand binding and activation
FGF4,FGFR4 ligand binding and activation
FGF4,Negative regulation of the PI3K/AKT network
FGF4,Activated point mutants of FGFR2
FGF4,PI3K/AKT Signaling in Cancer
FGF4,Constitutive Signaling by Aberrant PI3K in Cancer
FGF4,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF4,IGF1R signaling cascade
FGF4,IRS-related events triggered by IGF1R
FGF4,Phospholipase C-mediated cascade; FGFR2
FGF4,Phospholipase C-mediated cascade; FGFR4
FGF4,Downstream signaling of activated FGFR1
FGF4,PI-3K cascade:FGFR1
FGF4,FRS-mediated FGFR1 signaling
FGF4,PI-3K cascade:FGFR2
FGF4,Downstream signaling of activated FGFR2
FGF4,SHC-mediated cascade:FGFR2
FGF4,FRS-mediated FGFR2 signaling
FGF4,FRS-mediated FGFR3 signaling
FGF4,Downstream signaling of activated FGFR3
FGF4,FRS-mediated FGFR4 signaling
FGF4,Downstream signaling of activated FGFR4
FGF4,SHC-mediated cascade:FGFR4
FGF4,PI-3K cascade:FGFR4
FGF4,Negative regulation of FGFR1 signaling
FGF4,Negative regulation of FGFR2 signaling
FGF4,Negative regulation of FGFR3 signaling
FGF4,Negative regulation of FGFR4 signaling
FGF4,Signaling by FGFR1
FGF4,Signaling by FGFR2
FGF4,Signaling by FGFR3
FGF4,Signaling by FGFR4
FGF4,Signaling by FGFR2 in disease
FGF4,Signaling by FGFR1 in disease
FGF4,Signaling by FGFR3 in disease
FGF4,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF4,Insulin receptor signalling cascade
FGF4,Signaling by Insulin receptor
FGF6,PI3K Cascade
FGF6,IRS-mediated signalling
FGF6,Signaling by FGFR in disease
FGF6,FGFR1 mutant receptor activation
FGF6,FGFR2 mutant receptor activation
FGF6,Signaling by FGFR
FGF6,FGFR2 ligand binding and activation
FGF6,FGFR4 ligand binding and activation
FGF6,Negative regulation of the PI3K/AKT network
FGF6,Activated point mutants of FGFR2
FGF6,PI3K/AKT Signaling in Cancer
FGF6,Constitutive Signaling by Aberrant PI3K in Cancer
FGF6,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF6,IGF1R signaling cascade
FGF6,IRS-related events triggered by IGF1R
FGF6,Phospholipase C-mediated cascade; FGFR2
FGF6,Phospholipase C-mediated cascade; FGFR4
FGF6,Downstream signaling of activated FGFR1
FGF6,PI-3K cascade:FGFR1
FGF6,FRS-mediated FGFR1 signaling
FGF6,PI-3K cascade:FGFR2
FGF6,Downstream signaling of activated FGFR2
FGF6,SHC-mediated cascade:FGFR2
FGF6,FRS-mediated FGFR2 signaling
FGF6,FRS-mediated FGFR4 signaling
FGF6,Downstream signaling of activated FGFR4
FGF6,SHC-mediated cascade:FGFR4
FGF6,PI-3K cascade:FGFR4
FGF6,Negative regulation of FGFR1 signaling
FGF6,Negative regulation of FGFR2 signaling
FGF6,Negative regulation of FGFR4 signaling
FGF6,Signaling by FGFR1
FGF6,Signaling by FGFR2
FGF6,Signaling by FGFR4
FGF6,Signaling by FGFR2 in disease
FGF6,Signaling by FGFR1 in disease
FGF6,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF6,Insulin receptor signalling cascade
FGF6,Signaling by Insulin receptor
FGF7,PI3K Cascade
FGF7,IRS-mediated signalling
FGF7,Signaling by FGFR in disease
FGF7,FGFR2 mutant receptor activation
FGF7,Signaling by FGFR
FGF7,FGFR2 ligand binding and activation
FGF7,Negative regulation of the PI3K/AKT network
FGF7,Activated point mutants of FGFR2
FGF7,PI3K/AKT Signaling in Cancer
FGF7,Constitutive Signaling by Aberrant PI3K in Cancer
FGF7,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF7,IGF1R signaling cascade
FGF7,IRS-related events triggered by IGF1R
FGF7,Phospholipase C-mediated cascade; FGFR2
FGF7,PI-3K cascade:FGFR2
FGF7,Downstream signaling of activated FGFR2
FGF7,SHC-mediated cascade:FGFR2
FGF7,FRS-mediated FGFR2 signaling
FGF7,Negative regulation of FGFR2 signaling
FGF7,Signaling by FGFR2
FGF7,Signaling by FGFR2 in disease
FGF7,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF7,Insulin receptor signalling cascade
FGF7,Signaling by Insulin receptor
FGF9,PI3K Cascade
FGF9,IRS-mediated signalling
FGF9,Signaling by FGFR in disease
FGF9,FGFR1 mutant receptor activation
FGF9,FGFR2 mutant receptor activation
FGF9,Signaling by FGFR
FGF9,FGFR2 ligand binding and activation
FGF9,FGFR4 ligand binding and activation
FGF9,Negative regulation of the PI3K/AKT network
FGF9,Activated point mutants of FGFR2
FGF9,PI3K/AKT Signaling in Cancer
FGF9,Constitutive Signaling by Aberrant PI3K in Cancer
FGF9,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF9,IGF1R signaling cascade
FGF9,IRS-related events triggered by IGF1R
FGF9,Phospholipase C-mediated cascade; FGFR2
FGF9,Phospholipase C-mediated cascade; FGFR4
FGF9,Downstream signaling of activated FGFR1
FGF9,PI-3K cascade:FGFR1
FGF9,FRS-mediated FGFR1 signaling
FGF9,PI-3K cascade:FGFR2
FGF9,Downstream signaling of activated FGFR2
FGF9,SHC-mediated cascade:FGFR2
FGF9,FRS-mediated FGFR2 signaling
FGF9,FRS-mediated FGFR3 signaling
FGF9,Downstream signaling of activated FGFR3
FGF9,FRS-mediated FGFR4 signaling
FGF9,Downstream signaling of activated FGFR4
FGF9,SHC-mediated cascade:FGFR4
FGF9,PI-3K cascade:FGFR4
FGF9,Negative regulation of FGFR1 signaling
FGF9,Negative regulation of FGFR2 signaling
FGF9,Negative regulation of FGFR3 signaling
FGF9,Negative regulation of FGFR4 signaling
FGF9,Signaling by FGFR1
FGF9,Signaling by FGFR2
FGF9,Signaling by FGFR3
FGF9,Signaling by FGFR4
FGF9,Signaling by FGFR2 in disease
FGF9,Signaling by FGFR1 in disease
FGF9,Signaling by FGFR3 in disease
FGF9,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF9,Insulin receptor signalling cascade
FGF9,Signaling by Insulin receptor
FGF10,PI3K Cascade
FGF10,IRS-mediated signalling
FGF10,Signaling by FGFR in disease
FGF10,FGFR2 mutant receptor activation
FGF10,Signaling by FGFR
FGF10,FGFR2 ligand binding and activation
FGF10,Negative regulation of the PI3K/AKT network
FGF10,Activated point mutants of FGFR2
FGF10,PI3K/AKT Signaling in Cancer
FGF10,Constitutive Signaling by Aberrant PI3K in Cancer
FGF10,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF10,IGF1R signaling cascade
FGF10,IRS-related events triggered by IGF1R
FGF10,Phospholipase C-mediated cascade; FGFR2
FGF10,Downstream signaling of activated FGFR1
FGF10,PI-3K cascade:FGFR1
FGF10,FRS-mediated FGFR1 signaling
FGF10,PI-3K cascade:FGFR2
FGF10,Downstream signaling of activated FGFR2
FGF10,SHC-mediated cascade:FGFR2
FGF10,FRS-mediated FGFR2 signaling
FGF10,Negative regulation of FGFR1 signaling
FGF10,Negative regulation of FGFR2 signaling
FGF10,Signaling by FGFR1
FGF10,Signaling by FGFR2
FGF10,Signaling by FGFR2 in disease
FGF10,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF10,Insulin receptor signalling cascade
FGF10,Signaling by Insulin receptor
FGFR3,Signaling by FGFR in disease
FGFR3,Signaling by FGFR3 in disease
FGFR2,Signaling by FGFR in disease
FGFR2,FGFR2 mutant receptor activation
FGFR2,Signaling by FGFR2 in disease
FGFR4,Signaling by FGFR
FGFR4,FGFR4 ligand binding and activation
FGFR4,Signaling by FGFR4
FGG,Integrin signaling
FGG,p130Cas linkage to MAPK signaling for integrins
FGG,Diseases of Immune System
FGG,Diseases associated with the TLR signaling cascade
FGG,MAP2K and MAPK activation
FGG,Signaling by moderate kinase activity BRAF mutants
FGG,Signaling by high-kinase activity BRAF mutants
FGG,Signaling by RAS mutants
FGG,Signaling by BRAF and RAF1 fusions
FGG,Paradoxical activation of RAF signaling by kinase inactive BRAF
FGG,Oncogenic MAPK signaling
FGG,Signaling downstream of RAS mutants
FGG,Signaling by RAF1 mutants
FGR,Anti-inflammatory response favouring Leishmania parasite infection
FGR,FCGR3A-mediated IL10 synthesis
FGR,Parasite infection
FGR,Leishmania phagocytosis
FGR,FCGR3A-mediated phagocytosis
FGR,Leishmania parasite growth and survival
FKBP1A,MTOR signalling
FKBP1A,mTORC1-mediated signalling
FKBP1A,Signaling by TGF-beta Receptor Complex
FKBP1A,TGF-beta receptor signaling activates SMADs
FKBP1A,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
FKBP1A,Potential therapeutics for SARS
FKBP1A,SARS-CoV-1-host interactions
FKBP1A,SARS-CoV-1 activates/modulates innate immune responses
RRAS2,RND1 GTPase cycle
RASA3,Regulation of RAS by GAPs
RHOBTB3,RHOBTB3 ATPase cycle
ANKRD26,RND3 GTPase cycle
ANKRD26,RND2 GTPase cycle
ANKRD26,RND1 GTPase cycle
SLITRK3,RAC3 GTPase cycle
CNKSR2,MAP2K and MAPK activation
CNKSR2,Signaling by moderate kinase activity BRAF mutants
CNKSR2,Signaling by high-kinase activity BRAF mutants
CNKSR2,Signaling by RAS mutants
CNKSR2,Signaling by BRAF and RAF1 fusions
CNKSR2,Paradoxical activation of RAF signaling by kinase inactive BRAF
CNKSR2,Oncogenic MAPK signaling
CNKSR2,Signaling downstream of RAS mutants
CNKSR2,Signaling by RAF1 mutants
DZIP1,Hedgehog 'on' state
FKBP4,Estrogen-dependent gene expression
FKBP4,Potential therapeutics for SARS
ARHGEF15,NRAGE signals death through JNK
ARHGEF15,p75 NTR receptor-mediated signalling
ARHGEF15,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF15,G alpha (12/13) signalling events
ARHGEF15,RHOA GTPase cycle
NCBP2,Signaling by FGFR in disease
NCBP2,Formation of HIV elongation complex in the absence of HIV Tat
NCBP2,Formation of the HIV-1 Early Elongation Complex
NCBP2,HIV Transcription Elongation
NCBP2,Transcription of the HIV genome
NCBP2,Formation of HIV-1 elongation complex containing HIV-1 Tat
NCBP2,Abortive elongation of HIV-1 transcript in the absence of Tat
NCBP2,Tat-mediated elongation of the HIV-1 transcript
NCBP2,FGFR2 mutant receptor activation
NCBP2,Signaling by FGFR
NCBP2,Signaling by FGFR2
NCBP2,Signaling by FGFR2 in disease
NCBP2,FGFR2 alternative splicing
NCBP2,Signaling by FGFR2 IIIa TM
SNW1,Signaling by TGF-beta Receptor Complex
SNW1,Pre-NOTCH Transcription and Translation
SNW1,Pre-NOTCH Expression and Processing
SNW1,Signaling by NOTCH1
SNW1,NOTCH1 Intracellular Domain Regulates Transcription
SNW1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SNW1,Downregulation of SMAD2/3:SMAD4 transcriptional activity
SNW1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
SNW1,Signaling by NOTCH1 in Cancer
SNW1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
SNW1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
SNW1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
SNW1,Signaling by NOTCH3
SNW1,NOTCH3 Intracellular Domain Regulates Transcription
SNW1,Signaling by NOTCH4
SNW1,NOTCH4 Intracellular Domain Regulates Transcription
DKK1,Signaling by WNT in cancer
SV2C,Neurotoxicity of clostridium toxins
SV2C,Uptake and actions of bacterial toxins
SV2C,Bacterial Infection Pathways
DAAM1,PCP/CE pathway
DAAM1,RHO GTPases Activate Formins
DAAM1,RHOA GTPase cycle
DAAM1,RHOB GTPase cycle
DAAM1,RHOC GTPase cycle
SPEN,RHOBTB1 GTPase cycle
SPEN,RHOBTB GTPase Cycle
KDM1A,RHO GTPases activate PKNs
KDM1A,Regulation of PTEN gene transcription
KDM1A,Estrogen-dependent gene expression
KDM1A,NR1H2 and NR1H3-mediated signaling
KDM1A,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
KDM1A,Potential therapeutics for SARS
KDM4B,Estrogen-dependent gene expression
PHLPP2,Negative regulation of the PI3K/AKT network
FNBP1,RHOQ GTPase cycle
FNBP1,RHOJ GTPase cycle
FNBP1,RND2 GTPase cycle
FOXM1,Signaling by ALK in cancer
FOXM1,Signaling by ALK fusions and activated point mutants
FOXM1,Nuclear events stimulated by ALK signaling in cancer
HECW1,Degradation of DVL
SWAP70,RAC2 GTPase cycle
SWAP70,RAC3 GTPase cycle
FOXO1,PI3K/AKT Signaling in Cancer
FOXO1,Constitutive Signaling by AKT1 E17K in Cancer
FOXO1,MAPK6/MAPK4 signaling
KDM4C,RHO GTPases activate PKNs
FOXO3,PI3K/AKT Signaling in Cancer
FOXO3,Constitutive Signaling by AKT1 E17K in Cancer
FOXO3,MAPK6/MAPK4 signaling
FOXO3,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
FOXO3,Neurodegenerative Diseases
FOXO3,Extra-nuclear estrogen signaling
FOXO3,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
FOXO3,Diseases of programmed cell death
FOXO3,Defective Intrinsic Pathway for Apoptosis
ARHGAP26,RHOA GTPase cycle
ARHGAP26,RHOB GTPase cycle
ARHGAP26,RHOC GTPase cycle
ARHGAP26,RAC2 GTPase cycle
ARHGAP26,RHOD GTPase cycle
ARHGAP26,RHOQ GTPase cycle
ARHGAP26,RHOJ GTPase cycle
ARHGAP26,RAC3 GTPase cycle
CDK19,Respiratory Syncytial Virus Infection Pathway
CDK19,RSV-host interactions
TNRC6B,Pre-NOTCH Transcription and Translation
TNRC6B,Pre-NOTCH Expression and Processing
TNRC6B,Ca2+ pathway
TNRC6B,MAPK6/MAPK4 signaling
TNRC6B,Regulation of PTEN mRNA translation
TNRC6B,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
TNRC6B,Estrogen-dependent gene expression
TNRC6B,NR1H2 and NR1H3-mediated signaling
TNRC6B,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
TNRC6B,Signaling by TGFBR3
TNRC6B,TGFBR3 expression
TAB2,Signaling by ERBB4
TAB2,Nuclear signaling by ERBB4
TAB2,TNFR1-induced NF-kappa-B signaling pathway
TAB2,TNF signaling
TAB2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PLXND1,Signaling by NOTCH3
PLXND1,NOTCH3 Intracellular Domain Regulates Transcription
PLXND1,RND2 GTPase cycle
ANKLE2,RAC2 GTPase cycle
ANKLE2,RHOG GTPase cycle
FLNA,RHO GTPases activate PAKs
GGA3,Signaling by MET
NUP205,Host Interactions of HIV factors
NUP205,Rev-mediated nuclear export of HIV RNA
NUP205,Transport of Ribonucleoproteins into the Host Nucleus
NUP205,Export of Viral Ribonucleoproteins from Nucleus
NUP205,NS1 Mediated Effects on Host Pathways
NUP205,Viral Messenger RNA Synthesis
NUP205,NEP/NS2 Interacts with the Cellular Export Machinery
NUP205,Interactions of Vpr with host cellular proteins
NUP205,Interactions of Rev with host cellular proteins
NUP205,Nuclear import of Rev protein
NUP205,Vpr-mediated nuclear import of PICs
NUP205,SLC transporter disorders
NUP205,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP205,Disorders of transmembrane transporters
NUP205,HCMV Infection
NUP205,HCMV Early Events
NUP205,HCMV Late Events
NUP205,SARS-CoV-2 activates/modulates innate and adaptive immune responses
RCOR1,Regulation of PTEN gene transcription
RCOR1,Potential therapeutics for SARS
KANK1,Estrogen-dependent gene expression
FLOT2,RHOA GTPase cycle
FLOT2,RHOB GTPase cycle
FLOT2,RHOC GTPase cycle
FLOT2,RND3 GTPase cycle
FLOT2,RND1 GTPase cycle
CYFIP1,Signaling by VEGF
CYFIP1,VEGFA-VEGFR2 Pathway
CYFIP1,RHO GTPases Activate WASPs and WAVEs
CYFIP1,RAC2 GTPase cycle
CYFIP1,RHOG GTPase cycle
CYFIP1,RAC3 GTPase cycle
CYFIP1,Parasite infection
CYFIP1,Leishmania phagocytosis
CYFIP1,FCGR3A-mediated phagocytosis
GANAB,Maturation of spike protein
GANAB,Translation of Structural Proteins
GANAB,Late SARS-CoV-2 Infection Events
DTX4,Signaling by NOTCH1
DTX4,Activated NOTCH1 Transmits Signal to the Nucleus
RHOBTB2,RHOBTB2 GTPase cycle
RHOBTB2,RHOBTB GTPase Cycle
NUP210,Host Interactions of HIV factors
NUP210,Rev-mediated nuclear export of HIV RNA
NUP210,Transport of Ribonucleoproteins into the Host Nucleus
NUP210,Export of Viral Ribonucleoproteins from Nucleus
NUP210,NS1 Mediated Effects on Host Pathways
NUP210,Viral Messenger RNA Synthesis
NUP210,NEP/NS2 Interacts with the Cellular Export Machinery
NUP210,Interactions of Vpr with host cellular proteins
NUP210,Interactions of Rev with host cellular proteins
NUP210,Nuclear import of Rev protein
NUP210,Vpr-mediated nuclear import of PICs
NUP210,SLC transporter disorders
NUP210,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP210,Disorders of transmembrane transporters
NUP210,HCMV Infection
NUP210,HCMV Early Events
NUP210,HCMV Late Events
NUP210,SARS-CoV-2 activates/modulates innate and adaptive immune responses
ARHGEF9,NRAGE signals death through JNK
ARHGEF9,p75 NTR receptor-mediated signalling
ARHGEF9,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF9,G alpha (12/13) signalling events
ARHGEF9,RHOQ GTPase cycle
FLT3LG,PI3K Cascade
FLT3LG,IRS-mediated signalling
FLT3LG,Negative regulation of the PI3K/AKT network
FLT3LG,PI3K/AKT Signaling in Cancer
FLT3LG,Constitutive Signaling by Aberrant PI3K in Cancer
FLT3LG,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FLT3LG,IGF1R signaling cascade
FLT3LG,IRS-related events triggered by IGF1R
FLT3LG,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FLT3LG,Insulin receptor signalling cascade
FLT3LG,Signaling by Insulin receptor
FLT3LG,FLT3 signaling in disease
PLCB1,Opioid Signalling
PLCB1,G-protein mediated events
PLCB1,PLC beta mediated events
PLCB1,G-protein beta:gamma signalling
PLCB1,Ca2+ pathway
PLCB1,G beta:gamma signalling through PLC beta
ARC,Signaling by NTRK1 (TRKA)
ARC,Nuclear Events (kinase and transcription factor activation)
ARC,NGF-stimulated transcription
PHLPP1,Negative regulation of the PI3K/AKT network
FLT4,Signaling by VEGF
FLT4,Signaling by NOTCH4
FLT4,NOTCH4 Intracellular Domain Regulates Transcription
OTUD3,Regulation of PTEN stability and activity
MCF2L,NRAGE signals death through JNK
MCF2L,p75 NTR receptor-mediated signalling
MCF2L,"Cell death signalling via NRAGE, NRIF and NADE"
MCF2L,G alpha (12/13) signalling events
MCF2L,RHOA GTPase cycle
MCF2L,RHOB GTPase cycle
MCF2L,RHOC GTPase cycle
MCF2L,RHOG GTPase cycle
NUP160,Host Interactions of HIV factors
NUP160,Rev-mediated nuclear export of HIV RNA
NUP160,Transport of Ribonucleoproteins into the Host Nucleus
NUP160,Export of Viral Ribonucleoproteins from Nucleus
NUP160,NS1 Mediated Effects on Host Pathways
NUP160,Viral Messenger RNA Synthesis
NUP160,NEP/NS2 Interacts with the Cellular Export Machinery
NUP160,Interactions of Vpr with host cellular proteins
NUP160,Interactions of Rev with host cellular proteins
NUP160,Nuclear import of Rev protein
NUP160,Vpr-mediated nuclear import of PICs
NUP160,SLC transporter disorders
NUP160,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP160,Disorders of transmembrane transporters
NUP160,RHO GTPases Activate Formins
NUP160,HCMV Infection
NUP160,HCMV Early Events
NUP160,HCMV Late Events
NUP160,SARS-CoV-2 activates/modulates innate and adaptive immune responses
WWC1,Signaling by Hippo
WWC1,Signaling by NOTCH3
WWC1,NOTCH3 Intracellular Domain Regulates Transcription
IQCE,Hedgehog 'on' state
IQCE,Activation of SMO
RPGRIP1L,Hedgehog 'off' state
NEDD4L,Budding and maturation of HIV virion
NEDD4L,Signaling by TGF-beta Receptor Complex
NEDD4L,Downregulation of TGF-beta receptor signaling
NEDD4L,TGF-beta receptor signaling activates SMADs
NEDD4L,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
NEDD4L,Downregulation of SMAD2/3:SMAD4 transcriptional activity
VPS39,SARS-CoV-2 modulates autophagy
ESYT1,RAC2 GTPase cycle
ESYT1,RHOD GTPase cycle
ESYT1,RHOG GTPase cycle
ESYT1,RAC3 GTPase cycle
ESYT1,RHOF GTPase cycle
ARHGEF12,NRAGE signals death through JNK
ARHGEF12,p75 NTR receptor-mediated signalling
ARHGEF12,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF12,G alpha (12/13) signalling events
ARHGEF12,RHOA GTPase cycle
ARHGEF12,RHOB GTPase cycle
ARHGEF12,RHOC GTPase cycle
LARP1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
ARHGEF18,Signaling by TGF-beta Receptor Complex
ARHGEF18,NRAGE signals death through JNK
ARHGEF18,p75 NTR receptor-mediated signalling
ARHGEF18,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF18,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
ARHGEF18,G alpha (12/13) signalling events
ARHGEF18,RHOA GTPase cycle
SRGAP2,RHO GTPases Activate Formins
SRGAP2,RHOQ GTPase cycle
SRGAP2,RHOU GTPase cycle
SRGAP2,RAC3 GTPase cycle
SRGAP2,RHOF GTPase cycle
NCSTN,Signaling by ERBB4
NCSTN,Nuclear signaling by ERBB4
NCSTN,p75 NTR receptor-mediated signalling
NCSTN,Signaling by NOTCH1
NCSTN,Signaling by NOTCH2
NCSTN,"Cell death signalling via NRAGE, NRIF and NADE"
NCSTN,NRIF signals cell death from the nucleus
NCSTN,Activated NOTCH1 Transmits Signal to the Nucleus
NCSTN,Signaling by NOTCH1 PEST Domain Mutants in Cancer
NCSTN,Signaling by NOTCH1 in Cancer
NCSTN,Constitutive Signaling by NOTCH1 PEST Domain Mutants
NCSTN,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
NCSTN,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
NCSTN,NOTCH2 Activation and Transmission of Signal to the Nucleus
NCSTN,Signaling by NOTCH3
NCSTN,NOTCH3 Activation and Transmission of Signal to the Nucleus
NCSTN,Signaling by NOTCH4
NCSTN,Signaling by TGFBR3
MED13L,Respiratory Syncytial Virus Infection Pathway
MED13L,RSV-host interactions
PIP5K1C,Negative regulation of the PI3K/AKT network
PIP5K1C,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FRAT2,Degradation of beta-catenin by the destruction complex
FRAT2,Beta-catenin phosphorylation cascade
FRAT2,Disassembly of the destruction complex and recruitment of AXIN to the membrane
ITGB3BP,p75 NTR receptor-mediated signalling
ITGB3BP,"Cell death signalling via NRAGE, NRIF and NADE"
ITGB3BP,NRIF signals cell death from the nucleus
ITGB3BP,RHO GTPases Activate Formins
GPR161,Hedgehog 'off' state
GPR161,Hedgehog 'on' state
RHOQ,RHOQ GTPase cycle
ATP1B4,Signaling by TGF-beta Receptor Complex
ATP1B4,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
ATP1B4,Downregulation of SMAD2/3:SMAD4 transcriptional activity
HEY1,Signaling by NOTCH1
HEY1,NOTCH1 Intracellular Domain Regulates Transcription
HEY1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HEY1,Signaling by NOTCH1 in Cancer
HEY1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HEY1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HEY1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HEY1,Signaling by NOTCH3
HEY1,NOTCH3 Intracellular Domain Regulates Transcription
HEY1,Signaling by NOTCH4
HEY1,NOTCH4 Intracellular Domain Regulates Transcription
ICMT,RAS processing
CBX6,Regulation of PTEN gene transcription
BRD4,Potential therapeutics for SARS
SEC11A,Respiratory Syncytial Virus Infection Pathway
SEC11A,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
SEC11A,Maturation of hRSV A proteins
ISCU,Translation of Replicase and Assembly of the Replication Transcription Complex
ISCU,Early SARS-CoV-2 Infection Events
HEY2,Signaling by NOTCH1
HEY2,NOTCH1 Intracellular Domain Regulates Transcription
HEY2,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HEY2,Signaling by NOTCH1 in Cancer
HEY2,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HEY2,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HEY2,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HEY2,Signaling by NOTCH3
HEY2,NOTCH3 Intracellular Domain Regulates Transcription
HEY2,Signaling by NOTCH4
HEY2,NOTCH4 Intracellular Domain Regulates Transcription
POFUT1,Pre-NOTCH Expression and Processing
NUP188,Host Interactions of HIV factors
NUP188,Rev-mediated nuclear export of HIV RNA
NUP188,Transport of Ribonucleoproteins into the Host Nucleus
NUP188,Export of Viral Ribonucleoproteins from Nucleus
NUP188,NS1 Mediated Effects on Host Pathways
NUP188,Viral Messenger RNA Synthesis
NUP188,NEP/NS2 Interacts with the Cellular Export Machinery
NUP188,Interactions of Vpr with host cellular proteins
NUP188,Interactions of Rev with host cellular proteins
NUP188,Nuclear import of Rev protein
NUP188,Vpr-mediated nuclear import of PICs
NUP188,SLC transporter disorders
NUP188,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP188,Disorders of transmembrane transporters
NUP188,HCMV Infection
NUP188,HCMV Early Events
NUP188,HCMV Late Events
NUP188,SARS-CoV-2 activates/modulates innate and adaptive immune responses
SUZ12,Regulation of PTEN gene transcription
SUZ12,HCMV Infection
SUZ12,HCMV Early Events
SUZ12,Diseases of programmed cell death
SUZ12,Defective pyroptosis
SCRIB,PCP/CE pathway
SCRIB,Asymmetric localization of PCP proteins
SCRIB,RHOQ GTPase cycle
SCRIB,RHOJ GTPase cycle
SCRIB,RND3 GTPase cycle
SCRIB,RND2 GTPase cycle
RPL13A,Viral mRNA Translation
FOS,Signaling by NTRK1 (TRKA)
FOS,Nuclear Events (kinase and transcription factor activation)
FOS,Extra-nuclear estrogen signaling
FOS,Estrogen-dependent gene expression
FOS,NGF-stimulated transcription
FOS,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
PIK3R5,G beta:gamma signalling through PI3Kgamma
PIK3R5,G-protein beta:gamma signalling
PIK3R5,Signaling by Erythropoietin
PIK3R5,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
FOSB,Signaling by NTRK1 (TRKA)
FOSB,Nuclear Events (kinase and transcription factor activation)
FOSB,Estrogen-dependent gene expression
FOSB,NGF-stimulated transcription
ATP6V0A2,Signaling by Insulin receptor
ATP6V0A2,Insulin receptor recycling
CDC42EP4,RAC2 GTPase cycle
CDC42EP4,RHOQ GTPase cycle
LEMD3,RAC2 GTPase cycle
LEMD3,RHOD GTPase cycle
LEMD3,RHOG GTPase cycle
LEMD3,RAC3 GTPase cycle
LEMD3,RND3 GTPase cycle
LEMD3,RND2 GTPase cycle
LEMD3,RND1 GTPase cycle
MKRN1,AKT phosphorylates targets in the cytosol
MKRN1,Regulation of PTEN stability and activity
NUP62,Host Interactions of HIV factors
NUP62,Rev-mediated nuclear export of HIV RNA
NUP62,Transport of Ribonucleoproteins into the Host Nucleus
NUP62,Export of Viral Ribonucleoproteins from Nucleus
NUP62,NS1 Mediated Effects on Host Pathways
NUP62,Viral Messenger RNA Synthesis
NUP62,NEP/NS2 Interacts with the Cellular Export Machinery
NUP62,Interactions of Vpr with host cellular proteins
NUP62,Interactions of Rev with host cellular proteins
NUP62,Nuclear import of Rev protein
NUP62,Vpr-mediated nuclear import of PICs
NUP62,SLC transporter disorders
NUP62,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP62,Disorders of transmembrane transporters
NUP62,HCMV Infection
NUP62,HCMV Early Events
NUP62,HCMV Late Events
NUP62,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PPP1R15A,Signaling by TGF-beta Receptor Complex
PPP1R15A,Downregulation of TGF-beta receptor signaling
PPP1R15A,TGF-beta receptor signaling activates SMADs
POLA2,Diseases of programmed cell death
POLA2,Defective pyroptosis
IL17RA,SARS-CoV-2 activates/modulates innate and adaptive immune responses
FLRT3,Signaling by FGFR
FLRT3,Downstream signaling of activated FGFR1
FLRT3,Signaling by FGFR1
FLRT2,Signaling by FGFR
FLRT2,Downstream signaling of activated FGFR1
FLRT2,Signaling by FGFR1
FLRT1,Signaling by FGFR
FLRT1,Downstream signaling of activated FGFR1
FLRT1,Signaling by FGFR1
ALK,Signaling by ALK
ATP6V0D2,Signaling by Insulin receptor
ATP6V0D2,Insulin receptor recycling
ATP6V1C2,Signaling by Insulin receptor
ATP6V1C2,Insulin receptor recycling
CDC26,Diseases of mitotic cell cycle
CDC26,Aberrant regulation of mitotic exit in cancer due to RB1 defects
CDC26,Aberrant regulation of mitotic cell cycle due to RB1 defects
MTOR,MTOR signalling
MTOR,mTORC1-mediated signalling
MTOR,Signaling by VEGF
MTOR,PI3K/AKT Signaling in Cancer
MTOR,Energy dependent regulation of mTOR by LKB1-AMPK
MTOR,VEGFA-VEGFR2 Pathway
MTOR,VEGFR2 mediated vascular permeability
MTOR,Constitutive Signaling by AKT1 E17K in Cancer
MTOR,Regulation of PTEN gene transcription
NR5A2,Estrogen-dependent gene expression
ABL1,RHO GTPases Activate WASPs and WAVEs
ABL1,Parasite infection
ABL1,Leishmania phagocytosis
ABL1,FCGR3A-mediated phagocytosis
FUT8,Maturation of spike protein
FUT8,Translation of Structural Proteins
FUT8,Late SARS-CoV-2 Infection Events
RICTOR,Signaling by VEGF
RICTOR,PI3K/AKT Signaling in Cancer
RICTOR,VEGFA-VEGFR2 Pathway
RICTOR,VEGFR2 mediated vascular permeability
RICTOR,Constitutive Signaling by AKT1 E17K in Cancer
FYN,Signaling by SCF-KIT
FYN,Regulation of KIT signaling
FYN,Host Interactions of HIV factors
FYN,The role of Nef in HIV-1 replication and disease pathogenesis
FYN,Signaling by VEGF
FYN,Negative regulation of the PI3K/AKT network
FYN,PI3K/AKT Signaling in Cancer
FYN,Constitutive Signaling by Aberrant PI3K in Cancer
FYN,VEGFA-VEGFR2 Pathway
FYN,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FYN,Anti-inflammatory response favouring Leishmania parasite infection
FYN,FCGR3A-mediated IL10 synthesis
FYN,Parasite infection
FYN,Leishmania phagocytosis
FYN,FCGR3A-mediated phagocytosis
FYN,Leishmania parasite growth and survival
FYN,Signaling by KIT in disease
FYN,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
FZD2,Class B/2 (Secretin family receptors)
FZD2,Ca2+ pathway
FZD2,PCP/CE pathway
FZD2,Asymmetric localization of PCP proteins
FZD2,Disassembly of the destruction complex and recruitment of AXIN to the membrane
FZD2,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
ZDHHC20,Maturation of spike protein
ZDHHC20,Translation of Structural Proteins
ZDHHC20,Late SARS-CoV-2 Infection Events
RALGAPA1,RHOH GTPase cycle
KCTD13,RND3 GTPase cycle
KCTD13,RND2 GTPase cycle
XRCC6,Early Phase of HIV Life Cycle
GAB1,PI3K Cascade
GAB1,IRS-mediated signalling
GAB1,Signaling by FGFR in disease
GAB1,Signaling by ERBB2
GAB1,Signaling by ERBB2 in Cancer
GAB1,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
GAB1,Signaling by EGFR in Cancer
GAB1,Signaling by EGFR
GAB1,Signaling by FGFR
GAB1,Negative regulation of the PI3K/AKT network
GAB1,PI3K/AKT Signaling in Cancer
GAB1,Constitutive Signaling by Aberrant PI3K in Cancer
GAB1,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
GAB1,IGF1R signaling cascade
GAB1,IRS-related events triggered by IGF1R
GAB1,Constitutive Signaling by EGFRvIII
GAB1,Signaling by EGFRvIII in Cancer
GAB1,Signaling by Ligand-Responsive EGFR Variants in Cancer
GAB1,Downstream signaling of activated FGFR1
GAB1,PI-3K cascade:FGFR1
GAB1,PI-3K cascade:FGFR2
GAB1,Downstream signaling of activated FGFR2
GAB1,Downstream signaling of activated FGFR3
GAB1,Downstream signaling of activated FGFR4
GAB1,PI-3K cascade:FGFR4
GAB1,Signaling by FGFR1
GAB1,Signaling by FGFR2
GAB1,Signaling by FGFR3
GAB1,Signaling by FGFR4
GAB1,Signaling by FGFR2 in disease
GAB1,Signaling by FGFR1 in disease
GAB1,Signaling by FGFR3 in disease
GAB1,Signaling by MET
GAB1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
GAB1,Insulin receptor signalling cascade
GAB1,Signaling by Insulin receptor
GAB1,Signaling by NTRK2 (TRKB)
GAB1,Signaling by Erythropoietin
GAB1,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
GAB1,Signaling by ERBB2 KD Mutants
GAB1,Signaling by ERBB2 ECD mutants
GABBR1,Class C/3 (Metabotropic glutamate/pheromone receptors)
GABRA1,Signaling by ERBB4
GABRB1,Signaling by ERBB4
GABRB2,Signaling by ERBB4
GABRB3,Signaling by ERBB4
ST6GALNAC3,Translation of Structural Proteins
ST6GALNAC3,Maturation of spike protein
ST6GALNAC3,Late SARS-CoV-2 Infection Events
GABRG2,Signaling by ERBB4
GABRG3,Signaling by ERBB4
ARHGAP30,RHOA GTPase cycle
ARHGAP30,RHOU GTPase cycle
TAB3,TNFR1-induced NF-kappa-B signaling pathway
TAB3,TNF signaling
TAB3,SARS-CoV-2 activates/modulates innate and adaptive immune responses
SHC2,Signalling to RAS
SHC2,Signaling by NTRK1 (TRKA)
SHC2,Signalling to ERKs
SHC2,Signaling by VEGF
SHC2,VEGFA-VEGFR2 Pathway
CBY1,Deactivation of the beta-catenin transactivating complex
NGEF,NRAGE signals death through JNK
NGEF,p75 NTR receptor-mediated signalling
NGEF,"Cell death signalling via NRAGE, NRIF and NADE"
NGEF,G alpha (12/13) signalling events
NGEF,RHOA GTPase cycle
BAMBI,Signaling by TGF-beta Receptor Complex
BAMBI,Downregulation of TGF-beta receptor signaling
BAMBI,TGF-beta receptor signaling activates SMADs
SAMM50,RAC2 GTPase cycle
ARIH1,Respiratory Syncytial Virus Infection Pathway
ARIH1,RSV-host interactions
MGAT4C,Maturation of spike protein
MGAT4C,Translation of Structural Proteins
MGAT4C,Late SARS-CoV-2 Infection Events
BRMS1,Potential therapeutics for SARS
RPL36,Viral mRNA Translation
GALNT1,Translation of Structural Proteins
GALNT1,Late SARS-CoV-2 Infection Events
GALNT3,Signaling by FGFR
GALNT3,Signaling by FGFR3
ZDHHC5,Maturation of spike protein
ZDHHC5,Translation of Structural Proteins
ZDHHC5,Late SARS-CoV-2 Infection Events
TAS2R39,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R40,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R41,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R43,Class C/3 (Metabotropic glutamate/pheromone receptors)
GEMIN5,SARS-CoV-2 modulates host translation machinery
TAS2R31,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R46,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R30,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R19,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R20,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R50,Class C/3 (Metabotropic glutamate/pheromone receptors)
WWTR1,Signaling by TGF-beta Receptor Complex
WWTR1,Signaling by Hippo
WWTR1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
WWTR1,Downregulation of SMAD2/3:SMAD4 transcriptional activity
WWTR1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
SIN3A,Signaling by ALK
SIN3A,Loss of function of MECP2 in Rett syndrome
SIN3A,Pervasive developmental disorders
SIN3A,Disorders of Developmental Biology
SIN3A,Disorders of Nervous System Development
SIN3A,STAT3 nuclear events downstream of ALK signaling
MMACHC,Defects in vitamin and cofactor metabolism
MMACHC,Diseases of metabolism
CHMP2B,Budding and maturation of HIV virion
CHMP2B,HCMV Infection
CHMP2B,HCMV Late Events
CHMP2B,Translation of Replicase and Assembly of the Replication Transcription Complex
CHMP2B,Early SARS-CoV-2 Infection Events
ULK3,Hedgehog 'on' state
CLIP3,Regulation of TNFR1 signaling
CLIP3,TNF signaling
LRIG1,Signaling by EGFR
LRIG1,Signaling by MET
LRIG1,Negative regulation of MET activity
PLEKHG3,RHOA GTPase cycle
PLEKHG3,RHOQ GTPase cycle
PLEKHG3,RHOG GTPase cycle
FAM169A,RHOF GTPase cycle
SLITRK5,RAC2 GTPase cycle
SLITRK5,RAC3 GTPase cycle
DNM3,Retrograde neurotrophin signalling
DNM3,Signaling by NTRK1 (TRKA)
ABHD12,Effects of PIP2 hydrolysis
TOR1AIP1,RHOD GTPase cycle
TOR1AIP1,RHOF GTPase cycle
PYGO1,Formation of the beta-catenin:TCF transactivating complex
PYGO1,Deactivation of the beta-catenin transactivating complex
IFT172,Hedgehog 'off' state
NPHP4,Signaling by Hippo
GAS1,Hedgehog 'on' state
GAS1,Activation of SMO
GAS8,Hedgehog 'on' state
GAS8,Activation of SMO
TIAM2,NRAGE signals death through JNK
TIAM2,p75 NTR receptor-mediated signalling
TIAM2,"Cell death signalling via NRAGE, NRIF and NADE"
TIAM2,G alpha (12/13) signalling events
GATA3,Estrogen-dependent gene expression
VPS33B,Infection with Mycobacterium tuberculosis
VPS33B,Response of Mtb to phagocytosis
VPS33B,SARS-CoV-2 modulates autophagy
VPS33B,Bacterial Infection Pathways
FGF20,PI3K Cascade
FGF20,IRS-mediated signalling
FGF20,Signaling by FGFR in disease
FGF20,FGFR1 mutant receptor activation
FGF20,FGFR2 mutant receptor activation
FGF20,Signaling by FGFR
FGF20,FGFR2 ligand binding and activation
FGF20,FGFR4 ligand binding and activation
FGF20,Negative regulation of the PI3K/AKT network
FGF20,Activated point mutants of FGFR2
FGF20,PI3K/AKT Signaling in Cancer
FGF20,Constitutive Signaling by Aberrant PI3K in Cancer
FGF20,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF20,IGF1R signaling cascade
FGF20,IRS-related events triggered by IGF1R
FGF20,Phospholipase C-mediated cascade; FGFR2
FGF20,Phospholipase C-mediated cascade; FGFR4
FGF20,Downstream signaling of activated FGFR1
FGF20,PI-3K cascade:FGFR1
FGF20,FRS-mediated FGFR1 signaling
FGF20,PI-3K cascade:FGFR2
FGF20,Downstream signaling of activated FGFR2
FGF20,SHC-mediated cascade:FGFR2
FGF20,FRS-mediated FGFR2 signaling
FGF20,FRS-mediated FGFR3 signaling
FGF20,Downstream signaling of activated FGFR3
FGF20,FRS-mediated FGFR4 signaling
FGF20,Downstream signaling of activated FGFR4
FGF20,SHC-mediated cascade:FGFR4
FGF20,PI-3K cascade:FGFR4
FGF20,Negative regulation of FGFR1 signaling
FGF20,Negative regulation of FGFR2 signaling
FGF20,Negative regulation of FGFR3 signaling
FGF20,Negative regulation of FGFR4 signaling
FGF20,Signaling by FGFR1
FGF20,Signaling by FGFR2
FGF20,Signaling by FGFR3
FGF20,Signaling by FGFR4
FGF20,Signaling by FGFR2 in disease
FGF20,Signaling by FGFR1 in disease
FGF20,Signaling by FGFR3 in disease
FGF20,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF20,Insulin receptor signalling cascade
FGF20,Signaling by Insulin receptor
ARFGAP3,RHOG GTPase cycle
GCGR,Class B/2 (Secretin family receptors)
GCGR,G alpha (s) signalling events
GCGR,Glucagon-type ligand receptors
GCK,SLC transporter disorders
GCK,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
GCK,Disorders of transmembrane transporters
GCKR,SLC transporter disorders
GCKR,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
GCKR,Disorders of transmembrane transporters
PTPN18,Signaling by ERBB2
PTPN18,Downregulation of ERBB2 signaling
KAT2A,Pre-NOTCH Transcription and Translation
KAT2A,Pre-NOTCH Expression and Processing
KAT2A,Signaling by NOTCH1
KAT2A,NOTCH1 Intracellular Domain Regulates Transcription
KAT2A,Signaling by NOTCH1 PEST Domain Mutants in Cancer
KAT2A,Signaling by NOTCH1 in Cancer
KAT2A,Constitutive Signaling by NOTCH1 PEST Domain Mutants
KAT2A,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
KAT2A,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
KAT2A,Signaling by NOTCH3
KAT2A,NOTCH3 Intracellular Domain Regulates Transcription
KAT2A,Signaling by NOTCH4
KAT2A,NOTCH4 Intracellular Domain Regulates Transcription
HEYL,Signaling by NOTCH1
HEYL,NOTCH1 Intracellular Domain Regulates Transcription
HEYL,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HEYL,Signaling by NOTCH1 in Cancer
HEYL,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HEYL,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HEYL,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HEYL,Signaling by NOTCH3
HEYL,NOTCH3 Intracellular Domain Regulates Transcription
LATS2,Signaling by Hippo
AATF,NRAGE signals death through JNK
AATF,p75 NTR receptor-mediated signalling
AATF,"Cell death signalling via NRAGE, NRIF and NADE"
RGS17,G alpha (z) signalling events
GDF2,Signaling by BMP
GFAP,Signaling by ERBB4
GFAP,Nuclear signaling by ERBB4
HAVCR1,Early SARS-CoV-2 Infection Events
AMH,Signaling by BMP
B4GALT1,Pre-NOTCH Processing in Golgi
B4GALT1,Pre-NOTCH Expression and Processing
AMHR2,Signaling by BMP
GHRH,Class B/2 (Secretin family receptors)
GHRH,G alpha (s) signalling events
GHRH,Glucagon-type ligand receptors
GHRHR,Class B/2 (Secretin family receptors)
GHRHR,G alpha (s) signalling events
GHRHR,Glucagon-type ligand receptors
GIPR,Class B/2 (Secretin family receptors)
GIPR,G alpha (s) signalling events
GIPR,Glucagon-type ligand receptors
NBEA,Opioid Signalling
NBEA,PKA-mediated phosphorylation of CREB
NBEA,Calmodulin induced events
NBEA,Ca-dependent events
NBEA,CaM pathway
NBEA,G-protein mediated events
NBEA,PLC beta mediated events
NBEA,DAG and IP3 signaling
NBEA,PKA activation
NBEA,Signaling by NOTCH1
NBEA,NOTCH1 Intracellular Domain Regulates Transcription
GJA1,RHOQ GTPase cycle
GJA1,RHOJ GTPase cycle
CYFIP2,Signaling by VEGF
CYFIP2,VEGFA-VEGFR2 Pathway
CYFIP2,RHO GTPases Activate WASPs and WAVEs
CYFIP2,Parasite infection
CYFIP2,Leishmania phagocytosis
CYFIP2,FCGR3A-mediated phagocytosis
ABL2,RAC3 GTPase cycle
USP21,TNFR1-induced proapoptotic signaling
USP21,Regulation of TNFR1 signaling
USP21,TNFR1-induced NF-kappa-B signaling pathway
USP21,TNF signaling
FGF22,PI3K Cascade
FGF22,IRS-mediated signalling
FGF22,Signaling by FGFR in disease
FGF22,FGFR2 mutant receptor activation
FGF22,Signaling by FGFR
FGF22,FGFR2 ligand binding and activation
FGF22,Negative regulation of the PI3K/AKT network
FGF22,Activated point mutants of FGFR2
FGF22,PI3K/AKT Signaling in Cancer
FGF22,Constitutive Signaling by Aberrant PI3K in Cancer
FGF22,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF22,IGF1R signaling cascade
FGF22,IRS-related events triggered by IGF1R
FGF22,Phospholipase C-mediated cascade; FGFR2
FGF22,Downstream signaling of activated FGFR1
FGF22,PI-3K cascade:FGFR1
FGF22,FRS-mediated FGFR1 signaling
FGF22,PI-3K cascade:FGFR2
FGF22,Downstream signaling of activated FGFR2
FGF22,SHC-mediated cascade:FGFR2
FGF22,FRS-mediated FGFR2 signaling
FGF22,Negative regulation of FGFR1 signaling
FGF22,Negative regulation of FGFR2 signaling
FGF22,Signaling by FGFR1
FGF22,Signaling by FGFR2
FGF22,Signaling by FGFR2 in disease
FGF22,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF22,Insulin receptor signalling cascade
FGF22,Signaling by Insulin receptor
NOX1,RHO GTPases Activate NADPH Oxidases
NOX1,RAC3 GTPase cycle
PELP1,Signaling by PTK6
PELP1,Signaling by Non-Receptor Tyrosine Kinases
VPS41,SARS-CoV-2 modulates autophagy
ST6GALNAC4,Translation of Structural Proteins
ST6GALNAC4,Maturation of spike protein
ST6GALNAC4,Late SARS-CoV-2 Infection Events
DKK4,Signaling by WNT in cancer
DKK2,Signaling by WNT in cancer
FILIP1,RHOD GTPase cycle
INTU,Hedgehog 'off' state
VPS4A,Budding and maturation of HIV virion
VPS4A,HCMV Infection
VPS4A,HCMV Late Events
GLB1,Diseases of glycosylation
GLB1,Diseases of metabolism
ARHGEF16,NRAGE signals death through JNK
ARHGEF16,p75 NTR receptor-mediated signalling
ARHGEF16,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF16,G alpha (12/13) signalling events
ARHGEF16,RHOG GTPase cycle
CHMP2A,Budding and maturation of HIV virion
CHMP2A,HCMV Infection
CHMP2A,HCMV Late Events
CHMP2A,Translation of Replicase and Assembly of the Replication Transcription Complex
CHMP2A,Early SARS-CoV-2 Infection Events
ERLEC1,Hedgehog ligand biogenesis
ERLEC1,Hh mutants are degraded by ERAD
ERLEC1,Hh mutants abrogate ligand secretion
ERLEC1,ABC transporter disorders
ERLEC1,Disorders of transmembrane transporters
ERLEC1,Defective CFTR causes cystic fibrosis
RND1,RND1 GTPase cycle
GCLM,Diseases of metabolism
BMP10,Signaling by BMP
RBMX,RHOBTB2 GTPase cycle
RBMX,RHOBTB1 GTPase cycle
RBMX,RND3 GTPase cycle
RBMX,RND2 GTPase cycle
RBMX,RND1 GTPase cycle
RBMX,RHOBTB GTPase Cycle
TNRC6A,Pre-NOTCH Transcription and Translation
TNRC6A,Pre-NOTCH Expression and Processing
TNRC6A,Ca2+ pathway
TNRC6A,MAPK6/MAPK4 signaling
TNRC6A,Regulation of PTEN mRNA translation
TNRC6A,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
TNRC6A,Estrogen-dependent gene expression
TNRC6A,NR1H2 and NR1H3-mediated signaling
TNRC6A,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
TNRC6A,Signaling by TGFBR3
TNRC6A,TGFBR3 expression
ANGPTL3,NR1H2 and NR1H3-mediated signaling
P2RY10,P2Y receptors
P2RY10,Nucleotide-like (purinergic) receptors
UBE2S,Diseases of mitotic cell cycle
UBE2S,Aberrant regulation of mitotic exit in cancer due to RB1 defects
UBE2S,Aberrant regulation of mitotic cell cycle due to RB1 defects
GLI1,Degradation of GLI1 by the proteasome
GLI1,Hedgehog 'off' state
GLI1,Hedgehog 'on' state
GLI2,Degradation of GLI2 by the proteasome
GLI2,Hedgehog 'off' state
GLI2,Hedgehog 'on' state
GLI3,GLI3 is processed to GLI3R by the proteasome
GLI3,Hedgehog 'off' state
GLI3,Hedgehog 'on' state
GLP1R,Class B/2 (Secretin family receptors)
GLP1R,G alpha (s) signalling events
GLP1R,Glucagon-type ligand receptors
GNA11,Opioid Signalling
GNA11,G-protein mediated events
GNA11,PLC beta mediated events
GNA11,G-protein activation
GNA12,G alpha (12/13) signalling events
GNA15,Opioid Signalling
GNA15,G-protein mediated events
GNA15,PLC beta mediated events
GNA15,G-protein activation
GNAI1,Opioid Signalling
GNAI1,G-protein mediated events
GNAI1,Adenylate cyclase inhibitory pathway
GNAI1,G alpha (s) signalling events
GNAI1,G alpha (z) signalling events
GNAI1,Extra-nuclear estrogen signaling
GNAI1,GPER1 signaling
GNAI1,ADORA2B mediated anti-inflammatory cytokines production
GNAI1,Anti-inflammatory response favouring Leishmania parasite infection
GNAI1,Leishmania parasite growth and survival
GNAI2,Opioid Signalling
GNAI2,G-protein mediated events
GNAI2,Adenylate cyclase inhibitory pathway
GNAI2,G alpha (s) signalling events
GNAI2,G alpha (z) signalling events
GNAI2,Extra-nuclear estrogen signaling
GNAI2,GPER1 signaling
GNAI2,ADORA2B mediated anti-inflammatory cytokines production
GNAI2,Anti-inflammatory response favouring Leishmania parasite infection
GNAI2,Leishmania parasite growth and survival
GNAI3,Opioid Signalling
GNAI3,G-protein mediated events
GNAI3,Adenylate cyclase inhibitory pathway
GNAI3,G alpha (s) signalling events
GNAI3,G alpha (z) signalling events
GNAI3,Extra-nuclear estrogen signaling
GNAI3,GPER1 signaling
GNAI3,ADORA2B mediated anti-inflammatory cytokines production
GNAI3,Anti-inflammatory response favouring Leishmania parasite infection
GNAI3,Leishmania parasite growth and survival
GNAL,Opioid Signalling
GNAL,G-protein mediated events
GNAL,Adenylate cyclase activating pathway
GNAL,Adenylate cyclase inhibitory pathway
GNAO1,Ca2+ pathway
GNAQ,Opioid Signalling
GNAQ,G-protein mediated events
GNAQ,PLC beta mediated events
GNAQ,G-protein activation
GNAT2,Ca2+ pathway
GNAZ,G alpha (s) signalling events
GNAZ,G alpha (z) signalling events
GNAZ,GPER1 signaling
GNAZ,ADORA2B mediated anti-inflammatory cytokines production
GNAZ,Anti-inflammatory response favouring Leishmania parasite infection
GNAZ,Leishmania parasite growth and survival
GNB1,Opioid Signalling
GNB1,G-protein activation
GNB1,Class B/2 (Secretin family receptors)
GNB1,G beta:gamma signalling through PI3Kgamma
GNB1,G-protein beta:gamma signalling
GNB1,Ca2+ pathway
GNB1,G alpha (12/13) signalling events
GNB1,G beta:gamma signalling through PLC beta
GNB1,G alpha (s) signalling events
GNB1,G alpha (z) signalling events
GNB1,Glucagon-type ligand receptors
GNB1,G beta:gamma signalling through BTK
GNB1,G beta:gamma signalling through CDC42
GNB1,Extra-nuclear estrogen signaling
GNB1,GPER1 signaling
GNB1,ADORA2B mediated anti-inflammatory cytokines production
GNB1,Anti-inflammatory response favouring Leishmania parasite infection
GNB1,Leishmania parasite growth and survival
GNB2,Opioid Signalling
GNB2,G-protein activation
GNB2,Class B/2 (Secretin family receptors)
GNB2,G beta:gamma signalling through PI3Kgamma
GNB2,G-protein beta:gamma signalling
GNB2,Ca2+ pathway
GNB2,G alpha (12/13) signalling events
GNB2,G beta:gamma signalling through PLC beta
GNB2,G alpha (s) signalling events
GNB2,G alpha (z) signalling events
GNB2,Glucagon-type ligand receptors
GNB2,G beta:gamma signalling through BTK
GNB2,G beta:gamma signalling through CDC42
GNB2,Extra-nuclear estrogen signaling
GNB2,GPER1 signaling
GNB2,ADORA2B mediated anti-inflammatory cytokines production
GNB2,Anti-inflammatory response favouring Leishmania parasite infection
GNB2,Leishmania parasite growth and survival
GNB3,Opioid Signalling
GNB3,G-protein activation
GNB3,Class B/2 (Secretin family receptors)
GNB3,G beta:gamma signalling through PI3Kgamma
GNB3,G-protein beta:gamma signalling
GNB3,Ca2+ pathway
GNB3,G alpha (12/13) signalling events
GNB3,G beta:gamma signalling through PLC beta
GNB3,G alpha (s) signalling events
GNB3,G alpha (z) signalling events
GNB3,Glucagon-type ligand receptors
GNB3,G beta:gamma signalling through BTK
GNB3,G beta:gamma signalling through CDC42
GNB3,Extra-nuclear estrogen signaling
GNB3,GPER1 signaling
GNB3,ADORA2B mediated anti-inflammatory cytokines production
GNB3,Anti-inflammatory response favouring Leishmania parasite infection
GNB3,Leishmania parasite growth and survival
GNG3,Opioid Signalling
GNG3,G-protein activation
GNG3,Class B/2 (Secretin family receptors)
GNG3,G beta:gamma signalling through PI3Kgamma
GNG3,G-protein beta:gamma signalling
GNG3,Ca2+ pathway
GNG3,G alpha (12/13) signalling events
GNG3,G beta:gamma signalling through PLC beta
GNG3,G alpha (s) signalling events
GNG3,G alpha (z) signalling events
GNG3,Glucagon-type ligand receptors
GNG3,G beta:gamma signalling through BTK
GNG3,G beta:gamma signalling through CDC42
GNG3,Extra-nuclear estrogen signaling
GNG3,GPER1 signaling
GNG3,ADORA2B mediated anti-inflammatory cytokines production
GNG3,Anti-inflammatory response favouring Leishmania parasite infection
GNG3,Leishmania parasite growth and survival
GNG4,Opioid Signalling
GNG4,G-protein activation
GNG4,Class B/2 (Secretin family receptors)
GNG4,G beta:gamma signalling through PI3Kgamma
GNG4,G-protein beta:gamma signalling
GNG4,Ca2+ pathway
GNG4,G alpha (12/13) signalling events
GNG4,G beta:gamma signalling through PLC beta
GNG4,G alpha (s) signalling events
GNG4,G alpha (z) signalling events
GNG4,Glucagon-type ligand receptors
GNG4,G beta:gamma signalling through BTK
GNG4,G beta:gamma signalling through CDC42
GNG4,Extra-nuclear estrogen signaling
GNG4,GPER1 signaling
GNG4,ADORA2B mediated anti-inflammatory cytokines production
GNG4,Anti-inflammatory response favouring Leishmania parasite infection
GNG4,Leishmania parasite growth and survival
GNG5,Opioid Signalling
GNG5,G-protein activation
GNG5,Class B/2 (Secretin family receptors)
GNG5,G beta:gamma signalling through PI3Kgamma
GNG5,G-protein beta:gamma signalling
GNG5,Ca2+ pathway
GNG5,G alpha (12/13) signalling events
GNG5,G beta:gamma signalling through PLC beta
GNG5,G alpha (s) signalling events
GNG5,G alpha (z) signalling events
GNG5,Glucagon-type ligand receptors
GNG5,G beta:gamma signalling through BTK
GNG5,G beta:gamma signalling through CDC42
GNG5,Extra-nuclear estrogen signaling
GNG5,GPER1 signaling
GNG5,ADORA2B mediated anti-inflammatory cytokines production
GNG5,Anti-inflammatory response favouring Leishmania parasite infection
GNG5,Leishmania parasite growth and survival
GNG7,Opioid Signalling
GNG7,G-protein activation
GNG7,Class B/2 (Secretin family receptors)
GNG7,G beta:gamma signalling through PI3Kgamma
GNG7,G-protein beta:gamma signalling
GNG7,Ca2+ pathway
GNG7,G alpha (12/13) signalling events
GNG7,G beta:gamma signalling through PLC beta
GNG7,G alpha (s) signalling events
GNG7,G alpha (z) signalling events
GNG7,Glucagon-type ligand receptors
GNG7,G beta:gamma signalling through BTK
GNG7,G beta:gamma signalling through CDC42
GNG7,Extra-nuclear estrogen signaling
GNG7,GPER1 signaling
GNG7,ADORA2B mediated anti-inflammatory cytokines production
GNG7,Anti-inflammatory response favouring Leishmania parasite infection
GNG7,Leishmania parasite growth and survival
GNG10,Opioid Signalling
GNG10,G-protein activation
GNG10,Class B/2 (Secretin family receptors)
GNG10,G beta:gamma signalling through PI3Kgamma
GNG10,G-protein beta:gamma signalling
GNG10,Ca2+ pathway
GNG10,G alpha (12/13) signalling events
GNG10,G beta:gamma signalling through PLC beta
GNG10,G alpha (s) signalling events
GNG10,G alpha (z) signalling events
GNG10,Glucagon-type ligand receptors
GNG10,G beta:gamma signalling through BTK
GNG10,G beta:gamma signalling through CDC42
GNG10,Extra-nuclear estrogen signaling
GNG10,GPER1 signaling
GNG10,ADORA2B mediated anti-inflammatory cytokines production
GNG10,Anti-inflammatory response favouring Leishmania parasite infection
GNG10,Leishmania parasite growth and survival
GNG11,Opioid Signalling
GNG11,G-protein activation
GNG11,Class B/2 (Secretin family receptors)
GNG11,G beta:gamma signalling through PI3Kgamma
GNG11,G-protein beta:gamma signalling
GNG11,Ca2+ pathway
GNG11,G alpha (12/13) signalling events
GNG11,G beta:gamma signalling through PLC beta
GNG11,G alpha (s) signalling events
GNG11,G alpha (z) signalling events
GNG11,Glucagon-type ligand receptors
GNG11,G beta:gamma signalling through BTK
GNG11,G beta:gamma signalling through CDC42
GNG11,Extra-nuclear estrogen signaling
GNG11,GPER1 signaling
GNG11,ADORA2B mediated anti-inflammatory cytokines production
GNG11,Anti-inflammatory response favouring Leishmania parasite infection
GNG11,Leishmania parasite growth and survival
GNGT1,Opioid Signalling
GNGT1,G-protein activation
GNGT1,Class B/2 (Secretin family receptors)
GNGT1,G beta:gamma signalling through PI3Kgamma
GNGT1,G-protein beta:gamma signalling
GNGT1,Ca2+ pathway
GNGT1,G alpha (12/13) signalling events
GNGT1,G beta:gamma signalling through PLC beta
GNGT1,G alpha (s) signalling events
GNGT1,G alpha (z) signalling events
GNGT1,Glucagon-type ligand receptors
GNGT1,G beta:gamma signalling through BTK
GNGT1,G beta:gamma signalling through CDC42
GNGT1,Extra-nuclear estrogen signaling
GNGT1,GPER1 signaling
GNGT1,ADORA2B mediated anti-inflammatory cytokines production
GNGT1,Anti-inflammatory response favouring Leishmania parasite infection
GNGT1,Leishmania parasite growth and survival
GNGT2,Opioid Signalling
GNGT2,G-protein activation
GNGT2,Class B/2 (Secretin family receptors)
GNGT2,G beta:gamma signalling through PI3Kgamma
GNGT2,G-protein beta:gamma signalling
GNGT2,Ca2+ pathway
GNGT2,G alpha (12/13) signalling events
GNGT2,G beta:gamma signalling through PLC beta
GNGT2,G alpha (s) signalling events
GNGT2,G alpha (z) signalling events
GNGT2,Glucagon-type ligand receptors
GNGT2,G beta:gamma signalling through BTK
GNGT2,G beta:gamma signalling through CDC42
GNGT2,Extra-nuclear estrogen signaling
GNGT2,GPER1 signaling
GNGT2,ADORA2B mediated anti-inflammatory cytokines production
GNGT2,Anti-inflammatory response favouring Leishmania parasite infection
GNGT2,Leishmania parasite growth and survival
GOLGA2,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
GOLGA2,Neurodegenerative Diseases
GOLGA2,Diseases of programmed cell death
GOLGA2,Defective Intrinsic Pathway for Apoptosis
GOLGA3,RND2 GTPase cycle
SFN,RHO GTPases activate PKNs
SFN,SARS-CoV-1-host interactions
SFN,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
CCR10,Peptide ligand-binding receptors
CCR10,Chemokine receptors bind chemokines
XCR1,Peptide ligand-binding receptors
XCR1,Chemokine receptors bind chemokines
BCL9L,Formation of the beta-catenin:TCF transactivating complex
BCL9L,Deactivation of the beta-catenin transactivating complex
CXCR3,Peptide ligand-binding receptors
CXCR3,Chemokine receptors bind chemokines
KSR2,MAP2K and MAPK activation
KSR2,Signaling by moderate kinase activity BRAF mutants
KSR2,Signaling by high-kinase activity BRAF mutants
KSR2,Signaling by RAS mutants
KSR2,Signaling by BRAF and RAF1 fusions
KSR2,Paradoxical activation of RAF signaling by kinase inactive BRAF
KSR2,Oncogenic MAPK signaling
KSR2,Signaling downstream of RAS mutants
KSR2,Signaling by RAF1 mutants
GPR17,Eicosanoid ligand-binding receptors
GPR17,P2Y receptors
GPR17,Nucleotide-like (purinergic) receptors
LAMA1,Signaling by MET
LAMA1,MET activates PTK2 signaling
LAMA1,MET promotes cell motility
LPAR4,P2Y receptors
LPAR4,Nucleotide-like (purinergic) receptors
RSPO1,Regulation of FZD by ubiquitination
DLL1,Signaling by NOTCH1
DLL1,Signaling by NOTCH2
DLL1,Activated NOTCH1 Transmits Signal to the Nucleus
DLL1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
DLL1,Signaling by NOTCH1 in Cancer
DLL1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
DLL1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
DLL1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
DLL1,NOTCH2 Activation and Transmission of Signal to the Nucleus
DLL1,Signaling by NOTCH3
DLL1,NOTCH3 Activation and Transmission of Signal to the Nucleus
GPS1,RHOBTB1 GTPase cycle
GPS1,RHOBTB GTPase Cycle
GPS2,Loss of function of MECP2 in Rett syndrome
GPS2,Pervasive developmental disorders
GPS2,NR1H2 and NR1H3-mediated signaling
GPS2,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
GPS2,HCMV Infection
GPS2,HCMV Early Events
GPS2,Disorders of Developmental Biology
GPS2,Disorders of Nervous System Development
GRB2,FLT3 signaling in disease
GRB2,Signaling by ALK in cancer
GRB2,Signaling by FLT3 ITD and TKD mutants
GRB2,Signaling by ALK fusions and activated point mutants
GRB7,Signaling by ERBB2
GRB7,Signaling by SCF-KIT
GRB7,Downstream signal transduction
GRB7,Signaling by PDGF
GRB7,RND1 GTPase cycle
GRB10,Signaling by SCF-KIT
GRB10,Insulin receptor signalling cascade
GRB10,Signaling by Insulin receptor
RAPGEF1,Prolonged ERK activation events
RAPGEF1,Frs2-mediated activation
RAPGEF1,Downstream signal transduction
RAPGEF1,Signaling by PDGF
RAPGEF1,Signaling by NTRK1 (TRKA)
RAPGEF1,Signalling to ERKs
RAPGEF1,Signaling by MET
RAPGEF1,MET promotes cell motility
RAPGEF1,Signaling by Erythropoietin
RAPGEF1,RAC3 GTPase cycle
GIT1,RAC2 GTPase cycle
GIT1,RHOQ GTPase cycle
GIT1,RHOJ GTPase cycle
GIT1,RHOU GTPase cycle
GIT1,RAC3 GTPase cycle
GIT1,RHOV GTPase cycle
SPCS1,Respiratory Syncytial Virus Infection Pathway
SPCS1,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
SPCS1,Maturation of hRSV A proteins
ABR,NRAGE signals death through JNK
ABR,p75 NTR receptor-mediated signalling
ABR,"Cell death signalling via NRAGE, NRIF and NADE"
ABR,G alpha (12/13) signalling events
ABR,RHOA GTPase cycle
ABR,RHOB GTPase cycle
ABR,RHOC GTPase cycle
ABR,RAC2 GTPase cycle
ABR,RAC3 GTPase cycle
GRIN2B,Signaling by NTRK2 (TRKB)
MED4,Respiratory Syncytial Virus Infection Pathway
MED4,RSV-host interactions
NR3C1,Signaling by PTK6
NR3C1,Signaling by Non-Receptor Tyrosine Kinases
NR3C1,Potential therapeutics for SARS
CHMP4A,Budding and maturation of HIV virion
CHMP4A,HCMV Infection
CHMP4A,HCMV Late Events
CHMP4A,Translation of Replicase and Assembly of the Replication Transcription Complex
CHMP4A,Early SARS-CoV-2 Infection Events
PYCARD,Purinergic signaling in leishmaniasis infection
PYCARD,Cell recruitment (pro-inflammatory response)
PYCARD,SARS-CoV-1-host interactions
PYCARD,SARS-CoV-1 activates/modulates innate immune responses
GRM1,Class C/3 (Metabotropic glutamate/pheromone receptors)
TBK1,Regulation of TNFR1 signaling
TBK1,TNF signaling
TBK1,SARS-CoV-1-host interactions
TBK1,SARS-CoV-1 activates/modulates innate immune responses
TBK1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
MYLIP,NR1H2 and NR1H3-mediated signaling
GRM2,Class C/3 (Metabotropic glutamate/pheromone receptors)
CD274,Signaling by ALK
CD274,STAT3 nuclear events downstream of ALK signaling
RACGAP1,RHOA GTPase cycle
RACGAP1,RHOB GTPase cycle
RACGAP1,RHOC GTPase cycle
RACGAP1,RAC2 GTPase cycle
RACGAP1,RHOD GTPase cycle
RACGAP1,RAC3 GTPase cycle
GRM3,Class C/3 (Metabotropic glutamate/pheromone receptors)
GRM4,Class C/3 (Metabotropic glutamate/pheromone receptors)
GRM5,Class C/3 (Metabotropic glutamate/pheromone receptors)
GRM6,Class C/3 (Metabotropic glutamate/pheromone receptors)
GRM7,Class C/3 (Metabotropic glutamate/pheromone receptors)
GRM8,Class C/3 (Metabotropic glutamate/pheromone receptors)
SLC25A5,Host Interactions of HIV factors
SLC25A5,Interactions of Vpr with host cellular proteins
GRSF1,Viral mRNA Translation
SLC25A6,Host Interactions of HIV factors
SLC25A6,Interactions of Vpr with host cellular proteins
GSK3A,AKT phosphorylates targets in the cytosol
GSK3A,PI3K/AKT Signaling in Cancer
GSK3A,Constitutive Signaling by AKT1 E17K in Cancer
GSK3A,Infection with Mycobacterium tuberculosis
GSK3A,Response of Mtb to phagocytosis
GSK3A,Maturation of nucleoprotein
GSK3A,Translation of Structural Proteins
GSK3A,Late SARS-CoV-2 Infection Events
GSK3A,Bacterial Infection Pathways
GSK3B,Degradation of beta-catenin by the destruction complex
GSK3B,Beta-catenin phosphorylation cascade
GSK3B,AKT phosphorylates targets in the cytosol
GSK3B,PI3K/AKT Signaling in Cancer
GSK3B,Disassembly of the destruction complex and recruitment of AXIN to the membrane
GSK3B,Signaling by WNT in cancer
GSK3B,Signaling by AXIN mutants
GSK3B,Signaling by CTNNB1 phospho-site mutants
GSK3B,Signaling by APC mutants
GSK3B,Signaling by AMER1 mutants
GSK3B,CTNNB1 S33 mutants aren't phosphorylated
GSK3B,CTNNB1 S37 mutants aren't phosphorylated
GSK3B,CTNNB1 S45 mutants aren't phosphorylated
GSK3B,CTNNB1 T41 mutants aren't phosphorylated
GSK3B,APC truncation mutants have impaired AXIN binding
GSK3B,AXIN missense mutants destabilize the destruction complex
GSK3B,Truncations of AMER1 destabilize the destruction complex
GSK3B,Degradation of GLI2 by the proteasome
GSK3B,GLI3 is processed to GLI3R by the proteasome
GSK3B,Hedgehog 'off' state
GSK3B,Constitutive Signaling by AKT1 E17K in Cancer
GSK3B,Maturation of nucleoprotein
GSK3B,Translation of Structural Proteins
GSK3B,Late SARS-CoV-2 Infection Events
MSH6,Diseases of DNA repair
GTF2A2,HIV Transcription Initiation
GTF2A2,RNA Polymerase II HIV Promoter Escape
GTF2A2,Transcription of the HIV genome
GTF2A2,Estrogen-dependent gene expression
GTF2B,HIV Transcription Initiation
GTF2B,RNA Polymerase II HIV Promoter Escape
GTF2B,Transcription of the HIV genome
GTF2E1,HIV Transcription Initiation
GTF2E1,RNA Polymerase II HIV Promoter Escape
GTF2E1,Transcription of the HIV genome
GTF2E2,HIV Transcription Initiation
GTF2E2,RNA Polymerase II HIV Promoter Escape
GTF2E2,Transcription of the HIV genome
GTF2F1,Signaling by FGFR in disease
GTF2F1,Formation of HIV elongation complex in the absence of HIV Tat
GTF2F1,Formation of the HIV-1 Early Elongation Complex
GTF2F1,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
GTF2F1,HIV Transcription Initiation
GTF2F1,RNA Polymerase II HIV Promoter Escape
GTF2F1,HIV Transcription Elongation
GTF2F1,Transcription of the HIV genome
GTF2F1,Formation of HIV-1 elongation complex containing HIV-1 Tat
GTF2F1,Pausing and recovery of Tat-mediated HIV elongation
GTF2F1,Abortive elongation of HIV-1 transcript in the absence of Tat
GTF2F1,Tat-mediated HIV elongation arrest and recovery
GTF2F1,Tat-mediated elongation of the HIV-1 transcript
GTF2F1,HIV elongation arrest and recovery
GTF2F1,Pausing and recovery of HIV elongation
GTF2F1,Viral Messenger RNA Synthesis
GTF2F1,FGFR2 mutant receptor activation
GTF2F1,Signaling by FGFR
GTF2F1,Signaling by FGFR2
GTF2F1,Signaling by FGFR2 in disease
GTF2F1,FGFR2 alternative splicing
GTF2F1,Signaling by FGFR2 IIIa TM
GTF2F1,Estrogen-dependent gene expression
GTF2F2,Signaling by FGFR in disease
GTF2F2,Formation of HIV elongation complex in the absence of HIV Tat
GTF2F2,Formation of the HIV-1 Early Elongation Complex
GTF2F2,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
GTF2F2,HIV Transcription Initiation
GTF2F2,RNA Polymerase II HIV Promoter Escape
GTF2F2,HIV Transcription Elongation
GTF2F2,Transcription of the HIV genome
GTF2F2,Formation of HIV-1 elongation complex containing HIV-1 Tat
GTF2F2,Pausing and recovery of Tat-mediated HIV elongation
GTF2F2,Abortive elongation of HIV-1 transcript in the absence of Tat
GTF2F2,Tat-mediated HIV elongation arrest and recovery
GTF2F2,Tat-mediated elongation of the HIV-1 transcript
GTF2F2,HIV elongation arrest and recovery
GTF2F2,Pausing and recovery of HIV elongation
GTF2F2,Viral Messenger RNA Synthesis
GTF2F2,FGFR2 mutant receptor activation
GTF2F2,Signaling by FGFR
GTF2F2,Signaling by FGFR2
GTF2F2,Signaling by FGFR2 in disease
GTF2F2,FGFR2 alternative splicing
GTF2F2,Signaling by FGFR2 IIIa TM
GTF2F2,Estrogen-dependent gene expression
GTF2H1,Formation of HIV elongation complex in the absence of HIV Tat
GTF2H1,Formation of the HIV-1 Early Elongation Complex
GTF2H1,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
GTF2H1,HIV Transcription Initiation
GTF2H1,RNA Polymerase II HIV Promoter Escape
GTF2H1,HIV Transcription Elongation
GTF2H1,Transcription of the HIV genome
GTF2H1,Formation of HIV-1 elongation complex containing HIV-1 Tat
GTF2H1,Tat-mediated elongation of the HIV-1 transcript
GTF2H2,Formation of HIV elongation complex in the absence of HIV Tat
GTF2H2,Formation of the HIV-1 Early Elongation Complex
GTF2H2,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
GTF2H2,HIV Transcription Initiation
GTF2H2,RNA Polymerase II HIV Promoter Escape
GTF2H2,HIV Transcription Elongation
GTF2H2,Transcription of the HIV genome
GTF2H2,Formation of HIV-1 elongation complex containing HIV-1 Tat
GTF2H2,Tat-mediated elongation of the HIV-1 transcript
GTF2H3,Formation of HIV elongation complex in the absence of HIV Tat
GTF2H3,Formation of the HIV-1 Early Elongation Complex
GTF2H3,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
GTF2H3,HIV Transcription Initiation
GTF2H3,RNA Polymerase II HIV Promoter Escape
GTF2H3,HIV Transcription Elongation
GTF2H3,Transcription of the HIV genome
GTF2H3,Formation of HIV-1 elongation complex containing HIV-1 Tat
GTF2H3,Tat-mediated elongation of the HIV-1 transcript
GTF2H4,Formation of HIV elongation complex in the absence of HIV Tat
GTF2H4,Formation of the HIV-1 Early Elongation Complex
GTF2H4,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
GTF2H4,HIV Transcription Initiation
GTF2H4,RNA Polymerase II HIV Promoter Escape
GTF2H4,HIV Transcription Elongation
GTF2H4,Transcription of the HIV genome
GTF2H4,Formation of HIV-1 elongation complex containing HIV-1 Tat
GTF2H4,Tat-mediated elongation of the HIV-1 transcript
TMOD3,RHOBTB2 GTPase cycle
TMOD3,RND3 GTPase cycle
TMOD3,RHOBTB GTPase Cycle
ZDHHC8,Maturation of spike protein
ZDHHC8,Translation of Structural Proteins
ZDHHC8,Late SARS-CoV-2 Infection Events
GUCY2C,Uptake and actions of bacterial toxins
GUCY2C,Bacterial Infection Pathways
SENP1,RHOF GTPase cycle
ICOS,Signaling by ALK in cancer
ICOS,Signaling by ALK fusions and activated point mutants
ICOS,Nuclear events stimulated by ALK signaling in cancer
ANAPC2,Diseases of mitotic cell cycle
ANAPC2,Aberrant regulation of mitotic exit in cancer due to RB1 defects
ANAPC2,Aberrant regulation of mitotic cell cycle due to RB1 defects
EEF2K,MTOR signalling
EEF2K,mTORC1-mediated signalling
GYG1,Diseases of metabolism
EPN1,Signaling by EGFR
EPN1,EGFR downregulation
PKN3,RHO GTPases activate PKNs
PKN3,RHOA GTPase cycle
PKN3,RHOB GTPase cycle
PKN3,RHOC GTPase cycle
ANAPC4,Diseases of mitotic cell cycle
ANAPC4,Aberrant regulation of mitotic exit in cancer due to RB1 defects
ANAPC4,Aberrant regulation of mitotic cell cycle due to RB1 defects
POMT2,Diseases of glycosylation
POMT2,Diseases associated with O-glycosylation of proteins
POMT2,Diseases of metabolism
GYS1,Diseases of metabolism
GYS2,Diseases of metabolism
RHOD,RHO GTPases Activate Formins
RHOD,RHOD GTPase cycle
SH3KBP1,Signaling by EGFR
SH3KBP1,EGFR downregulation
SH3KBP1,Signaling by MET
SH3KBP1,Negative regulation of MET activity
SH3KBP1,InlB-mediated entry of Listeria monocytogenes into host cell
SH3KBP1,Listeria monocytogenes entry into host cells
SH3KBP1,Potential therapeutics for SARS
SH3KBP1,Bacterial Infection Pathways
GZMB,Signaling by NOTCH2
GZMB,NOTCH2 intracellular domain regulates transcription
GZMB,Signaling by ALK in cancer
GZMB,Signaling by ALK fusions and activated point mutants
GZMB,Nuclear events stimulated by ALK signaling in cancer
SLC40A1,SLC transporter disorders
SLC40A1,Disorders of transmembrane transporters
HCK,Host Interactions of HIV factors
HCK,The role of Nef in HIV-1 replication and disease pathogenesis
HCK,Anti-inflammatory response favouring Leishmania parasite infection
HCK,FCGR3A-mediated IL10 synthesis
HCK,Parasite infection
HCK,Leishmania phagocytosis
HCK,FCGR3A-mediated phagocytosis
HCK,Leishmania parasite growth and survival
HDAC1,Signaling by TGF-beta Receptor Complex
HDAC1,p75 NTR receptor-mediated signalling
HDAC1,Degradation of beta-catenin by the destruction complex
HDAC1,Signaling by NOTCH1
HDAC1,Signaling by ALK
HDAC1,Formation of the beta-catenin:TCF transactivating complex
HDAC1,NOTCH1 Intracellular Domain Regulates Transcription
HDAC1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
HDAC1,Downregulation of SMAD2/3:SMAD4 transcriptional activity
HDAC1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
HDAC1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC1,Signaling by NOTCH1 in Cancer
HDAC1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HDAC1,Deactivation of the beta-catenin transactivating complex
HDAC1,Repression of WNT target genes
HDAC1,Regulation of PTEN gene transcription
HDAC1,Loss of function of MECP2 in Rett syndrome
HDAC1,Pervasive developmental disorders
HDAC1,Estrogen-dependent gene expression
HDAC1,Disorders of Developmental Biology
HDAC1,Potential therapeutics for SARS
HDAC1,Disorders of Nervous System Development
HDAC1,Signaling by ALK in cancer
HDAC1,STAT3 nuclear events downstream of ALK signaling
HDAC1,Signaling by ALK fusions and activated point mutants
HDAC1,Nuclear events stimulated by ALK signaling in cancer
HDAC2,p75 NTR receptor-mediated signalling
HDAC2,Signaling by NOTCH1
HDAC2,Signaling by ALK
HDAC2,NOTCH1 Intracellular Domain Regulates Transcription
HDAC2,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC2,Signaling by NOTCH1 in Cancer
HDAC2,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC2,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC2,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HDAC2,Regulation of PTEN gene transcription
HDAC2,Potential therapeutics for SARS
HDAC2,STAT3 nuclear events downstream of ALK signaling
HELLS,Signaling by TGFBR3
HELLS,TGFBR3 expression
NCKAP1L,Signaling by VEGF
NCKAP1L,VEGFA-VEGFR2 Pathway
NCKAP1L,RHO GTPases Activate WASPs and WAVEs
NCKAP1L,RAC2 GTPase cycle
NCKAP1L,RAC3 GTPase cycle
NCKAP1L,Parasite infection
NCKAP1L,Leishmania phagocytosis
NCKAP1L,FCGR3A-mediated phagocytosis
DUT,HCMV Infection
DUT,HCMV Early Events
DBP,HCMV Infection
DBP,HCMV Early Events
DBP,HCMV Late Events
IRS1,HCMV Infection
IRS1,HCMV Early Events
IRS1,HCMV Late Events
CD209,Respiratory Syncytial Virus Infection Pathway
CD209,RSV-host interactions
NRG1,Signaling by ERBB2
NRG1,Signaling by ERBB2 in Cancer
NRG1,Signaling by ERBB4
NRG1,Nuclear signaling by ERBB4
NRG1,Negative regulation of the PI3K/AKT network
NRG1,PI3K/AKT Signaling in Cancer
NRG1,Constitutive Signaling by Aberrant PI3K in Cancer
NRG1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
NRG1,Signaling by PTK6
NRG1,Downregulation of ERBB2 signaling
NRG1,Signaling by Non-Receptor Tyrosine Kinases
NRG1,Signaling by ERBB2 KD Mutants
NRG1,Signaling by ERBB2 TMD/JMD mutants
PIK3R4,PI3K Cascade
PIK3R4,IRS-mediated signalling
PIK3R4,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
PIK3R4,IGF1R signaling cascade
PIK3R4,IRS-related events triggered by IGF1R
PIK3R4,RHO GTPases Activate NADPH Oxidases
PIK3R4,Insulin receptor signalling cascade
PIK3R4,Signaling by Insulin receptor
PIK3R4,Translation of Replicase and Assembly of the Replication Transcription Complex
PIK3R4,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PIK3R4,Early SARS-CoV-2 Infection Events
HIF1A,Signaling by NOTCH1
HIF1A,Signaling by ALK
HIF1A,NOTCH1 Intracellular Domain Regulates Transcription
HIF1A,Signaling by PTK6
HIF1A,Signaling by Non-Receptor Tyrosine Kinases
HIF1A,STAT3 nuclear events downstream of ALK signaling
ACACA,Defects in vitamin and cofactor metabolism
ACACA,Diseases of metabolism
HMGA1,Early Phase of HIV Life Cycle
HMGA1,Host Interactions of HIV factors
HMGA1,Interactions of Vpr with host cellular proteins
HMGA1,Vpr-mediated nuclear import of PICs
HMOX1,Purinergic signaling in leishmaniasis infection
HMOX1,Cell recruitment (pro-inflammatory response)
NR4A1,PI3K/AKT Signaling in Cancer
NR4A1,Constitutive Signaling by AKT1 E17K in Cancer
FOXA1,Estrogen-dependent gene expression
HNRNPA1,Signaling by FGFR
HNRNPA1,Signaling by FGFR2
HNRNPA1,FGFR2 alternative splicing
HNRNPA1,SARS-CoV-1-host interactions
HNRNPA1,SARS-CoV-1 modulates host translation machinery
HNRNPC,RHOBTB2 GTPase cycle
HNRNPC,RHOBTB1 GTPase cycle
HNRNPC,RHOBTB GTPase Cycle
HNRNPF,Signaling by FGFR
HNRNPF,Signaling by FGFR2
HNRNPF,FGFR2 alternative splicing
HNRNPH1,Signaling by FGFR
HNRNPH1,Signaling by FGFR2
HNRNPH1,FGFR2 alternative splicing
HNRNPK,HCMV Infection
HNRNPK,HCMV Late Events
TAAR6,Amine ligand-binding receptors
TAAR6,G alpha (s) signalling events
APC,Degradation of beta-catenin by the destruction complex
APC,Deactivation of the beta-catenin transactivating complex
APC,Signaling by WNT in cancer
APC,Signaling by GSK3beta mutants
HRAS,Signaling by moderate kinase activity BRAF mutants
HRAS,Oncogenic MAPK signaling
HRH1,Amine ligand-binding receptors
HRH2,Amine ligand-binding receptors
HRH2,G alpha (s) signalling events
PRMT1,Extra-nuclear estrogen signaling
PRMT1,Estrogen-dependent gene expression
PRMT1,Maturation of nucleoprotein
PRMT1,Translation of Structural Proteins
PRMT1,Late SARS-CoV-2 Infection Events
HES1,Signaling by NOTCH1
HES1,Signaling by NOTCH2
HES1,NOTCH1 Intracellular Domain Regulates Transcription
HES1,NOTCH2 intracellular domain regulates transcription
HES1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HES1,Signaling by NOTCH1 in Cancer
HES1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HES1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HES1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HES1,Signaling by NOTCH3
HES1,NOTCH3 Intracellular Domain Regulates Transcription
HES1,Signaling by NOTCH4
HES1,NOTCH4 Intracellular Domain Regulates Transcription
BIRC2,TNFR1-induced proapoptotic signaling
BIRC2,Regulation of TNFR1 signaling
BIRC2,TNFR1-induced NF-kappa-B signaling pathway
BIRC2,TNF signaling
BIRC3,TNFR1-induced proapoptotic signaling
BIRC3,Regulation of TNFR1 signaling
BIRC3,TNFR1-induced NF-kappa-B signaling pathway
BIRC3,TNF signaling
HSPA1A,Export of Viral Ribonucleoproteins from Nucleus
XIAP,Deactivation of the beta-catenin transactivating complex
XIAP,TNFR1-induced proapoptotic signaling
XIAP,Regulation of TNFR1 signaling
XIAP,TNFR1-induced NF-kappa-B signaling pathway
XIAP,TNF signaling
XIAP,Regulation of PTEN stability and activity
HSPA8,Respiratory Syncytial Virus Infection Pathway
HSPA8,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
HSPB1,Signaling by VEGF
HSPB1,VEGFA-VEGFR2 Pathway
HSPB1,MAPK6/MAPK4 signaling
HSPB1,Extra-nuclear estrogen signaling
HSP90AA1,Signaling by ERBB2
HSP90AA1,Signaling by ERBB2 in Cancer
HSP90AA1,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
HSP90AA1,Signaling by EGFR in Cancer
HSP90AA1,Signaling by VEGF
HSP90AA1,VEGFA-VEGFR2 Pathway
HSP90AA1,VEGFR2 mediated vascular permeability
HSP90AA1,Uptake and actions of bacterial toxins
HSP90AA1,Constitutive Signaling by EGFRvIII
HSP90AA1,Signaling by EGFRvIII in Cancer
HSP90AA1,Signaling by Ligand-Responsive EGFR Variants in Cancer
HSP90AA1,Downregulation of ERBB2 signaling
HSP90AA1,Extra-nuclear estrogen signaling
HSP90AA1,RHOBTB2 GTPase cycle
HSP90AA1,Estrogen-dependent gene expression
HSP90AA1,Signaling by ERBB2 KD Mutants
HSP90AA1,Signaling by ERBB2 ECD mutants
HSP90AA1,Signaling by ERBB2 TMD/JMD mutants
HSP90AA1,Potential therapeutics for SARS
HSP90AA1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
HSP90AA1,RHOBTB GTPase Cycle
HSP90AA1,Respiratory Syncytial Virus Infection Pathway
HSP90AA1,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
HSP90AA1,Bacterial Infection Pathways
HSP90AB1,Uptake and actions of bacterial toxins
HSP90AB1,RHOBTB2 GTPase cycle
HSP90AB1,Estrogen-dependent gene expression
HSP90AB1,Purinergic signaling in leishmaniasis infection
HSP90AB1,Cell recruitment (pro-inflammatory response)
HSP90AB1,Potential therapeutics for SARS
HSP90AB1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
HSP90AB1,RHOBTB GTPase Cycle
HSP90AB1,Respiratory Syncytial Virus Infection Pathway
HSP90AB1,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
HSP90AB1,Bacterial Infection Pathways
HSPE1,RHOG GTPase cycle
DNAJB1,MAPK6/MAPK4 signaling
HTR1A,Amine ligand-binding receptors
HTR1A,Serotonin receptors
HTR1B,Amine ligand-binding receptors
HTR1B,Serotonin receptors
HTR1D,Amine ligand-binding receptors
HTR1D,Serotonin receptors
HTR1E,Amine ligand-binding receptors
HTR1E,Serotonin receptors
HTR1F,Amine ligand-binding receptors
HTR1F,Serotonin receptors
HTR2A,Amine ligand-binding receptors
HTR2A,Serotonin receptors
HTR2B,Amine ligand-binding receptors
HTR2B,Serotonin receptors
HTR2C,Amine ligand-binding receptors
HTR2C,Serotonin receptors
HTR4,Amine ligand-binding receptors
HTR4,Serotonin receptors
HTR4,G alpha (s) signalling events
HTR5A,Amine ligand-binding receptors
HTR5A,Serotonin receptors
HTR6,Amine ligand-binding receptors
HTR6,Serotonin receptors
HTR6,G alpha (s) signalling events
HTR7,Amine ligand-binding receptors
HTR7,Serotonin receptors
HTR7,G alpha (s) signalling events
HTR7,RHOBTB3 ATPase cycle
HUS1,Diseases of DNA repair
HUS1,Diseases of DNA Double-Strand Break Repair
HUS1,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
HUS1,Impaired BRCA2 binding to RAD51
TAS2R60,Class C/3 (Metabotropic glutamate/pheromone receptors)
ANO9,Induction of Cell-Cell Fusion
ANO9,Late SARS-CoV-2 Infection Events
ID1,Signaling by NTRK1 (TRKA)
ID1,Nuclear Events (kinase and transcription factor activation)
ID1,NGF-stimulated transcription
SPOPL,Hedgehog 'on' state
ID2,Signaling by NTRK1 (TRKA)
ID2,Nuclear Events (kinase and transcription factor activation)
ID2,NGF-stimulated transcription
ID3,Signaling by NTRK1 (TRKA)
ID3,Nuclear Events (kinase and transcription factor activation)
ID3,NGF-stimulated transcription
ID4,Signaling by NTRK1 (TRKA)
ID4,Nuclear Events (kinase and transcription factor activation)
ID4,NGF-stimulated transcription
RSPO2,Regulation of FZD by ubiquitination
ZDHHC21,Extra-nuclear estrogen signaling
CYP26C1,Signaling by Retinoic Acid
CYP26C1,RA biosynthesis pathway
APOC1,NR1H2 and NR1H3-mediated signaling
APOC1,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
IDE,Signaling by Insulin receptor
IDE,Insulin receptor recycling
RSPO4,Regulation of FZD by ubiquitination
IFNA1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA1,Respiratory Syncytial Virus Infection Pathway
IFNA1,Evasion by RSV of host interferon responses
IFNA1,RSV-host interactions
APOC2,NR1H2 and NR1H3-mediated signaling
APOC2,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
IFNA2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA2,Respiratory Syncytial Virus Infection Pathway
IFNA2,Evasion by RSV of host interferon responses
IFNA2,RSV-host interactions
IFNA4,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA4,Respiratory Syncytial Virus Infection Pathway
IFNA4,Evasion by RSV of host interferon responses
IFNA4,RSV-host interactions
IFNA5,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA5,Respiratory Syncytial Virus Infection Pathway
IFNA5,Evasion by RSV of host interferon responses
IFNA5,RSV-host interactions
IFNA7,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA7,Respiratory Syncytial Virus Infection Pathway
IFNA7,Evasion by RSV of host interferon responses
IFNA7,RSV-host interactions
IFNA8,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA8,Respiratory Syncytial Virus Infection Pathway
IFNA8,Evasion by RSV of host interferon responses
IFNA8,RSV-host interactions
IFNA14,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA14,Respiratory Syncytial Virus Infection Pathway
IFNA14,Evasion by RSV of host interferon responses
IFNA14,RSV-host interactions
IFNA17,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA17,Respiratory Syncytial Virus Infection Pathway
IFNA17,Evasion by RSV of host interferon responses
IFNA17,RSV-host interactions
IFNA21,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNA21,Respiratory Syncytial Virus Infection Pathway
IFNA21,Evasion by RSV of host interferon responses
IFNA21,RSV-host interactions
IFNAR1,Potential therapeutics for SARS
IFNB1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFNB1,Respiratory Syncytial Virus Infection Pathway
IFNB1,Evasion by RSV of host interferon responses
IFNB1,RSV-host interactions
IFNGR1,Potential therapeutics for SARS
APOC4,NR1H2 and NR1H3-mediated signaling
APOC4,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
IFNGR2,Potential therapeutics for SARS
GNAT3,Opioid Signalling
GNAT3,G-protein mediated events
GNAT3,Adenylate cyclase inhibitory pathway
GNAT3,G alpha (s) signalling events
GNAT3,G alpha (z) signalling events
GNAT3,Extra-nuclear estrogen signaling
GNAT3,GPER1 signaling
GNAT3,ADORA2B mediated anti-inflammatory cytokines production
GNAT3,Anti-inflammatory response favouring Leishmania parasite infection
GNAT3,Leishmania parasite growth and survival
APOD,NR1H2 and NR1H3-mediated signaling
APOD,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
TUBB8,RHO GTPases activate IQGAPs
TUBB8,RHO GTPases Activate Formins
TUBB8,HCMV Infection
TUBB8,HCMV Early Events
TUBB2B,Hedgehog 'off' state
TUBB2B,RHO GTPases activate IQGAPs
TUBB2B,RHO GTPases Activate Formins
TUBB2B,HCMV Infection
TUBB2B,HCMV Early Events
IGF1,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
IGF1,IGF1R signaling cascade
IGF1,IRS-related events triggered by IGF1R
AMIGO2,RAC3 GTPase cycle
APOE,Signaling by ERBB4
APOE,Nuclear signaling by ERBB4
APOE,NR1H2 and NR1H3-mediated signaling
APOE,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
NUP43,Host Interactions of HIV factors
NUP43,Rev-mediated nuclear export of HIV RNA
NUP43,Transport of Ribonucleoproteins into the Host Nucleus
NUP43,Export of Viral Ribonucleoproteins from Nucleus
NUP43,NS1 Mediated Effects on Host Pathways
NUP43,Viral Messenger RNA Synthesis
NUP43,NEP/NS2 Interacts with the Cellular Export Machinery
NUP43,Interactions of Vpr with host cellular proteins
NUP43,Interactions of Rev with host cellular proteins
NUP43,Nuclear import of Rev protein
NUP43,Vpr-mediated nuclear import of PICs
NUP43,SLC transporter disorders
NUP43,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP43,Disorders of transmembrane transporters
NUP43,RHO GTPases Activate Formins
NUP43,HCMV Infection
NUP43,HCMV Early Events
NUP43,HCMV Late Events
NUP43,SARS-CoV-2 activates/modulates innate and adaptive immune responses
RBPJ,Pre-NOTCH Transcription and Translation
RBPJ,Pre-NOTCH Expression and Processing
RBPJ,Signaling by NOTCH1
RBPJ,Signaling by NOTCH2
RBPJ,NOTCH1 Intracellular Domain Regulates Transcription
RBPJ,NOTCH2 intracellular domain regulates transcription
RBPJ,Signaling by NOTCH1 PEST Domain Mutants in Cancer
RBPJ,Signaling by NOTCH1 in Cancer
RBPJ,Constitutive Signaling by NOTCH1 PEST Domain Mutants
RBPJ,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
RBPJ,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
RBPJ,Signaling by NOTCH3
RBPJ,NOTCH3 Intracellular Domain Regulates Transcription
RBPJ,Signaling by NOTCH4
RBPJ,NOTCH4 Intracellular Domain Regulates Transcription
TAS2R42,Class C/3 (Metabotropic glutamate/pheromone receptors)
RGSL1,G alpha (z) signalling events
KLK3,RHO GTPases activate PKNs
IHH,Hedgehog ligand biogenesis
IHH,Hedgehog 'on' state
IHH,Activation of SMO
IKBKB,p75NTR signals via NF-kB
IKBKB,p75 NTR receptor-mediated signalling
IKBKB,Diseases of Immune System
IKBKB,Regulation of TNFR1 signaling
IKBKB,TNFR1-induced NF-kappa-B signaling pathway
IKBKB,Diseases associated with the TLR signaling cascade
IKBKB,TNF signaling
IKBKB,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IL1B,Purinergic signaling in leishmaniasis infection
IL1B,Cell recruitment (pro-inflammatory response)
IL1R1,Potential therapeutics for SARS
IL2RG,Signaling by ALK
IL2RG,STAT3 nuclear events downstream of ALK signaling
IL6,RAF-independent MAPK1/3 activation
IL6,ADORA2B mediated anti-inflammatory cytokines production
IL6,Anti-inflammatory response favouring Leishmania parasite infection
IL6,Leishmania parasite growth and survival
IL6R,RAF-independent MAPK1/3 activation
IL6R,Potential therapeutics for SARS
CXCR1,Peptide ligand-binding receptors
CXCR1,Chemokine receptors bind chemokines
CXCR2,Peptide ligand-binding receptors
CXCR2,Chemokine receptors bind chemokines
IL10,Anti-inflammatory response favouring Leishmania parasite infection
IL10,FCGR3A-mediated IL10 synthesis
IL10,Leishmania parasite growth and survival
IL10,Signaling by ALK in cancer
IL10,Signaling by ALK fusions and activated point mutants
IL10RA,Signaling by ALK in cancer
IL10RA,Signaling by ALK fusions and activated point mutants
IL10RA,Nuclear events stimulated by ALK signaling in cancer
IL17A,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IL18,Purinergic signaling in leishmaniasis infection
IL18,Cell recruitment (pro-inflammatory response)
IMPDH1,Potential therapeutics for SARS
IMPDH2,Potential therapeutics for SARS
INHA,Signaling by Activin
INHA,Signaling by BMP
INHA,Signaling by TGFBR3
INHBA,Signaling by Activin
INHBA,Signaling by BMP
INHBA,Signaling by TGFBR3
INHBB,Signaling by Activin
IRAK1,p75NTR signals via NF-kB
IRAK1,p75 NTR receptor-mediated signalling
IRAK1,Negative regulation of the PI3K/AKT network
IRAK1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
IRF3,SARS-CoV-1-host interactions
IRF3,SARS-CoV-1 activates/modulates innate immune responses
IRF3,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IRF4,Signaling by ALK in cancer
IRF4,Signaling by ALK fusions and activated point mutants
IRF4,Nuclear events stimulated by ALK signaling in cancer
IRS1,Signaling by NTRK1 (TRKA)
IRS1,Signaling by ALK
IRS1,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
IRS1,IGF1R signaling cascade
IRS1,IRS-related events triggered by IGF1R
IRS1,Insulin receptor signalling cascade
IRS1,Signaling by Insulin receptor
IRS1,Signaling by NTRK3 (TRKC)
IRS1,Signaling by ALK in cancer
IRS1,Signaling by ALK fusions and activated point mutants
AR,RHO GTPases activate PKNs
ITGA2,Signaling by MET
ITGA2,MET activates PTK2 signaling
ITGA2,MET promotes cell motility
ITGA4,Potential therapeutics for SARS
ITGB1,Signaling by TGF-beta Receptor Complex
ITGB1,TGF-beta receptor signaling activates SMADs
ITGB1,G alpha (s) signalling events
ITGB1,RHO GTPases Activate Formins
ITGB1,Signaling by MET
ITGB1,MET activates PTK2 signaling
ITGB1,MET promotes cell motility
ITGB1,RAC2 GTPase cycle
ITGB1,RHOG GTPase cycle
ITGB1,RAC3 GTPase cycle
ITGB1,HCMV Infection
ITGB1,HCMV Early Events
ITGB1,GPER1 signaling
ITGB1,Potential therapeutics for SARS
ITGB3,Signaling by TGF-beta Receptor Complex
ITGB3,Signaling by VEGF
ITGB3,TGF-beta receptor signaling activates SMADs
ITGB3,Integrin signaling
ITGB3,p130Cas linkage to MAPK signaling for integrins
ITGB3,VEGFA-VEGFR2 Pathway
ITGB3,MAP2K and MAPK activation
ITGB3,Signaling by moderate kinase activity BRAF mutants
ITGB3,Signaling by high-kinase activity BRAF mutants
ITGB3,Signaling by RAS mutants
ITGB3,Signaling by BRAF and RAF1 fusions
ITGB3,Paradoxical activation of RAF signaling by kinase inactive BRAF
ITGB3,Oncogenic MAPK signaling
ITGB3,Signaling downstream of RAS mutants
ITGB3,Signaling by RAF1 mutants
ITGB5,Signaling by TGF-beta Receptor Complex
ITGB5,TGF-beta receptor signaling activates SMADs
ITGB6,Signaling by TGF-beta Receptor Complex
ITGB6,TGF-beta receptor signaling activates SMADs
ITGB8,Signaling by TGF-beta Receptor Complex
ITGB8,TGF-beta receptor signaling activates SMADs
STT3A,Maturation of spike protein
STT3A,Translation of Structural Proteins
STT3A,Late SARS-CoV-2 Infection Events
ITPR1,Opioid Signalling
ITPR1,G-protein mediated events
ITPR1,PLC beta mediated events
ITPR1,Effects of PIP2 hydrolysis
ITPR1,DAG and IP3 signaling
ITPR1,Signaling by VEGF
ITPR1,Ca2+ pathway
ITPR1,VEGFA-VEGFR2 Pathway
ITPR1,VEGFR2 mediated cell proliferation
ITPR1,Anti-inflammatory response favouring Leishmania parasite infection
ITPR1,FCGR3A-mediated IL10 synthesis
ITPR1,Leishmania parasite growth and survival
ITPR2,Opioid Signalling
ITPR2,G-protein mediated events
ITPR2,PLC beta mediated events
ITPR2,Effects of PIP2 hydrolysis
ITPR2,DAG and IP3 signaling
ITPR2,Signaling by VEGF
ITPR2,Ca2+ pathway
ITPR2,VEGFA-VEGFR2 Pathway
ITPR2,VEGFR2 mediated cell proliferation
ITPR2,Anti-inflammatory response favouring Leishmania parasite infection
ITPR2,FCGR3A-mediated IL10 synthesis
ITPR2,Leishmania parasite growth and survival
ITPR3,Opioid Signalling
ITPR3,G-protein mediated events
ITPR3,PLC beta mediated events
ITPR3,Effects of PIP2 hydrolysis
ITPR3,DAG and IP3 signaling
ITPR3,Signaling by VEGF
ITPR3,Ca2+ pathway
ITPR3,VEGFA-VEGFR2 Pathway
ITPR3,VEGFR2 mediated cell proliferation
ITPR3,Anti-inflammatory response favouring Leishmania parasite infection
ITPR3,FCGR3A-mediated IL10 synthesis
ITPR3,Leishmania parasite growth and survival
JAG2,Signaling by NOTCH1
JAG2,Signaling by NOTCH2
JAG2,Activated NOTCH1 Transmits Signal to the Nucleus
JAG2,Signaling by NOTCH1 PEST Domain Mutants in Cancer
JAG2,Signaling by NOTCH1 in Cancer
JAG2,Constitutive Signaling by NOTCH1 PEST Domain Mutants
JAG2,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
JAG2,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
JAG2,NOTCH2 Activation and Transmission of Signal to the Nucleus
JAG2,Signaling by NOTCH3
JAG2,NOTCH3 Activation and Transmission of Signal to the Nucleus
JAK1,Potential therapeutics for SARS
JAK2,Signaling by SCF-KIT
JAK2,RAF activation
JAK2,Signaling by moderate kinase activity BRAF mutants
JAK2,Signaling by RAS mutants
JAK2,Signaling by BRAF and RAF1 fusions
JAK2,Paradoxical activation of RAF signaling by kinase inactive BRAF
JAK2,Oncogenic MAPK signaling
JAK2,Signaling by Erythropoietin
JAK2,Signaling downstream of RAS mutants
JAK2,Signaling by RAF1 mutants
JAK2,Signaling by KIT in disease
JAK2,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
JAK2,Potential therapeutics for SARS
JAK3,Signaling by ALK
JAK3,Potential therapeutics for SARS
JUN,Pre-NOTCH Transcription and Translation
JUN,Pre-NOTCH Expression and Processing
JUN,MAPK6/MAPK4 signaling
JUN,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
JUN,Neurodegenerative Diseases
JUN,Regulation of PTEN gene transcription
JUN,Estrogen-dependent gene expression
JUN,Diseases of programmed cell death
JUN,Signaling by ALK in cancer
JUN,Signaling by ALK fusions and activated point mutants
JUN,Defective Intrinsic Pathway for Apoptosis
JUNB,Signaling by TGF-beta Receptor Complex
JUNB,Signaling by NTRK1 (TRKA)
JUNB,Nuclear Events (kinase and transcription factor activation)
JUNB,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
JUNB,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
JUNB,NGF-stimulated transcription
JUNB,Signaling by ALK in cancer
JUNB,Signaling by ALK fusions and activated point mutants
JUNB,Nuclear events stimulated by ALK signaling in cancer
JUND,Signaling by NTRK1 (TRKA)
JUND,Nuclear Events (kinase and transcription factor activation)
JUND,Estrogen-dependent gene expression
JUND,NGF-stimulated transcription
JUP,Signaling by VEGF
JUP,VEGFA-VEGFR2 Pathway
JUP,VEGFR2 mediated vascular permeability
JUP,RHOA GTPase cycle
JUP,RHOB GTPase cycle
JUP,RHOC GTPase cycle
JUP,RHOQ GTPase cycle
JUP,RHOH GTPase cycle
JUP,RHOJ GTPase cycle
KIF7,Hedgehog 'off' state
KIF7,Hedgehog 'on' state
ARF1,Host Interactions of HIV factors
ARF1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
ARF1,The role of Nef in HIV-1 replication and disease pathogenesis
KCNJ11,ABC transporter disorders
KCNJ11,Disorders of transmembrane transporters
USP17L2,RAS processing
KIF5A,RHO GTPases activate KTN1
KIF5B,RHO GTPases activate KTN1
KIT,Signaling by SCF-KIT
KIT,Regulation of KIT signaling
KLK2,RHO GTPases activate PKNs
ARF6,Signaling by MET
KLC1,RHO GTPases activate KTN1
KPNA1,Early Phase of HIV Life Cycle
KPNA1,Host Interactions of HIV factors
KPNA1,Transport of Ribonucleoproteins into the Host Nucleus
KPNA1,NS1 Mediated Effects on Host Pathways
KPNA1,Interactions of Vpr with host cellular proteins
KPNA1,Vpr-mediated nuclear import of PICs
KPNA1,Infection with Mycobacterium tuberculosis
KPNA1,Response of Mtb to phagocytosis
KPNA1,Bacterial Infection Pathways
KPNB1,Host Interactions of HIV factors
KPNB1,Transport of Ribonucleoproteins into the Host Nucleus
KPNB1,NS1 Mediated Effects on Host Pathways
KPNB1,Interactions of Rev with host cellular proteins
KPNB1,Nuclear import of Rev protein
KPNB1,Infection with Mycobacterium tuberculosis
KPNB1,Response of Mtb to phagocytosis
KPNB1,SARS-CoV-1-host interactions
KPNB1,SARS-CoV-1 activates/modulates innate immune responses
KPNB1,Bacterial Infection Pathways
KPNA2,Opioid Signalling
KPNA2,CaMK IV-mediated phosphorylation of CREB
KPNA2,Calmodulin induced events
KPNA2,Ca-dependent events
KPNA2,CaM pathway
KPNA2,G-protein mediated events
KPNA2,PLC beta mediated events
KPNA2,DAG and IP3 signaling
KPNA2,NS1 Mediated Effects on Host Pathways
KPNA2,Estrogen-dependent gene expression
KPNA2,SARS-CoV-1-host interactions
KPNA2,SARS-CoV-1 activates/modulates innate immune responses
KPNA2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
KPNA3,NS1 Mediated Effects on Host Pathways
KPNA4,NS1 Mediated Effects on Host Pathways
KPNA5,NS1 Mediated Effects on Host Pathways
KRAS,Signaling by moderate kinase activity BRAF mutants
KRAS,Oncogenic MAPK signaling
RHOA,Signaling by ERBB2
RHOA,Signaling by TGF-beta Receptor Complex
RHOA,Signaling by NTRK1 (TRKA)
RHOA,p75NTR regulates axonogenesis
RHOA,p75 NTR receptor-mediated signalling
RHOA,Signaling by VEGF
RHOA,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
RHOA,G beta:gamma signalling through PI3Kgamma
RHOA,G-protein beta:gamma signalling
RHOA,PCP/CE pathway
RHOA,G alpha (12/13) signalling events
RHOA,VEGFA-VEGFR2 Pathway
RHOA,RHO GTPases activate PKNs
RHOA,RHO GTPases activate CIT
RHOA,RHO GTPases activate KTN1
RHOA,RHO GTPases Activate ROCKs
RHOA,RHO GTPases Activate Formins
RHOA,Signaling by PTK6
RHOA,RHOA GTPase cycle
RHOA,Signaling by Non-Receptor Tyrosine Kinases
RHOA,RHOC GTPase cycle
UBE2V1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
RHOB,G alpha (12/13) signalling events
RHOB,RHO GTPases activate PKNs
RHOB,RHO GTPases activate CIT
RHOB,RHO GTPases Activate ROCKs
RHOB,RHO GTPases Activate Formins
RHOB,RHOB GTPase cycle
HES5,Signaling by NOTCH1
HES5,Signaling by NOTCH2
HES5,NOTCH1 Intracellular Domain Regulates Transcription
HES5,NOTCH2 intracellular domain regulates transcription
HES5,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HES5,Signaling by NOTCH1 in Cancer
HES5,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HES5,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HES5,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HES5,Signaling by NOTCH3
HES5,NOTCH3 Intracellular Domain Regulates Transcription
HES5,Signaling by NOTCH4
HES5,NOTCH4 Intracellular Domain Regulates Transcription
RHOC,G alpha (12/13) signalling events
RHOC,RHO GTPases activate PKNs
RHOC,RHO GTPases activate CIT
RHOC,RHO GTPases Activate ROCKs
RHOC,RHO GTPases Activate Formins
RHOC,RHOC GTPase cycle
ARHGEF37,NRAGE signals death through JNK
ARHGEF37,p75 NTR receptor-mediated signalling
ARHGEF37,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF37,G alpha (12/13) signalling events
KTN1,RHO GTPases activate KTN1
KTN1,RHOA GTPase cycle
KTN1,RHOG GTPase cycle
KTN1,RND3 GTPase cycle
KTN1,RND2 GTPase cycle
RND3,RND3 GTPase cycle
LAMA2,Signaling by MET
LAMA2,MET activates PTK2 signaling
LAMA2,MET promotes cell motility
LAMA3,Signaling by MET
LAMA3,MET activates PTK2 signaling
LAMA3,MET promotes cell motility
RHOG,Negative regulation of the PI3K/AKT network
RHOG,PI3K/AKT Signaling in Cancer
RHOG,Constitutive Signaling by Aberrant PI3K in Cancer
RHOG,RHO GTPases activate KTN1
RHOG,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
RHOG,RHOG GTPase cycle
LAMA4,Signaling by MET
LAMA4,MET activates PTK2 signaling
LAMA4,MET promotes cell motility
LAMA5,Signaling by MET
LAMA5,MET activates PTK2 signaling
LAMA5,MET promotes cell motility
LAMB1,Signaling by MET
LAMB1,MET activates PTK2 signaling
LAMB1,MET promotes cell motility
LAMB2,Signaling by MET
LAMB2,MET activates PTK2 signaling
LAMB2,MET promotes cell motility
LAMB3,Signaling by MET
LAMB3,MET activates PTK2 signaling
LAMB3,MET promotes cell motility
LAMC1,Signaling by MET
LAMC1,MET activates PTK2 signaling
LAMC1,MET promotes cell motility
LAMC2,Signaling by MET
LAMC2,MET activates PTK2 signaling
LAMC2,MET promotes cell motility
ARHGAP1,RHOA GTPase cycle
ARHGAP1,RHOB GTPase cycle
ARHGAP1,RHOC GTPase cycle
ARHGAP1,RAC2 GTPase cycle
ARHGAP1,RHOD GTPase cycle
ARHGAP1,RHOQ GTPase cycle
ARHGAP1,RHOG GTPase cycle
ARHGAP1,RHOJ GTPase cycle
ARHGAP1,RAC3 GTPase cycle
ARHGAP1,RHOF GTPase cycle
ARHGAP1,RND2 GTPase cycle
RPSA,Viral mRNA Translation
RPSA,SARS-CoV-1-host interactions
RPSA,SARS-CoV-1 modulates host translation machinery
RPSA,SARS-CoV-2 modulates host translation machinery
STMN1,Signaling by ERBB4
STMN1,Nuclear signaling by ERBB4
LBR,RHOA GTPase cycle
LBR,RHOC GTPase cycle
LBR,RAC2 GTPase cycle
LBR,RHOD GTPase cycle
LBR,RHOG GTPase cycle
LBR,RAC3 GTPase cycle
LCK,Signaling by SCF-KIT
LCK,Regulation of KIT signaling
LCK,Host Interactions of HIV factors
LCK,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
LCK,The role of Nef in HIV-1 replication and disease pathogenesis
LCK,Negative regulation of the PI3K/AKT network
LCK,PI3K/AKT Signaling in Cancer
LCK,Constitutive Signaling by Aberrant PI3K in Cancer
LCK,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
LCK,RHOH GTPase cycle
LCK,Signaling by KIT in disease
LCK,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
ARHGAP5,RHOA GTPase cycle
ARHGAP5,RHOB GTPase cycle
ARHGAP5,RHOC GTPase cycle
ARHGAP5,RHOD GTPase cycle
ARHGAP5,RHOQ GTPase cycle
ARHGAP5,RHOG GTPase cycle
ARHGAP5,RHOJ GTPase cycle
ARHGAP5,RAC3 GTPase cycle
ARHGAP5,RHOF GTPase cycle
ARHGAP5,RND3 GTPase cycle
ARHGAP5,RND2 GTPase cycle
ARHGAP5,RND1 GTPase cycle
MUC21,Diseases of glycosylation
MUC21,Diseases associated with O-glycosylation of proteins
MUC21,Defective GALNT3 causes HFTC
MUC21,Defective GALNT12 causes CRCS1
MUC21,Diseases of metabolism
ARHGAP6,RHOA GTPase cycle
ARHGAP6,RAC3 GTPase cycle
LETM1,RHOG GTPase cycle
LFNG,Pre-NOTCH Processing in Golgi
LFNG,Pre-NOTCH Expression and Processing
ARHGDIA,p75NTR regulates axonogenesis
ARHGDIA,p75 NTR receptor-mediated signalling
ARHGDIA,RHOA GTPase cycle
ARHGDIA,RHOC GTPase cycle
ARHGDIA,RAC2 GTPase cycle
ARHGDIA,RHOH GTPase cycle
ARHGDIA,RHOG GTPase cycle
ARHGDIB,RHOA GTPase cycle
ARHGDIB,RHOH GTPase cycle
ARHGDIB,RHOG GTPase cycle
ARHGDIB,RAC3 GTPase cycle
LIG1,Early Phase of HIV Life Cycle
ARHGDIG,RHOB GTPase cycle
ARHGDIG,RHOH GTPase cycle
ARHGDIG,RHOG GTPase cycle
LIG4,Early Phase of HIV Life Cycle
LIMK1,RHO GTPases Activate ROCKs
LIMK1,RHO GTPases activate PAKs
LIMK2,RHO GTPases Activate ROCKs
RHOH,RHOH GTPase cycle
SPRED3,Regulation of RAS by GAPs
SPRED3,Oncogenic MAPK signaling
LMAN1,RHOA GTPase cycle
LMAN1,RHOC GTPase cycle
LMAN1,RAC2 GTPase cycle
LMAN1,RHOD GTPase cycle
LMAN1,RHOG GTPase cycle
LMAN1,RAC3 GTPase cycle
LMNB1,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
LMNB1,Neurodegenerative Diseases
LMNB1,RHOD GTPase cycle
LMNB1,RHOF GTPase cycle
LMNB1,Diseases of programmed cell death
LMNB1,Defective Intrinsic Pathway for Apoptosis
MED11,Respiratory Syncytial Virus Infection Pathway
MED11,RSV-host interactions
ARL2,RAS processing
KPNA7,NS1 Mediated Effects on Host Pathways
LRP6,Disassembly of the destruction complex and recruitment of AXIN to the membrane
LRP6,Regulation of FZD by ubiquitination
LRP6,Signaling by WNT in cancer
LRP5,Disassembly of the destruction complex and recruitment of AXIN to the membrane
LRP5,Regulation of FZD by ubiquitination
LRP5,Signaling by WNT in cancer
GTF2H5,Formation of HIV elongation complex in the absence of HIV Tat
GTF2H5,Formation of the HIV-1 Early Elongation Complex
GTF2H5,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
GTF2H5,HIV Transcription Initiation
GTF2H5,RNA Polymerase II HIV Promoter Escape
GTF2H5,HIV Transcription Elongation
GTF2H5,Transcription of the HIV genome
GTF2H5,Formation of HIV-1 elongation complex containing HIV-1 Tat
GTF2H5,Tat-mediated elongation of the HIV-1 transcript
LTBP1,Signaling by TGF-beta Receptor Complex
LTBP1,TGF-beta receptor signaling activates SMADs
LTBP2,Signaling by TGF-beta Receptor Complex
LTBP2,TGF-beta receptor signaling activates SMADs
LTBP3,Signaling by TGF-beta Receptor Complex
LTBP3,TGF-beta receptor signaling activates SMADs
LTF,Infection with Mycobacterium tuberculosis
LTF,Bacterial Infection Pathways
LYL1,Signaling by NTRK1 (TRKA)
LYL1,Nuclear Events (kinase and transcription factor activation)
LYL1,NGF-stimulated transcription
LYN,Signaling by SCF-KIT
LYN,Regulation of KIT signaling
LYN,Signaling by Erythropoietin
LYN,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
LYN,Anti-inflammatory response favouring Leishmania parasite infection
LYN,FCGR3A-mediated IL10 synthesis
LYN,Parasite infection
LYN,Leishmania phagocytosis
LYN,FCGR3A-mediated phagocytosis
LYN,Leishmania parasite growth and survival
LYN,Signaling by KIT in disease
LYN,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
ARRB1,Signaling by NOTCH1
ARRB1,Activated NOTCH1 Transmits Signal to the Nucleus
ARRB1,G alpha (s) signalling events
ARRB1,Hedgehog 'on' state
ARRB1,Activation of SMO
ARRB1,MAP2K and MAPK activation
ARRB1,Signaling by moderate kinase activity BRAF mutants
ARRB1,Signaling by high-kinase activity BRAF mutants
ARRB1,Signaling by RAS mutants
ARRB1,Signaling by BRAF and RAF1 fusions
ARRB1,Paradoxical activation of RAF signaling by kinase inactive BRAF
ARRB1,Oncogenic MAPK signaling
ARRB1,Signaling downstream of RAS mutants
ARRB1,Signaling by RAF1 mutants
ARRB1,Signaling by TGFBR3
SMAD1,Signaling by BMP
SMAD2,Signaling by Activin
SMAD2,Signaling by TGF-beta Receptor Complex
SMAD2,Downregulation of TGF-beta receptor signaling
SMAD2,TGF-beta receptor signaling activates SMADs
SMAD2,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SMAD2,Downregulation of SMAD2/3:SMAD4 transcriptional activity
SMAD3,Signaling by Activin
SMAD3,Signaling by TGF-beta Receptor Complex
SMAD3,Downregulation of TGF-beta receptor signaling
SMAD3,TGF-beta receptor signaling activates SMADs
SMAD3,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SMAD3,Downregulation of SMAD2/3:SMAD4 transcriptional activity
SMAD3,SARS-CoV-1-host interactions
SMAD3,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
SMAD4,Signaling by Activin
SMAD4,Signaling by TGF-beta Receptor Complex
SMAD4,Signaling by BMP
SMAD4,TGF-beta receptor signaling activates SMADs
SMAD4,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SMAD4,Downregulation of SMAD2/3:SMAD4 transcriptional activity
SMAD4,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
SMAD4,SARS-CoV-1-host interactions
SMAD4,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
SMAD4,Signaling by TGFBR3
SMAD4,TGFBR3 expression
ARRB2,Signaling by NOTCH1
ARRB2,Activated NOTCH1 Transmits Signal to the Nucleus
ARRB2,PCP/CE pathway
ARRB2,G alpha (s) signalling events
ARRB2,WNT5A-dependent internalization of FZD4
ARRB2,Hedgehog 'on' state
ARRB2,Activation of SMO
ARRB2,MAP2K and MAPK activation
ARRB2,Signaling by moderate kinase activity BRAF mutants
ARRB2,Signaling by high-kinase activity BRAF mutants
ARRB2,Signaling by RAS mutants
ARRB2,Signaling by BRAF and RAF1 fusions
ARRB2,Paradoxical activation of RAF signaling by kinase inactive BRAF
ARRB2,Oncogenic MAPK signaling
ARRB2,Signaling downstream of RAS mutants
ARRB2,Signaling by RAF1 mutants
ARRB2,Signaling by TGFBR3
SMAD5,Signaling by BMP
SMAD6,Signaling by BMP
SMAD7,Signaling by TGF-beta Receptor Complex
SMAD7,Signaling by BMP
SMAD7,Downregulation of TGF-beta receptor signaling
SMAD7,TGF-beta receptor signaling activates SMADs
SMAD7,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SMAD7,Downregulation of SMAD2/3:SMAD4 transcriptional activity
SMAD7,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
SMAD9,Signaling by BMP
MAG,p75NTR regulates axonogenesis
MAG,p75 NTR receptor-mediated signalling
MAN2A1,Maturation of spike protein
MAN2A1,Translation of Structural Proteins
MAN2A1,Late SARS-CoV-2 Infection Events
MARK3,RAF activation
MARK3,MAP2K and MAPK activation
MARK3,Negative regulation of MAPK pathway
MARK3,Signaling by moderate kinase activity BRAF mutants
MARK3,Signaling by high-kinase activity BRAF mutants
MARK3,Signaling by RAS mutants
MARK3,Signaling by BRAF and RAF1 fusions
MARK3,Paradoxical activation of RAF signaling by kinase inactive BRAF
MARK3,Oncogenic MAPK signaling
MARK3,Signaling downstream of RAS mutants
MARK3,Signaling by RAF1 mutants
MATK,Signaling by ERBB2
MATK,Downregulation of ERBB2 signaling
MBL2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
MC2R,Peptide ligand-binding receptors
MC2R,G alpha (s) signalling events
MC2R,Diseases of metabolism
MCAM,RHOA GTPase cycle
MCAM,RHOB GTPase cycle
MCAM,RHOC GTPase cycle
MCAM,RAC2 GTPase cycle
MCAM,RHOD GTPase cycle
MCAM,RHOG GTPase cycle
MCAM,RAC3 GTPase cycle
MCAM,RHOF GTPase cycle
MCF2,NRAGE signals death through JNK
MCF2,p75NTR regulates axonogenesis
MCF2,p75 NTR receptor-mediated signalling
MCF2,"Cell death signalling via NRAGE, NRIF and NADE"
MCF2,G alpha (12/13) signalling events
MCF2,RHOA GTPase cycle
MCF2,RHOB GTPase cycle
MCF2,RHOC GTPase cycle
MCF2,RAC2 GTPase cycle
MCF2,RHOG GTPase cycle
MCF2,RAC3 GTPase cycle
MCL1,Signaling by ALK in cancer
MCL1,Signaling by ALK fusions and activated point mutants
MDK,Signaling by NOTCH2
MDK,Signaling by ALK
MDK,NOTCH2 Activation and Transmission of Signal to the Nucleus
MDM2,AKT phosphorylates targets in the cytosol
MDM2,PI3K/AKT Signaling in Cancer
MDM2,Constitutive Signaling by AKT1 E17K in Cancer
MDM2,Signaling by ALK in cancer
MDM2,Signaling by ALK fusions and activated point mutants
MEF2A,Signaling by NTRK1 (TRKA)
MEF2A,Nuclear Events (kinase and transcription factor activation)
MEF2A,ERK/MAPK targets
MEF2C,Signaling by NTRK1 (TRKA)
MEF2C,Nuclear Events (kinase and transcription factor activation)
MEF2C,ERK/MAPK targets
MEF2D,Signaling by NTRK1 (TRKA)
MEF2D,Nuclear Events (kinase and transcription factor activation)
MEF2D,NGF-stimulated transcription
MEFV,Purinergic signaling in leishmaniasis infection
MEFV,Cell recruitment (pro-inflammatory response)
MEN1,Signaling by TGF-beta Receptor Complex
MEN1,Formation of the beta-catenin:TCF transactivating complex
MEN1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
MEN1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
MEN1,Deactivation of the beta-catenin transactivating complex
MEN1,RHO GTPases activate IQGAPs
MET,Signaling by MET
MET,Negative regulation of MET activity
MET,InlB-mediated entry of Listeria monocytogenes into host cell
MET,Listeria monocytogenes entry into host cells
MET,Bacterial Infection Pathways
MFNG,Pre-NOTCH Processing in Golgi
MFNG,Pre-NOTCH Expression and Processing
MGAT1,Maturation of spike protein
MGAT1,Translation of Structural Proteins
MGAT1,Late SARS-CoV-2 Infection Events
MGAT2,Maturation of spike protein
MGAT2,Translation of Structural Proteins
MGAT2,Late SARS-CoV-2 Infection Events
MGAT5,Maturation of spike protein
MGAT5,Translation of Structural Proteins
MGAT5,Late SARS-CoV-2 Infection Events
CXCL9,Peptide ligand-binding receptors
CXCL9,Chemokine receptors bind chemokines
ASCL1,Signaling by NTRK1 (TRKA)
ASCL1,Nuclear Events (kinase and transcription factor activation)
ASCL1,NGF-stimulated transcription
MLH1,Diseases of DNA repair
MAP3K11,RAF activation
MAP3K11,Signaling by moderate kinase activity BRAF mutants
MAP3K11,Signaling by RAS mutants
MAP3K11,Paradoxical activation of RAF signaling by kinase inactive BRAF
MAP3K11,Oncogenic MAPK signaling
MAP3K11,RHOG GTPase cycle
MAP3K11,RHOV GTPase cycle
MAP3K11,Signaling downstream of RAS mutants
FOXO4,PI3K/AKT Signaling in Cancer
FOXO4,Constitutive Signaling by AKT1 E17K in Cancer
MMP14,Signaling by TGFBR3
MMP16,Signaling by TGFBR3
MNAT1,Formation of HIV elongation complex in the absence of HIV Tat
MNAT1,Formation of the HIV-1 Early Elongation Complex
MNAT1,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
MNAT1,HIV Transcription Initiation
MNAT1,RNA Polymerase II HIV Promoter Escape
MNAT1,HIV Transcription Elongation
MNAT1,Transcription of the HIV genome
MNAT1,Formation of HIV-1 elongation complex containing HIV-1 Tat
MNAT1,Tat-mediated elongation of the HIV-1 transcript
MOV10,Pre-NOTCH Transcription and Translation
MOV10,Pre-NOTCH Expression and Processing
MOV10,Ca2+ pathway
MOV10,MAPK6/MAPK4 signaling
MOV10,Regulation of PTEN mRNA translation
MOV10,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
MOV10,Estrogen-dependent gene expression
MOV10,NR1H2 and NR1H3-mediated signaling
MOV10,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
MOV10,Signaling by ALK in cancer
MOV10,Signaling by ALK fusions and activated point mutants
MOV10,Nuclear events stimulated by ALK signaling in cancer
MOV10,Signaling by TGFBR3
MOV10,TGFBR3 expression
MRC1,Infection with Mycobacterium tuberculosis
MRC1,Bacterial Infection Pathways
CITED1,Estrogen-dependent gene expression
MSH2,Diseases of DNA repair
MSH3,Diseases of DNA repair
ARHGEF35,NRAGE signals death through JNK
ARHGEF35,p75 NTR receptor-mediated signalling
ARHGEF35,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF35,G alpha (12/13) signalling events
POTEE,RHOF GTPase cycle
MTR,Defects in vitamin and cofactor metabolism
MTR,Diseases of metabolism
MTR,RHOH GTPase cycle
MTRR,Defects in vitamin and cofactor metabolism
MTRR,Diseases of metabolism
MTX1,RAC2 GTPase cycle
MUC2,Diseases of glycosylation
MUC2,Diseases associated with O-glycosylation of proteins
MUC2,Defective GALNT3 causes HFTC
MUC2,Defective GALNT12 causes CRCS1
MUC2,Diseases of metabolism
MUC4,Diseases of glycosylation
MUC4,Diseases associated with O-glycosylation of proteins
MUC4,Defective GALNT3 causes HFTC
MUC4,Defective GALNT12 causes CRCS1
MUC4,Diseases of metabolism
MUC7,Diseases of glycosylation
MUC7,Diseases associated with O-glycosylation of proteins
MUC7,Defective GALNT3 causes HFTC
MUC7,Defective GALNT12 causes CRCS1
MUC7,Diseases of metabolism
MYB,Estrogen-dependent gene expression
MYC,Signaling by TGF-beta Receptor Complex
MYC,Signaling by NOTCH1
MYC,Signaling by ALK
MYC,Formation of the beta-catenin:TCF transactivating complex
MYC,NOTCH1 Intracellular Domain Regulates Transcription
MYC,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
MYC,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
MYC,Signaling by NOTCH1 PEST Domain Mutants in Cancer
MYC,Signaling by NOTCH1 in Cancer
MYC,Constitutive Signaling by NOTCH1 PEST Domain Mutants
MYC,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
MYC,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MYC,MAPK6/MAPK4 signaling
MYC,Estrogen-dependent gene expression
MYCN,Signaling by ALK
MYCN,Signaling by TGFBR3
MYCN,TGFBR3 expression
MYD88,p75NTR signals via NF-kB
MYD88,p75 NTR receptor-mediated signalling
MYD88,Negative regulation of the PI3K/AKT network
MYD88,Diseases of Immune System
MYD88,Diseases associated with the TLR signaling cascade
MYD88,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
MYF5,Signaling by TGFBR3
MYF5,TGFBR3 expression
MYF6,Signaling by TGFBR3
MYF6,TGFBR3 expression
MYH2,Parasite infection
MYH2,Leishmania phagocytosis
MYH2,FCGR3A-mediated phagocytosis
MYH9,RHO GTPases activate PKNs
MYH9,RHO GTPases activate CIT
MYH9,RHO GTPases Activate ROCKs
MYH9,RHO GTPases activate PAKs
MYH9,Anti-inflammatory response favouring Leishmania parasite infection
MYH9,Parasite infection
MYH9,Leishmania phagocytosis
MYH9,FCGR3A-mediated phagocytosis
MYH9,Leishmania parasite growth and survival
MYH10,RHO GTPases activate PKNs
MYH10,RHO GTPases activate CIT
MYH10,RHO GTPases Activate ROCKs
MYH10,RHO GTPases activate PAKs
MYH11,RHO GTPases activate PKNs
MYH11,RHO GTPases activate CIT
MYH11,RHO GTPases Activate ROCKs
MYH11,RHO GTPases activate PAKs
MYL6,RHO GTPases activate PKNs
MYL6,RHO GTPases activate CIT
MYL6,RHO GTPases Activate ROCKs
MYL6,RHO GTPases activate PAKs
MYO1C,Parasite infection
MYO1C,Leishmania phagocytosis
MYO1C,FCGR3A-mediated phagocytosis
MYO5A,Parasite infection
MYO5A,Leishmania phagocytosis
MYO5A,FCGR3A-mediated phagocytosis
MYO6,RHOBTB2 GTPase cycle
MYO6,RHOU GTPase cycle
MYO6,RHOBTB1 GTPase cycle
MYO6,RHOBTB GTPase Cycle
MYO9A,RHOA GTPase cycle
MYO9A,RHOB GTPase cycle
MYO9A,RHOV GTPase cycle
MYO9B,RHOA GTPase cycle
MYO9B,RHOB GTPase cycle
MYO9B,RHOC GTPase cycle
MYO9B,RHOF GTPase cycle
MYO9B,Parasite infection
MYO9B,Leishmania phagocytosis
MYO9B,FCGR3A-mediated phagocytosis
MYO10,Parasite infection
MYO10,Leishmania phagocytosis
MYO10,FCGR3A-mediated phagocytosis
MYOD1,Signaling by TGFBR3
MYOD1,TGFBR3 expression
MYOG,Signaling by TGFBR3
MYOG,TGFBR3 expression
PPP1R12A,RHO GTPases activate PKNs
PPP1R12A,RHO GTPases activate CIT
PPP1R12A,RHO GTPases Activate ROCKs
PPP1R12A,RHO GTPases activate PAKs
ATF1,Signaling by NTRK1 (TRKA)
ATF1,Nuclear Events (kinase and transcription factor activation)
PPP1R12B,RHO GTPases activate PKNs
PPP1R12B,RHO GTPases activate CIT
PPP1R12B,RHO GTPases Activate ROCKs
PPP1R12B,RHO GTPases activate PAKs
NAB1,Signaling by NTRK1 (TRKA)
NAB1,Nuclear Events (kinase and transcription factor activation)
NAB1,NGF-stimulated transcription
NAB2,Signaling by NTRK1 (TRKA)
NAB2,Nuclear Events (kinase and transcription factor activation)
NAB2,NGF-stimulated transcription
HNRNPM,Signaling by FGFR
HNRNPM,Signaling by FGFR2
HNRNPM,FGFR2 alternative splicing
NCBP1,Signaling by FGFR in disease
NCBP1,Formation of HIV elongation complex in the absence of HIV Tat
NCBP1,Formation of the HIV-1 Early Elongation Complex
NCBP1,HIV Transcription Elongation
NCBP1,Transcription of the HIV genome
NCBP1,Formation of HIV-1 elongation complex containing HIV-1 Tat
NCBP1,Abortive elongation of HIV-1 transcript in the absence of Tat
NCBP1,Tat-mediated elongation of the HIV-1 transcript
NCBP1,FGFR2 mutant receptor activation
NCBP1,Signaling by FGFR
NCBP1,Signaling by FGFR2
NCBP1,Signaling by FGFR2 in disease
NCBP1,FGFR2 alternative splicing
NCBP1,Signaling by FGFR2 IIIa TM
NCF2,Signaling by VEGF
NCF2,VEGFA-VEGFR2 Pathway
NCF2,RHO GTPases Activate NADPH Oxidases
NCF2,RAC3 GTPase cycle
NCF4,Signaling by VEGF
NCF4,VEGFA-VEGFR2 Pathway
NCF4,RHO GTPases Activate NADPH Oxidases
NCF4,RAC3 GTPase cycle
NCK1,Downstream signal transduction
NCK1,Signaling by PDGF
NCK1,Signaling by VEGF
NCK1,Activation of RAC1
NCK1,VEGFA-VEGFR2 Pathway
NCK1,RHO GTPases Activate WASPs and WAVEs
NCK1,RHOU GTPase cycle
NCK1,RHOV GTPase cycle
NCK1,Parasite infection
NCK1,Leishmania phagocytosis
NCK1,FCGR3A-mediated phagocytosis
NCK1,Potential therapeutics for SARS
NCL,Respiratory Syncytial Virus Infection Pathway
NDUFA5,RHOG GTPase cycle
NDUFS3,RHOG GTPase cycle
NEDD4,Signaling by ERBB4
NEDD4,Regulation of PTEN stability and activity
RPL10A,Viral mRNA Translation
ATP1A1,Potential therapeutics for SARS
ATP1A2,Potential therapeutics for SARS
NF2,RHO GTPases activate PAKs
ATP1A3,Potential therapeutics for SARS
NFE2L2,Potential therapeutics for SARS
NFKBIA,p75NTR signals via NF-kB
NFKBIA,p75 NTR receptor-mediated signalling
ATP1A4,Potential therapeutics for SARS
NGF,Signalling to RAS
NGF,Prolonged ERK activation events
NGF,Frs2-mediated activation
NGF,Retrograde neurotrophin signalling
NGF,Signaling by NTRK1 (TRKA)
NGF,Signalling to ERKs
NGF,p75NTR signals via NF-kB
NGF,NRAGE signals death through JNK
NGF,p75NTR regulates axonogenesis
NGF,p75 NTR receptor-mediated signalling
NGF,"Cell death signalling via NRAGE, NRIF and NADE"
NGF,NRIF signals cell death from the nucleus
NGFR,p75NTR signals via NF-kB
NGFR,NRAGE signals death through JNK
NGFR,p75NTR regulates axonogenesis
NGFR,p75 NTR receptor-mediated signalling
NGFR,"Cell death signalling via NRAGE, NRIF and NADE"
NGFR,NRIF signals cell death from the nucleus
ATP1B1,Potential therapeutics for SARS
NHS,RAC2 GTPase cycle
NHS,RAC3 GTPase cycle
ATP1B2,Potential therapeutics for SARS
ATP1B3,Potential therapeutics for SARS
NOS2,Infection with Mycobacterium tuberculosis
NOS2,Response of Mtb to phagocytosis
NOS2,Bacterial Infection Pathways
FXYD2,Potential therapeutics for SARS
NPM1,Host Interactions of HIV factors
NPM1,Interactions of Rev with host cellular proteins
NPM1,Nuclear import of Rev protein
NPM1,SARS-CoV-1-host interactions
NPM1,Signaling by ALK in cancer
NPM1,Signaling by ALK fusions and activated point mutants
NPM1,Nuclear events stimulated by ALK signaling in cancer
ATP2A1,Pre-NOTCH Processing in Golgi
ATP2A1,Pre-NOTCH Expression and Processing
ATP2A2,Pre-NOTCH Processing in Golgi
ATP2A2,Pre-NOTCH Expression and Processing
ATP2A3,Pre-NOTCH Processing in Golgi
ATP2A3,Pre-NOTCH Expression and Processing
NRAS,Signaling by moderate kinase activity BRAF mutants
NRAS,Oncogenic MAPK signaling
YBX1,Signaling by NOTCH3
YBX1,NOTCH3 Activation and Transmission of Signal to the Nucleus
NT5E,Purinergic signaling in leishmaniasis infection
NT5E,Cell recruitment (pro-inflammatory response)
NTF3,Negative regulation of the PI3K/AKT network
NTF3,PI3K/AKT Signaling in Cancer
NTF3,Constitutive Signaling by Aberrant PI3K in Cancer
NTF3,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
NTF3,Signaling by NTRK2 (TRKB)
NTF3,Signaling by NTRK3 (TRKC)
NTF4,Negative regulation of the PI3K/AKT network
NTF4,PI3K/AKT Signaling in Cancer
NTF4,Constitutive Signaling by Aberrant PI3K in Cancer
NTF4,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
NTF4,Signaling by NTRK2 (TRKB)
NTRK1,Signaling by NTRK1 (TRKA)
NTRK2,Signaling by NTRK1 (TRKA)
NTRK2,Signaling by NTRK2 (TRKB)
NTRK3,Signaling by NTRK3 (TRKC)
ROR1,PCP/CE pathway
ROR1,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
ROR2,PCP/CE pathway
ROR2,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
NUP88,Host Interactions of HIV factors
NUP88,Rev-mediated nuclear export of HIV RNA
NUP88,Transport of Ribonucleoproteins into the Host Nucleus
NUP88,Export of Viral Ribonucleoproteins from Nucleus
NUP88,NS1 Mediated Effects on Host Pathways
NUP88,Viral Messenger RNA Synthesis
NUP88,NEP/NS2 Interacts with the Cellular Export Machinery
NUP88,Interactions of Vpr with host cellular proteins
NUP88,Interactions of Rev with host cellular proteins
NUP88,Nuclear import of Rev protein
NUP88,Vpr-mediated nuclear import of PICs
NUP88,SLC transporter disorders
NUP88,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP88,Disorders of transmembrane transporters
NUP88,HCMV Infection
NUP88,HCMV Early Events
NUP88,HCMV Late Events
NUP88,SARS-CoV-2 activates/modulates innate and adaptive immune responses
GPR143,Amine ligand-binding receptors
OAS2,Respiratory Syncytial Virus Infection Pathway
OAS2,RSV-host interactions
OCRL,RHOJ GTPase cycle
OCRL,RAC3 GTPase cycle
OMG,p75NTR regulates axonogenesis
OMG,p75 NTR receptor-mediated signalling
OPHN1,RHOA GTPase cycle
OPHN1,RHOB GTPase cycle
OPHN1,RHOC GTPase cycle
OPHN1,RAC2 GTPase cycle
OPHN1,RHOQ GTPase cycle
OPHN1,RHOG GTPase cycle
OPHN1,RHOJ GTPase cycle
OPHN1,RAC3 GTPase cycle
OPRM1,Opioid Signalling
OPRM1,G-protein activation
OPRM1,Peptide ligand-binding receptors
P2RX4,Purinergic signaling in leishmaniasis infection
P2RX4,Cell recruitment (pro-inflammatory response)
P2RX7,Purinergic signaling in leishmaniasis infection
P2RX7,Cell recruitment (pro-inflammatory response)
P2RY1,P2Y receptors
P2RY1,Nucleotide-like (purinergic) receptors
P2RY2,P2Y receptors
P2RY2,Nucleotide-like (purinergic) receptors
P2RY4,P2Y receptors
P2RY4,Nucleotide-like (purinergic) receptors
P2RY6,P2Y receptors
P2RY6,Nucleotide-like (purinergic) receptors
P2RY11,P2Y receptors
P2RY11,Nucleotide-like (purinergic) receptors
P2RY11,G alpha (s) signalling events
P4HB,Hedgehog ligand biogenesis
PEBP1,MAP2K and MAPK activation
PEBP1,Negative regulation of MAPK pathway
PEBP1,Signaling by moderate kinase activity BRAF mutants
PEBP1,Signaling by high-kinase activity BRAF mutants
PEBP1,Signaling by RAS mutants
PEBP1,Signaling by BRAF and RAF1 fusions
PEBP1,Paradoxical activation of RAF signaling by kinase inactive BRAF
PEBP1,Oncogenic MAPK signaling
PEBP1,Signaling downstream of RAS mutants
FURIN,Signaling by TGF-beta Receptor Complex
FURIN,Assembly Of The HIV Virion
FURIN,Signaling by PDGF
FURIN,Pre-NOTCH Processing in Golgi
FURIN,Pre-NOTCH Expression and Processing
FURIN,TGF-beta receptor signaling activates SMADs
FURIN,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
FURIN,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
FURIN,Uptake and actions of bacterial toxins
FURIN,Anti-inflammatory response favouring Leishmania parasite infection
FURIN,Leishmania parasite growth and survival
FURIN,Potential therapeutics for SARS
FURIN,Induction of Cell-Cell Fusion
FURIN,Early SARS-CoV-2 Infection Events
FURIN,Late SARS-CoV-2 Infection Events
FURIN,Respiratory Syncytial Virus Infection Pathway
FURIN,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
FURIN,Bacterial Infection Pathways
FURIN,Maturation of hRSV A proteins
NOX4,FLT3 signaling in disease
NOX4,Signaling by FLT3 ITD and TKD mutants
NOX3,RHO GTPases Activate NADPH Oxidases
NOX3,RAC3 GTPase cycle
COL5A3,Signaling by PDGF
COL5A3,Signaling by MET
COL5A3,MET activates PTK2 signaling
COL5A3,MET promotes cell motility
PRDX1,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
PRDX1,Neurodegenerative Diseases
PRDX1,Diseases of programmed cell death
PRDX1,Defective Intrinsic Pathway for Apoptosis
SERPINE1,Signaling by TGF-beta Receptor Complex
SERPINE1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SERPINE1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
PAK1,Signaling by VEGF
PAK1,G-protein beta:gamma signalling
PAK1,Activation of RAC1
PAK1,VEGFA-VEGFR2 Pathway
PAK1,VEGFR2 mediated vascular permeability
PAK1,RHO GTPases activate PAKs
PAK1,MAPK6/MAPK4 signaling
PAK1,G beta:gamma signalling through CDC42
PAK1,RAC2 GTPase cycle
PAK1,RHOQ GTPase cycle
PAK1,RHOH GTPase cycle
PAK1,RHOJ GTPase cycle
PAK1,RHOU GTPase cycle
PAK1,RAC3 GTPase cycle
PAK1,RHOV GTPase cycle
IL22,Signaling by ALK in cancer
IL22,Signaling by ALK fusions and activated point mutants
ATP6V0A4,Signaling by Insulin receptor
ATP6V0A4,Insulin receptor recycling
ITSN2,RHOU GTPase cycle
DEF6,RHOA GTPase cycle
DEF6,RAC2 GTPase cycle
PAK2,Signaling by VEGF
PAK2,Activation of RAC1
PAK2,VEGFA-VEGFR2 Pathway
PAK2,VEGFR2 mediated vascular permeability
PAK2,RHO GTPases activate PAKs
PAK2,MAPK6/MAPK4 signaling
PAK2,RAC2 GTPase cycle
PAK2,RHOQ GTPase cycle
PAK2,RHOH GTPase cycle
PAK2,RHOG GTPase cycle
PAK2,RHOJ GTPase cycle
PAK2,RHOU GTPase cycle
PAK2,RAC3 GTPase cycle
PAK2,RHOV GTPase cycle
GEMIN4,SARS-CoV-2 modulates host translation machinery
PAK3,Signaling by VEGF
PAK3,Activation of RAC1
PAK3,VEGFA-VEGFR2 Pathway
PAK3,VEGFR2 mediated vascular permeability
PAK3,RHO GTPases activate PAKs
PAK3,MAPK6/MAPK4 signaling
PAK3,RHOJ GTPase cycle
PAK3,RHOU GTPase cycle
ANO7,Induction of Cell-Cell Fusion
ANO7,Late SARS-CoV-2 Infection Events
ARHGEF4,NRAGE signals death through JNK
ARHGEF4,p75 NTR receptor-mediated signalling
ARHGEF4,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF4,G alpha (12/13) signalling events
ARHGEF4,RHOA GTPase cycle
ARHGEF3,NRAGE signals death through JNK
ARHGEF3,p75 NTR receptor-mediated signalling
ARHGEF3,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF3,G alpha (12/13) signalling events
ARHGEF3,RHOA GTPase cycle
ARHGEF3,RHOB GTPase cycle
TAS2R3,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R4,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R1,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R9,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R8,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R7,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R13,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R10,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS2R14,Class C/3 (Metabotropic glutamate/pheromone receptors)
F11R,Signaling by TGF-beta Receptor Complex
F11R,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
PARD6A,Signaling by TGF-beta Receptor Complex
PARD6A,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
PARD6A,PCP/CE pathway
PARD6A,Asymmetric localization of PCP proteins
PARD6A,RHOU GTPase cycle
PARD6A,RHOV GTPase cycle
PBX1,Signaling by NOTCH3
PBX1,NOTCH3 Intracellular Domain Regulates Transcription
PC,Defects in vitamin and cofactor metabolism
PC,Diseases of metabolism
CDON,Hedgehog 'on' state
CDON,Activation of SMO
PCBP2,SARS-CoV-1-host interactions
PCBP2,SARS-CoV-1 activates/modulates innate immune responses
PCCA,Defects in vitamin and cofactor metabolism
PCCA,Diseases of metabolism
PCCB,Defects in vitamin and cofactor metabolism
PCCB,Diseases of metabolism
PCDH7,RHOA GTPase cycle
PCDH7,RHOB GTPase cycle
TMED5,WNT ligand biogenesis and trafficking
MED31,Respiratory Syncytial Virus Infection Pathway
MED31,RSV-host interactions
DERL2,Hedgehog ligand biogenesis
DERL2,Hh mutants are degraded by ERAD
DERL2,Hh mutants abrogate ligand secretion
DERL2,ABC transporter disorders
DERL2,Disorders of transmembrane transporters
DERL2,Defective CFTR causes cystic fibrosis
VPS36,HCMV Infection
VPS36,HCMV Late Events
PCK1,NR1H2 and NR1H3-mediated signaling
RPS27L,Viral mRNA Translation
RPS27L,SARS-CoV-1-host interactions
RPS27L,SARS-CoV-1 modulates host translation machinery
RPS27L,SARS-CoV-2 modulates host translation machinery
MEMO1,Signaling by ERBB2
IFT52,Hedgehog 'off' state
APH1A,Signaling by ERBB4
APH1A,Nuclear signaling by ERBB4
APH1A,p75 NTR receptor-mediated signalling
APH1A,Signaling by NOTCH1
APH1A,Signaling by NOTCH2
APH1A,"Cell death signalling via NRAGE, NRIF and NADE"
APH1A,NRIF signals cell death from the nucleus
APH1A,Activated NOTCH1 Transmits Signal to the Nucleus
APH1A,Signaling by NOTCH1 PEST Domain Mutants in Cancer
APH1A,Signaling by NOTCH1 in Cancer
APH1A,Constitutive Signaling by NOTCH1 PEST Domain Mutants
APH1A,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
APH1A,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
APH1A,NOTCH2 Activation and Transmission of Signal to the Nucleus
APH1A,Signaling by NOTCH3
APH1A,NOTCH3 Activation and Transmission of Signal to the Nucleus
APH1A,Signaling by NOTCH4
APH1A,Signaling by TGFBR3
RDH11,Signaling by Retinoic Acid
RDH11,RA biosynthesis pathway
ZDHHC9,RAS processing
ZDHHC9,Maturation of spike protein
ZDHHC9,Translation of Structural Proteins
ZDHHC9,Late SARS-CoV-2 Infection Events
RPL26L1,Viral mRNA Translation
GOLGA7,RAS processing
GOLGA7,Maturation of spike protein
GOLGA7,Translation of Structural Proteins
GOLGA7,Late SARS-CoV-2 Infection Events
SAR1B,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IRAK4,Negative regulation of the PI3K/AKT network
IRAK4,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
COPS4,RHOBTB1 GTPase cycle
COPS4,RHOBTB GTPase Cycle
DYNC1LI1,RHO GTPases Activate Formins
DYNC1LI1,HCMV Infection
DYNC1LI1,HCMV Early Events
VPS28,Budding and maturation of HIV virion
VPS28,Assembly Of The HIV Virion
VPS28,HCMV Infection
VPS28,HCMV Late Events
LEF1,Degradation of beta-catenin by the destruction complex
LEF1,Formation of the beta-catenin:TCF transactivating complex
LEF1,Deactivation of the beta-catenin transactivating complex
LEF1,Ca2+ pathway
LEF1,Repression of WNT target genes
CRBN,Potential therapeutics for SARS
CHMP1A,HCMV Infection
CHMP1A,HCMV Late Events
HERC5,Respiratory Syncytial Virus Infection Pathway
HERC5,RSV-host interactions
ZDHHC2,Maturation of spike protein
ZDHHC2,Translation of Structural Proteins
ZDHHC2,Late SARS-CoV-2 Infection Events
RAB9B,RHOBTB3 ATPase cycle
VRK3,Signaling by NTRK1 (TRKA)
VRK3,Nuclear Events (kinase and transcription factor activation)
VRK3,ERK/MAPK targets
VRK3,ERKs are inactivated
UBAP1,Budding and maturation of HIV virion
UBAP1,Assembly Of The HIV Virion
UBAP1,HCMV Infection
UBAP1,HCMV Late Events
ZDHHC3,Maturation of spike protein
ZDHHC3,Translation of Structural Proteins
ZDHHC3,Late SARS-CoV-2 Infection Events
TLR8,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PHF21A,Potential therapeutics for SARS
PDCD1,Potential therapeutics for SARS
DACT1,Degradation of DVL
FZR1,Diseases of mitotic cell cycle
FZR1,Aberrant regulation of mitotic exit in cancer due to RB1 defects
FZR1,Aberrant regulation of mitotic cell cycle due to RB1 defects
TAOK3,RAC2 GTPase cycle
TAOK3,RAC3 GTPase cycle
PDE1A,Opioid Signalling
PDE1A,Calmodulin induced events
PDE1A,Ca-dependent events
PDE1A,CaM pathway
PDE1A,G-protein mediated events
PDE1A,PLC beta mediated events
PDE1A,DAG and IP3 signaling
PDE1A,G alpha (s) signalling events
PDE1C,Opioid Signalling
PDE1C,Calmodulin induced events
PDE1C,Ca-dependent events
PDE1C,CaM pathway
PDE1C,G-protein mediated events
PDE1C,PLC beta mediated events
PDE1C,DAG and IP3 signaling
UCHL5,Signaling by TGF-beta Receptor Complex
UCHL5,Downregulation of TGF-beta receptor signaling
UCHL5,TGF-beta receptor signaling activates SMADs
ATP6V1D,Signaling by Insulin receptor
ATP6V1D,Insulin receptor recycling
WNT16,WNT ligand biogenesis and trafficking
WNT16,Class B/2 (Secretin family receptors)
PDE3B,PI3K Cascade
PDE3B,IRS-mediated signalling
PDE3B,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
PDE3B,IGF1R signaling cascade
PDE3B,IRS-related events triggered by IGF1R
PDE3B,G alpha (s) signalling events
PDE3B,Insulin receptor signalling cascade
PDE3B,Signaling by Insulin receptor
PDE4A,Opioid Signalling
PDE4A,DARPP-32 events
PDE4A,G alpha (s) signalling events
AMOTL2,Signaling by Hippo
PRKAG2,MTOR signalling
PRKAG2,Energy dependent regulation of mTOR by LKB1-AMPK
PDE4C,Opioid Signalling
PDE4C,DARPP-32 events
PDE4C,G alpha (s) signalling events
ANAPC5,Diseases of mitotic cell cycle
ANAPC5,Aberrant regulation of mitotic exit in cancer due to RB1 defects
ANAPC5,Aberrant regulation of mitotic cell cycle due to RB1 defects
PDE4D,Opioid Signalling
PDE4D,DARPP-32 events
PDE4D,G alpha (s) signalling events
PDE6A,Ca2+ pathway
PDE6D,RAS processing
ANKFY1,RHOD GTPase cycle
PDE6G,Ca2+ pathway
CHMP5,Budding and maturation of HIV virion
NCKIPSD,RHO GTPases Activate WASPs and WAVEs
NCKIPSD,Parasite infection
NCKIPSD,Leishmania phagocytosis
NCKIPSD,FCGR3A-mediated phagocytosis
CXXC5,Estrogen-dependent gene expression
ANAPC11,Diseases of mitotic cell cycle
ANAPC11,Aberrant regulation of mitotic exit in cancer due to RB1 defects
ANAPC11,Aberrant regulation of mitotic cell cycle due to RB1 defects
PDE1B,Opioid Signalling
PDE1B,Calmodulin induced events
PDE1B,Ca-dependent events
PDE1B,CaM pathway
PDE1B,G-protein mediated events
PDE1B,PLC beta mediated events
PDE1B,DAG and IP3 signaling
PDE1B,G alpha (s) signalling events
ZC3HC1,Signaling by ALK in cancer
ZC3HC1,Signaling by ALK fusions and activated point mutants
ZC3HC1,Nuclear events stimulated by ALK signaling in cancer
VTA1,Budding and maturation of HIV virion
SIRT6,Pre-NOTCH Transcription and Translation
SIRT6,Pre-NOTCH Expression and Processing
PDGFRA,Signaling by PDGF
HDAC7,Signaling by NOTCH1
HDAC7,NOTCH1 Intracellular Domain Regulates Transcription
HDAC7,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC7,Signaling by NOTCH1 in Cancer
HDAC7,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC7,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC7,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HDAC7,Regulation of PTEN gene transcription
ARMCX3,RAC2 GTPase cycle
PDE6B,Ca2+ pathway
MED15,Respiratory Syncytial Virus Infection Pathway
MED15,RSV-host interactions
PDGFRB,Signaling by PDGF
TRIM33,Signaling by TGF-beta Receptor Complex
TRIM33,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TRIM33,Downregulation of SMAD2/3:SMAD4 transcriptional activity
PDHA1,Signaling by Retinoic Acid
ATP6V1H,Host Interactions of HIV factors
ATP6V1H,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
ATP6V1H,The role of Nef in HIV-1 replication and disease pathogenesis
ATP6V1H,Signaling by Insulin receptor
ATP6V1H,Insulin receptor recycling
ATP6V1H,Infection with Mycobacterium tuberculosis
ATP6V1H,Response of Mtb to phagocytosis
ATP6V1H,Bacterial Infection Pathways
PDHA2,Signaling by Retinoic Acid
TAF9B,HIV Transcription Initiation
TAF9B,RNA Polymerase II HIV Promoter Escape
TAF9B,Transcription of the HIV genome
PDHB,Signaling by Retinoic Acid
PDK1,Signaling by Retinoic Acid
SUFU,Degradation of GLI1 by the proteasome
SUFU,Degradation of GLI2 by the proteasome
SUFU,GLI3 is processed to GLI3R by the proteasome
SUFU,Hedgehog 'off' state
SUFU,Hedgehog 'on' state
VPS29,WNT ligand biogenesis and trafficking
PDPK1,PI3K Cascade
PDPK1,IRS-mediated signalling
PDPK1,Signaling by VEGF
PDPK1,PI3K/AKT Signaling in Cancer
PDPK1,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
PDPK1,IGF1R signaling cascade
PDPK1,IRS-related events triggered by IGF1R
PDPK1,Integrin signaling
PDPK1,G beta:gamma signalling through PI3Kgamma
PDPK1,G-protein beta:gamma signalling
PDPK1,VEGFA-VEGFR2 Pathway
PDPK1,VEGFR2 mediated vascular permeability
PDPK1,VEGFR2 mediated cell proliferation
PDPK1,RHO GTPases activate PKNs
PDPK1,Constitutive Signaling by AKT1 E17K in Cancer
PDPK1,Insulin receptor signalling cascade
PDPK1,Signaling by Insulin receptor
PDPK1,Extra-nuclear estrogen signaling
PDPK1,SARS-CoV-1-host interactions
PDPK1,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
NLK,Ca2+ pathway
CAB39,MTOR signalling
CAB39,Energy dependent regulation of mTOR by LKB1-AMPK
WWOX,Signaling by ERBB4
WWOX,Nuclear signaling by ERBB4
ARID4B,Potential therapeutics for SARS
GNG13,Opioid Signalling
GNG13,G-protein activation
GNG13,Class B/2 (Secretin family receptors)
GNG13,G beta:gamma signalling through PI3Kgamma
GNG13,G-protein beta:gamma signalling
GNG13,Ca2+ pathway
GNG13,G alpha (12/13) signalling events
GNG13,G beta:gamma signalling through PLC beta
GNG13,G alpha (s) signalling events
GNG13,G alpha (z) signalling events
GNG13,Glucagon-type ligand receptors
GNG13,G beta:gamma signalling through BTK
GNG13,G beta:gamma signalling through CDC42
GNG13,Extra-nuclear estrogen signaling
GNG13,GPER1 signaling
GNG13,ADORA2B mediated anti-inflammatory cytokines production
GNG13,Anti-inflammatory response favouring Leishmania parasite infection
GNG13,Leishmania parasite growth and survival
TUBA8,RHO GTPases activate IQGAPs
TUBA8,RHO GTPases Activate Formins
TUBA8,HCMV Infection
TUBA8,HCMV Early Events
PFN1,PCP/CE pathway
PFN1,RHO GTPases Activate Formins
PGF,Signaling by VEGF
ATP6V1A,Signaling by Insulin receptor
ATP6V1A,Insulin receptor recycling
PGK1,Infection with Mycobacterium tuberculosis
PGK1,Response of Mtb to phagocytosis
PGK1,Bacterial Infection Pathways
PGR,Signaling by ERBB4
PGR,Nuclear signaling by ERBB4
PGR,Estrogen-dependent gene expression
ATP6V1B1,Signaling by Insulin receptor
ATP6V1B1,Insulin receptor recycling
ATP6V1B2,Signaling by Insulin receptor
ATP6V1B2,Insulin receptor recycling
ATP6V0C,Signaling by Insulin receptor
ATP6V0C,Insulin receptor recycling
ATP6V1C1,Signaling by Insulin receptor
ATP6V1C1,Insulin receptor recycling
PIK3C3,PI3K Cascade
PIK3C3,IRS-mediated signalling
PIK3C3,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
PIK3C3,IGF1R signaling cascade
PIK3C3,IRS-related events triggered by IGF1R
PIK3C3,RHO GTPases Activate NADPH Oxidases
PIK3C3,Insulin receptor signalling cascade
PIK3C3,Signaling by Insulin receptor
PIK3C3,Translation of Replicase and Assembly of the Replication Transcription Complex
PIK3C3,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PIK3C3,Early SARS-CoV-2 Infection Events
ATP6V1E1,Signaling by Insulin receptor
ATP6V1E1,Insulin receptor recycling
PIK3CA,PI3K Cascade
PIK3CA,IRS-mediated signalling
PIK3CA,Signaling by FGFR in disease
PIK3CA,Signaling by ERBB2
PIK3CA,Signaling by ERBB2 in Cancer
PIK3CA,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
PIK3CA,Signaling by ERBB4
PIK3CA,Signaling by SCF-KIT
PIK3CA,Signaling by EGFR in Cancer
PIK3CA,Signaling by EGFR
PIK3CA,FGFR1 mutant receptor activation
PIK3CA,Downstream signal transduction
PIK3CA,Signaling by PDGF
PIK3CA,Signaling by NTRK1 (TRKA)
PIK3CA,Signaling by FGFR
PIK3CA,Signaling by VEGF
PIK3CA,Negative regulation of the PI3K/AKT network
PIK3CA,Signaling by ALK
PIK3CA,PI3K/AKT Signaling in Cancer
PIK3CA,Constitutive Signaling by Aberrant PI3K in Cancer
PIK3CA,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
PIK3CA,IGF1R signaling cascade
PIK3CA,IRS-related events triggered by IGF1R
PIK3CA,VEGFA-VEGFR2 Pathway
PIK3CA,Constitutive Signaling by EGFRvIII
PIK3CA,Signaling by EGFRvIII in Cancer
PIK3CA,Signaling by Ligand-Responsive EGFR Variants in Cancer
PIK3CA,Downstream signaling of activated FGFR1
PIK3CA,PI-3K cascade:FGFR1
PIK3CA,PI-3K cascade:FGFR2
PIK3CA,Downstream signaling of activated FGFR2
PIK3CA,Downstream signaling of activated FGFR3
PIK3CA,Downstream signaling of activated FGFR4
PIK3CA,PI-3K cascade:FGFR4
PIK3CA,Signaling by FGFR1
PIK3CA,Signaling by FGFR2
PIK3CA,Signaling by FGFR3
PIK3CA,Signaling by FGFR4
PIK3CA,Signaling by FGFR2 in disease
PIK3CA,Signaling by FGFR1 in disease
PIK3CA,Signaling by FGFR3 in disease
PIK3CA,Signaling by MET
PIK3CA,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PIK3CA,Insulin receptor signalling cascade
PIK3CA,Signaling by Insulin receptor
PIK3CA,Signaling by NTRK2 (TRKB)
PIK3CA,Signaling by Erythropoietin
PIK3CA,Extra-nuclear estrogen signaling
PIK3CA,RAC2 GTPase cycle
PIK3CA,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
PIK3CA,Signaling by NTRK3 (TRKC)
PIK3CA,Signaling by ERBB2 KD Mutants
PIK3CA,Signaling by ERBB2 ECD mutants
PIK3CA,Signaling by KIT in disease
PIK3CA,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
PIK3CA,FLT3 signaling in disease
PIK3CA,Signaling by ALK in cancer
PIK3CA,Signaling by FLT3 ITD and TKD mutants
PIK3CA,Signaling by ALK fusions and activated point mutants
PIK3CB,PI3K Cascade
PIK3CB,IRS-mediated signalling
PIK3CB,Downstream signal transduction
PIK3CB,Signaling by PDGF
PIK3CB,Signaling by NTRK1 (TRKA)
PIK3CB,Signaling by VEGF
PIK3CB,Negative regulation of the PI3K/AKT network
PIK3CB,Signaling by ALK
PIK3CB,PI3K/AKT Signaling in Cancer
PIK3CB,Constitutive Signaling by Aberrant PI3K in Cancer
PIK3CB,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
PIK3CB,IGF1R signaling cascade
PIK3CB,IRS-related events triggered by IGF1R
PIK3CB,VEGFA-VEGFR2 Pathway
PIK3CB,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PIK3CB,Insulin receptor signalling cascade
PIK3CB,Signaling by Insulin receptor
PIK3CB,Signaling by Erythropoietin
PIK3CB,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
PIK3CB,Signaling by ALK in cancer
PIK3CB,Signaling by ALK fusions and activated point mutants
PIM1,FLT3 signaling in disease
PIM1,Signaling by FLT3 ITD and TKD mutants
PIK3CD,Negative regulation of the PI3K/AKT network
PIK3CD,PI3K/AKT Signaling in Cancer
PIK3CD,Constitutive Signaling by Aberrant PI3K in Cancer
PIK3CD,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PIK3CD,Signaling by Erythropoietin
PIK3CD,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
PIK3CG,G beta:gamma signalling through PI3Kgamma
PIK3CG,G-protein beta:gamma signalling
PIK3CG,Signaling by Erythropoietin
PIK3CG,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
PIK3R1,PI3K Cascade
PIK3R1,IRS-mediated signalling
PIK3R1,Signaling by FGFR in disease
PIK3R1,Signaling by ERBB2
PIK3R1,Signaling by ERBB2 in Cancer
PIK3R1,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
PIK3R1,Signaling by ERBB4
PIK3R1,Signaling by SCF-KIT
PIK3R1,Signaling by EGFR in Cancer
PIK3R1,Signaling by EGFR
PIK3R1,FGFR1 mutant receptor activation
PIK3R1,Downstream signal transduction
PIK3R1,Signaling by PDGF
PIK3R1,Signaling by NTRK1 (TRKA)
PIK3R1,Signaling by FGFR
PIK3R1,Signaling by VEGF
PIK3R1,Negative regulation of the PI3K/AKT network
PIK3R1,Signaling by ALK
PIK3R1,PI3K/AKT Signaling in Cancer
PIK3R1,Constitutive Signaling by Aberrant PI3K in Cancer
PIK3R1,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
PIK3R1,IGF1R signaling cascade
PIK3R1,IRS-related events triggered by IGF1R
PIK3R1,VEGFA-VEGFR2 Pathway
PIK3R1,Constitutive Signaling by EGFRvIII
PIK3R1,Signaling by EGFRvIII in Cancer
PIK3R1,Signaling by Ligand-Responsive EGFR Variants in Cancer
PIK3R1,Downstream signaling of activated FGFR1
PIK3R1,PI-3K cascade:FGFR1
PIK3R1,PI-3K cascade:FGFR2
PIK3R1,Downstream signaling of activated FGFR2
PIK3R1,Downstream signaling of activated FGFR3
PIK3R1,Downstream signaling of activated FGFR4
PIK3R1,PI-3K cascade:FGFR4
PIK3R1,Signaling by FGFR1
PIK3R1,Signaling by FGFR2
PIK3R1,Signaling by FGFR3
PIK3R1,Signaling by FGFR4
PIK3R1,Signaling by FGFR2 in disease
PIK3R1,Signaling by FGFR1 in disease
PIK3R1,Signaling by FGFR3 in disease
PIK3R1,Signaling by MET
PIK3R1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PIK3R1,Insulin receptor signalling cascade
PIK3R1,Signaling by Insulin receptor
PIK3R1,RHOA GTPase cycle
PIK3R1,Signaling by NTRK2 (TRKB)
PIK3R1,Signaling by Erythropoietin
PIK3R1,Extra-nuclear estrogen signaling
PIK3R1,RHOB GTPase cycle
PIK3R1,RHOC GTPase cycle
PIK3R1,RAC2 GTPase cycle
PIK3R1,RHOD GTPase cycle
PIK3R1,RHOG GTPase cycle
PIK3R1,RHOJ GTPase cycle
PIK3R1,RHOU GTPase cycle
PIK3R1,RAC3 GTPase cycle
PIK3R1,RHOV GTPase cycle
PIK3R1,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
PIK3R1,Signaling by NTRK3 (TRKC)
PIK3R1,RHOF GTPase cycle
PIK3R1,Signaling by ERBB2 KD Mutants
PIK3R1,Signaling by ERBB2 ECD mutants
PIK3R1,Signaling by KIT in disease
PIK3R1,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
PIK3R1,FLT3 signaling in disease
PIK3R1,RND3 GTPase cycle
PIK3R1,RND2 GTPase cycle
PIK3R1,RND1 GTPase cycle
PIK3R1,Signaling by ALK in cancer
PIK3R1,Signaling by FLT3 ITD and TKD mutants
PIK3R1,Signaling by ALK fusions and activated point mutants
PIK3R2,PI3K Cascade
PIK3R2,IRS-mediated signalling
PIK3R2,Signaling by SCF-KIT
PIK3R2,Downstream signal transduction
PIK3R2,Signaling by PDGF
PIK3R2,Signaling by NTRK1 (TRKA)
PIK3R2,Signaling by VEGF
PIK3R2,Negative regulation of the PI3K/AKT network
PIK3R2,Signaling by ALK
PIK3R2,PI3K/AKT Signaling in Cancer
PIK3R2,Constitutive Signaling by Aberrant PI3K in Cancer
PIK3R2,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
PIK3R2,IGF1R signaling cascade
PIK3R2,IRS-related events triggered by IGF1R
PIK3R2,VEGFA-VEGFR2 Pathway
PIK3R2,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PIK3R2,Insulin receptor signalling cascade
PIK3R2,Signaling by Insulin receptor
PIK3R2,RHOA GTPase cycle
PIK3R2,Extra-nuclear estrogen signaling
PIK3R2,RHOB GTPase cycle
PIK3R2,RAC2 GTPase cycle
PIK3R2,RHOD GTPase cycle
PIK3R2,RHOJ GTPase cycle
PIK3R2,RHOU GTPase cycle
PIK3R2,RAC3 GTPase cycle
PIK3R2,RHOF GTPase cycle
PIK3R2,Signaling by KIT in disease
PIK3R2,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
PIK3R2,RND3 GTPase cycle
PIK3R2,RND2 GTPase cycle
PIK3R2,RND1 GTPase cycle
PIK3R2,Signaling by ALK in cancer
PIK3R2,Signaling by ALK fusions and activated point mutants
PIN1,RHO GTPases Activate NADPH Oxidases
PIP4K2A,Negative regulation of the PI3K/AKT network
PIP4K2A,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PLA2G4A,Opioid Signalling
PLA2G4A,Ca-dependent events
PLA2G4A,G-protein mediated events
PLA2G4A,PLC beta mediated events
ATP6V0B,Signaling by Insulin receptor
ATP6V0B,Insulin receptor recycling
PLCB2,Opioid Signalling
PLCB2,G-protein mediated events
PLCB2,PLC beta mediated events
PLCB2,G-protein beta:gamma signalling
PLCB2,Ca2+ pathway
PLCB2,G beta:gamma signalling through PLC beta
PLCB3,Opioid Signalling
PLCB3,G-protein mediated events
PLCB3,PLC beta mediated events
PLCB3,G-protein beta:gamma signalling
PLCB3,Ca2+ pathway
PLCB3,G beta:gamma signalling through PLC beta
PLCB4,Opioid Signalling
PLCB4,G-protein mediated events
PLCB4,PLC beta mediated events
PLCG1,Signaling by FGFR in disease
PLCG1,Signaling by ERBB2
PLCG1,Signaling by ERBB2 in Cancer
PLCG1,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
PLCG1,Signaling by EGFR in Cancer
PLCG1,Signaling by EGFR
PLCG1,Downstream signal transduction
PLCG1,Signaling by PDGF
PLCG1,Signaling by NTRK1 (TRKA)
PLCG1,Signaling by FGFR
PLCG1,Signaling by VEGF
PLCG1,Signaling by ALK
PLCG1,VEGFA-VEGFR2 Pathway
PLCG1,VEGFR2 mediated cell proliferation
PLCG1,Constitutive Signaling by EGFRvIII
PLCG1,Signaling by EGFRvIII in Cancer
PLCG1,Signaling by Ligand-Responsive EGFR Variants in Cancer
PLCG1,Phospholipase C-mediated cascade; FGFR2
PLCG1,Phospholipase C-mediated cascade; FGFR4
PLCG1,Downstream signaling of activated FGFR1
PLCG1,Downstream signaling of activated FGFR2
PLCG1,Downstream signaling of activated FGFR3
PLCG1,Downstream signaling of activated FGFR4
PLCG1,Signaling by FGFR1
PLCG1,Signaling by FGFR2
PLCG1,Signaling by FGFR3
PLCG1,Signaling by FGFR4
PLCG1,Signaling by FGFR2 in disease
PLCG1,Signaling by FGFR1 in disease
PLCG1,Signaling by FGFR3 in disease
PLCG1,Signaling by NTRK2 (TRKB)
PLCG1,Signaling by Erythropoietin
PLCG1,Signaling by NTRK3 (TRKC)
PLCG1,Anti-inflammatory response favouring Leishmania parasite infection
PLCG1,FCGR3A-mediated IL10 synthesis
PLCG1,Leishmania parasite growth and survival
PLCG1,Signaling by ERBB2 KD Mutants
PLCG1,Signaling by ERBB2 ECD mutants
PLCG1,Signaling by ERBB2 TMD/JMD mutants
PLCG1,Signaling by ALK in cancer
PLCG1,Signaling by ALK fusions and activated point mutants
SHC3,Signalling to RAS
SHC3,Signaling by NTRK1 (TRKA)
SHC3,Signalling to ERKs
PLCG2,Signaling by Erythropoietin
PLCG2,Anti-inflammatory response favouring Leishmania parasite infection
PLCG2,FCGR3A-mediated IL10 synthesis
PLCG2,Leishmania parasite growth and survival
PLCG2,Potential therapeutics for SARS
PLD1,RHOA GTPase cycle
PLD1,RHOG GTPase cycle
NUP54,Host Interactions of HIV factors
NUP54,Rev-mediated nuclear export of HIV RNA
NUP54,Transport of Ribonucleoproteins into the Host Nucleus
NUP54,Export of Viral Ribonucleoproteins from Nucleus
NUP54,NS1 Mediated Effects on Host Pathways
NUP54,Viral Messenger RNA Synthesis
NUP54,NEP/NS2 Interacts with the Cellular Export Machinery
NUP54,Interactions of Vpr with host cellular proteins
NUP54,Interactions of Rev with host cellular proteins
NUP54,Nuclear import of Rev protein
NUP54,Vpr-mediated nuclear import of PICs
NUP54,SLC transporter disorders
NUP54,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP54,Disorders of transmembrane transporters
NUP54,HCMV Infection
NUP54,HCMV Early Events
NUP54,HCMV Late Events
NUP54,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PLD2,RAC2 GTPase cycle
ATP6V1G2,Signaling by Insulin receptor
ATP6V1G2,Insulin receptor recycling
PLIN1,NR1H2 and NR1H3-mediated signaling
FXYD1,Potential therapeutics for SARS
FXYD3,Potential therapeutics for SARS
ATP6V0A1,Signaling by Insulin receptor
ATP6V0A1,Insulin receptor recycling
PLXNA1,RHOD GTPase cycle
PLXNA1,RND1 GTPase cycle
MBD3,Regulation of PTEN gene transcription
MBD3,Potential therapeutics for SARS
PRKAG3,MTOR signalling
PRKAG3,Energy dependent regulation of mTOR by LKB1-AMPK
PLXNB1,G alpha (12/13) signalling events
PLXNB1,RHOD GTPase cycle
ATP6AP1,Signaling by Insulin receptor
ATP6AP1,Insulin receptor recycling
ATP6AP1,RHOA GTPase cycle
PML,HCMV Infection
PML,HCMV Early Events
FXYD7,Potential therapeutics for SARS
FXYD6,Potential therapeutics for SARS
FXYD4,Potential therapeutics for SARS
P2RY13,P2Y receptors
P2RY13,Nucleotide-like (purinergic) receptors
FGFRL1,Signaling by FGFR
FGFRL1,Signaling by FGFR1
PMS2,Diseases of DNA repair
TLR9,PI3K Cascade
TLR9,IRS-mediated signalling
TLR9,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TLR9,IGF1R signaling cascade
TLR9,IRS-related events triggered by IGF1R
TLR9,Insulin receptor signalling cascade
TLR9,Signaling by Insulin receptor
POLA1,Diseases of programmed cell death
POLA1,Defective pyroptosis
POLR2A,Signaling by FGFR in disease
POLR2A,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2A,HIV Transcription Initiation
POLR2A,RNA Polymerase II HIV Promoter Escape
POLR2A,Transcription of the HIV genome
POLR2A,FGFR2 mutant receptor activation
POLR2A,Signaling by FGFR
POLR2A,Signaling by FGFR2
POLR2A,Signaling by FGFR2 in disease
POLR2A,FGFR2 alternative splicing
POLR2A,Signaling by FGFR2 IIIa TM
POLR2B,Signaling by FGFR in disease
POLR2B,Formation of HIV elongation complex in the absence of HIV Tat
POLR2B,Formation of the HIV-1 Early Elongation Complex
POLR2B,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2B,HIV Transcription Initiation
POLR2B,RNA Polymerase II HIV Promoter Escape
POLR2B,HIV Transcription Elongation
POLR2B,Transcription of the HIV genome
POLR2B,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2B,Pausing and recovery of Tat-mediated HIV elongation
POLR2B,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2B,Tat-mediated HIV elongation arrest and recovery
POLR2B,Tat-mediated elongation of the HIV-1 transcript
POLR2B,HIV elongation arrest and recovery
POLR2B,Pausing and recovery of HIV elongation
POLR2B,Viral Messenger RNA Synthesis
POLR2B,FGFR2 mutant receptor activation
POLR2B,Signaling by FGFR
POLR2B,Signaling by FGFR2
POLR2B,Signaling by FGFR2 in disease
POLR2B,FGFR2 alternative splicing
POLR2B,Signaling by FGFR2 IIIa TM
POLR2B,Estrogen-dependent gene expression
POLR2C,Signaling by FGFR in disease
POLR2C,Formation of HIV elongation complex in the absence of HIV Tat
POLR2C,Formation of the HIV-1 Early Elongation Complex
POLR2C,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2C,HIV Transcription Initiation
POLR2C,RNA Polymerase II HIV Promoter Escape
POLR2C,HIV Transcription Elongation
POLR2C,Transcription of the HIV genome
POLR2C,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2C,Pausing and recovery of Tat-mediated HIV elongation
POLR2C,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2C,Tat-mediated HIV elongation arrest and recovery
POLR2C,Tat-mediated elongation of the HIV-1 transcript
POLR2C,HIV elongation arrest and recovery
POLR2C,Pausing and recovery of HIV elongation
POLR2C,Viral Messenger RNA Synthesis
POLR2C,FGFR2 mutant receptor activation
POLR2C,Signaling by FGFR
POLR2C,Signaling by FGFR2
POLR2C,Signaling by FGFR2 in disease
POLR2C,FGFR2 alternative splicing
POLR2C,Signaling by FGFR2 IIIa TM
POLR2C,Estrogen-dependent gene expression
POLR2D,Signaling by FGFR in disease
POLR2D,Formation of HIV elongation complex in the absence of HIV Tat
POLR2D,Formation of the HIV-1 Early Elongation Complex
POLR2D,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2D,HIV Transcription Initiation
POLR2D,RNA Polymerase II HIV Promoter Escape
POLR2D,HIV Transcription Elongation
POLR2D,Transcription of the HIV genome
POLR2D,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2D,Pausing and recovery of Tat-mediated HIV elongation
POLR2D,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2D,Tat-mediated HIV elongation arrest and recovery
POLR2D,Tat-mediated elongation of the HIV-1 transcript
POLR2D,HIV elongation arrest and recovery
POLR2D,Pausing and recovery of HIV elongation
POLR2D,Viral Messenger RNA Synthesis
POLR2D,FGFR2 mutant receptor activation
POLR2D,Signaling by FGFR
POLR2D,Signaling by FGFR2
POLR2D,Signaling by FGFR2 in disease
POLR2D,FGFR2 alternative splicing
POLR2D,Signaling by FGFR2 IIIa TM
POLR2D,Estrogen-dependent gene expression
GNG2,Opioid Signalling
GNG2,G-protein activation
GNG2,Class B/2 (Secretin family receptors)
GNG2,G beta:gamma signalling through PI3Kgamma
GNG2,G-protein beta:gamma signalling
GNG2,Ca2+ pathway
GNG2,G alpha (12/13) signalling events
GNG2,G beta:gamma signalling through PLC beta
GNG2,G alpha (s) signalling events
GNG2,G alpha (z) signalling events
GNG2,Glucagon-type ligand receptors
GNG2,G beta:gamma signalling through BTK
GNG2,G beta:gamma signalling through CDC42
GNG2,Extra-nuclear estrogen signaling
GNG2,GPER1 signaling
GNG2,ADORA2B mediated anti-inflammatory cytokines production
GNG2,Anti-inflammatory response favouring Leishmania parasite infection
GNG2,Leishmania parasite growth and survival
POLR2E,Signaling by FGFR in disease
POLR2E,Formation of HIV elongation complex in the absence of HIV Tat
POLR2E,Formation of the HIV-1 Early Elongation Complex
POLR2E,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2E,HIV Transcription Initiation
POLR2E,RNA Polymerase II HIV Promoter Escape
POLR2E,HIV Transcription Elongation
POLR2E,Transcription of the HIV genome
POLR2E,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2E,Pausing and recovery of Tat-mediated HIV elongation
POLR2E,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2E,Tat-mediated HIV elongation arrest and recovery
POLR2E,Tat-mediated elongation of the HIV-1 transcript
POLR2E,HIV elongation arrest and recovery
POLR2E,Pausing and recovery of HIV elongation
POLR2E,Viral Messenger RNA Synthesis
POLR2E,FGFR2 mutant receptor activation
POLR2E,Signaling by FGFR
POLR2E,Signaling by FGFR2
POLR2E,Signaling by FGFR2 in disease
POLR2E,FGFR2 alternative splicing
POLR2E,Signaling by FGFR2 IIIa TM
POLR2E,Estrogen-dependent gene expression
DPM3,Diseases of glycosylation
DPM3,Diseases of metabolism
POLR2F,Signaling by FGFR in disease
POLR2F,Formation of HIV elongation complex in the absence of HIV Tat
POLR2F,Formation of the HIV-1 Early Elongation Complex
POLR2F,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2F,HIV Transcription Initiation
POLR2F,RNA Polymerase II HIV Promoter Escape
POLR2F,HIV Transcription Elongation
POLR2F,Transcription of the HIV genome
POLR2F,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2F,Pausing and recovery of Tat-mediated HIV elongation
POLR2F,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2F,Tat-mediated HIV elongation arrest and recovery
POLR2F,Tat-mediated elongation of the HIV-1 transcript
POLR2F,HIV elongation arrest and recovery
POLR2F,Pausing and recovery of HIV elongation
POLR2F,Viral Messenger RNA Synthesis
POLR2F,FGFR2 mutant receptor activation
POLR2F,Signaling by FGFR
POLR2F,Signaling by FGFR2
POLR2F,Signaling by FGFR2 in disease
POLR2F,FGFR2 alternative splicing
POLR2F,Signaling by FGFR2 IIIa TM
POLR2F,Estrogen-dependent gene expression
POLR2G,Signaling by FGFR in disease
POLR2G,Formation of HIV elongation complex in the absence of HIV Tat
POLR2G,Formation of the HIV-1 Early Elongation Complex
POLR2G,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2G,HIV Transcription Initiation
POLR2G,RNA Polymerase II HIV Promoter Escape
POLR2G,HIV Transcription Elongation
POLR2G,Transcription of the HIV genome
POLR2G,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2G,Pausing and recovery of Tat-mediated HIV elongation
POLR2G,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2G,Tat-mediated HIV elongation arrest and recovery
POLR2G,Tat-mediated elongation of the HIV-1 transcript
POLR2G,HIV elongation arrest and recovery
POLR2G,Pausing and recovery of HIV elongation
POLR2G,Viral Messenger RNA Synthesis
POLR2G,FGFR2 mutant receptor activation
POLR2G,Signaling by FGFR
POLR2G,Signaling by FGFR2
POLR2G,Signaling by FGFR2 in disease
POLR2G,FGFR2 alternative splicing
POLR2G,Signaling by FGFR2 IIIa TM
POLR2G,Estrogen-dependent gene expression
WNT4,WNT ligand biogenesis and trafficking
WNT4,Class B/2 (Secretin family receptors)
POLR2H,Signaling by FGFR in disease
POLR2H,Formation of HIV elongation complex in the absence of HIV Tat
POLR2H,Formation of the HIV-1 Early Elongation Complex
POLR2H,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2H,HIV Transcription Initiation
POLR2H,RNA Polymerase II HIV Promoter Escape
POLR2H,HIV Transcription Elongation
POLR2H,Transcription of the HIV genome
POLR2H,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2H,Pausing and recovery of Tat-mediated HIV elongation
POLR2H,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2H,Tat-mediated HIV elongation arrest and recovery
POLR2H,Tat-mediated elongation of the HIV-1 transcript
POLR2H,HIV elongation arrest and recovery
POLR2H,Pausing and recovery of HIV elongation
POLR2H,Viral Messenger RNA Synthesis
POLR2H,FGFR2 mutant receptor activation
POLR2H,Signaling by FGFR
POLR2H,Signaling by FGFR2
POLR2H,Signaling by FGFR2 in disease
POLR2H,FGFR2 alternative splicing
POLR2H,Signaling by FGFR2 IIIa TM
POLR2H,Estrogen-dependent gene expression
POLR2I,Signaling by FGFR in disease
POLR2I,Formation of HIV elongation complex in the absence of HIV Tat
POLR2I,Formation of the HIV-1 Early Elongation Complex
POLR2I,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2I,HIV Transcription Initiation
POLR2I,RNA Polymerase II HIV Promoter Escape
POLR2I,HIV Transcription Elongation
POLR2I,Transcription of the HIV genome
POLR2I,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2I,Pausing and recovery of Tat-mediated HIV elongation
POLR2I,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2I,Tat-mediated HIV elongation arrest and recovery
POLR2I,Tat-mediated elongation of the HIV-1 transcript
POLR2I,HIV elongation arrest and recovery
POLR2I,Pausing and recovery of HIV elongation
POLR2I,Viral Messenger RNA Synthesis
POLR2I,FGFR2 mutant receptor activation
POLR2I,Signaling by FGFR
POLR2I,Signaling by FGFR2
POLR2I,Signaling by FGFR2 in disease
POLR2I,FGFR2 alternative splicing
POLR2I,Signaling by FGFR2 IIIa TM
POLR2I,Estrogen-dependent gene expression
POLR2J,Signaling by FGFR in disease
POLR2J,Formation of HIV elongation complex in the absence of HIV Tat
POLR2J,Formation of the HIV-1 Early Elongation Complex
POLR2J,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2J,HIV Transcription Initiation
POLR2J,RNA Polymerase II HIV Promoter Escape
POLR2J,HIV Transcription Elongation
POLR2J,Transcription of the HIV genome
POLR2J,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2J,Pausing and recovery of Tat-mediated HIV elongation
POLR2J,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2J,Tat-mediated HIV elongation arrest and recovery
POLR2J,Tat-mediated elongation of the HIV-1 transcript
POLR2J,HIV elongation arrest and recovery
POLR2J,Pausing and recovery of HIV elongation
POLR2J,Viral Messenger RNA Synthesis
POLR2J,FGFR2 mutant receptor activation
POLR2J,Signaling by FGFR
POLR2J,Signaling by FGFR2
POLR2J,Signaling by FGFR2 in disease
POLR2J,FGFR2 alternative splicing
POLR2J,Signaling by FGFR2 IIIa TM
POLR2J,Estrogen-dependent gene expression
POLR2K,Signaling by FGFR in disease
POLR2K,Formation of HIV elongation complex in the absence of HIV Tat
POLR2K,Formation of the HIV-1 Early Elongation Complex
POLR2K,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2K,HIV Transcription Initiation
POLR2K,RNA Polymerase II HIV Promoter Escape
POLR2K,HIV Transcription Elongation
POLR2K,Transcription of the HIV genome
POLR2K,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2K,Pausing and recovery of Tat-mediated HIV elongation
POLR2K,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2K,Tat-mediated HIV elongation arrest and recovery
POLR2K,Tat-mediated elongation of the HIV-1 transcript
POLR2K,HIV elongation arrest and recovery
POLR2K,Pausing and recovery of HIV elongation
POLR2K,Viral Messenger RNA Synthesis
POLR2K,FGFR2 mutant receptor activation
POLR2K,Signaling by FGFR
POLR2K,Signaling by FGFR2
POLR2K,Signaling by FGFR2 in disease
POLR2K,FGFR2 alternative splicing
POLR2K,Signaling by FGFR2 IIIa TM
POLR2K,Estrogen-dependent gene expression
POLR2L,Signaling by FGFR in disease
POLR2L,Formation of HIV elongation complex in the absence of HIV Tat
POLR2L,Formation of the HIV-1 Early Elongation Complex
POLR2L,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
POLR2L,HIV Transcription Initiation
POLR2L,RNA Polymerase II HIV Promoter Escape
POLR2L,HIV Transcription Elongation
POLR2L,Transcription of the HIV genome
POLR2L,Formation of HIV-1 elongation complex containing HIV-1 Tat
POLR2L,Pausing and recovery of Tat-mediated HIV elongation
POLR2L,Abortive elongation of HIV-1 transcript in the absence of Tat
POLR2L,Tat-mediated HIV elongation arrest and recovery
POLR2L,Tat-mediated elongation of the HIV-1 transcript
POLR2L,HIV elongation arrest and recovery
POLR2L,Pausing and recovery of HIV elongation
POLR2L,Viral Messenger RNA Synthesis
POLR2L,FGFR2 mutant receptor activation
POLR2L,Signaling by FGFR
POLR2L,Signaling by FGFR2
POLR2L,Signaling by FGFR2 in disease
POLR2L,FGFR2 alternative splicing
POLR2L,Signaling by FGFR2 IIIa TM
POLR2L,Estrogen-dependent gene expression
TAS2R5,Class C/3 (Metabotropic glutamate/pheromone receptors)
GFOD1,RHOQ GTPase cycle
ANLN,RHOA GTPase cycle
ANLN,RHOB GTPase cycle
ANLN,RHOC GTPase cycle
TAF7L,HIV Transcription Initiation
TAF7L,RNA Polymerase II HIV Promoter Escape
TAF7L,Transcription of the HIV genome
NEURL1B,Signaling by NOTCH1
NEURL1B,Signaling by NOTCH2
NEURL1B,Activated NOTCH1 Transmits Signal to the Nucleus
NEURL1B,Signaling by NOTCH1 PEST Domain Mutants in Cancer
NEURL1B,Signaling by NOTCH1 in Cancer
NEURL1B,Constitutive Signaling by NOTCH1 PEST Domain Mutants
NEURL1B,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
NEURL1B,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
NEURL1B,NOTCH2 Activation and Transmission of Signal to the Nucleus
NEURL1B,Signaling by NOTCH3
NEURL1B,NOTCH3 Activation and Transmission of Signal to the Nucleus
ATR,Diseases of DNA repair
ATR,Diseases of DNA Double-Strand Break Repair
ATR,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
ATR,Impaired BRCA2 binding to RAD51
RHOF,RHOF GTPase cycle
POU2F1,Estrogen-dependent gene expression
DDX4,RND3 GTPase cycle
APBB1IP,Integrin signaling
APBB1IP,p130Cas linkage to MAPK signaling for integrins
APBB1IP,MAP2K and MAPK activation
APBB1IP,Signaling by moderate kinase activity BRAF mutants
APBB1IP,Signaling by high-kinase activity BRAF mutants
APBB1IP,Signaling by RAS mutants
APBB1IP,Signaling by BRAF and RAF1 fusions
APBB1IP,Paradoxical activation of RAF signaling by kinase inactive BRAF
APBB1IP,Oncogenic MAPK signaling
APBB1IP,Signaling downstream of RAS mutants
APBB1IP,Signaling by RAF1 mutants
DLL4,Signaling by NOTCH1
DLL4,Signaling by NOTCH2
DLL4,Activated NOTCH1 Transmits Signal to the Nucleus
DLL4,Signaling by NOTCH1 PEST Domain Mutants in Cancer
DLL4,Signaling by NOTCH1 in Cancer
DLL4,Constitutive Signaling by NOTCH1 PEST Domain Mutants
DLL4,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
DLL4,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
DLL4,NOTCH2 Activation and Transmission of Signal to the Nucleus
DLL4,Signaling by NOTCH3
DLL4,NOTCH3 Activation and Transmission of Signal to the Nucleus
DLL4,Signaling by NOTCH4
ATRX,Diseases of mitotic cell cycle
PARP14,Maturation of nucleoprotein
PARP14,Translation of Structural Proteins
PARP14,Late SARS-CoV-2 Infection Events
UGT1A3,NR1H2 and NR1H3-mediated signaling
PPARD,Signaling by Retinoic Acid
PPARG,Regulation of PTEN gene transcription
MED1,Estrogen-dependent gene expression
MED1,Respiratory Syncytial Virus Infection Pathway
MED1,RSV-host interactions
IL17RD,MAP2K and MAPK activation
ZRANB1,Degradation of beta-catenin by the destruction complex
RNF111,Signaling by TGF-beta Receptor Complex
RNF111,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
RNF111,Downregulation of SMAD2/3:SMAD4 transcriptional activity
RNF111,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
PPIA,Budding and maturation of HIV virion
PPIA,Early Phase of HIV Life Cycle
PPIA,Host Interactions of HIV factors
PPIA,Assembly Of The HIV Virion
PPIA,SARS-CoV-1-host interactions
PPIA,SARS-CoV-1 activates/modulates innate immune responses
PPIB,SARS-CoV-1-host interactions
PPIB,SARS-CoV-1 activates/modulates innate immune responses
MED18,Respiratory Syncytial Virus Infection Pathway
MED18,RSV-host interactions
GATAD2A,Regulation of PTEN gene transcription
GATAD2A,Potential therapeutics for SARS
ESRP1,Signaling by FGFR
ESRP1,Signaling by FGFR2
ESRP1,FGFR2 alternative splicing
ARHGEF38,NRAGE signals death through JNK
ARHGEF38,p75 NTR receptor-mediated signalling
ARHGEF38,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF38,G alpha (12/13) signalling events
FNBP1L,RHOJ GTPase cycle
RNF43,Regulation of FZD by ubiquitination
MKS1,Hedgehog 'off' state
PPM1A,MTOR signalling
PPM1A,Signaling by TGF-beta Receptor Complex
PPM1A,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
PPM1A,Downregulation of SMAD2/3:SMAD4 transcriptional activity
PPM1A,Energy dependent regulation of mTOR by LKB1-AMPK
PARP16,Maturation of nucleoprotein
PARP16,Translation of Structural Proteins
PARP16,Late SARS-CoV-2 Infection Events
GEMIN8,SARS-CoV-2 modulates host translation machinery
PPP1CA,Opioid Signalling
PPP1CA,Signaling by TGF-beta Receptor Complex
PPP1CA,DARPP-32 events
PPP1CA,Downregulation of TGF-beta receptor signaling
PPP1CA,TGF-beta receptor signaling activates SMADs
PPP1CA,Respiratory Syncytial Virus Infection Pathway
PPP1CA,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
PPP1CA,Maturation of hRSV A proteins
PPP1CB,Signaling by TGF-beta Receptor Complex
PPP1CB,Downregulation of TGF-beta receptor signaling
PPP1CB,TGF-beta receptor signaling activates SMADs
PPP1CB,RHO GTPases activate PKNs
PPP1CB,RHO GTPases activate CIT
PPP1CB,RHO GTPases Activate ROCKs
PPP1CB,RHO GTPases activate PAKs
PPP1CB,RAF activation
PPP1CB,Oncogenic MAPK signaling
PPP1CB,Respiratory Syncytial Virus Infection Pathway
PPP1CB,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
PPP1CB,Maturation of hRSV A proteins
PPP1CC,Signaling by TGF-beta Receptor Complex
PPP1CC,Downregulation of TGF-beta receptor signaling
PPP1CC,TGF-beta receptor signaling activates SMADs
PPP1CC,RHO GTPases Activate Formins
PPP1CC,RAF activation
PPP1CC,Oncogenic MAPK signaling
PPP1CC,Respiratory Syncytial Virus Infection Pathway
PPP1CC,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
PPP1CC,Maturation of hRSV A proteins
PHIP,RHOBTB2 GTPase cycle
PHIP,RHOBTB GTPase Cycle
VPS37C,Budding and maturation of HIV virion
VPS37C,Assembly Of The HIV Virion
VPS37C,HCMV Infection
VPS37C,HCMV Late Events
PPP1R3C,Diseases of metabolism
RNF31,TNFR1-induced proapoptotic signaling
RNF31,Regulation of TNFR1 signaling
RNF31,TNFR1-induced NF-kappa-B signaling pathway
RNF31,TNF signaling
UACA,RHOH GTPase cycle
IFT57,Hedgehog 'off' state
MED9,Respiratory Syncytial Virus Infection Pathway
MED9,RSV-host interactions
ANO1,Induction of Cell-Cell Fusion
ANO1,Late SARS-CoV-2 Infection Events
ARHGAP17,RAC2 GTPase cycle
ARHGAP17,RHOD GTPase cycle
ARHGAP17,RHOQ GTPase cycle
ARHGAP17,RAC3 GTPase cycle
ANO10,Induction of Cell-Cell Fusion
ANO10,Late SARS-CoV-2 Infection Events
PPP2CA,Opioid Signalling
PPP2CA,DARPP-32 events
PPP2CA,Signaling by NTRK1 (TRKA)
PPP2CA,Signaling by FGFR
PPP2CA,Degradation of beta-catenin by the destruction complex
PPP2CA,Beta-catenin phosphorylation cascade
PPP2CA,Nuclear Events (kinase and transcription factor activation)
PPP2CA,ERK/MAPK targets
PPP2CA,Negative regulation of the PI3K/AKT network
PPP2CA,ERKs are inactivated
PPP2CA,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2CA,Signaling by WNT in cancer
PPP2CA,Signaling by AXIN mutants
PPP2CA,Signaling by CTNNB1 phospho-site mutants
PPP2CA,Signaling by APC mutants
PPP2CA,Signaling by AMER1 mutants
PPP2CA,Signaling by GSK3beta mutants
PPP2CA,CTNNB1 S33 mutants aren't phosphorylated
PPP2CA,CTNNB1 S37 mutants aren't phosphorylated
PPP2CA,CTNNB1 S45 mutants aren't phosphorylated
PPP2CA,CTNNB1 T41 mutants aren't phosphorylated
PPP2CA,APC truncation mutants have impaired AXIN binding
PPP2CA,AXIN missense mutants destabilize the destruction complex
PPP2CA,Truncations of AMER1 destabilize the destruction complex
PPP2CA,Negative regulation of FGFR1 signaling
PPP2CA,Negative regulation of FGFR2 signaling
PPP2CA,Negative regulation of FGFR3 signaling
PPP2CA,Negative regulation of FGFR4 signaling
PPP2CA,Signaling by FGFR1
PPP2CA,Signaling by FGFR2
PPP2CA,Signaling by FGFR3
PPP2CA,Signaling by FGFR4
PPP2CA,RHO GTPases Activate Formins
PPP2CA,RAF activation
PPP2CA,Negative regulation of MAPK pathway
PPP2CA,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PPP2CB,Opioid Signalling
PPP2CB,DARPP-32 events
PPP2CB,Signaling by NTRK1 (TRKA)
PPP2CB,Signaling by FGFR
PPP2CB,Degradation of beta-catenin by the destruction complex
PPP2CB,Beta-catenin phosphorylation cascade
PPP2CB,Nuclear Events (kinase and transcription factor activation)
PPP2CB,ERK/MAPK targets
PPP2CB,Negative regulation of the PI3K/AKT network
PPP2CB,ERKs are inactivated
PPP2CB,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2CB,Signaling by WNT in cancer
PPP2CB,Signaling by AXIN mutants
PPP2CB,Signaling by CTNNB1 phospho-site mutants
PPP2CB,Signaling by APC mutants
PPP2CB,Signaling by AMER1 mutants
PPP2CB,Signaling by GSK3beta mutants
PPP2CB,CTNNB1 S33 mutants aren't phosphorylated
PPP2CB,CTNNB1 S37 mutants aren't phosphorylated
PPP2CB,CTNNB1 S45 mutants aren't phosphorylated
PPP2CB,CTNNB1 T41 mutants aren't phosphorylated
PPP2CB,APC truncation mutants have impaired AXIN binding
PPP2CB,AXIN missense mutants destabilize the destruction complex
PPP2CB,Truncations of AMER1 destabilize the destruction complex
PPP2CB,Negative regulation of FGFR1 signaling
PPP2CB,Negative regulation of FGFR2 signaling
PPP2CB,Negative regulation of FGFR3 signaling
PPP2CB,Negative regulation of FGFR4 signaling
PPP2CB,Signaling by FGFR1
PPP2CB,Signaling by FGFR2
PPP2CB,Signaling by FGFR3
PPP2CB,Signaling by FGFR4
PPP2CB,RHO GTPases Activate Formins
PPP2CB,RAF activation
PPP2CB,Negative regulation of MAPK pathway
PPP2CB,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
ARHGEF10L,NRAGE signals death through JNK
ARHGEF10L,p75 NTR receptor-mediated signalling
ARHGEF10L,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF10L,G alpha (12/13) signalling events
ARHGEF10L,RHOA GTPase cycle
ARHGEF10L,RHOB GTPase cycle
ARHGEF10L,RHOC GTPase cycle
PPP2R1A,Opioid Signalling
PPP2R1A,DARPP-32 events
PPP2R1A,Signaling by NTRK1 (TRKA)
PPP2R1A,Signaling by FGFR
PPP2R1A,Degradation of beta-catenin by the destruction complex
PPP2R1A,Beta-catenin phosphorylation cascade
PPP2R1A,Nuclear Events (kinase and transcription factor activation)
PPP2R1A,ERK/MAPK targets
PPP2R1A,Negative regulation of the PI3K/AKT network
PPP2R1A,ERKs are inactivated
PPP2R1A,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2R1A,Signaling by WNT in cancer
PPP2R1A,Signaling by AXIN mutants
PPP2R1A,Signaling by CTNNB1 phospho-site mutants
PPP2R1A,Signaling by APC mutants
PPP2R1A,Signaling by AMER1 mutants
PPP2R1A,Signaling by GSK3beta mutants
PPP2R1A,CTNNB1 S33 mutants aren't phosphorylated
PPP2R1A,CTNNB1 S37 mutants aren't phosphorylated
PPP2R1A,CTNNB1 S45 mutants aren't phosphorylated
PPP2R1A,CTNNB1 T41 mutants aren't phosphorylated
PPP2R1A,APC truncation mutants have impaired AXIN binding
PPP2R1A,AXIN missense mutants destabilize the destruction complex
PPP2R1A,Truncations of AMER1 destabilize the destruction complex
PPP2R1A,Negative regulation of FGFR1 signaling
PPP2R1A,Negative regulation of FGFR2 signaling
PPP2R1A,Negative regulation of FGFR3 signaling
PPP2R1A,Negative regulation of FGFR4 signaling
PPP2R1A,Signaling by FGFR1
PPP2R1A,Signaling by FGFR2
PPP2R1A,Signaling by FGFR3
PPP2R1A,Signaling by FGFR4
PPP2R1A,RHO GTPases Activate Formins
PPP2R1A,RAF activation
PPP2R1A,Negative regulation of MAPK pathway
PPP2R1A,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PPP2R1B,Opioid Signalling
PPP2R1B,DARPP-32 events
PPP2R1B,Signaling by NTRK1 (TRKA)
PPP2R1B,Degradation of beta-catenin by the destruction complex
PPP2R1B,Beta-catenin phosphorylation cascade
PPP2R1B,Nuclear Events (kinase and transcription factor activation)
PPP2R1B,ERK/MAPK targets
PPP2R1B,Negative regulation of the PI3K/AKT network
PPP2R1B,ERKs are inactivated
PPP2R1B,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2R1B,Signaling by WNT in cancer
PPP2R1B,Signaling by AXIN mutants
PPP2R1B,Signaling by CTNNB1 phospho-site mutants
PPP2R1B,Signaling by APC mutants
PPP2R1B,Signaling by AMER1 mutants
PPP2R1B,Signaling by GSK3beta mutants
PPP2R1B,CTNNB1 S33 mutants aren't phosphorylated
PPP2R1B,CTNNB1 S37 mutants aren't phosphorylated
PPP2R1B,CTNNB1 S45 mutants aren't phosphorylated
PPP2R1B,CTNNB1 T41 mutants aren't phosphorylated
PPP2R1B,APC truncation mutants have impaired AXIN binding
PPP2R1B,AXIN missense mutants destabilize the destruction complex
PPP2R1B,Truncations of AMER1 destabilize the destruction complex
PPP2R1B,RHO GTPases Activate Formins
PPP2R1B,RAF activation
PPP2R1B,Negative regulation of MAPK pathway
PPP2R1B,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
AVPR1A,Peptide ligand-binding receptors
AVPR1A,SLC transporter disorders
AVPR1A,Disorders of transmembrane transporters
LRRC1,RND2 GTPase cycle
STEAP3,RHOD GTPase cycle
STEAP3,RHOQ GTPase cycle
STEAP3,RHOJ GTPase cycle
STEAP3,RHOF GTPase cycle
PPP2R5A,Degradation of beta-catenin by the destruction complex
PPP2R5A,Beta-catenin phosphorylation cascade
PPP2R5A,Negative regulation of the PI3K/AKT network
PPP2R5A,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2R5A,Signaling by WNT in cancer
PPP2R5A,Signaling by AXIN mutants
PPP2R5A,Signaling by CTNNB1 phospho-site mutants
PPP2R5A,Signaling by APC mutants
PPP2R5A,Signaling by AMER1 mutants
PPP2R5A,Signaling by GSK3beta mutants
PPP2R5A,CTNNB1 S33 mutants aren't phosphorylated
PPP2R5A,CTNNB1 S37 mutants aren't phosphorylated
PPP2R5A,CTNNB1 S45 mutants aren't phosphorylated
PPP2R5A,CTNNB1 T41 mutants aren't phosphorylated
PPP2R5A,APC truncation mutants have impaired AXIN binding
PPP2R5A,AXIN missense mutants destabilize the destruction complex
PPP2R5A,Truncations of AMER1 destabilize the destruction complex
PPP2R5A,RHO GTPases Activate Formins
PPP2R5A,RAF activation
PPP2R5A,Negative regulation of MAPK pathway
PPP2R5A,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PPP2R5B,Degradation of beta-catenin by the destruction complex
PPP2R5B,Beta-catenin phosphorylation cascade
PPP2R5B,Negative regulation of the PI3K/AKT network
PPP2R5B,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2R5B,Signaling by WNT in cancer
PPP2R5B,Signaling by AXIN mutants
PPP2R5B,Signaling by CTNNB1 phospho-site mutants
PPP2R5B,Signaling by APC mutants
PPP2R5B,Signaling by AMER1 mutants
PPP2R5B,Signaling by GSK3beta mutants
PPP2R5B,CTNNB1 S33 mutants aren't phosphorylated
PPP2R5B,CTNNB1 S37 mutants aren't phosphorylated
PPP2R5B,CTNNB1 S45 mutants aren't phosphorylated
PPP2R5B,CTNNB1 T41 mutants aren't phosphorylated
PPP2R5B,APC truncation mutants have impaired AXIN binding
PPP2R5B,AXIN missense mutants destabilize the destruction complex
PPP2R5B,Truncations of AMER1 destabilize the destruction complex
PPP2R5B,RHO GTPases Activate Formins
PPP2R5B,RAF activation
PPP2R5B,Negative regulation of MAPK pathway
PPP2R5B,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PPP2R5C,Degradation of beta-catenin by the destruction complex
PPP2R5C,Beta-catenin phosphorylation cascade
PPP2R5C,Negative regulation of the PI3K/AKT network
PPP2R5C,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2R5C,Signaling by WNT in cancer
PPP2R5C,Signaling by AXIN mutants
PPP2R5C,Signaling by CTNNB1 phospho-site mutants
PPP2R5C,Signaling by APC mutants
PPP2R5C,Signaling by AMER1 mutants
PPP2R5C,Signaling by GSK3beta mutants
PPP2R5C,CTNNB1 S33 mutants aren't phosphorylated
PPP2R5C,CTNNB1 S37 mutants aren't phosphorylated
PPP2R5C,CTNNB1 S45 mutants aren't phosphorylated
PPP2R5C,CTNNB1 T41 mutants aren't phosphorylated
PPP2R5C,APC truncation mutants have impaired AXIN binding
PPP2R5C,AXIN missense mutants destabilize the destruction complex
PPP2R5C,Truncations of AMER1 destabilize the destruction complex
PPP2R5C,RHO GTPases Activate Formins
PPP2R5C,RAF activation
PPP2R5C,Negative regulation of MAPK pathway
PPP2R5C,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PPP2R5D,Opioid Signalling
PPP2R5D,DARPP-32 events
PPP2R5D,Signaling by NTRK1 (TRKA)
PPP2R5D,Degradation of beta-catenin by the destruction complex
PPP2R5D,Beta-catenin phosphorylation cascade
PPP2R5D,Nuclear Events (kinase and transcription factor activation)
PPP2R5D,ERK/MAPK targets
PPP2R5D,Negative regulation of the PI3K/AKT network
PPP2R5D,ERKs are inactivated
PPP2R5D,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2R5D,Signaling by WNT in cancer
PPP2R5D,Signaling by AXIN mutants
PPP2R5D,Signaling by CTNNB1 phospho-site mutants
PPP2R5D,Signaling by APC mutants
PPP2R5D,Signaling by AMER1 mutants
PPP2R5D,Signaling by GSK3beta mutants
PPP2R5D,CTNNB1 S33 mutants aren't phosphorylated
PPP2R5D,CTNNB1 S37 mutants aren't phosphorylated
PPP2R5D,CTNNB1 S45 mutants aren't phosphorylated
PPP2R5D,CTNNB1 T41 mutants aren't phosphorylated
PPP2R5D,APC truncation mutants have impaired AXIN binding
PPP2R5D,AXIN missense mutants destabilize the destruction complex
PPP2R5D,Truncations of AMER1 destabilize the destruction complex
PPP2R5D,RHO GTPases Activate Formins
PPP2R5D,RAF activation
PPP2R5D,Negative regulation of MAPK pathway
PPP2R5D,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PPP2R5E,Degradation of beta-catenin by the destruction complex
PPP2R5E,Beta-catenin phosphorylation cascade
PPP2R5E,Negative regulation of the PI3K/AKT network
PPP2R5E,Disassembly of the destruction complex and recruitment of AXIN to the membrane
PPP2R5E,Signaling by WNT in cancer
PPP2R5E,Signaling by AXIN mutants
PPP2R5E,Signaling by CTNNB1 phospho-site mutants
PPP2R5E,Signaling by APC mutants
PPP2R5E,Signaling by AMER1 mutants
PPP2R5E,Signaling by GSK3beta mutants
PPP2R5E,CTNNB1 S33 mutants aren't phosphorylated
PPP2R5E,CTNNB1 S37 mutants aren't phosphorylated
PPP2R5E,CTNNB1 S45 mutants aren't phosphorylated
PPP2R5E,CTNNB1 T41 mutants aren't phosphorylated
PPP2R5E,APC truncation mutants have impaired AXIN binding
PPP2R5E,AXIN missense mutants destabilize the destruction complex
PPP2R5E,Truncations of AMER1 destabilize the destruction complex
PPP2R5E,RHO GTPases Activate Formins
PPP2R5E,RAF activation
PPP2R5E,Negative regulation of MAPK pathway
PPP2R5E,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
AVPR1B,Peptide ligand-binding receptors
AVPR1B,SLC transporter disorders
AVPR1B,Disorders of transmembrane transporters
PPP3CA,Opioid Signalling
PPP3CA,DARPP-32 events
PPP3CA,Ca2+ pathway
PPP3CB,Opioid Signalling
PPP3CB,DARPP-32 events
PPP3CB,Ca2+ pathway
PPP3CC,Opioid Signalling
PPP3CC,DARPP-32 events
PPP3R1,Opioid Signalling
PPP3R1,DARPP-32 events
PPP3R1,Ca2+ pathway
PPP5C,Negative regulation of MAPK pathway
LGR4,Regulation of FZD by ubiquitination
AVPR2,Peptide ligand-binding receptors
AVPR2,G alpha (s) signalling events
AVPR2,SLC transporter disorders
AVPR2,Disorders of transmembrane transporters
STRADB,MTOR signalling
STRADB,Energy dependent regulation of mTOR by LKB1-AMPK
PRF1,Signaling by ALK in cancer
PRF1,Signaling by ALK fusions and activated point mutants
PRF1,Nuclear events stimulated by ALK signaling in cancer
SMPD3,TNF signaling
MAML3,Pre-NOTCH Transcription and Translation
MAML3,Pre-NOTCH Expression and Processing
MAML3,Signaling by NOTCH1
MAML3,Signaling by NOTCH2
MAML3,NOTCH1 Intracellular Domain Regulates Transcription
MAML3,NOTCH2 intracellular domain regulates transcription
MAML3,Signaling by NOTCH1 PEST Domain Mutants in Cancer
MAML3,Signaling by NOTCH1 in Cancer
MAML3,Constitutive Signaling by NOTCH1 PEST Domain Mutants
MAML3,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
MAML3,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MAML3,Signaling by NOTCH3
MAML3,NOTCH3 Intracellular Domain Regulates Transcription
MAML3,Signaling by NOTCH4
MAML3,NOTCH4 Intracellular Domain Regulates Transcription
SOX6,Deactivation of the beta-catenin transactivating complex
PRIM1,Diseases of programmed cell death
PRIM1,Defective pyroptosis
PRIM2,Diseases of programmed cell death
PRIM2,Defective pyroptosis
MED29,Respiratory Syncytial Virus Infection Pathway
MED29,RSV-host interactions
PRR5,Signaling by VEGF
PRR5,PI3K/AKT Signaling in Cancer
PRR5,VEGFA-VEGFR2 Pathway
PRR5,VEGFR2 mediated vascular permeability
PRR5,Constitutive Signaling by AKT1 E17K in Cancer
DOCK10,RAC2 GTPase cycle
DOCK10,RAC3 GTPase cycle
PRKAA1,MTOR signalling
PRKAA1,Energy dependent regulation of mTOR by LKB1-AMPK
STAP2,Signaling by PTK6
STAP2,Signaling by Non-Receptor Tyrosine Kinases
ZDHHC7,Extra-nuclear estrogen signaling
PRKAA2,MTOR signalling
PRKAA2,Energy dependent regulation of mTOR by LKB1-AMPK
PRKAB1,MTOR signalling
PRKAB1,Energy dependent regulation of mTOR by LKB1-AMPK
PRKAB2,MTOR signalling
PRKAB2,Energy dependent regulation of mTOR by LKB1-AMPK
PRKACA,Opioid Signalling
PRKACA,PKA-mediated phosphorylation of CREB
PRKACA,Calmodulin induced events
PRKACA,Ca-dependent events
PRKACA,CaM pathway
PRKACA,G-protein mediated events
PRKACA,PLC beta mediated events
PRKACA,DAG and IP3 signaling
PRKACA,PKA activation
PRKACA,DARPP-32 events
PRKACA,Signaling by VEGF
PRKACA,G alpha (s) signalling events
PRKACA,VEGFA-VEGFR2 Pathway
PRKACA,Degradation of GLI1 by the proteasome
PRKACA,Degradation of GLI2 by the proteasome
PRKACA,GLI3 is processed to GLI3R by the proteasome
PRKACA,Hedgehog 'off' state
PRKACA,MAPK6/MAPK4 signaling
PRKACA,Loss of function of MECP2 in Rett syndrome
PRKACA,Pervasive developmental disorders
PRKACA,GPER1 signaling
PRKACA,ADORA2B mediated anti-inflammatory cytokines production
PRKACA,Anti-inflammatory response favouring Leishmania parasite infection
PRKACA,FCGR3A-mediated IL10 synthesis
PRKACA,Leishmania parasite growth and survival
PRKACA,Disorders of Developmental Biology
PRKACA,Disorders of Nervous System Development
PRKACB,Opioid Signalling
PRKACB,PKA-mediated phosphorylation of CREB
PRKACB,Calmodulin induced events
PRKACB,Ca-dependent events
PRKACB,CaM pathway
PRKACB,G-protein mediated events
PRKACB,PLC beta mediated events
PRKACB,DAG and IP3 signaling
PRKACB,PKA activation
PRKACB,DARPP-32 events
PRKACB,Signaling by VEGF
PRKACB,G alpha (s) signalling events
PRKACB,VEGFA-VEGFR2 Pathway
PRKACB,Degradation of GLI1 by the proteasome
PRKACB,Degradation of GLI2 by the proteasome
PRKACB,GLI3 is processed to GLI3R by the proteasome
PRKACB,Hedgehog 'off' state
PRKACB,MAPK6/MAPK4 signaling
PRKACB,GPER1 signaling
PRKACB,ADORA2B mediated anti-inflammatory cytokines production
PRKACB,Anti-inflammatory response favouring Leishmania parasite infection
PRKACB,FCGR3A-mediated IL10 synthesis
PRKACB,Leishmania parasite growth and survival
PRKACG,Opioid Signalling
PRKACG,PKA-mediated phosphorylation of CREB
PRKACG,Calmodulin induced events
PRKACG,Ca-dependent events
PRKACG,CaM pathway
PRKACG,G-protein mediated events
PRKACG,PLC beta mediated events
PRKACG,DAG and IP3 signaling
PRKACG,PKA activation
PRKACG,DARPP-32 events
PRKACG,Signaling by VEGF
PRKACG,G alpha (s) signalling events
PRKACG,VEGFA-VEGFR2 Pathway
PRKACG,Degradation of GLI1 by the proteasome
PRKACG,Degradation of GLI2 by the proteasome
PRKACG,GLI3 is processed to GLI3R by the proteasome
PRKACG,Hedgehog 'off' state
PRKACG,MAPK6/MAPK4 signaling
PRKACG,GPER1 signaling
PRKACG,ADORA2B mediated anti-inflammatory cytokines production
PRKACG,Anti-inflammatory response favouring Leishmania parasite infection
PRKACG,FCGR3A-mediated IL10 synthesis
PRKACG,Leishmania parasite growth and survival
PACS1,Host Interactions of HIV factors
PACS1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
PACS1,The role of Nef in HIV-1 replication and disease pathogenesis
CCDC88A,RND3 GTPase cycle
CCDC88A,RND1 GTPase cycle
PRKAG1,MTOR signalling
PRKAG1,Energy dependent regulation of mTOR by LKB1-AMPK
WDR11,RHOH GTPase cycle
PRKAR1A,Opioid Signalling
PRKAR1A,PKA-mediated phosphorylation of CREB
PRKAR1A,Calmodulin induced events
PRKAR1A,Ca-dependent events
PRKAR1A,CaM pathway
PRKAR1A,G-protein mediated events
PRKAR1A,PLC beta mediated events
PRKAR1A,DAG and IP3 signaling
PRKAR1A,PKA activation
PRKAR1A,DARPP-32 events
PRKAR1A,G alpha (s) signalling events
PRKAR1A,Hedgehog 'off' state
PRKAR1A,GPER1 signaling
PRKAR1A,ADORA2B mediated anti-inflammatory cytokines production
PRKAR1A,Anti-inflammatory response favouring Leishmania parasite infection
PRKAR1A,FCGR3A-mediated IL10 synthesis
PRKAR1A,Leishmania parasite growth and survival
HHAT,Hedgehog ligand biogenesis
VPS35,WNT ligand biogenesis and trafficking
EDEM2,Maturation of spike protein
EDEM2,Translation of Structural Proteins
EDEM2,Late SARS-CoV-2 Infection Events
NUP133,Host Interactions of HIV factors
NUP133,Rev-mediated nuclear export of HIV RNA
NUP133,Transport of Ribonucleoproteins into the Host Nucleus
NUP133,Export of Viral Ribonucleoproteins from Nucleus
NUP133,NS1 Mediated Effects on Host Pathways
NUP133,Viral Messenger RNA Synthesis
NUP133,NEP/NS2 Interacts with the Cellular Export Machinery
NUP133,Interactions of Vpr with host cellular proteins
NUP133,Interactions of Rev with host cellular proteins
NUP133,Nuclear import of Rev protein
NUP133,Vpr-mediated nuclear import of PICs
NUP133,SLC transporter disorders
NUP133,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP133,Disorders of transmembrane transporters
NUP133,RHO GTPases Activate Formins
NUP133,HCMV Infection
NUP133,HCMV Early Events
NUP133,HCMV Late Events
NUP133,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PRKAR1B,Opioid Signalling
PRKAR1B,PKA-mediated phosphorylation of CREB
PRKAR1B,Calmodulin induced events
PRKAR1B,Ca-dependent events
PRKAR1B,CaM pathway
PRKAR1B,G-protein mediated events
PRKAR1B,PLC beta mediated events
PRKAR1B,DAG and IP3 signaling
PRKAR1B,PKA activation
PRKAR1B,DARPP-32 events
PRKAR1B,G alpha (s) signalling events
PRKAR1B,Hedgehog 'off' state
PRKAR1B,GPER1 signaling
PRKAR1B,ADORA2B mediated anti-inflammatory cytokines production
PRKAR1B,Anti-inflammatory response favouring Leishmania parasite infection
PRKAR1B,FCGR3A-mediated IL10 synthesis
PRKAR1B,Leishmania parasite growth and survival
PRKAR2A,Opioid Signalling
PRKAR2A,PKA-mediated phosphorylation of CREB
PRKAR2A,Calmodulin induced events
PRKAR2A,Ca-dependent events
PRKAR2A,CaM pathway
PRKAR2A,G-protein mediated events
PRKAR2A,PLC beta mediated events
PRKAR2A,DAG and IP3 signaling
PRKAR2A,PKA activation
PRKAR2A,DARPP-32 events
PRKAR2A,G alpha (s) signalling events
PRKAR2A,Hedgehog 'off' state
PRKAR2A,GPER1 signaling
PRKAR2A,ADORA2B mediated anti-inflammatory cytokines production
PRKAR2A,Anti-inflammatory response favouring Leishmania parasite infection
PRKAR2A,FCGR3A-mediated IL10 synthesis
PRKAR2A,Leishmania parasite growth and survival
IFT122,Hedgehog 'off' state
PRKAR2B,Opioid Signalling
PRKAR2B,PKA-mediated phosphorylation of CREB
PRKAR2B,Calmodulin induced events
PRKAR2B,Ca-dependent events
PRKAR2B,CaM pathway
PRKAR2B,G-protein mediated events
PRKAR2B,PLC beta mediated events
PRKAR2B,DAG and IP3 signaling
PRKAR2B,PKA activation
PRKAR2B,DARPP-32 events
PRKAR2B,G alpha (s) signalling events
PRKAR2B,Hedgehog 'off' state
PRKAR2B,GPER1 signaling
PRKAR2B,ADORA2B mediated anti-inflammatory cytokines production
PRKAR2B,Anti-inflammatory response favouring Leishmania parasite infection
PRKAR2B,FCGR3A-mediated IL10 synthesis
PRKAR2B,Leishmania parasite growth and survival
PRKCA,Opioid Signalling
PRKCA,Calmodulin induced events
PRKCA,Ca-dependent events
PRKCA,CaM pathway
PRKCA,G-protein mediated events
PRKCA,PLC beta mediated events
PRKCA,Signaling by SCF-KIT
PRKCA,Regulation of KIT signaling
PRKCA,DAG and IP3 signaling
PRKCA,Signaling by VEGF
PRKCA,PCP/CE pathway
PRKCA,G alpha (z) signalling events
PRKCA,VEGFA-VEGFR2 Pathway
PRKCA,WNT5A-dependent internalization of FZD4
PRKCA,VEGFR2 mediated cell proliferation
LMBRD1,Defects in vitamin and cofactor metabolism
LMBRD1,ABC transporter disorders
LMBRD1,Disorders of transmembrane transporters
LMBRD1,Diseases of metabolism
DEPDC1B,RHOA GTPase cycle
DEPDC1B,RHOB GTPase cycle
DEPDC1B,RHOC GTPase cycle
DEPDC1B,RAC2 GTPase cycle
DEPDC1B,RHOD GTPase cycle
DEPDC1B,RHOQ GTPase cycle
DEPDC1B,RHOG GTPase cycle
DEPDC1B,RHOJ GTPase cycle
DEPDC1B,RHOU GTPase cycle
DEPDC1B,RAC3 GTPase cycle
DEPDC1B,RHOV GTPase cycle
DEPDC1B,RHOF GTPase cycle
DEPDC1B,RND3 GTPase cycle
DEPDC1B,RND2 GTPase cycle
DEPDC1B,RND1 GTPase cycle
PRKCB,Signaling by VEGF
PRKCB,PCP/CE pathway
PRKCB,G alpha (z) signalling events
PRKCB,VEGFA-VEGFR2 Pathway
PRKCB,WNT5A-dependent internalization of FZD4
PRKCB,VEGFR2 mediated cell proliferation
AXL,Signaling by VEGF
AXL,VEGFA-VEGFR2 Pathway
PRKCD,Opioid Signalling
PRKCD,Calmodulin induced events
PRKCD,Ca-dependent events
PRKCD,CaM pathway
PRKCD,G-protein mediated events
PRKCD,PLC beta mediated events
PRKCD,Effects of PIP2 hydrolysis
PRKCD,DAG and IP3 signaling
PRKCD,Signaling by VEGF
PRKCD,G alpha (z) signalling events
PRKCD,VEGFA-VEGFR2 Pathway
PRKCD,VEGFR2 mediated cell proliferation
PRKCE,Effects of PIP2 hydrolysis
PRKCE,DAG and IP3 signaling
PRKCE,G alpha (z) signalling events
ADCY10,Hedgehog 'off' state
KDM3A,NR1H2 and NR1H3-mediated signaling
KDM3A,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
PRKCG,Opioid Signalling
PRKCG,Calmodulin induced events
PRKCG,Ca-dependent events
PRKCG,CaM pathway
PRKCG,G-protein mediated events
PRKCG,PLC beta mediated events
PRKCG,DAG and IP3 signaling
PRKCG,PCP/CE pathway
PRKCG,G alpha (z) signalling events
PRKCG,WNT5A-dependent internalization of FZD4
VPS11,SARS-CoV-2 modulates autophagy
PAG1,Signaling by EGFR
PRKCH,Effects of PIP2 hydrolysis
PRKCH,G alpha (z) signalling events
PRKCI,Pre-NOTCH Transcription and Translation
PRKCI,Pre-NOTCH Expression and Processing
PRKCI,p75NTR signals via NF-kB
PRKCI,p75 NTR receptor-mediated signalling
ARHGAP15,RAC3 GTPase cycle
PKN1,RHO GTPases activate PKNs
PKN1,RHOA GTPase cycle
PKN1,RHOB GTPase cycle
PKN1,RHOC GTPase cycle
PSENEN,Signaling by ERBB4
PSENEN,Nuclear signaling by ERBB4
PSENEN,p75 NTR receptor-mediated signalling
PSENEN,Signaling by NOTCH1
PSENEN,Signaling by NOTCH2
PSENEN,"Cell death signalling via NRAGE, NRIF and NADE"
PSENEN,NRIF signals cell death from the nucleus
PSENEN,Activated NOTCH1 Transmits Signal to the Nucleus
PSENEN,Signaling by NOTCH1 PEST Domain Mutants in Cancer
PSENEN,Signaling by NOTCH1 in Cancer
PSENEN,Constitutive Signaling by NOTCH1 PEST Domain Mutants
PSENEN,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
PSENEN,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
PSENEN,NOTCH2 Activation and Transmission of Signal to the Nucleus
PSENEN,Signaling by NOTCH3
PSENEN,NOTCH3 Activation and Transmission of Signal to the Nucleus
PSENEN,Signaling by NOTCH4
PSENEN,Signaling by TGFBR3
PKN2,RHO GTPases activate PKNs
PKN2,RHOA GTPase cycle
PKN2,RHOB GTPase cycle
PKN2,RHOC GTPase cycle
HDAC8,Signaling by NOTCH1
HDAC8,NOTCH1 Intracellular Domain Regulates Transcription
HDAC8,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC8,Signaling by NOTCH1 in Cancer
HDAC8,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC8,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC8,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
GABRQ,Signaling by ERBB4
PRKCQ,Effects of PIP2 hydrolysis
PRKCQ,G alpha (z) signalling events
PRKCSH,Maturation of spike protein
PRKCSH,Translation of Structural Proteins
PRKCSH,Late SARS-CoV-2 Infection Events
PRKCZ,Signaling by TGF-beta Receptor Complex
PRKCZ,Signaling by VEGF
PRKCZ,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
PRKCZ,VEGFA-VEGFR2 Pathway
PRKCZ,VEGFR2 mediated cell proliferation
PRKCZ,Extra-nuclear estrogen signaling
PRKG1,Ca2+ pathway
PRKG2,Ca2+ pathway
PRKG2,RAS processing
MAPK1,RAF-independent MAPK1/3 activation
MAPK1,Prolonged ERK activation events
MAPK1,Frs2-mediated activation
MAPK1,Signaling by NTRK1 (TRKA)
MAPK1,Signalling to ERKs
MAPK1,Nuclear Events (kinase and transcription factor activation)
MAPK1,ERK/MAPK targets
MAPK1,ERKs are inactivated
MAPK1,MAP2K and MAPK activation
MAPK1,Negative regulation of MAPK pathway
MAPK1,Signaling by moderate kinase activity BRAF mutants
MAPK1,Signaling by high-kinase activity BRAF mutants
MAPK1,Signaling by RAS mutants
MAPK1,Signaling by BRAF and RAF1 fusions
MAPK1,Paradoxical activation of RAF signaling by kinase inactive BRAF
MAPK1,Oncogenic MAPK signaling
MAPK1,Insulin receptor signalling cascade
MAPK1,Signaling by Insulin receptor
MAPK1,Infection with Mycobacterium tuberculosis
MAPK1,Response of Mtb to phagocytosis
MAPK1,Signaling downstream of RAS mutants
MAPK1,Signaling by RAF1 mutants
MAPK1,Bacterial Infection Pathways
MAPK3,RAF-independent MAPK1/3 activation
MAPK3,Prolonged ERK activation events
MAPK3,Frs2-mediated activation
MAPK3,Signaling by NTRK1 (TRKA)
MAPK3,Signalling to ERKs
MAPK3,Nuclear Events (kinase and transcription factor activation)
MAPK3,ERK/MAPK targets
MAPK3,ERKs are inactivated
MAPK3,MAP2K and MAPK activation
MAPK3,Negative regulation of MAPK pathway
MAPK3,Signaling by moderate kinase activity BRAF mutants
MAPK3,Signaling by high-kinase activity BRAF mutants
MAPK3,Signaling by RAS mutants
MAPK3,Signaling by BRAF and RAF1 fusions
MAPK3,Paradoxical activation of RAF signaling by kinase inactive BRAF
MAPK3,Oncogenic MAPK signaling
MAPK3,Insulin receptor signalling cascade
MAPK3,Signaling by Insulin receptor
MAPK3,Infection with Mycobacterium tuberculosis
MAPK3,Response of Mtb to phagocytosis
MAPK3,Signaling downstream of RAS mutants
MAPK3,Signaling by RAF1 mutants
MAPK3,Bacterial Infection Pathways
MAPK4,MAPK6/MAPK4 signaling
NSFL1C,RHOH GTPase cycle
MAPK6,MAPK6/MAPK4 signaling
GNG12,Opioid Signalling
GNG12,G-protein activation
GNG12,Class B/2 (Secretin family receptors)
GNG12,G beta:gamma signalling through PI3Kgamma
GNG12,G-protein beta:gamma signalling
GNG12,Ca2+ pathway
GNG12,G alpha (12/13) signalling events
GNG12,G beta:gamma signalling through PLC beta
GNG12,G alpha (s) signalling events
GNG12,G alpha (z) signalling events
GNG12,Glucagon-type ligand receptors
GNG12,G beta:gamma signalling through BTK
GNG12,G beta:gamma signalling through CDC42
GNG12,Extra-nuclear estrogen signaling
GNG12,GPER1 signaling
GNG12,ADORA2B mediated anti-inflammatory cytokines production
GNG12,Anti-inflammatory response favouring Leishmania parasite infection
GNG12,Leishmania parasite growth and survival
BAIAP2L1,RAC2 GTPase cycle
BAIAP2L1,RAC3 GTPase cycle
BAIAP2L1,RHOF GTPase cycle
MAPK7,Signaling by NTRK1 (TRKA)
MAPK7,Nuclear Events (kinase and transcription factor activation)
MAPK7,ERK/MAPK targets
MAPK7,ERKs are inactivated
MAPK8,NRAGE signals death through JNK
MAPK8,p75 NTR receptor-mediated signalling
MAPK8,"Cell death signalling via NRAGE, NRIF and NADE"
MAPK8,NRIF signals cell death from the nucleus
MAPK8,Signaling by ALK in cancer
MAPK8,Signaling by ALK fusions and activated point mutants
MAPK11,Signalling to RAS
MAPK11,Signaling by NTRK1 (TRKA)
MAPK11,Signalling to ERKs
MAPK11,Signaling by VEGF
MAPK11,VEGFA-VEGFR2 Pathway
MAPK9,Signaling by ALK in cancer
MAPK9,Signaling by ALK fusions and activated point mutants
MAPK13,Signalling to RAS
MAPK13,Signaling by NTRK1 (TRKA)
MAPK13,Signalling to ERKs
MAPK13,Signaling by VEGF
MAPK13,VEGFA-VEGFR2 Pathway
MAP2K1,RAF-independent MAPK1/3 activation
MAP2K1,Prolonged ERK activation events
MAP2K1,Frs2-mediated activation
MAP2K1,Signaling by NTRK1 (TRKA)
MAP2K1,Signalling to ERKs
MAP2K1,Uptake and actions of bacterial toxins
MAP2K1,MAP2K and MAPK activation
MAP2K1,Signaling by moderate kinase activity BRAF mutants
MAP2K1,Signaling by high-kinase activity BRAF mutants
MAP2K1,Signaling by RAS mutants
MAP2K1,Signaling by BRAF and RAF1 fusions
MAP2K1,Paradoxical activation of RAF signaling by kinase inactive BRAF
MAP2K1,Oncogenic MAPK signaling
MAP2K1,Signaling downstream of RAS mutants
MAP2K1,Signaling by RAF1 mutants
MAP2K1,Bacterial Infection Pathways
MAP2K2,Prolonged ERK activation events
MAP2K2,Frs2-mediated activation
MAP2K2,Signaling by NTRK1 (TRKA)
MAP2K2,Signalling to ERKs
MAP2K2,Uptake and actions of bacterial toxins
MAP2K2,MAP2K and MAPK activation
MAP2K2,Signaling by moderate kinase activity BRAF mutants
MAP2K2,Signaling by high-kinase activity BRAF mutants
MAP2K2,Signaling by RAS mutants
MAP2K2,Signaling by BRAF and RAF1 fusions
MAP2K2,Paradoxical activation of RAF signaling by kinase inactive BRAF
MAP2K2,Oncogenic MAPK signaling
MAP2K2,Signaling downstream of RAS mutants
MAP2K2,Signaling by RAF1 mutants
MAP2K2,Bacterial Infection Pathways
MAP2K5,Signaling by NTRK1 (TRKA)
MAP2K7,Uptake and actions of bacterial toxins
MAP2K7,Bacterial Infection Pathways
EIF2AK2,NS1 Mediated Effects on Host Pathways
EIF2AK2,Respiratory Syncytial Virus Infection Pathway
EIF2AK2,Evasion by RSV of host interferon responses
EIF2AK2,RSV-host interactions
DNAJC3,Viral mRNA Translation
PRKX,Opioid Signalling
PRKX,PKA-mediated phosphorylation of CREB
PRKX,Calmodulin induced events
PRKX,Ca-dependent events
PRKX,CaM pathway
PRKX,G-protein mediated events
PRKX,PLC beta mediated events
PRKX,DAG and IP3 signaling
PRKX,ADORA2B mediated anti-inflammatory cytokines production
PRKX,Anti-inflammatory response favouring Leishmania parasite infection
PRKX,FCGR3A-mediated IL10 synthesis
PRKX,Leishmania parasite growth and survival
RNF20,RHOBTB1 GTPase cycle
RNF20,RHOBTB GTPase Cycle
PARD3,Signaling by TGF-beta Receptor Complex
PARD3,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
LTB4R2,Eicosanoid ligand-binding receptors
CCL28,Peptide ligand-binding receptors
CCL28,Chemokine receptors bind chemokines
CYP26B1,Signaling by Retinoic Acid
CYP26B1,RA biosynthesis pathway
MUC13,Diseases of glycosylation
MUC13,Diseases associated with O-glycosylation of proteins
MUC13,Defective GALNT3 causes HFTC
MUC13,Defective GALNT12 causes CRCS1
MUC13,Diseases of metabolism
MUC13,RND3 GTPase cycle
MUC13,RND2 GTPase cycle
MUC13,RND1 GTPase cycle
PSMA1,Host Interactions of HIV factors
PSMA1,Vpu mediated degradation of CD4
PSMA1,Vif-mediated degradation of APOBEC3G
PSMA1,Degradation of beta-catenin by the destruction complex
PSMA1,PCP/CE pathway
PSMA1,Asymmetric localization of PCP proteins
PSMA1,Degradation of AXIN
PSMA1,Degradation of DVL
PSMA1,Hedgehog ligand biogenesis
PSMA1,Hh mutants are degraded by ERAD
PSMA1,Hh mutants abrogate ligand secretion
PSMA1,Degradation of GLI1 by the proteasome
PSMA1,Degradation of GLI2 by the proteasome
PSMA1,GLI3 is processed to GLI3R by the proteasome
PSMA1,Hedgehog 'off' state
PSMA1,ABC transporter disorders
PSMA1,Disorders of transmembrane transporters
PSMA1,Hedgehog 'on' state
PSMA1,Regulation of RAS by GAPs
PSMA1,Defective CFTR causes cystic fibrosis
PSMA1,MAPK6/MAPK4 signaling
PSMA1,Regulation of PTEN stability and activity
PSMA1,Signaling by NOTCH4
PSMA1,Negative regulation of NOTCH4 signaling
PSMA2,Host Interactions of HIV factors
PSMA2,Vpu mediated degradation of CD4
PSMA2,Vif-mediated degradation of APOBEC3G
PSMA2,Degradation of beta-catenin by the destruction complex
PSMA2,PCP/CE pathway
PSMA2,Asymmetric localization of PCP proteins
PSMA2,Degradation of AXIN
PSMA2,Degradation of DVL
PSMA2,Hedgehog ligand biogenesis
PSMA2,Hh mutants are degraded by ERAD
PSMA2,Hh mutants abrogate ligand secretion
PSMA2,Degradation of GLI1 by the proteasome
PSMA2,Degradation of GLI2 by the proteasome
PSMA2,GLI3 is processed to GLI3R by the proteasome
PSMA2,Hedgehog 'off' state
PSMA2,ABC transporter disorders
PSMA2,Disorders of transmembrane transporters
PSMA2,Hedgehog 'on' state
PSMA2,Regulation of RAS by GAPs
PSMA2,Defective CFTR causes cystic fibrosis
PSMA2,MAPK6/MAPK4 signaling
PSMA2,Regulation of PTEN stability and activity
PSMA2,Signaling by NOTCH4
PSMA2,Negative regulation of NOTCH4 signaling
PSMA3,Host Interactions of HIV factors
PSMA3,Vpu mediated degradation of CD4
PSMA3,Vif-mediated degradation of APOBEC3G
PSMA3,Degradation of beta-catenin by the destruction complex
PSMA3,PCP/CE pathway
PSMA3,Asymmetric localization of PCP proteins
PSMA3,Degradation of AXIN
PSMA3,Degradation of DVL
PSMA3,Hedgehog ligand biogenesis
PSMA3,Hh mutants are degraded by ERAD
PSMA3,Hh mutants abrogate ligand secretion
PSMA3,Degradation of GLI1 by the proteasome
PSMA3,Degradation of GLI2 by the proteasome
PSMA3,GLI3 is processed to GLI3R by the proteasome
PSMA3,Hedgehog 'off' state
PSMA3,ABC transporter disorders
PSMA3,Disorders of transmembrane transporters
PSMA3,Hedgehog 'on' state
PSMA3,Regulation of RAS by GAPs
PSMA3,Defective CFTR causes cystic fibrosis
PSMA3,MAPK6/MAPK4 signaling
PSMA3,Regulation of PTEN stability and activity
PSMA3,Signaling by NOTCH4
PSMA3,Negative regulation of NOTCH4 signaling
PSMA4,Host Interactions of HIV factors
PSMA4,Vpu mediated degradation of CD4
PSMA4,Vif-mediated degradation of APOBEC3G
PSMA4,Degradation of beta-catenin by the destruction complex
PSMA4,PCP/CE pathway
PSMA4,Asymmetric localization of PCP proteins
PSMA4,Degradation of AXIN
PSMA4,Degradation of DVL
PSMA4,Hedgehog ligand biogenesis
PSMA4,Hh mutants are degraded by ERAD
PSMA4,Hh mutants abrogate ligand secretion
PSMA4,Degradation of GLI1 by the proteasome
PSMA4,Degradation of GLI2 by the proteasome
PSMA4,GLI3 is processed to GLI3R by the proteasome
PSMA4,Hedgehog 'off' state
PSMA4,ABC transporter disorders
PSMA4,Disorders of transmembrane transporters
PSMA4,Hedgehog 'on' state
PSMA4,Regulation of RAS by GAPs
PSMA4,Defective CFTR causes cystic fibrosis
PSMA4,MAPK6/MAPK4 signaling
PSMA4,Regulation of PTEN stability and activity
PSMA4,Signaling by NOTCH4
PSMA4,Negative regulation of NOTCH4 signaling
PSMA5,Host Interactions of HIV factors
PSMA5,Vpu mediated degradation of CD4
PSMA5,Vif-mediated degradation of APOBEC3G
PSMA5,Degradation of beta-catenin by the destruction complex
PSMA5,PCP/CE pathway
PSMA5,Asymmetric localization of PCP proteins
PSMA5,Degradation of AXIN
PSMA5,Degradation of DVL
PSMA5,Hedgehog ligand biogenesis
PSMA5,Hh mutants are degraded by ERAD
PSMA5,Hh mutants abrogate ligand secretion
PSMA5,Degradation of GLI1 by the proteasome
PSMA5,Degradation of GLI2 by the proteasome
PSMA5,GLI3 is processed to GLI3R by the proteasome
PSMA5,Hedgehog 'off' state
PSMA5,ABC transporter disorders
PSMA5,Disorders of transmembrane transporters
PSMA5,Hedgehog 'on' state
PSMA5,Regulation of RAS by GAPs
PSMA5,Defective CFTR causes cystic fibrosis
PSMA5,MAPK6/MAPK4 signaling
PSMA5,Regulation of PTEN stability and activity
PSMA5,Signaling by NOTCH4
PSMA5,Negative regulation of NOTCH4 signaling
PSMA6,Host Interactions of HIV factors
PSMA6,Vpu mediated degradation of CD4
PSMA6,Vif-mediated degradation of APOBEC3G
PSMA6,Degradation of beta-catenin by the destruction complex
PSMA6,PCP/CE pathway
PSMA6,Asymmetric localization of PCP proteins
PSMA6,Degradation of AXIN
PSMA6,Degradation of DVL
PSMA6,Hedgehog ligand biogenesis
PSMA6,Hh mutants are degraded by ERAD
PSMA6,Hh mutants abrogate ligand secretion
PSMA6,Degradation of GLI1 by the proteasome
PSMA6,Degradation of GLI2 by the proteasome
PSMA6,GLI3 is processed to GLI3R by the proteasome
PSMA6,Hedgehog 'off' state
PSMA6,ABC transporter disorders
PSMA6,Disorders of transmembrane transporters
PSMA6,Hedgehog 'on' state
PSMA6,Regulation of RAS by GAPs
PSMA6,Defective CFTR causes cystic fibrosis
PSMA6,MAPK6/MAPK4 signaling
PSMA6,Regulation of PTEN stability and activity
PSMA6,Signaling by NOTCH4
PSMA6,Negative regulation of NOTCH4 signaling
PSMA7,Host Interactions of HIV factors
PSMA7,Vpu mediated degradation of CD4
PSMA7,Vif-mediated degradation of APOBEC3G
PSMA7,Degradation of beta-catenin by the destruction complex
PSMA7,PCP/CE pathway
PSMA7,Asymmetric localization of PCP proteins
PSMA7,Degradation of AXIN
PSMA7,Degradation of DVL
PSMA7,Hedgehog ligand biogenesis
PSMA7,Hh mutants are degraded by ERAD
PSMA7,Hh mutants abrogate ligand secretion
PSMA7,Degradation of GLI1 by the proteasome
PSMA7,Degradation of GLI2 by the proteasome
PSMA7,GLI3 is processed to GLI3R by the proteasome
PSMA7,Hedgehog 'off' state
PSMA7,ABC transporter disorders
PSMA7,Disorders of transmembrane transporters
PSMA7,Hedgehog 'on' state
PSMA7,Regulation of RAS by GAPs
PSMA7,Defective CFTR causes cystic fibrosis
PSMA7,MAPK6/MAPK4 signaling
PSMA7,Regulation of PTEN stability and activity
PSMA7,Signaling by NOTCH4
PSMA7,Negative regulation of NOTCH4 signaling
PSMB1,Host Interactions of HIV factors
PSMB1,Vpu mediated degradation of CD4
PSMB1,Vif-mediated degradation of APOBEC3G
PSMB1,Degradation of beta-catenin by the destruction complex
PSMB1,PCP/CE pathway
PSMB1,Asymmetric localization of PCP proteins
PSMB1,Degradation of AXIN
PSMB1,Degradation of DVL
PSMB1,Hedgehog ligand biogenesis
PSMB1,Hh mutants are degraded by ERAD
PSMB1,Hh mutants abrogate ligand secretion
PSMB1,Degradation of GLI1 by the proteasome
PSMB1,Degradation of GLI2 by the proteasome
PSMB1,GLI3 is processed to GLI3R by the proteasome
PSMB1,Hedgehog 'off' state
PSMB1,ABC transporter disorders
PSMB1,Disorders of transmembrane transporters
PSMB1,Hedgehog 'on' state
PSMB1,Regulation of RAS by GAPs
PSMB1,Defective CFTR causes cystic fibrosis
PSMB1,MAPK6/MAPK4 signaling
PSMB1,Regulation of PTEN stability and activity
PSMB1,Signaling by NOTCH4
PSMB1,Negative regulation of NOTCH4 signaling
PSMB2,Host Interactions of HIV factors
PSMB2,Vpu mediated degradation of CD4
PSMB2,Vif-mediated degradation of APOBEC3G
PSMB2,Degradation of beta-catenin by the destruction complex
PSMB2,PCP/CE pathway
PSMB2,Asymmetric localization of PCP proteins
PSMB2,Degradation of AXIN
PSMB2,Degradation of DVL
PSMB2,Hedgehog ligand biogenesis
PSMB2,Hh mutants are degraded by ERAD
PSMB2,Hh mutants abrogate ligand secretion
PSMB2,Degradation of GLI1 by the proteasome
PSMB2,Degradation of GLI2 by the proteasome
PSMB2,GLI3 is processed to GLI3R by the proteasome
PSMB2,Hedgehog 'off' state
PSMB2,ABC transporter disorders
PSMB2,Disorders of transmembrane transporters
PSMB2,Hedgehog 'on' state
PSMB2,Regulation of RAS by GAPs
PSMB2,Defective CFTR causes cystic fibrosis
PSMB2,MAPK6/MAPK4 signaling
PSMB2,Regulation of PTEN stability and activity
PSMB2,Signaling by NOTCH4
PSMB2,Negative regulation of NOTCH4 signaling
PSMB3,Host Interactions of HIV factors
PSMB3,Vpu mediated degradation of CD4
PSMB3,Vif-mediated degradation of APOBEC3G
PSMB3,Degradation of beta-catenin by the destruction complex
PSMB3,PCP/CE pathway
PSMB3,Asymmetric localization of PCP proteins
PSMB3,Degradation of AXIN
PSMB3,Degradation of DVL
PSMB3,Hedgehog ligand biogenesis
PSMB3,Hh mutants are degraded by ERAD
PSMB3,Hh mutants abrogate ligand secretion
PSMB3,Degradation of GLI1 by the proteasome
PSMB3,Degradation of GLI2 by the proteasome
PSMB3,GLI3 is processed to GLI3R by the proteasome
PSMB3,Hedgehog 'off' state
PSMB3,ABC transporter disorders
PSMB3,Disorders of transmembrane transporters
PSMB3,Hedgehog 'on' state
PSMB3,Regulation of RAS by GAPs
PSMB3,Defective CFTR causes cystic fibrosis
PSMB3,MAPK6/MAPK4 signaling
PSMB3,Regulation of PTEN stability and activity
PSMB3,Signaling by NOTCH4
PSMB3,Negative regulation of NOTCH4 signaling
C1GALT1,Diseases of glycosylation
C1GALT1,Diseases associated with O-glycosylation of proteins
C1GALT1,Diseases of metabolism
PSMB4,Host Interactions of HIV factors
PSMB4,Vpu mediated degradation of CD4
PSMB4,Vif-mediated degradation of APOBEC3G
PSMB4,Degradation of beta-catenin by the destruction complex
PSMB4,PCP/CE pathway
PSMB4,Asymmetric localization of PCP proteins
PSMB4,Degradation of AXIN
PSMB4,Degradation of DVL
PSMB4,Hedgehog ligand biogenesis
PSMB4,Hh mutants are degraded by ERAD
PSMB4,Hh mutants abrogate ligand secretion
PSMB4,Degradation of GLI1 by the proteasome
PSMB4,Degradation of GLI2 by the proteasome
PSMB4,GLI3 is processed to GLI3R by the proteasome
PSMB4,Hedgehog 'off' state
PSMB4,ABC transporter disorders
PSMB4,Disorders of transmembrane transporters
PSMB4,Hedgehog 'on' state
PSMB4,Regulation of RAS by GAPs
PSMB4,Defective CFTR causes cystic fibrosis
PSMB4,MAPK6/MAPK4 signaling
PSMB4,Regulation of PTEN stability and activity
PSMB4,Signaling by NOTCH4
PSMB4,Negative regulation of NOTCH4 signaling
MCCC1,Defects in vitamin and cofactor metabolism
MCCC1,Diseases of metabolism
SPPL2B,Regulation of TNFR1 signaling
SPPL2B,TNF signaling
PSMB5,Host Interactions of HIV factors
PSMB5,Vpu mediated degradation of CD4
PSMB5,Vif-mediated degradation of APOBEC3G
PSMB5,Degradation of beta-catenin by the destruction complex
PSMB5,PCP/CE pathway
PSMB5,Asymmetric localization of PCP proteins
PSMB5,Degradation of AXIN
PSMB5,Degradation of DVL
PSMB5,Hedgehog ligand biogenesis
PSMB5,Hh mutants are degraded by ERAD
PSMB5,Hh mutants abrogate ligand secretion
PSMB5,Degradation of GLI1 by the proteasome
PSMB5,Degradation of GLI2 by the proteasome
PSMB5,GLI3 is processed to GLI3R by the proteasome
PSMB5,Hedgehog 'off' state
PSMB5,ABC transporter disorders
PSMB5,Disorders of transmembrane transporters
PSMB5,Hedgehog 'on' state
PSMB5,Regulation of RAS by GAPs
PSMB5,Defective CFTR causes cystic fibrosis
PSMB5,MAPK6/MAPK4 signaling
PSMB5,Regulation of PTEN stability and activity
PSMB5,Signaling by NOTCH4
PSMB5,Negative regulation of NOTCH4 signaling
PMEPA1,Signaling by TGF-beta Receptor Complex
PMEPA1,Downregulation of TGF-beta receptor signaling
PMEPA1,TGF-beta receptor signaling activates SMADs
PSMB6,Host Interactions of HIV factors
PSMB6,Vpu mediated degradation of CD4
PSMB6,Vif-mediated degradation of APOBEC3G
PSMB6,Degradation of beta-catenin by the destruction complex
PSMB6,PCP/CE pathway
PSMB6,Asymmetric localization of PCP proteins
PSMB6,Degradation of AXIN
PSMB6,Degradation of DVL
PSMB6,Hedgehog ligand biogenesis
PSMB6,Hh mutants are degraded by ERAD
PSMB6,Hh mutants abrogate ligand secretion
PSMB6,Degradation of GLI1 by the proteasome
PSMB6,Degradation of GLI2 by the proteasome
PSMB6,GLI3 is processed to GLI3R by the proteasome
PSMB6,Hedgehog 'off' state
PSMB6,ABC transporter disorders
PSMB6,Disorders of transmembrane transporters
PSMB6,Hedgehog 'on' state
PSMB6,Regulation of RAS by GAPs
PSMB6,Defective CFTR causes cystic fibrosis
PSMB6,MAPK6/MAPK4 signaling
PSMB6,Regulation of PTEN stability and activity
PSMB6,Signaling by NOTCH4
PSMB6,Negative regulation of NOTCH4 signaling
PSMB7,Host Interactions of HIV factors
PSMB7,Vpu mediated degradation of CD4
PSMB7,Vif-mediated degradation of APOBEC3G
PSMB7,Degradation of beta-catenin by the destruction complex
PSMB7,PCP/CE pathway
PSMB7,Asymmetric localization of PCP proteins
PSMB7,Degradation of AXIN
PSMB7,Degradation of DVL
PSMB7,Hedgehog ligand biogenesis
PSMB7,Hh mutants are degraded by ERAD
PSMB7,Hh mutants abrogate ligand secretion
PSMB7,Degradation of GLI1 by the proteasome
PSMB7,Degradation of GLI2 by the proteasome
PSMB7,GLI3 is processed to GLI3R by the proteasome
PSMB7,Hedgehog 'off' state
PSMB7,ABC transporter disorders
PSMB7,Disorders of transmembrane transporters
PSMB7,Hedgehog 'on' state
PSMB7,Regulation of RAS by GAPs
PSMB7,Defective CFTR causes cystic fibrosis
PSMB7,MAPK6/MAPK4 signaling
PSMB7,Regulation of PTEN stability and activity
PSMB7,Signaling by NOTCH4
PSMB7,Negative regulation of NOTCH4 signaling
OTUD7B,TNFR1-induced proapoptotic signaling
OTUD7B,Regulation of TNFR1 signaling
OTUD7B,TNFR1-induced NF-kappa-B signaling pathway
OTUD7B,TNF signaling
PARP6,Maturation of nucleoprotein
PARP6,Translation of Structural Proteins
PARP6,Late SARS-CoV-2 Infection Events
CTNNBIP1,Deactivation of the beta-catenin transactivating complex
PSMC1,Host Interactions of HIV factors
PSMC1,Vpu mediated degradation of CD4
PSMC1,Vif-mediated degradation of APOBEC3G
PSMC1,Degradation of beta-catenin by the destruction complex
PSMC1,PCP/CE pathway
PSMC1,Asymmetric localization of PCP proteins
PSMC1,Degradation of AXIN
PSMC1,Degradation of DVL
PSMC1,Hedgehog ligand biogenesis
PSMC1,Hh mutants are degraded by ERAD
PSMC1,Hh mutants abrogate ligand secretion
PSMC1,Degradation of GLI1 by the proteasome
PSMC1,Degradation of GLI2 by the proteasome
PSMC1,GLI3 is processed to GLI3R by the proteasome
PSMC1,Hedgehog 'off' state
PSMC1,ABC transporter disorders
PSMC1,Disorders of transmembrane transporters
PSMC1,Hedgehog 'on' state
PSMC1,Regulation of RAS by GAPs
PSMC1,Defective CFTR causes cystic fibrosis
PSMC1,MAPK6/MAPK4 signaling
PSMC1,Regulation of PTEN stability and activity
PSMC1,Signaling by NOTCH4
PSMC1,Negative regulation of NOTCH4 signaling
PSMC2,Host Interactions of HIV factors
PSMC2,Vpu mediated degradation of CD4
PSMC2,Vif-mediated degradation of APOBEC3G
PSMC2,Degradation of beta-catenin by the destruction complex
PSMC2,PCP/CE pathway
PSMC2,Asymmetric localization of PCP proteins
PSMC2,Degradation of AXIN
PSMC2,Degradation of DVL
PSMC2,Hedgehog ligand biogenesis
PSMC2,Hh mutants are degraded by ERAD
PSMC2,Hh mutants abrogate ligand secretion
PSMC2,Degradation of GLI1 by the proteasome
PSMC2,Degradation of GLI2 by the proteasome
PSMC2,GLI3 is processed to GLI3R by the proteasome
PSMC2,Hedgehog 'off' state
PSMC2,ABC transporter disorders
PSMC2,Disorders of transmembrane transporters
PSMC2,Hedgehog 'on' state
PSMC2,Regulation of RAS by GAPs
PSMC2,Defective CFTR causes cystic fibrosis
PSMC2,MAPK6/MAPK4 signaling
PSMC2,Regulation of PTEN stability and activity
PSMC2,Signaling by NOTCH4
PSMC2,Negative regulation of NOTCH4 signaling
PSMC3,Host Interactions of HIV factors
PSMC3,Vpu mediated degradation of CD4
PSMC3,Vif-mediated degradation of APOBEC3G
PSMC3,Degradation of beta-catenin by the destruction complex
PSMC3,PCP/CE pathway
PSMC3,Asymmetric localization of PCP proteins
PSMC3,Degradation of AXIN
PSMC3,Degradation of DVL
PSMC3,Hedgehog ligand biogenesis
PSMC3,Hh mutants are degraded by ERAD
PSMC3,Hh mutants abrogate ligand secretion
PSMC3,Degradation of GLI1 by the proteasome
PSMC3,Degradation of GLI2 by the proteasome
PSMC3,GLI3 is processed to GLI3R by the proteasome
PSMC3,Hedgehog 'off' state
PSMC3,ABC transporter disorders
PSMC3,Disorders of transmembrane transporters
PSMC3,Hedgehog 'on' state
PSMC3,Regulation of RAS by GAPs
PSMC3,Defective CFTR causes cystic fibrosis
PSMC3,MAPK6/MAPK4 signaling
PSMC3,Regulation of PTEN stability and activity
PSMC3,Signaling by NOTCH4
PSMC3,Negative regulation of NOTCH4 signaling
PSMC4,Host Interactions of HIV factors
PSMC4,Vpu mediated degradation of CD4
PSMC4,Vif-mediated degradation of APOBEC3G
PSMC4,Degradation of beta-catenin by the destruction complex
PSMC4,PCP/CE pathway
PSMC4,Asymmetric localization of PCP proteins
PSMC4,Degradation of AXIN
PSMC4,Degradation of DVL
PSMC4,Hedgehog ligand biogenesis
PSMC4,Hh mutants are degraded by ERAD
PSMC4,Hh mutants abrogate ligand secretion
PSMC4,Degradation of GLI1 by the proteasome
PSMC4,Degradation of GLI2 by the proteasome
PSMC4,GLI3 is processed to GLI3R by the proteasome
PSMC4,Hedgehog 'off' state
PSMC4,ABC transporter disorders
PSMC4,Disorders of transmembrane transporters
PSMC4,Hedgehog 'on' state
PSMC4,Regulation of RAS by GAPs
PSMC4,Defective CFTR causes cystic fibrosis
PSMC4,MAPK6/MAPK4 signaling
PSMC4,Regulation of PTEN stability and activity
PSMC4,Signaling by NOTCH4
PSMC4,Negative regulation of NOTCH4 signaling
PSMC5,Host Interactions of HIV factors
PSMC5,Vpu mediated degradation of CD4
PSMC5,Vif-mediated degradation of APOBEC3G
PSMC5,Degradation of beta-catenin by the destruction complex
PSMC5,PCP/CE pathway
PSMC5,Asymmetric localization of PCP proteins
PSMC5,Degradation of AXIN
PSMC5,Degradation of DVL
PSMC5,Hedgehog ligand biogenesis
PSMC5,Hh mutants are degraded by ERAD
PSMC5,Hh mutants abrogate ligand secretion
PSMC5,Degradation of GLI1 by the proteasome
PSMC5,Degradation of GLI2 by the proteasome
PSMC5,GLI3 is processed to GLI3R by the proteasome
PSMC5,Hedgehog 'off' state
PSMC5,ABC transporter disorders
PSMC5,Disorders of transmembrane transporters
PSMC5,Hedgehog 'on' state
PSMC5,Regulation of RAS by GAPs
PSMC5,Defective CFTR causes cystic fibrosis
PSMC5,MAPK6/MAPK4 signaling
PSMC5,Regulation of PTEN stability and activity
PSMC5,Signaling by NOTCH4
PSMC5,Negative regulation of NOTCH4 signaling
PSMC6,Host Interactions of HIV factors
PSMC6,Vpu mediated degradation of CD4
PSMC6,Vif-mediated degradation of APOBEC3G
PSMC6,Degradation of beta-catenin by the destruction complex
PSMC6,PCP/CE pathway
PSMC6,Asymmetric localization of PCP proteins
PSMC6,Degradation of AXIN
PSMC6,Degradation of DVL
PSMC6,Hedgehog ligand biogenesis
PSMC6,Hh mutants are degraded by ERAD
PSMC6,Hh mutants abrogate ligand secretion
PSMC6,Degradation of GLI1 by the proteasome
PSMC6,Degradation of GLI2 by the proteasome
PSMC6,GLI3 is processed to GLI3R by the proteasome
PSMC6,Hedgehog 'off' state
PSMC6,ABC transporter disorders
PSMC6,Disorders of transmembrane transporters
PSMC6,Hedgehog 'on' state
PSMC6,Regulation of RAS by GAPs
PSMC6,Defective CFTR causes cystic fibrosis
PSMC6,MAPK6/MAPK4 signaling
PSMC6,Regulation of PTEN stability and activity
PSMC6,Signaling by NOTCH4
PSMC6,Negative regulation of NOTCH4 signaling
PSMC6,SARS-CoV-1-host interactions
PSMC6,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
PSMD1,Host Interactions of HIV factors
PSMD1,Vpu mediated degradation of CD4
PSMD1,Vif-mediated degradation of APOBEC3G
PSMD1,Degradation of beta-catenin by the destruction complex
PSMD1,PCP/CE pathway
PSMD1,Asymmetric localization of PCP proteins
PSMD1,Degradation of AXIN
PSMD1,Degradation of DVL
PSMD1,Hedgehog ligand biogenesis
PSMD1,Hh mutants are degraded by ERAD
PSMD1,Hh mutants abrogate ligand secretion
PSMD1,Degradation of GLI1 by the proteasome
PSMD1,Degradation of GLI2 by the proteasome
PSMD1,GLI3 is processed to GLI3R by the proteasome
PSMD1,Hedgehog 'off' state
PSMD1,ABC transporter disorders
PSMD1,Disorders of transmembrane transporters
PSMD1,Hedgehog 'on' state
PSMD1,Regulation of RAS by GAPs
PSMD1,Defective CFTR causes cystic fibrosis
PSMD1,MAPK6/MAPK4 signaling
PSMD1,Regulation of PTEN stability and activity
PSMD1,Signaling by NOTCH4
PSMD1,Negative regulation of NOTCH4 signaling
PSMD2,Host Interactions of HIV factors
PSMD2,Vpu mediated degradation of CD4
PSMD2,Vif-mediated degradation of APOBEC3G
PSMD2,Degradation of beta-catenin by the destruction complex
PSMD2,PCP/CE pathway
PSMD2,Asymmetric localization of PCP proteins
PSMD2,Degradation of AXIN
PSMD2,Degradation of DVL
PSMD2,Hedgehog ligand biogenesis
PSMD2,Hh mutants are degraded by ERAD
PSMD2,Hh mutants abrogate ligand secretion
PSMD2,Degradation of GLI1 by the proteasome
PSMD2,Degradation of GLI2 by the proteasome
PSMD2,GLI3 is processed to GLI3R by the proteasome
PSMD2,Hedgehog 'off' state
PSMD2,ABC transporter disorders
PSMD2,Disorders of transmembrane transporters
PSMD2,Hedgehog 'on' state
PSMD2,Regulation of RAS by GAPs
PSMD2,Defective CFTR causes cystic fibrosis
PSMD2,MAPK6/MAPK4 signaling
PSMD2,Regulation of PTEN stability and activity
PSMD2,Signaling by NOTCH4
PSMD2,Negative regulation of NOTCH4 signaling
PSMD3,Host Interactions of HIV factors
PSMD3,Vpu mediated degradation of CD4
PSMD3,Vif-mediated degradation of APOBEC3G
PSMD3,Degradation of beta-catenin by the destruction complex
PSMD3,PCP/CE pathway
PSMD3,Asymmetric localization of PCP proteins
PSMD3,Degradation of AXIN
PSMD3,Degradation of DVL
PSMD3,Hedgehog ligand biogenesis
PSMD3,Hh mutants are degraded by ERAD
PSMD3,Hh mutants abrogate ligand secretion
PSMD3,Degradation of GLI1 by the proteasome
PSMD3,Degradation of GLI2 by the proteasome
PSMD3,GLI3 is processed to GLI3R by the proteasome
PSMD3,Hedgehog 'off' state
PSMD3,ABC transporter disorders
PSMD3,Disorders of transmembrane transporters
PSMD3,Hedgehog 'on' state
PSMD3,Regulation of RAS by GAPs
PSMD3,Defective CFTR causes cystic fibrosis
PSMD3,MAPK6/MAPK4 signaling
PSMD3,Regulation of PTEN stability and activity
PSMD3,Signaling by NOTCH4
PSMD3,Negative regulation of NOTCH4 signaling
ANO2,Induction of Cell-Cell Fusion
ANO2,Late SARS-CoV-2 Infection Events
CYSLTR2,Eicosanoid ligand-binding receptors
CYSLTR2,G alpha (s) signalling events
CYSLTR2,Anti-inflammatory response favouring Leishmania parasite infection
CYSLTR2,Leishmania parasite growth and survival
TRPC7,Effects of PIP2 hydrolysis
GOPC,RHOQ GTPase cycle
NUP107,Host Interactions of HIV factors
NUP107,Rev-mediated nuclear export of HIV RNA
NUP107,Transport of Ribonucleoproteins into the Host Nucleus
NUP107,Export of Viral Ribonucleoproteins from Nucleus
NUP107,NS1 Mediated Effects on Host Pathways
NUP107,Viral Messenger RNA Synthesis
NUP107,NEP/NS2 Interacts with the Cellular Export Machinery
NUP107,Interactions of Vpr with host cellular proteins
NUP107,Interactions of Rev with host cellular proteins
NUP107,Nuclear import of Rev protein
NUP107,Vpr-mediated nuclear import of PICs
NUP107,SLC transporter disorders
NUP107,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP107,Disorders of transmembrane transporters
NUP107,RHO GTPases Activate Formins
NUP107,HCMV Infection
NUP107,HCMV Early Events
NUP107,HCMV Late Events
NUP107,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PSMD7,Host Interactions of HIV factors
PSMD7,Vpu mediated degradation of CD4
PSMD7,Vif-mediated degradation of APOBEC3G
PSMD7,Degradation of beta-catenin by the destruction complex
PSMD7,PCP/CE pathway
PSMD7,Asymmetric localization of PCP proteins
PSMD7,Degradation of AXIN
PSMD7,Degradation of DVL
PSMD7,Hedgehog ligand biogenesis
PSMD7,Hh mutants are degraded by ERAD
PSMD7,Hh mutants abrogate ligand secretion
PSMD7,Degradation of GLI1 by the proteasome
PSMD7,Degradation of GLI2 by the proteasome
PSMD7,GLI3 is processed to GLI3R by the proteasome
PSMD7,Hedgehog 'off' state
PSMD7,ABC transporter disorders
PSMD7,Disorders of transmembrane transporters
PSMD7,Hedgehog 'on' state
PSMD7,Regulation of RAS by GAPs
PSMD7,Defective CFTR causes cystic fibrosis
PSMD7,MAPK6/MAPK4 signaling
PSMD7,Regulation of PTEN stability and activity
PSMD7,Signaling by NOTCH4
PSMD7,Negative regulation of NOTCH4 signaling
PSMD8,Host Interactions of HIV factors
PSMD8,Vpu mediated degradation of CD4
PSMD8,Vif-mediated degradation of APOBEC3G
PSMD8,Degradation of beta-catenin by the destruction complex
PSMD8,PCP/CE pathway
PSMD8,Asymmetric localization of PCP proteins
PSMD8,Degradation of AXIN
PSMD8,Degradation of DVL
PSMD8,Hedgehog ligand biogenesis
PSMD8,Hh mutants are degraded by ERAD
PSMD8,Hh mutants abrogate ligand secretion
PSMD8,Degradation of GLI1 by the proteasome
PSMD8,Degradation of GLI2 by the proteasome
PSMD8,GLI3 is processed to GLI3R by the proteasome
PSMD8,Hedgehog 'off' state
PSMD8,ABC transporter disorders
PSMD8,Disorders of transmembrane transporters
PSMD8,Hedgehog 'on' state
PSMD8,Regulation of RAS by GAPs
PSMD8,Defective CFTR causes cystic fibrosis
PSMD8,MAPK6/MAPK4 signaling
PSMD8,Regulation of PTEN stability and activity
PSMD8,Signaling by NOTCH4
PSMD8,Negative regulation of NOTCH4 signaling
RTN4,p75NTR regulates axonogenesis
RTN4,p75 NTR receptor-mediated signalling
SMURF1,Signaling by TGF-beta Receptor Complex
SMURF1,Signaling by BMP
SMURF1,Downregulation of TGF-beta receptor signaling
SMURF1,TGF-beta receptor signaling activates SMADs
SMURF1,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
SMURF1,PCP/CE pathway
SMURF1,Asymmetric localization of PCP proteins
SMURF1,Hedgehog 'on' state
SALL4,Regulation of PTEN gene transcription
PSMD11,Host Interactions of HIV factors
PSMD11,Vpu mediated degradation of CD4
PSMD11,Vif-mediated degradation of APOBEC3G
PSMD11,Degradation of beta-catenin by the destruction complex
PSMD11,PCP/CE pathway
PSMD11,Asymmetric localization of PCP proteins
PSMD11,Degradation of AXIN
PSMD11,Degradation of DVL
PSMD11,Hedgehog ligand biogenesis
PSMD11,Hh mutants are degraded by ERAD
PSMD11,Hh mutants abrogate ligand secretion
PSMD11,Degradation of GLI1 by the proteasome
PSMD11,Degradation of GLI2 by the proteasome
PSMD11,GLI3 is processed to GLI3R by the proteasome
PSMD11,Hedgehog 'off' state
PSMD11,ABC transporter disorders
PSMD11,Disorders of transmembrane transporters
PSMD11,Hedgehog 'on' state
PSMD11,Regulation of RAS by GAPs
PSMD11,Defective CFTR causes cystic fibrosis
PSMD11,MAPK6/MAPK4 signaling
PSMD11,Regulation of PTEN stability and activity
PSMD11,Signaling by NOTCH4
PSMD11,Negative regulation of NOTCH4 signaling
PSMD12,Host Interactions of HIV factors
PSMD12,Vpu mediated degradation of CD4
PSMD12,Vif-mediated degradation of APOBEC3G
PSMD12,Degradation of beta-catenin by the destruction complex
PSMD12,PCP/CE pathway
PSMD12,Asymmetric localization of PCP proteins
PSMD12,Degradation of AXIN
PSMD12,Degradation of DVL
PSMD12,Hedgehog ligand biogenesis
PSMD12,Hh mutants are degraded by ERAD
PSMD12,Hh mutants abrogate ligand secretion
PSMD12,Degradation of GLI1 by the proteasome
PSMD12,Degradation of GLI2 by the proteasome
PSMD12,GLI3 is processed to GLI3R by the proteasome
PSMD12,Hedgehog 'off' state
PSMD12,ABC transporter disorders
PSMD12,Disorders of transmembrane transporters
PSMD12,Hedgehog 'on' state
PSMD12,Regulation of RAS by GAPs
PSMD12,Defective CFTR causes cystic fibrosis
PSMD12,MAPK6/MAPK4 signaling
PSMD12,Regulation of PTEN stability and activity
PSMD12,Signaling by NOTCH4
PSMD12,Negative regulation of NOTCH4 signaling
PSMD13,Host Interactions of HIV factors
PSMD13,Vpu mediated degradation of CD4
PSMD13,Vif-mediated degradation of APOBEC3G
PSMD13,Degradation of beta-catenin by the destruction complex
PSMD13,PCP/CE pathway
PSMD13,Asymmetric localization of PCP proteins
PSMD13,Degradation of AXIN
PSMD13,Degradation of DVL
PSMD13,Hedgehog ligand biogenesis
PSMD13,Hh mutants are degraded by ERAD
PSMD13,Hh mutants abrogate ligand secretion
PSMD13,Degradation of GLI1 by the proteasome
PSMD13,Degradation of GLI2 by the proteasome
PSMD13,GLI3 is processed to GLI3R by the proteasome
PSMD13,Hedgehog 'off' state
PSMD13,ABC transporter disorders
PSMD13,Disorders of transmembrane transporters
PSMD13,Hedgehog 'on' state
PSMD13,Regulation of RAS by GAPs
PSMD13,Defective CFTR causes cystic fibrosis
PSMD13,MAPK6/MAPK4 signaling
PSMD13,Regulation of PTEN stability and activity
PSMD13,Signaling by NOTCH4
PSMD13,Negative regulation of NOTCH4 signaling
BAD,NRAGE signals death through JNK
BAD,p75 NTR receptor-mediated signalling
BAD,AKT phosphorylates targets in the cytosol
BAD,"Cell death signalling via NRAGE, NRIF and NADE"
BAD,PI3K/AKT Signaling in Cancer
BAD,Constitutive Signaling by AKT1 E17K in Cancer
VANGL2,PCP/CE pathway
VANGL2,Asymmetric localization of PCP proteins
VANGL2,RND3 GTPase cycle
VANGL2,RND2 GTPase cycle
VANGL2,RND1 GTPase cycle
PTBP1,Signaling by FGFR
PTBP1,Signaling by FGFR2
PTBP1,FGFR2 alternative splicing
TAS2R38,Class C/3 (Metabotropic glutamate/pheromone receptors)
PTCH1,Class B/2 (Secretin family receptors)
PTCH1,Hedgehog 'off' state
PTCH1,Hedgehog 'on' state
PTCH1,Activation of SMO
PTEN,Negative regulation of the PI3K/AKT network
PTEN,Regulation of PTEN mRNA translation
PTEN,Regulation of PTEN stability and activity
PTGDR,Eicosanoid ligand-binding receptors
PTGDR,G alpha (s) signalling events
PTGER1,Eicosanoid ligand-binding receptors
PTGER2,Eicosanoid ligand-binding receptors
PTGER2,G alpha (s) signalling events
PTGER3,Eicosanoid ligand-binding receptors
CBX8,Regulation of PTEN gene transcription
PTGER4,Eicosanoid ligand-binding receptors
PTGER4,G alpha (s) signalling events
PTGFR,Eicosanoid ligand-binding receptors
RHOJ,RHOJ GTPase cycle
PTGIR,Eicosanoid ligand-binding receptors
PTGIR,G alpha (s) signalling events
ABHD6,Effects of PIP2 hydrolysis
PTH,Class B/2 (Secretin family receptors)
PTH,G alpha (s) signalling events
PTHLH,Class B/2 (Secretin family receptors)
PTHLH,G alpha (s) signalling events
PLEKHG5,NRAGE signals death through JNK
PLEKHG5,p75 NTR receptor-mediated signalling
PLEKHG5,"Cell death signalling via NRAGE, NRIF and NADE"
PLEKHG5,G alpha (12/13) signalling events
PLEKHG5,RHOA GTPase cycle
PLEKHG5,RND3 GTPase cycle
PLEKHG5,RND1 GTPase cycle
PTH1R,Class B/2 (Secretin family receptors)
PTH1R,G alpha (s) signalling events
GATAD2B,Regulation of PTEN gene transcription
GATAD2B,Potential therapeutics for SARS
PTH2R,Class B/2 (Secretin family receptors)
PTH2R,G alpha (s) signalling events
PTK2,Signaling by VEGF
PTK2,Integrin signaling
PTK2,VEGFA-VEGFR2 Pathway
PTK2,RHO GTPases Activate WASPs and WAVEs
PTK2,Signaling by MET
PTK2,MET activates PTK2 signaling
PTK2,MET promotes cell motility
PTK2,Extra-nuclear estrogen signaling
PTK2,Parasite infection
PTK2,Leishmania phagocytosis
PTK2,FCGR3A-mediated phagocytosis
ZNF512B,RHOV GTPase cycle
KIDINS220,Prolonged ERK activation events
KIDINS220,Signaling by NTRK1 (TRKA)
KIDINS220,Signalling to ERKs
KIDINS220,RND2 GTPase cycle
KIDINS220,RND1 GTPase cycle
MTA3,Regulation of PTEN gene transcription
MTA3,Potential therapeutics for SARS
MAVS,SARS-CoV-1-host interactions
MAVS,SARS-CoV-1 activates/modulates innate immune responses
MAVS,SARS-CoV-2 activates/modulates innate and adaptive immune responses
MAVS,Respiratory Syncytial Virus Infection Pathway
MAVS,Evasion by RSV of host interferon responses
MAVS,RSV-host interactions
ARHGAP31,RHOA GTPase cycle
ARHGAP31,RHOU GTPase cycle
RPTOR,MTOR signalling
RPTOR,mTORC1-mediated signalling
RPTOR,Energy dependent regulation of mTOR by LKB1-AMPK
RPTOR,Regulation of PTEN gene transcription
PTK6,Signaling by ERBB2
PTK6,Signaling by PTK6
PTK6,Signaling by Non-Receptor Tyrosine Kinases
CGN,Signaling by TGF-beta Receptor Complex
CGN,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
MIB1,Signaling by NOTCH1
MIB1,Signaling by NOTCH2
MIB1,Activated NOTCH1 Transmits Signal to the Nucleus
MIB1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
MIB1,Signaling by NOTCH1 in Cancer
MIB1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
MIB1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
MIB1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MIB1,NOTCH2 Activation and Transmission of Signal to the Nucleus
MIB1,Signaling by NOTCH3
MIB1,NOTCH3 Activation and Transmission of Signal to the Nucleus
WDR35,Hedgehog 'off' state
TWF1,RHOBTB2 GTPase cycle
TWF1,RHOBTB GTPase Cycle
FAM135A,RND1 GTPase cycle
PREX1,NRAGE signals death through JNK
PREX1,p75 NTR receptor-mediated signalling
PREX1,"Cell death signalling via NRAGE, NRIF and NADE"
PREX1,G alpha (12/13) signalling events
PREX1,RHOA GTPase cycle
PREX1,RHOB GTPase cycle
PREX1,RHOC GTPase cycle
PREX1,RAC2 GTPase cycle
PREX1,RHOQ GTPase cycle
PREX1,RHOG GTPase cycle
PREX1,RHOJ GTPase cycle
PREX1,RAC3 GTPase cycle
ARHGAP21,RHOA GTPase cycle
ARHGAP21,RHOB GTPase cycle
ARHGAP21,RHOC GTPase cycle
ARHGAP21,RAC2 GTPase cycle
ARHGAP21,RHOD GTPase cycle
ARHGAP21,RHOQ GTPase cycle
ARHGAP21,RHOG GTPase cycle
ARHGAP21,RHOJ GTPase cycle
ARHGAP21,RAC3 GTPase cycle
ARHGAP21,RHOF GTPase cycle
ARHGAP21,RND3 GTPase cycle
RANBP10,Signaling by MET
VPS18,SARS-CoV-2 modulates autophagy
SH3RF1,RHOV GTPase cycle
PTN,Signaling by ALK
RDH14,Signaling by Retinoic Acid
RDH14,RA biosynthesis pathway
RNF213,Infection with Mycobacterium tuberculosis
RNF213,Response of Mtb to phagocytosis
RNF213,Bacterial Infection Pathways
CHD8,Deactivation of the beta-catenin transactivating complex
TNRC6C,Pre-NOTCH Transcription and Translation
TNRC6C,Pre-NOTCH Expression and Processing
TNRC6C,Ca2+ pathway
TNRC6C,MAPK6/MAPK4 signaling
TNRC6C,Regulation of PTEN mRNA translation
TNRC6C,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
TNRC6C,Estrogen-dependent gene expression
TNRC6C,NR1H2 and NR1H3-mediated signaling
TNRC6C,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
TNRC6C,Signaling by ALK in cancer
TNRC6C,Signaling by ALK fusions and activated point mutants
TNRC6C,Nuclear events stimulated by ALK signaling in cancer
TNRC6C,Signaling by TGFBR3
TNRC6C,TGFBR3 expression
PTPN1,Integrin signaling
PTPN1,Signaling by MET
PTPN1,Negative regulation of MET activity
PTPN1,Signaling by Insulin receptor
PTPN1,Insulin receptor recycling
PTPN1,Signaling by PTK6
PTPN1,Signaling by Non-Receptor Tyrosine Kinases
PTPN2,Signaling by MET
PTPN2,Negative regulation of MET activity
ANO8,Induction of Cell-Cell Fusion
ANO8,Late SARS-CoV-2 Infection Events
WDR19,Hedgehog 'off' state
PTPN3,Signaling by EGFR
PTPN3,EGFR downregulation
PTPN3,Negative regulation of MAPK pathway
SCUBE2,Hedgehog ligand biogenesis
TRIB3,PI3K Cascade
TRIB3,IRS-mediated signalling
TRIB3,Signaling by VEGF
TRIB3,Negative regulation of the PI3K/AKT network
TRIB3,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
TRIB3,IGF1R signaling cascade
TRIB3,IRS-related events triggered by IGF1R
TRIB3,VEGFA-VEGFR2 Pathway
TRIB3,VEGFR2 mediated vascular permeability
TRIB3,Insulin receptor signalling cascade
TRIB3,Signaling by Insulin receptor
PTPN6,Signaling by SCF-KIT
PTPN6,Regulation of KIT signaling
PTPN6,Signaling by ALK
PTPN6,Signaling by ALK in cancer
PTPN6,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PTPN6,Signaling by ALK fusions and activated point mutants
PTPN6,Nuclear events stimulated by ALK signaling in cancer
PTPN7,Negative regulation of MAPK pathway
PTPN11,Signaling by SCF-KIT
PTPN11,Signaling by EGFR
PTPN11,Downstream signal transduction
PTPN11,Signaling by PDGF
PTPN11,Signaling by FGFR
PTPN11,Downstream signaling of activated FGFR1
PTPN11,FRS-mediated FGFR1 signaling
PTPN11,Downstream signaling of activated FGFR2
PTPN11,FRS-mediated FGFR2 signaling
PTPN11,FRS-mediated FGFR3 signaling
PTPN11,Downstream signaling of activated FGFR3
PTPN11,FRS-mediated FGFR4 signaling
PTPN11,Downstream signaling of activated FGFR4
PTPN11,Negative regulation of FGFR1 signaling
PTPN11,Negative regulation of FGFR2 signaling
PTPN11,Negative regulation of FGFR3 signaling
PTPN11,Negative regulation of FGFR4 signaling
PTPN11,Signaling by FGFR1
PTPN11,Signaling by FGFR2
PTPN11,Signaling by FGFR3
PTPN11,Signaling by FGFR4
PTPN11,Signaling by MET
PTPN11,Signaling by NTRK2 (TRKB)
PTPN11,FLT3 signaling in disease
PTPN11,Signaling by FLT3 ITD and TKD mutants
PTPN11,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PTPN12,Signaling by ERBB2
PTPN12,Signaling by ERBB2 in Cancer
PTPN12,Signaling by EGFR
PTPN12,EGFR downregulation
PTPN12,Signaling by PDGF
PTPN12,Downregulation of ERBB2 signaling
PTPN13,RND3 GTPase cycle
PTPN13,RND2 GTPase cycle
PTPN13,RND1 GTPase cycle
PTPRF,Signaling by Insulin receptor
PTPRF,Insulin receptor recycling
PTPRJ,Signaling by MET
PTPRJ,Negative regulation of MET activity
PTPRK,Signaling by EGFR
PTPRK,EGFR downregulation
BARD1,Diseases of DNA repair
BARD1,Diseases of DNA Double-Strand Break Repair
PTPRO,Signaling by NTRK3 (TRKC)
PTPRS,Signaling by NTRK3 (TRKC)
BAX,Signaling by NTRK3 (TRKC)
RAD1,Diseases of DNA repair
RAD1,Diseases of DNA Double-Strand Break Repair
RAD1,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RAD1,Impaired BRCA2 binding to RAD51
CXCL16,Peptide ligand-binding receptors
CXCL16,Chemokine receptors bind chemokines
ABCD3,RHOA GTPase cycle
ABCD3,RHOC GTPase cycle
PXN,Signaling by EGFR
PXN,Signaling by VEGF
PXN,VEGFA-VEGFR2 Pathway
PXN,Signaling by PTK6
PXN,Signaling by Non-Receptor Tyrosine Kinases
RHOU,RHOU GTPase cycle
EPS15L1,Signaling by EGFR
EPS15L1,EGFR downregulation
RRAGD,MTOR signalling
RRAGD,mTORC1-mediated signalling
RRAGD,Energy dependent regulation of mTOR by LKB1-AMPK
RRAGD,Regulation of PTEN gene transcription
RAB5A,Infection with Mycobacterium tuberculosis
RAB5A,Response of Mtb to phagocytosis
RAB5A,Bacterial Infection Pathways
RAB6A,Pre-NOTCH Processing in Golgi
RAB6A,Pre-NOTCH Expression and Processing
RAC1,Signaling by SCF-KIT
RAC1,Host Interactions of HIV factors
RAC1,The role of Nef in HIV-1 replication and disease pathogenesis
RAC1,Signaling by VEGF
RAC1,Negative regulation of the PI3K/AKT network
RAC1,PI3K/AKT Signaling in Cancer
RAC1,Constitutive Signaling by Aberrant PI3K in Cancer
RAC1,PCP/CE pathway
RAC1,Activation of RAC1
RAC1,VEGFA-VEGFR2 Pathway
RAC1,VEGFR2 mediated vascular permeability
RAC1,RHO GTPases activate PKNs
RAC1,RHO GTPases activate CIT
RAC1,RHO GTPases activate KTN1
RAC1,RHO GTPases activate IQGAPs
RAC1,RHO GTPases activate PAKs
RAC1,RHO GTPases Activate WASPs and WAVEs
RAC1,RHO GTPases Activate Formins
RAC1,RHO GTPases Activate NADPH Oxidases
RAC1,MAPK6/MAPK4 signaling
RAC1,Signaling by MET
RAC1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
RAC1,Signaling by PTK6
RAC1,MET promotes cell motility
RAC1,Signaling by NTRK2 (TRKB)
RAC1,Signaling by Non-Receptor Tyrosine Kinases
RAC1,Parasite infection
RAC1,Leishmania phagocytosis
RAC1,FCGR3A-mediated phagocytosis
RAC2,Negative regulation of the PI3K/AKT network
RAC2,PI3K/AKT Signaling in Cancer
RAC2,Constitutive Signaling by Aberrant PI3K in Cancer
RAC2,PCP/CE pathway
RAC2,RHO GTPases Activate NADPH Oxidases
RAC2,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
RAC2,RAC2 GTPase cycle
RAC3,PCP/CE pathway
RAC3,RAC3 GTPase cycle
RAD9A,Diseases of DNA repair
RAD9A,Diseases of DNA Double-Strand Break Repair
RAD9A,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RAD9A,Impaired BRCA2 binding to RAD51
RAD17,Diseases of DNA repair
RAD17,Diseases of DNA Double-Strand Break Repair
RAD17,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RAD17,Impaired BRCA2 binding to RAD51
RAD21,Estrogen-dependent gene expression
RAD51C,Diseases of DNA repair
RAD51C,Diseases of DNA Double-Strand Break Repair
RAD51C,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RAD51C,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
RAD51C,Defective homologous recombination repair (HRR) due to PALB2 loss of function
RAD51C,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
RAD51C,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
RAD51C,Impaired BRCA2 binding to PALB2
RAG1,MAPK6/MAPK4 signaling
RAG2,MAPK6/MAPK4 signaling
RALA,Signalling to RAS
RALA,Signaling by NTRK1 (TRKA)
RALA,Signalling to ERKs
RALB,Signalling to RAS
RALB,Signaling by NTRK1 (TRKA)
RALB,Signalling to ERKs
ACTA2,Signaling by NOTCH4
ACTA2,NOTCH4 Intracellular Domain Regulates Transcription
RALGDS,Signalling to RAS
RALGDS,Signaling by NTRK1 (TRKA)
RALGDS,Signalling to ERKs
RAN,Host Interactions of HIV factors
RAN,Rev-mediated nuclear export of HIV RNA
RAN,Export of Viral Ribonucleoproteins from Nucleus
RAN,NEP/NS2 Interacts with the Cellular Export Machinery
RAN,Interactions of Rev with host cellular proteins
RAN,Nuclear import of Rev protein
RANBP1,Host Interactions of HIV factors
RANBP1,Rev-mediated nuclear export of HIV RNA
RANBP1,Interactions of Rev with host cellular proteins
RANBP2,Host Interactions of HIV factors
RANBP2,Rev-mediated nuclear export of HIV RNA
RANBP2,Transport of Ribonucleoproteins into the Host Nucleus
RANBP2,Export of Viral Ribonucleoproteins from Nucleus
RANBP2,NS1 Mediated Effects on Host Pathways
RANBP2,Viral Messenger RNA Synthesis
RANBP2,NEP/NS2 Interacts with the Cellular Export Machinery
RANBP2,Interactions of Vpr with host cellular proteins
RANBP2,Interactions of Rev with host cellular proteins
RANBP2,Nuclear import of Rev protein
RANBP2,Vpr-mediated nuclear import of PICs
RANBP2,SLC transporter disorders
RANBP2,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
RANBP2,Disorders of transmembrane transporters
RANBP2,RHO GTPases Activate Formins
RANBP2,HCMV Infection
RANBP2,HCMV Early Events
RANBP2,HCMV Late Events
RANBP2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
RANGAP1,Host Interactions of HIV factors
RANGAP1,Rev-mediated nuclear export of HIV RNA
RANGAP1,Interactions of Rev with host cellular proteins
RANGAP1,RHO GTPases Activate Formins
RAP1A,Prolonged ERK activation events
RAP1A,Frs2-mediated activation
RAP1A,Signaling by NTRK1 (TRKA)
RAP1A,Signalling to ERKs
RAP1A,Integrin signaling
RAP1A,p130Cas linkage to MAPK signaling for integrins
RAP1A,MAP2K and MAPK activation
RAP1A,Signaling by moderate kinase activity BRAF mutants
RAP1A,Signaling by high-kinase activity BRAF mutants
RAP1A,Signaling by RAS mutants
RAP1A,Signaling by BRAF and RAF1 fusions
RAP1A,Paradoxical activation of RAF signaling by kinase inactive BRAF
RAP1A,Oncogenic MAPK signaling
RAP1A,Signaling by MET
RAP1A,MET promotes cell motility
RAP1A,Signaling downstream of RAS mutants
RAP1A,Signaling by RAF1 mutants
RAP1B,Integrin signaling
RAP1B,p130Cas linkage to MAPK signaling for integrins
RAP1B,MAP2K and MAPK activation
RAP1B,Signaling by moderate kinase activity BRAF mutants
RAP1B,Signaling by high-kinase activity BRAF mutants
RAP1B,Signaling by RAS mutants
RAP1B,Signaling by BRAF and RAF1 fusions
RAP1B,Paradoxical activation of RAF signaling by kinase inactive BRAF
RAP1B,Oncogenic MAPK signaling
RAP1B,Signaling by MET
RAP1B,MET promotes cell motility
RAP1B,Signaling downstream of RAS mutants
RAP1B,Signaling by RAF1 mutants
RARA,Signaling by TGFBR3
RARA,TGFBR3 expression
RARB,Signaling by Retinoic Acid
RARG,Signaling by Retinoic Acid
RASA1,Downstream signal transduction
RASA1,Signaling by PDGF
RASA1,Signaling by VEGF
RASA1,VEGFA-VEGFR2 Pathway
RASA1,VEGFR2 mediated cell proliferation
RASA1,Regulation of RAS by GAPs
RASA1,Signaling by PTK6
RASA1,Signaling by Non-Receptor Tyrosine Kinases
RASA2,Regulation of RAS by GAPs
RASGRF2,NRAGE signals death through JNK
RASGRF2,p75 NTR receptor-mediated signalling
RASGRF2,"Cell death signalling via NRAGE, NRIF and NADE"
RASGRF2,G alpha (12/13) signalling events
RASGRF2,RHOA GTPase cycle
RB1,Signaling by ALK in cancer
RB1,Signaling by ALK fusions and activated point mutants
RB1,Nuclear events stimulated by ALK signaling in cancer
RB1,Early SARS-CoV-2 Infection Events
ARID4A,Potential therapeutics for SARS
ACE2,Potential therapeutics for SARS
ACE2,Early SARS-CoV-2 Infection Events
RBBP4,Regulation of PTEN gene transcription
RBBP4,HCMV Infection
RBBP4,HCMV Early Events
RBBP4,Diseases of programmed cell death
RBBP4,Potential therapeutics for SARS
RBBP4,Defective pyroptosis
RBBP5,Formation of the beta-catenin:TCF transactivating complex
RBBP5,Deactivation of the beta-catenin transactivating complex
BCKDHA,Diseases of metabolism
RBBP6,RHOBTB1 GTPase cycle
RBBP6,RHOBTB GTPase Cycle
RBBP7,Regulation of PTEN gene transcription
RBBP7,HCMV Infection
RBBP7,HCMV Early Events
RBBP7,Diseases of programmed cell death
RBBP7,Potential therapeutics for SARS
RBBP7,Defective pyroptosis
RBL1,Signaling by TGF-beta Receptor Complex
RBL1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
RBL1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
HRH4,Amine ligand-binding receptors
GNB4,Opioid Signalling
GNB4,G-protein activation
GNB4,Class B/2 (Secretin family receptors)
GNB4,G beta:gamma signalling through PI3Kgamma
GNB4,G-protein beta:gamma signalling
GNB4,Ca2+ pathway
GNB4,G alpha (12/13) signalling events
GNB4,G beta:gamma signalling through PLC beta
GNB4,G alpha (s) signalling events
GNB4,G alpha (z) signalling events
GNB4,Glucagon-type ligand receptors
GNB4,G beta:gamma signalling through BTK
GNB4,G beta:gamma signalling through CDC42
GNB4,Extra-nuclear estrogen signaling
GNB4,GPER1 signaling
GNB4,ADORA2B mediated anti-inflammatory cytokines production
GNB4,Anti-inflammatory response favouring Leishmania parasite infection
GNB4,Leishmania parasite growth and survival
KLHL12,Degradation of DVL
LGR6,Regulation of FZD by ubiquitination
BCKDHB,Diseases of metabolism
CCND1,Pre-NOTCH Transcription and Translation
CCND1,Pre-NOTCH Expression and Processing
CCND1,Signaling by PTK6
CCND1,Signaling by Non-Receptor Tyrosine Kinases
CCND1,Extra-nuclear estrogen signaling
CCND1,Estrogen-dependent gene expression
CCND1,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
CCND1,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
CCND1,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
CCND1,Diseases of mitotic cell cycle
CCND1,Aberrant regulation of mitotic cell cycle due to RB1 defects
RDH5,Signaling by Retinoic Acid
RDH5,RA biosynthesis pathway
BCL2,Extra-nuclear estrogen signaling
BCL2,Estrogen-dependent gene expression
BCL2,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
BCL2A1,Signaling by ALK in cancer
BCL2A1,Signaling by ALK fusions and activated point mutants
BCL2A1,Nuclear events stimulated by ALK signaling in cancer
RELA,p75NTR signals via NF-kB
RELA,p75 NTR receptor-mediated signalling
RELA,Diseases of Immune System
RELA,Diseases associated with the TLR signaling cascade
RELA,Purinergic signaling in leishmaniasis infection
RELA,Cell recruitment (pro-inflammatory response)
RELA,SARS-CoV-1-host interactions
RELA,SARS-CoV-1 activates/modulates innate immune responses
REST,Signaling by NTRK1 (TRKA)
REST,Nuclear Events (kinase and transcription factor activation)
REST,Regulation of PTEN gene transcription
REST,NGF-stimulated transcription
REST,Potential therapeutics for SARS
BCL2L1,RAS processing
BCL2L1,FLT3 signaling in disease
BCL2L1,SARS-CoV-1-host interactions
BCL2L1,Signaling by FLT3 ITD and TKD mutants
RFC2,Diseases of DNA repair
RFC2,Diseases of DNA Double-Strand Break Repair
RFC2,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RFC2,Impaired BRCA2 binding to RAD51
RFC3,Diseases of DNA repair
RFC3,Diseases of DNA Double-Strand Break Repair
RFC3,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RFC3,Impaired BRCA2 binding to RAD51
RFC4,Diseases of DNA repair
RFC4,Diseases of DNA Double-Strand Break Repair
RFC4,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RFC4,Impaired BRCA2 binding to RAD51
RFC5,Diseases of DNA repair
RFC5,Diseases of DNA Double-Strand Break Repair
RFC5,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RFC5,Impaired BRCA2 binding to RAD51
RFNG,Pre-NOTCH Processing in Golgi
RFNG,Pre-NOTCH Expression and Processing
TRIM27,Regulation of PTEN stability and activity
TRIM27,Infection with Mycobacterium tuberculosis
TRIM27,Response of Mtb to phagocytosis
TRIM27,Bacterial Infection Pathways
RGS4,G alpha (z) signalling events
ACTB,Signaling by VEGF
ACTB,VEGFA-VEGFR2 Pathway
ACTB,RHO GTPases activate IQGAPs
ACTB,RHO GTPases Activate WASPs and WAVEs
ACTB,RHO GTPases Activate Formins
ACTB,MAP2K and MAPK activation
ACTB,Signaling by moderate kinase activity BRAF mutants
ACTB,Signaling by high-kinase activity BRAF mutants
ACTB,Signaling by RAS mutants
ACTB,Signaling by BRAF and RAF1 fusions
ACTB,Paradoxical activation of RAF signaling by kinase inactive BRAF
ACTB,Oncogenic MAPK signaling
ACTB,RHOF GTPase cycle
ACTB,Signaling downstream of RAS mutants
ACTB,Signaling by RAF1 mutants
ACTB,Parasite infection
ACTB,Leishmania phagocytosis
ACTB,FCGR3A-mediated phagocytosis
RGS16,G alpha (z) signalling events
RHEB,MTOR signalling
RHEB,mTORC1-mediated signalling
RHEB,Energy dependent regulation of mTOR by LKB1-AMPK
RHEB,Regulation of PTEN gene transcription
RIT2,Signaling by NTRK1 (TRKA)
RIT2,Signalling to ERKs
RING1,Regulation of PTEN gene transcription
RIT1,Signaling by NTRK1 (TRKA)
RIT1,Signalling to ERKs
TGIF2,Signaling by TGF-beta Receptor Complex
TGIF2,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TGIF2,Downregulation of SMAD2/3:SMAD4 transcriptional activity
TGIF2,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
RNF2,Regulation of PTEN gene transcription
RNF5,ABC transporter disorders
RNF5,Disorders of transmembrane transporters
RNF5,Defective CFTR causes cystic fibrosis
SAV1,Signaling by Hippo
APOBEC3G,Host Interactions of HIV factors
APOBEC3G,Vif-mediated degradation of APOBEC3G
SPCS3,Respiratory Syncytial Virus Infection Pathway
SPCS3,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
SPCS3,Maturation of hRSV A proteins
BCL9,Formation of the beta-catenin:TCF transactivating complex
BCL9,Deactivation of the beta-catenin transactivating complex
ROBO1,Activation of RAC1
ROCK1,Signaling by VEGF
ROCK1,G alpha (12/13) signalling events
ROCK1,VEGFA-VEGFR2 Pathway
ROCK1,RHO GTPases Activate ROCKs
ROCK1,RHOA GTPase cycle
ROCK1,RHOB GTPase cycle
ROCK1,RHOC GTPase cycle
ROCK1,RHOH GTPase cycle
ROCK1,RHOBTB1 GTPase cycle
ROCK1,Potential therapeutics for SARS
ROCK1,RND3 GTPase cycle
ROCK1,RHOBTB GTPase Cycle
RPA1,Diseases of DNA repair
RPA1,Diseases of DNA Double-Strand Break Repair
RPA1,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RPA1,Impaired BRCA2 binding to RAD51
RPA3,Diseases of DNA repair
RPA3,Diseases of DNA Double-Strand Break Repair
RPA3,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RPA3,Impaired BRCA2 binding to RAD51
RPL3,Viral mRNA Translation
RPL3L,Viral mRNA Translation
RPL4,Viral mRNA Translation
RPL5,Viral mRNA Translation
RPL6,Viral mRNA Translation
RPL7,Viral mRNA Translation
BCR,RHOA GTPase cycle
BCR,RHOB GTPase cycle
BCR,RHOC GTPase cycle
BCR,RAC2 GTPase cycle
BCR,RAC3 GTPase cycle
RPL7A,Viral mRNA Translation
RPL8,Viral mRNA Translation
RPL9,Viral mRNA Translation
RPL10,Viral mRNA Translation
RPL11,Viral mRNA Translation
RPL12,Viral mRNA Translation
RPL13,Viral mRNA Translation
RPL15,Viral mRNA Translation
RPL17,Viral mRNA Translation
RPL18,Viral mRNA Translation
RPL18A,Viral mRNA Translation
RPL19,Viral mRNA Translation
RPL21,Viral mRNA Translation
RPL22,Viral mRNA Translation
RPL23A,Viral mRNA Translation
RPL24,Viral mRNA Translation
RPL26,Viral mRNA Translation
RPL27,Viral mRNA Translation
RPL30,Viral mRNA Translation
RPL27A,Viral mRNA Translation
RPL28,Viral mRNA Translation
RPL29,Viral mRNA Translation
RPL31,Viral mRNA Translation
RPL32,Viral mRNA Translation
RPL34,Viral mRNA Translation
RPL35A,Viral mRNA Translation
RPL36AL,Viral mRNA Translation
RPL37,Viral mRNA Translation
RPL37A,Viral mRNA Translation
RPL38,Viral mRNA Translation
RPL39,Viral mRNA Translation
RPL41,Viral mRNA Translation
RPL36A,Viral mRNA Translation
RPLP0,Viral mRNA Translation
RPLP1,Viral mRNA Translation
RPLP2,Viral mRNA Translation
RPN1,Maturation of spike protein
RPN1,Translation of Structural Proteins
RPN1,Late SARS-CoV-2 Infection Events
RPN2,Maturation of spike protein
RPN2,Translation of Structural Proteins
RPN2,Late SARS-CoV-2 Infection Events
RPS2,Viral mRNA Translation
RPS2,SARS-CoV-1-host interactions
RPS2,SARS-CoV-1 modulates host translation machinery
RPS2,SARS-CoV-2 modulates host translation machinery
RPS3,Viral mRNA Translation
RPS3,SARS-CoV-1-host interactions
RPS3,SARS-CoV-1 modulates host translation machinery
RPS3,SARS-CoV-2 modulates host translation machinery
RPS3A,Viral mRNA Translation
RPS3A,SARS-CoV-1-host interactions
RPS3A,SARS-CoV-1 modulates host translation machinery
RPS3A,SARS-CoV-2 modulates host translation machinery
RPS4X,Viral mRNA Translation
RPS4X,SARS-CoV-1-host interactions
RPS4X,SARS-CoV-1 modulates host translation machinery
RPS4X,SARS-CoV-2 modulates host translation machinery
RPS4Y1,Viral mRNA Translation
RPS4Y1,SARS-CoV-1-host interactions
RPS4Y1,SARS-CoV-1 modulates host translation machinery
RPS4Y1,SARS-CoV-2 modulates host translation machinery
RPS5,Viral mRNA Translation
RPS5,SARS-CoV-1-host interactions
RPS5,SARS-CoV-1 modulates host translation machinery
RPS5,SARS-CoV-2 modulates host translation machinery
RPS6,MTOR signalling
RPS6,mTORC1-mediated signalling
RPS6,Viral mRNA Translation
RPS6,SARS-CoV-1-host interactions
RPS6,SARS-CoV-1 modulates host translation machinery
RPS6,SARS-CoV-2 modulates host translation machinery
RPS6KA1,Signaling by NTRK1 (TRKA)
RPS6KA1,Nuclear Events (kinase and transcription factor activation)
RPS6KA1,ERK/MAPK targets
RPS6KA2,Signaling by NTRK1 (TRKA)
RPS6KA2,Nuclear Events (kinase and transcription factor activation)
RPS6KA2,ERK/MAPK targets
RPS6KA3,Signaling by NTRK1 (TRKA)
RPS6KA3,Nuclear Events (kinase and transcription factor activation)
RPS6KA3,ERK/MAPK targets
RPS6KB1,MTOR signalling
RPS6KB1,mTORC1-mediated signalling
RPS6KB2,PI3K/AKT Signaling in Cancer
RPS6KB2,Constitutive Signaling by AKT1 E17K in Cancer
RPS7,Viral mRNA Translation
RPS7,SARS-CoV-1-host interactions
RPS7,SARS-CoV-1 modulates host translation machinery
RPS7,SARS-CoV-2 modulates host translation machinery
RPS8,Viral mRNA Translation
RPS8,SARS-CoV-1-host interactions
RPS8,SARS-CoV-1 modulates host translation machinery
RPS8,SARS-CoV-2 modulates host translation machinery
RPS9,Viral mRNA Translation
RPS9,SARS-CoV-1-host interactions
RPS9,SARS-CoV-1 modulates host translation machinery
RPS9,SARS-CoV-2 modulates host translation machinery
RPS10,Viral mRNA Translation
RPS10,SARS-CoV-1-host interactions
RPS10,SARS-CoV-1 modulates host translation machinery
RPS10,SARS-CoV-2 modulates host translation machinery
RPS11,Viral mRNA Translation
RPS11,SARS-CoV-1-host interactions
RPS11,SARS-CoV-1 modulates host translation machinery
RPS11,SARS-CoV-2 modulates host translation machinery
RPS12,Viral mRNA Translation
RPS12,SARS-CoV-1-host interactions
RPS12,SARS-CoV-1 modulates host translation machinery
RPS12,SARS-CoV-2 modulates host translation machinery
RPS13,Viral mRNA Translation
RPS13,SARS-CoV-1-host interactions
RPS13,SARS-CoV-1 modulates host translation machinery
RPS13,SARS-CoV-2 modulates host translation machinery
RPS14,Viral mRNA Translation
RPS14,SARS-CoV-1-host interactions
RPS14,SARS-CoV-1 modulates host translation machinery
RPS14,SARS-CoV-2 modulates host translation machinery
RPS15,Viral mRNA Translation
RPS15,SARS-CoV-1-host interactions
RPS15,SARS-CoV-1 modulates host translation machinery
RPS15,SARS-CoV-2 modulates host translation machinery
RPS15A,Viral mRNA Translation
RPS15A,SARS-CoV-1-host interactions
RPS15A,SARS-CoV-1 modulates host translation machinery
RPS15A,SARS-CoV-2 modulates host translation machinery
RPS16,Viral mRNA Translation
RPS16,SARS-CoV-1-host interactions
RPS16,SARS-CoV-1 modulates host translation machinery
RPS16,SARS-CoV-2 modulates host translation machinery
RPS17,Viral mRNA Translation
RPS17,SARS-CoV-1-host interactions
RPS17,SARS-CoV-1 modulates host translation machinery
RPS17,SARS-CoV-2 modulates host translation machinery
RPS18,Viral mRNA Translation
RPS18,SARS-CoV-1-host interactions
RPS18,SARS-CoV-1 modulates host translation machinery
RPS18,SARS-CoV-2 modulates host translation machinery
RPS19,Viral mRNA Translation
RPS19,SARS-CoV-1-host interactions
RPS19,SARS-CoV-1 modulates host translation machinery
RPS19,SARS-CoV-2 modulates host translation machinery
RPS20,Viral mRNA Translation
RPS20,SARS-CoV-1-host interactions
RPS20,SARS-CoV-1 modulates host translation machinery
RPS20,SARS-CoV-2 modulates host translation machinery
RPS21,Viral mRNA Translation
RPS21,SARS-CoV-1-host interactions
RPS21,SARS-CoV-1 modulates host translation machinery
RPS21,SARS-CoV-2 modulates host translation machinery
RPS23,Viral mRNA Translation
RPS23,SARS-CoV-1-host interactions
RPS23,SARS-CoV-1 modulates host translation machinery
RPS23,SARS-CoV-2 modulates host translation machinery
RPS24,Viral mRNA Translation
RPS24,SARS-CoV-1-host interactions
RPS24,SARS-CoV-1 modulates host translation machinery
RPS24,SARS-CoV-2 modulates host translation machinery
RPS25,Viral mRNA Translation
RPS25,SARS-CoV-1-host interactions
RPS25,SARS-CoV-1 modulates host translation machinery
RPS25,SARS-CoV-2 modulates host translation machinery
RPS26,Viral mRNA Translation
RPS26,SARS-CoV-1-host interactions
RPS26,SARS-CoV-1 modulates host translation machinery
RPS26,SARS-CoV-2 modulates host translation machinery
RPS27,Viral mRNA Translation
RPS27,RHO GTPases Activate Formins
RPS27,SARS-CoV-1-host interactions
RPS27,SARS-CoV-1 modulates host translation machinery
RPS27,SARS-CoV-2 modulates host translation machinery
RPS28,Viral mRNA Translation
RPS28,SARS-CoV-1-host interactions
RPS28,SARS-CoV-1 modulates host translation machinery
RPS28,SARS-CoV-2 modulates host translation machinery
RPS29,Viral mRNA Translation
RPS29,SARS-CoV-1-host interactions
RPS29,SARS-CoV-1 modulates host translation machinery
RPS29,SARS-CoV-2 modulates host translation machinery
RRAD,Signaling by NTRK1 (TRKA)
RRAD,Nuclear Events (kinase and transcription factor activation)
RRAD,NGF-stimulated transcription
RTKN,RHOA GTPase cycle
RTKN,RHOB GTPase cycle
RTKN,RHOC GTPase cycle
CLIP1,RHO GTPases activate IQGAPs
CLIP1,RHO GTPases Activate Formins
RXRA,Signaling by Retinoic Acid
RXRA,NR1H2 and NR1H3-mediated signaling
RXRA,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
RXRA,Signaling by TGFBR3
RXRA,TGFBR3 expression
RXRB,Signaling by Retinoic Acid
RXRB,NR1H2 and NR1H3-mediated signaling
RXRB,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
RXRG,Signaling by Retinoic Acid
RYK,PCP/CE pathway
BDNF,Negative regulation of the PI3K/AKT network
BDNF,PI3K/AKT Signaling in Cancer
BDNF,Constitutive Signaling by Aberrant PI3K in Cancer
BDNF,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
BDNF,Signaling by NTRK2 (TRKB)
S100A1,Diseases of Immune System
S100A1,Diseases associated with the TLR signaling cascade
S100A8,Diseases of Immune System
S100A8,Diseases associated with the TLR signaling cascade
S100A8,RHO GTPases Activate NADPH Oxidases
S100A9,Diseases of Immune System
S100A9,Diseases associated with the TLR signaling cascade
S100A9,RHO GTPases Activate NADPH Oxidases
S100B,Signaling by ERBB4
S100B,Nuclear signaling by ERBB4
MAPK12,Signalling to RAS
MAPK12,Signaling by NTRK1 (TRKA)
MAPK12,Signalling to ERKs
MAPK12,Signaling by VEGF
MAPK12,VEGFA-VEGFR2 Pathway
MAPK12,Negative regulation of MAPK pathway
SCD,NR1H2 and NR1H3-mediated signaling
SCT,Class B/2 (Secretin family receptors)
SCT,G alpha (s) signalling events
SCT,Glucagon-type ligand receptors
SCTR,Class B/2 (Secretin family receptors)
SCTR,G alpha (s) signalling events
SCTR,Glucagon-type ligand receptors
CCL1,Peptide ligand-binding receptors
CCL1,Chemokine receptors bind chemokines
CCL2,Peptide ligand-binding receptors
CCL2,Chemokine receptors bind chemokines
CCL7,Peptide ligand-binding receptors
CCL7,Chemokine receptors bind chemokines
CCL11,Peptide ligand-binding receptors
CCL11,Chemokine receptors bind chemokines
CCL13,Peptide ligand-binding receptors
CCL13,Chemokine receptors bind chemokines
CCL16,Peptide ligand-binding receptors
CCL16,Chemokine receptors bind chemokines
CCL17,Peptide ligand-binding receptors
CCL17,Chemokine receptors bind chemokines
CCL19,Peptide ligand-binding receptors
CCL19,Chemokine receptors bind chemokines
CCL21,Peptide ligand-binding receptors
CCL21,Chemokine receptors bind chemokines
CCL25,Peptide ligand-binding receptors
CCL25,Chemokine receptors bind chemokines
CXCL11,Peptide ligand-binding receptors
CXCL11,Chemokine receptors bind chemokines
XCL1,Peptide ligand-binding receptors
XCL1,Chemokine receptors bind chemokines
CX3CL1,Peptide ligand-binding receptors
CX3CL1,Chemokine receptors bind chemokines
PRDM1,Signaling by ALK
PRDM1,STAT3 nuclear events downstream of ALK signaling
ELMO2,Signaling by VEGF
ELMO2,VEGFA-VEGFR2 Pathway
ELMO2,Signaling by PTK6
ELMO2,Signaling by Non-Receptor Tyrosine Kinases
ELMO2,RHOG GTPase cycle
ELMO2,Parasite infection
ELMO2,Leishmania phagocytosis
ELMO2,FCGR3A-mediated phagocytosis
SEC13,Host Interactions of HIV factors
SEC13,Rev-mediated nuclear export of HIV RNA
SEC13,Transport of Ribonucleoproteins into the Host Nucleus
SEC13,Export of Viral Ribonucleoproteins from Nucleus
SEC13,NS1 Mediated Effects on Host Pathways
SEC13,Viral Messenger RNA Synthesis
SEC13,NEP/NS2 Interacts with the Cellular Export Machinery
SEC13,Interactions of Vpr with host cellular proteins
SEC13,Interactions of Rev with host cellular proteins
SEC13,Nuclear import of Rev protein
SEC13,Vpr-mediated nuclear import of PICs
SEC13,SLC transporter disorders
SEC13,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
SEC13,Disorders of transmembrane transporters
SEC13,RHO GTPases Activate Formins
SEC13,HCMV Infection
SEC13,HCMV Early Events
SEC13,HCMV Late Events
SEC13,SARS-CoV-2 activates/modulates innate and adaptive immune responses
ANO3,Induction of Cell-Cell Fusion
ANO3,Late SARS-CoV-2 Infection Events
SEL1L,Pre-NOTCH Processing in Golgi
SEL1L,Pre-NOTCH Expression and Processing
SEL1L,Hedgehog ligand biogenesis
SEL1L,Hh mutants are degraded by ERAD
SEL1L,Hh mutants abrogate ligand secretion
SEL1L,ABC transporter disorders
SEL1L,Disorders of transmembrane transporters
SEL1L,Defective CFTR causes cystic fibrosis
MCCC2,Defects in vitamin and cofactor metabolism
MCCC2,Diseases of metabolism
BLM,Diseases of DNA repair
BLM,Diseases of DNA Double-Strand Break Repair
BLM,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
BLM,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
BLM,Defective homologous recombination repair (HRR) due to PALB2 loss of function
BLM,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
BLM,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
BLM,Impaired BRCA2 binding to RAD51
BLM,Impaired BRCA2 binding to PALB2
RRAGC,MTOR signalling
RRAGC,mTORC1-mediated signalling
RRAGC,Energy dependent regulation of mTOR by LKB1-AMPK
RRAGC,Regulation of PTEN gene transcription
NOD2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFIH1,SARS-CoV-1-host interactions
IFIH1,SARS-CoV-1 activates/modulates innate immune responses
IFIH1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFIH1,Respiratory Syncytial Virus Infection Pathway
IFIH1,Evasion by RSV of host interferon responses
IFIH1,RSV-host interactions
MAP2K4,Uptake and actions of bacterial toxins
MAP2K4,Bacterial Infection Pathways
DPEP2,Anti-inflammatory response favouring Leishmania parasite infection
DPEP2,Leishmania parasite growth and survival
SFPQ,Signaling by PTK6
SFPQ,Signaling by Non-Receptor Tyrosine Kinases
SFPQ,Infection with Mycobacterium tuberculosis
SFPQ,Response of Mtb to phagocytosis
SFPQ,Bacterial Infection Pathways
MLST8,MTOR signalling
MLST8,mTORC1-mediated signalling
MLST8,Signaling by VEGF
MLST8,PI3K/AKT Signaling in Cancer
MLST8,Energy dependent regulation of mTOR by LKB1-AMPK
MLST8,VEGFA-VEGFR2 Pathway
MLST8,VEGFR2 mediated vascular permeability
MLST8,Constitutive Signaling by AKT1 E17K in Cancer
MLST8,Regulation of PTEN gene transcription
ABCG5,ABC transporter disorders
ABCG5,Disorders of transmembrane transporters
ABCG5,NR1H2 and NR1H3-mediated signaling
ABCG5,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
ABCG8,ABC transporter disorders
ABCG8,Disorders of transmembrane transporters
ABCG8,NR1H2 and NR1H3-mediated signaling
ABCG8,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
CXCR5,Peptide ligand-binding receptors
CXCR5,Chemokine receptors bind chemokines
SOX17,Deactivation of the beta-catenin transactivating complex
TRA2B,RHOBTB2 GTPase cycle
TRA2B,RHOBTB1 GTPase cycle
TRA2B,RHOBTB GTPase Cycle
GREM2,Signaling by BMP
SFTPB,Diseases of metabolism
HHIP,Hedgehog 'on' state
SFTPC,Diseases of metabolism
SFTPD,Diseases of metabolism
SFTPD,SARS-CoV-1-host interactions
SFTPD,SARS-CoV-1 activates/modulates innate immune responses
SFTPD,SARS-CoV-2 activates/modulates innate and adaptive immune responses
ARAP3,RHOA GTPase cycle
ARAP3,RAC3 GTPase cycle
WIPF3,RHO GTPases Activate WASPs and WAVEs
WIPF3,Parasite infection
WIPF3,Leishmania phagocytosis
WIPF3,FCGR3A-mediated phagocytosis
SUDS3,Potential therapeutics for SARS
ITSN1,NRAGE signals death through JNK
ITSN1,p75 NTR receptor-mediated signalling
ITSN1,"Cell death signalling via NRAGE, NRIF and NADE"
ITSN1,G alpha (12/13) signalling events
ITSN1,RHOQ GTPase cycle
ITSN1,RHOG GTPase cycle
SH3GL1,Signaling by EGFR
SH3GL1,EGFR downregulation
SH3GL1,Signaling by MET
SH3GL1,Negative regulation of MET activity
SH3GL1,InlB-mediated entry of Listeria monocytogenes into host cell
SH3GL1,Listeria monocytogenes entry into host cells
SH3GL1,Bacterial Infection Pathways
SH3GL2,Retrograde neurotrophin signalling
SH3GL2,Signaling by EGFR
SH3GL2,EGFR downregulation
SH3GL2,Signaling by NTRK1 (TRKA)
SH3GL2,Signaling by MET
SH3GL2,Negative regulation of MET activity
SH3GL2,InlB-mediated entry of Listeria monocytogenes into host cell
SH3GL2,Listeria monocytogenes entry into host cells
SH3GL2,Bacterial Infection Pathways
SH3GL3,Signaling by EGFR
SH3GL3,EGFR downregulation
SH3GL3,Signaling by NTRK1 (TRKA)
SH3GL3,Nuclear Events (kinase and transcription factor activation)
SH3GL3,Signaling by MET
SH3GL3,Negative regulation of MET activity
SH3GL3,InlB-mediated entry of Listeria monocytogenes into host cell
SH3GL3,Listeria monocytogenes entry into host cells
SH3GL3,NGF-stimulated transcription
SH3GL3,Bacterial Infection Pathways
ALDH8A1,Signaling by Retinoic Acid
ALDH8A1,RA biosynthesis pathway
VPS16,SARS-CoV-2 modulates autophagy
SHB,Signaling by VEGF
SHB,VEGFA-VEGFR2 Pathway
SHC1,Signaling by ERBB2
SHC1,Signaling by ERBB2 in Cancer
SHC1,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
SHC1,Signaling by ERBB4
SHC1,Signaling by EGFR in Cancer
SHC1,Signalling to RAS
SHC1,Signaling by EGFR
SHC1,Signaling by NTRK1 (TRKA)
SHC1,Signalling to ERKs
SHC1,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
SHC1,IGF1R signaling cascade
SHC1,Integrin signaling
SHC1,Constitutive Signaling by EGFRvIII
SHC1,Signaling by EGFRvIII in Cancer
SHC1,Signaling by Ligand-Responsive EGFR Variants in Cancer
SHC1,Insulin receptor signalling cascade
SHC1,Signaling by Insulin receptor
SHC1,Signaling by Erythropoietin
SHC1,Signaling by ERBB2 KD Mutants
SHC1,Signaling by ERBB2 ECD mutants
SHC1,Signaling by ERBB2 TMD/JMD mutants
ANAPC1,Diseases of mitotic cell cycle
ANAPC1,Aberrant regulation of mitotic exit in cancer due to RB1 defects
ANAPC1,Aberrant regulation of mitotic cell cycle due to RB1 defects
SHMT2,RHOG GTPase cycle
SMURF2,Signaling by TGF-beta Receptor Complex
SMURF2,Signaling by BMP
SMURF2,Downregulation of TGF-beta receptor signaling
SMURF2,TGF-beta receptor signaling activates SMADs
SMURF2,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SMURF2,Downregulation of SMAD2/3:SMAD4 transcriptional activity
SMURF2,PCP/CE pathway
SMURF2,Asymmetric localization of PCP proteins
SMURF2,Degradation of AXIN
SMURF2,Hedgehog 'on' state
TNS3,Signaling by MET
TNS3,MET promotes cell motility
ST6GAL1,Translation of Structural Proteins
ST6GAL1,Maturation of spike protein
ST6GAL1,Late SARS-CoV-2 Infection Events
P2RY12,P2Y receptors
P2RY12,Nucleotide-like (purinergic) receptors
ST3GAL1,Translation of Structural Proteins
ST3GAL1,Maturation of spike protein
ST3GAL1,Late SARS-CoV-2 Infection Events
ST3GAL2,Translation of Structural Proteins
ST3GAL2,Maturation of spike protein
ST3GAL2,Late SARS-CoV-2 Infection Events
KLC2,RHO GTPases activate KTN1
ST3GAL4,Pre-NOTCH Processing in Golgi
ST3GAL4,Pre-NOTCH Expression and Processing
ST3GAL4,Translation of Structural Proteins
ST3GAL4,Maturation of spike protein
ST3GAL4,Late SARS-CoV-2 Infection Events
PORCN,WNT ligand biogenesis and trafficking
PORCN,Signaling by WNT in cancer
PLEKHG2,NRAGE signals death through JNK
PLEKHG2,p75 NTR receptor-mediated signalling
PLEKHG2,"Cell death signalling via NRAGE, NRIF and NADE"
PLEKHG2,G alpha (12/13) signalling events
ST3GAL3,Pre-NOTCH Processing in Golgi
ST3GAL3,Pre-NOTCH Expression and Processing
ST3GAL3,Translation of Structural Proteins
ST3GAL3,Maturation of spike protein
ST3GAL3,Late SARS-CoV-2 Infection Events
RASAL3,Regulation of RAS by GAPs
SKI,Signaling by TGF-beta Receptor Complex
SKI,Signaling by BMP
SKI,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SKI,Downregulation of SMAD2/3:SMAD4 transcriptional activity
SKIL,Signaling by TGF-beta Receptor Complex
SKIL,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SKIL,Downregulation of SMAD2/3:SMAD4 transcriptional activity
BMP2,Signaling by BMP
SKP1,Host Interactions of HIV factors
SKP1,Vpu mediated degradation of CD4
SKP1,Degradation of beta-catenin by the destruction complex
SKP1,Signaling by NOTCH1
SKP1,NOTCH1 Intracellular Domain Regulates Transcription
SKP1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
SKP1,Signaling by NOTCH1 in Cancer
SKP1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
SKP1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
SKP1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
SKP1,Degradation of GLI1 by the proteasome
SKP1,Degradation of GLI2 by the proteasome
SKP1,GLI3 is processed to GLI3R by the proteasome
SKP1,Hedgehog 'off' state
SKP1,Signaling by NOTCH4
SKP1,Negative regulation of NOTCH4 signaling
SKP1,Signaling by ALK in cancer
SKP1,Signaling by ALK fusions and activated point mutants
SKP1,Nuclear events stimulated by ALK signaling in cancer
SKP2,Diseases of mitotic cell cycle
SKP2,Aberrant regulation of mitotic exit in cancer due to RB1 defects
SKP2,Aberrant regulation of mitotic cell cycle due to RB1 defects
RTN4R,p75NTR regulates axonogenesis
RTN4R,p75 NTR receptor-mediated signalling
VPS33A,SARS-CoV-2 modulates autophagy
SLC1A5,RHOQ GTPase cycle
SLC1A5,RHOH GTPase cycle
SLC1A5,RHOJ GTPase cycle
SLC1A5,RAC3 GTPase cycle
SLC3A1,SLC transporter disorders
SLC3A1,Disorders of transmembrane transporters
SLC3A2,SLC transporter disorders
SLC3A2,Disorders of transmembrane transporters
NCF1,Signaling by VEGF
NCF1,VEGFA-VEGFR2 Pathway
NCF1,RHO GTPases Activate NADPH Oxidases
NCF1,RAC3 GTPase cycle
SFTPA1,Diseases of metabolism
BMPR1A,Signaling by BMP
BMPR1B,Signaling by BMP
BMPR2,Signaling by BMP
SNAI2,Regulation of PTEN gene transcription
SMARCA4,Formation of the beta-catenin:TCF transactivating complex
SMN1,SARS-CoV-2 modulates host translation machinery
SMO,Class B/2 (Secretin family receptors)
SMO,Hedgehog 'off' state
SMO,Hedgehog 'on' state
SMO,Activation of SMO
SMPD2,p75 NTR receptor-mediated signalling
SMPD2,TNF signaling
SNAI1,Regulation of PTEN gene transcription
SNAP25,Neurotoxicity of clostridium toxins
SNAP25,Uptake and actions of bacterial toxins
SNAP25,Bacterial Infection Pathways
SNRPD2,SARS-CoV-2 modulates host translation machinery
SNRPE,SARS-CoV-2 modulates host translation machinery
SNRPF,SARS-CoV-2 modulates host translation machinery
SNRPG,SARS-CoV-2 modulates host translation machinery
SOD2,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
SOD2,Neurodegenerative Diseases
SOD2,Diseases of programmed cell death
SOD2,Defective Intrinsic Pathway for Apoptosis
SOS1,IRS-mediated signalling
SOS1,Signaling by FGFR in disease
SOS1,Signaling by ERBB2
SOS1,Signaling by ERBB2 in Cancer
SOS1,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
SOS1,Signaling by ERBB4
SOS1,Signaling by SCF-KIT
SOS1,Regulation of KIT signaling
SOS1,Signaling by EGFR in Cancer
SOS1,Signalling to RAS
SOS1,Signaling by EGFR
SOS1,Downstream signal transduction
SOS1,Signaling by PDGF
SOS1,Signaling by NTRK1 (TRKA)
SOS1,Signalling to ERKs
SOS1,Signaling by FGFR
SOS1,NRAGE signals death through JNK
SOS1,p75 NTR receptor-mediated signalling
SOS1,"Cell death signalling via NRAGE, NRIF and NADE"
SOS1,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
SOS1,IGF1R signaling cascade
SOS1,IRS-related events triggered by IGF1R
SOS1,Integrin signaling
SOS1,G alpha (12/13) signalling events
SOS1,Activation of RAC1
SOS1,Constitutive Signaling by EGFRvIII
SOS1,Signaling by EGFRvIII in Cancer
SOS1,Signaling by Ligand-Responsive EGFR Variants in Cancer
SOS1,Downstream signaling of activated FGFR1
SOS1,FRS-mediated FGFR1 signaling
SOS1,Downstream signaling of activated FGFR2
SOS1,SHC-mediated cascade:FGFR2
SOS1,FRS-mediated FGFR2 signaling
SOS1,FRS-mediated FGFR3 signaling
SOS1,Downstream signaling of activated FGFR3
SOS1,FRS-mediated FGFR4 signaling
SOS1,Downstream signaling of activated FGFR4
SOS1,SHC-mediated cascade:FGFR4
SOS1,Signaling by FGFR1
SOS1,Signaling by FGFR2
SOS1,Signaling by FGFR3
SOS1,Signaling by FGFR4
SOS1,Signaling by FGFR2 in disease
SOS1,Signaling by FGFR1 in disease
SOS1,Signaling by FGFR3 in disease
SOS1,Signaling by MET
SOS1,Insulin receptor signalling cascade
SOS1,Signaling by Insulin receptor
SOS1,Signaling by NTRK2 (TRKB)
SOS1,Signaling by Erythropoietin
SOS1,Signaling by NTRK3 (TRKC)
SOS1,Signaling by ERBB2 KD Mutants
SOS1,Signaling by ERBB2 ECD mutants
SOS1,Signaling by ERBB2 TMD/JMD mutants
SOS1,Signaling by KIT in disease
SOS1,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
SOS1,Potential therapeutics for SARS
SOS1,FLT3 signaling in disease
SOS1,Signaling by FLT3 ITD and TKD mutants
SOS2,NRAGE signals death through JNK
SOS2,p75 NTR receptor-mediated signalling
SOS2,"Cell death signalling via NRAGE, NRIF and NADE"
SOS2,G alpha (12/13) signalling events
SOS2,Activation of RAC1
SOX2,Deactivation of the beta-catenin transactivating complex
SOX3,Deactivation of the beta-catenin transactivating complex
SOX4,Deactivation of the beta-catenin transactivating complex
SOX9,Deactivation of the beta-catenin transactivating complex
SP1,Signaling by TGF-beta Receptor Complex
SP1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
SP1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
SP1,Estrogen-dependent gene expression
SP1,SARS-CoV-1-host interactions
SP1,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
SP1,Signaling by TGFBR3
SP1,TGFBR3 expression
DST,RHOU GTPase cycle
DST,RHOV GTPase cycle
DST,RND3 GTPase cycle
DST,RND2 GTPase cycle
DST,RND1 GTPase cycle
SPARC,Signaling by ERBB4
SPARC,Nuclear signaling by ERBB4
SPINT1,Signaling by MET
SPP1,Signaling by PDGF
SPTAN1,RHOU GTPase cycle
SPTAN1,RHOV GTPase cycle
SPTBN1,RHOU GTPase cycle
SPTBN1,RHOV GTPase cycle
BRCA1,Diseases of DNA repair
BRCA1,Diseases of DNA Double-Strand Break Repair
SRF,Signaling by NTRK1 (TRKA)
SRF,Nuclear Events (kinase and transcription factor activation)
SRF,RHO GTPases Activate Formins
SRF,Extra-nuclear estrogen signaling
SRF,NGF-stimulated transcription
SRF,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
SRMS,Signaling by PTK6
SRMS,Signaling by Non-Receptor Tyrosine Kinases
BRAF,Prolonged ERK activation events
BRAF,Signaling by NTRK1 (TRKA)
BRAF,Signalling to ERKs
BRAF,Signaling by FGFR
BRAF,Negative regulation of FGFR1 signaling
BRAF,Negative regulation of FGFR2 signaling
BRAF,Negative regulation of FGFR3 signaling
BRAF,Negative regulation of FGFR4 signaling
BRAF,Signaling by FGFR1
BRAF,Signaling by FGFR2
BRAF,Signaling by FGFR3
BRAF,Signaling by FGFR4
BRAF,Paradoxical activation of RAF signaling by kinase inactive BRAF
BRAF,Oncogenic MAPK signaling
SRPK1,Maturation of nucleoprotein
SRPK1,Translation of Structural Proteins
SRPK1,Late SARS-CoV-2 Infection Events
SRPK2,Maturation of nucleoprotein
SRPK2,Translation of Structural Proteins
SRPK2,Late SARS-CoV-2 Infection Events
SRY,Deactivation of the beta-catenin transactivating complex
SSRP1,Formation of HIV elongation complex in the absence of HIV Tat
SSRP1,HIV Transcription Elongation
SSRP1,Transcription of the HIV genome
SSRP1,Formation of HIV-1 elongation complex containing HIV-1 Tat
SSRP1,Pausing and recovery of Tat-mediated HIV elongation
SSRP1,Tat-mediated HIV elongation arrest and recovery
SSRP1,Tat-mediated elongation of the HIV-1 transcript
SSRP1,HIV elongation arrest and recovery
SSRP1,Pausing and recovery of HIV elongation
STAT1,Signaling by FGFR in disease
STAT1,Signaling by SCF-KIT
STAT1,FGFR1 mutant receptor activation
STAT1,Downstream signal transduction
STAT1,Signaling by PDGF
STAT1,Signaling by FGFR1 in disease
STAT1,Signaling by KIT in disease
STAT1,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
STAT1,Signaling by ALK in cancer
STAT1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
STAT1,Signaling by ALK fusions and activated point mutants
STAT2,Potential therapeutics for SARS
STAT2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
STAT2,Respiratory Syncytial Virus Infection Pathway
STAT2,Evasion by RSV of host interferon responses
STAT2,RSV-host interactions
STAT3,Signaling by FGFR in disease
STAT3,Signaling by SCF-KIT
STAT3,FGFR1 mutant receptor activation
STAT3,Downstream signal transduction
STAT3,Signaling by PDGF
STAT3,Signaling by NTRK1 (TRKA)
STAT3,Signaling by ALK
STAT3,Signaling by FGFR1 in disease
STAT3,Signaling by MET
STAT3,Signaling by PTK6
STAT3,Signaling by Non-Receptor Tyrosine Kinases
STAT3,Signaling by KIT in disease
STAT3,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
STAT3,Signaling by ALK in cancer
STAT3,Signaling by ALK fusions and activated point mutants
STAT5A,Signaling by FGFR in disease
STAT5A,Signaling by SCF-KIT
STAT5A,FGFR1 mutant receptor activation
STAT5A,Downstream signal transduction
STAT5A,Signaling by PDGF
STAT5A,Signaling by FGFR1 in disease
STAT5A,Signaling by Erythropoietin
STAT5A,Signaling by KIT in disease
STAT5A,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
STAT5A,FLT3 signaling in disease
STAT5A,Signaling by ALK in cancer
STAT5A,Signaling by FLT3 ITD and TKD mutants
STAT5A,Signaling by ALK fusions and activated point mutants
STAT5A,Nuclear events stimulated by ALK signaling in cancer
STAT5B,Signaling by FGFR in disease
STAT5B,Signaling by SCF-KIT
STAT5B,FGFR1 mutant receptor activation
STAT5B,Downstream signal transduction
STAT5B,Signaling by PDGF
STAT5B,Signaling by FGFR1 in disease
STAT5B,Signaling by Erythropoietin
STAT5B,Signaling by KIT in disease
STAT5B,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
STAT5B,FLT3 signaling in disease
STAT5B,Signaling by FLT3 ITD and TKD mutants
STAT6,Downstream signal transduction
STAT6,Signaling by PDGF
STK10,RHOA GTPase cycle
STK10,RHOB GTPase cycle
STK10,RHOC GTPase cycle
STK11,MTOR signalling
STK11,Energy dependent regulation of mTOR by LKB1-AMPK
STRN,Negative regulation of the PI3K/AKT network
STRN,PI3K/AKT Signaling in Cancer
STRN,Constitutive Signaling by Aberrant PI3K in Cancer
STRN,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
STRN,Extra-nuclear estrogen signaling
STX1A,Neurotoxicity of clostridium toxins
STX1A,Uptake and actions of bacterial toxins
STX1A,Bacterial Infection Pathways
STX5,RHOA GTPase cycle
STX5,RHOC GTPase cycle
STX5,RHOG GTPase cycle
BSG,SLC transporter disorders
BSG,Disorders of transmembrane transporters
SUPT4H1,Formation of HIV elongation complex in the absence of HIV Tat
SUPT4H1,Formation of the HIV-1 Early Elongation Complex
SUPT4H1,HIV Transcription Elongation
SUPT4H1,Transcription of the HIV genome
SUPT4H1,Formation of HIV-1 elongation complex containing HIV-1 Tat
SUPT4H1,Pausing and recovery of Tat-mediated HIV elongation
SUPT4H1,Abortive elongation of HIV-1 transcript in the absence of Tat
SUPT4H1,Tat-mediated HIV elongation arrest and recovery
SUPT4H1,Tat-mediated elongation of the HIV-1 transcript
SUPT4H1,HIV elongation arrest and recovery
SUPT4H1,Pausing and recovery of HIV elongation
MED22,Respiratory Syncytial Virus Infection Pathway
MED22,RSV-host interactions
BST2,SARS-CoV-1-host interactions
BST2,SARS-CoV-1 activates/modulates innate immune responses
VAMP1,Neurotoxicity of clostridium toxins
VAMP1,Uptake and actions of bacterial toxins
VAMP1,Bacterial Infection Pathways
VAMP2,Neurotoxicity of clostridium toxins
VAMP2,Uptake and actions of bacterial toxins
VAMP2,Bacterial Infection Pathways
XCL2,Peptide ligand-binding receptors
XCL2,Chemokine receptors bind chemokines
SYK,Integrin signaling
SYK,Anti-inflammatory response favouring Leishmania parasite infection
SYK,FCGR3A-mediated IL10 synthesis
SYK,Parasite infection
SYK,Leishmania phagocytosis
SYK,FCGR3A-mediated phagocytosis
SYK,Leishmania parasite growth and survival
SYT1,Neurotoxicity of clostridium toxins
SYT1,Uptake and actions of bacterial toxins
SYT1,Bacterial Infection Pathways
ADAM17,Signaling by ERBB4
ADAM17,Nuclear signaling by ERBB4
ADAM17,Signaling by EGFR
ADAM17,Signaling by NOTCH1
ADAM17,Activated NOTCH1 Transmits Signal to the Nucleus
ADAM17,Signaling by NOTCH1 PEST Domain Mutants in Cancer
ADAM17,Signaling by NOTCH1 in Cancer
ADAM17,Constitutive Signaling by NOTCH1 PEST Domain Mutants
ADAM17,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
ADAM17,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
ADAM17,Hedgehog ligand biogenesis
ADAM17,TNF signaling
ADAM17,Anti-inflammatory response favouring Leishmania parasite infection
ADAM17,Leishmania parasite growth and survival
TAF1,HIV Transcription Initiation
TAF1,RNA Polymerase II HIV Promoter Escape
TAF1,Transcription of the HIV genome
TAF2,HIV Transcription Initiation
TAF2,RNA Polymerase II HIV Promoter Escape
TAF2,Transcription of the HIV genome
TAF4,HIV Transcription Initiation
TAF4,RNA Polymerase II HIV Promoter Escape
TAF4,Transcription of the HIV genome
TAF4B,HIV Transcription Initiation
TAF4B,RNA Polymerase II HIV Promoter Escape
TAF4B,Transcription of the HIV genome
TAF5,HIV Transcription Initiation
TAF5,RNA Polymerase II HIV Promoter Escape
TAF5,Transcription of the HIV genome
TAF6,HIV Transcription Initiation
TAF6,RNA Polymerase II HIV Promoter Escape
TAF6,Transcription of the HIV genome
TAF7,HIV Transcription Initiation
TAF7,RNA Polymerase II HIV Promoter Escape
TAF7,Transcription of the HIV genome
TAF9,HIV Transcription Initiation
TAF9,RNA Polymerase II HIV Promoter Escape
TAF9,Transcription of the HIV genome
TAF10,HIV Transcription Initiation
TAF10,RNA Polymerase II HIV Promoter Escape
TAF10,Transcription of the HIV genome
TAF11,HIV Transcription Initiation
TAF11,RNA Polymerase II HIV Promoter Escape
TAF11,Transcription of the HIV genome
TAF12,HIV Transcription Initiation
TAF12,RNA Polymerase II HIV Promoter Escape
TAF12,Transcription of the HIV genome
TAF13,HIV Transcription Initiation
TAF13,RNA Polymerase II HIV Promoter Escape
TAF13,Transcription of the HIV genome
MAP3K7,Ca2+ pathway
MAP3K7,TNFR1-induced NF-kappa-B signaling pathway
MAP3K7,TNF signaling
MAP3K7,SARS-CoV-2 activates/modulates innate and adaptive immune responses
TBL1X,Signaling by NOTCH1
TBL1X,NOTCH1 Intracellular Domain Regulates Transcription
TBL1X,Signaling by NOTCH1 PEST Domain Mutants in Cancer
TBL1X,Signaling by NOTCH1 in Cancer
TBL1X,Constitutive Signaling by NOTCH1 PEST Domain Mutants
TBL1X,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
TBL1X,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
TBL1X,Loss of function of MECP2 in Rett syndrome
TBL1X,Pervasive developmental disorders
TBL1X,NR1H2 and NR1H3-mediated signaling
TBL1X,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
TBL1X,HCMV Infection
TBL1X,HCMV Early Events
TBL1X,Disorders of Developmental Biology
TBL1X,Disorders of Nervous System Development
TBP,HIV Transcription Initiation
TBP,RNA Polymerase II HIV Promoter Escape
TBP,Transcription of the HIV genome
TBP,Estrogen-dependent gene expression
TBXA2R,Eicosanoid ligand-binding receptors
TBXA2R,G alpha (12/13) signalling events
TCEA1,Formation of HIV elongation complex in the absence of HIV Tat
TCEA1,HIV Transcription Elongation
TCEA1,Transcription of the HIV genome
TCEA1,Formation of HIV-1 elongation complex containing HIV-1 Tat
TCEA1,Pausing and recovery of Tat-mediated HIV elongation
TCEA1,Tat-mediated HIV elongation arrest and recovery
TCEA1,Tat-mediated elongation of the HIV-1 transcript
TCEA1,HIV elongation arrest and recovery
TCEA1,Pausing and recovery of HIV elongation
TCF4,Signaling by TGFBR3
TCF4,TGFBR3 expression
TCF7,Degradation of beta-catenin by the destruction complex
TCF7,Formation of the beta-catenin:TCF transactivating complex
TCF7,Deactivation of the beta-catenin transactivating complex
TCF7,Ca2+ pathway
TCF7,Repression of WNT target genes
TCF7L2,Degradation of beta-catenin by the destruction complex
TCF7L2,Formation of the beta-catenin:TCF transactivating complex
TCF7L2,Deactivation of the beta-catenin transactivating complex
TCF7L2,Ca2+ pathway
TCF7L2,Repression of WNT target genes
TCF12,Signaling by NTRK1 (TRKA)
TCF12,Nuclear Events (kinase and transcription factor activation)
TCF12,NGF-stimulated transcription
TCF12,Signaling by TGFBR3
TCF12,TGFBR3 expression
TCN2,Defects in vitamin and cofactor metabolism
TCN2,Diseases of metabolism
BTK,G-protein beta:gamma signalling
BTK,G alpha (12/13) signalling events
BTK,Diseases of Immune System
BTK,Diseases associated with the TLR signaling cascade
BTK,RHO GTPases Activate WASPs and WAVEs
BTK,G beta:gamma signalling through BTK
BTK,Parasite infection
BTK,Leishmania phagocytosis
BTK,FCGR3A-mediated phagocytosis
BTK,Potential therapeutics for SARS
ACTC1,RHOA GTPase cycle
ACTC1,RHOB GTPase cycle
PRDX2,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
PRDX2,Neurodegenerative Diseases
PRDX2,Diseases of programmed cell death
PRDX2,Defective Intrinsic Pathway for Apoptosis
TEC,Signaling by SCF-KIT
TERT,Formation of the beta-catenin:TCF transactivating complex
TFDP1,Signaling by TGF-beta Receptor Complex
TFDP1,Pre-NOTCH Transcription and Translation
TFDP1,Pre-NOTCH Expression and Processing
TFDP1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TFDP1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
TFDP1,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
TFDP1,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
TFDP1,Diseases of mitotic cell cycle
TFDP1,Aberrant regulation of mitotic cell cycle due to RB1 defects
TFDP2,Signaling by TGF-beta Receptor Complex
TFDP2,Pre-NOTCH Transcription and Translation
TFDP2,Pre-NOTCH Expression and Processing
TFDP2,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TFDP2,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
TFDP2,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
TFDP2,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
TFDP2,Diseases of mitotic cell cycle
TFDP2,Aberrant regulation of mitotic cell cycle due to RB1 defects
TFF1,Estrogen-dependent gene expression
TFF3,Estrogen-dependent gene expression
TGFB1,Signaling by TGF-beta Receptor Complex
TGFB1,Downregulation of TGF-beta receptor signaling
TGFB1,TGF-beta receptor signaling activates SMADs
TGFB1,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
TGFB1,Signaling by TGFBR3
TGFB2,Signaling by TGF-beta Receptor Complex
TGFB2,TGF-beta receptor signaling activates SMADs
TGFB2,Signaling by TGFBR3
TGFB3,Signaling by TGF-beta Receptor Complex
TGFB3,TGF-beta receptor signaling activates SMADs
TGFBR1,Signaling by TGF-beta Receptor Complex
TGFBR1,Downregulation of TGF-beta receptor signaling
TGFBR1,TGF-beta receptor signaling activates SMADs
TGFBR1,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
TGFBR1,Signaling by TGFBR3
TGFBR2,Signaling by TGF-beta Receptor Complex
TGFBR2,Downregulation of TGF-beta receptor signaling
TGFBR2,TGF-beta receptor signaling activates SMADs
TGFBR2,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
TGFBR2,Signaling by TGFBR3
TGFBR3,Signaling by TGFBR3
TGFBR3,TGFBR3 expression
TGIF1,Signaling by TGF-beta Receptor Complex
TGIF1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
TGIF1,Downregulation of SMAD2/3:SMAD4 transcriptional activity
TGIF1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
THBS1,Signaling by PDGF
THBS2,Signaling by PDGF
THBS3,Signaling by PDGF
THBS4,Signaling by PDGF
TIA1,Signaling by FGFR
TIA1,Signaling by FGFR2
TIA1,FGFR2 alternative splicing
TIAL1,Signaling by FGFR
TIAL1,Signaling by FGFR2
TIAL1,FGFR2 alternative splicing
TIAM1,NRAGE signals death through JNK
TIAM1,p75 NTR receptor-mediated signalling
TIAM1,"Cell death signalling via NRAGE, NRIF and NADE"
TIAM1,G alpha (12/13) signalling events
TIAM1,RHOA GTPase cycle
TIAM1,Signaling by NTRK2 (TRKB)
TIAM1,RAC2 GTPase cycle
TIAM1,RAC3 GTPase cycle
TIMP1,Signaling by TGFBR3
TIMP2,Signaling by TGFBR3
C1QBP,RHOA GTPase cycle
C1QBP,RHOC GTPase cycle
C1QBP,Diseases of programmed cell death
C1QBP,Defective Intrinsic Pathway for Apoptosis
TJP1,Signaling by Hippo
TLE1,Degradation of beta-catenin by the destruction complex
TLE1,Signaling by NOTCH1
TLE1,Formation of the beta-catenin:TCF transactivating complex
TLE1,NOTCH1 Intracellular Domain Regulates Transcription
TLE1,Deactivation of the beta-catenin transactivating complex
TLE1,Repression of WNT target genes
TLE2,Degradation of beta-catenin by the destruction complex
TLE2,Signaling by NOTCH1
TLE2,Formation of the beta-catenin:TCF transactivating complex
TLE2,NOTCH1 Intracellular Domain Regulates Transcription
TLE2,Deactivation of the beta-catenin transactivating complex
TLE2,Repression of WNT target genes
TLE3,Degradation of beta-catenin by the destruction complex
TLE3,Formation of the beta-catenin:TCF transactivating complex
TLE3,Deactivation of the beta-catenin transactivating complex
TLE3,Repression of WNT target genes
TLE3,Estrogen-dependent gene expression
TLE4,Degradation of beta-catenin by the destruction complex
TLE4,Signaling by NOTCH1
TLE4,Formation of the beta-catenin:TCF transactivating complex
TLE4,NOTCH1 Intracellular Domain Regulates Transcription
TLE4,Deactivation of the beta-catenin transactivating complex
TLE4,Repression of WNT target genes
TLN1,Integrin signaling
TLN1,p130Cas linkage to MAPK signaling for integrins
TLN1,MAP2K and MAPK activation
TLN1,Signaling by moderate kinase activity BRAF mutants
TLN1,Signaling by high-kinase activity BRAF mutants
TLN1,Signaling by RAS mutants
TLN1,Signaling by BRAF and RAF1 fusions
TLN1,Paradoxical activation of RAF signaling by kinase inactive BRAF
TLN1,Oncogenic MAPK signaling
TLN1,Signaling downstream of RAS mutants
TLN1,Signaling by RAF1 mutants
TLR1,Diseases of Immune System
TLR1,Diseases associated with the TLR signaling cascade
TLR1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
TLR2,Diseases of Immune System
TLR2,Diseases associated with the TLR signaling cascade
TLR2,Infection with Mycobacterium tuberculosis
TLR2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
TLR2,Respiratory Syncytial Virus Infection Pathway
TLR2,Bacterial Infection Pathways
TLR2,RSV-host interactions
TLR3,Diseases of Immune System
TLR3,Diseases associated with the TLR signaling cascade
TLR3,Respiratory Syncytial Virus Infection Pathway
TLR3,RSV-host interactions
ACTG1,Signaling by VEGF
ACTG1,VEGFA-VEGFR2 Pathway
ACTG1,RHO GTPases activate IQGAPs
ACTG1,RHO GTPases Activate WASPs and WAVEs
ACTG1,RHO GTPases Activate Formins
ACTG1,MAP2K and MAPK activation
ACTG1,Signaling by moderate kinase activity BRAF mutants
ACTG1,Signaling by high-kinase activity BRAF mutants
ACTG1,Signaling by RAS mutants
ACTG1,Signaling by BRAF and RAF1 fusions
ACTG1,Paradoxical activation of RAF signaling by kinase inactive BRAF
ACTG1,Oncogenic MAPK signaling
ACTG1,RHOBTB2 GTPase cycle
ACTG1,Signaling downstream of RAS mutants
ACTG1,Signaling by RAF1 mutants
ACTG1,Parasite infection
ACTG1,Leishmania phagocytosis
ACTG1,FCGR3A-mediated phagocytosis
ACTG1,RHOBTB GTPase Cycle
TLR5,Diseases of Immune System
TLR5,Diseases associated with the TLR signaling cascade
NR2E1,Regulation of PTEN gene transcription
TMPO,RHOA GTPase cycle
TMPO,RHOC GTPase cycle
TMPO,RAC2 GTPase cycle
TMPO,RHOD GTPase cycle
TMPO,RHOG GTPase cycle
TMPO,RHOJ GTPase cycle
TMPO,RAC3 GTPase cycle
TMPO,RHOF GTPase cycle
TMPRSS2,Induction of Cell-Cell Fusion
TMPRSS2,Early SARS-CoV-2 Infection Events
TMPRSS2,Late SARS-CoV-2 Infection Events
TNFAIP1,RND3 GTPase cycle
TNFAIP1,RND2 GTPase cycle
TNFAIP3,TNFR1-induced proapoptotic signaling
TNFAIP3,Regulation of TNFR1 signaling
TNFAIP3,TNFR1-induced NF-kappa-B signaling pathway
TNFAIP3,TNF signaling
TOP3A,Diseases of DNA repair
TOP3A,Diseases of DNA Double-Strand Break Repair
TOP3A,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
TOP3A,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
TOP3A,Defective homologous recombination repair (HRR) due to PALB2 loss of function
TOP3A,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
TOP3A,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
TOP3A,Impaired BRCA2 binding to RAD51
TOP3A,Impaired BRCA2 binding to PALB2
TP53,Pre-NOTCH Transcription and Translation
TP53,Pre-NOTCH Expression and Processing
TP53,Regulation of PTEN gene transcription
TPH1,Signaling by NTRK1 (TRKA)
TPH1,Nuclear Events (kinase and transcription factor activation)
TPH1,NGF-stimulated transcription
TPM3,RHOV GTPase cycle
TPM4,RHOV GTPase cycle
TPR,Host Interactions of HIV factors
TPR,Rev-mediated nuclear export of HIV RNA
TPR,Transport of Ribonucleoproteins into the Host Nucleus
TPR,Export of Viral Ribonucleoproteins from Nucleus
TPR,NS1 Mediated Effects on Host Pathways
TPR,Viral Messenger RNA Synthesis
TPR,NEP/NS2 Interacts with the Cellular Export Machinery
TPR,Interactions of Vpr with host cellular proteins
TPR,Interactions of Rev with host cellular proteins
TPR,Nuclear import of Rev protein
TPR,Vpr-mediated nuclear import of PICs
TPR,HCMV Infection
TPR,HCMV Early Events
TPR,HCMV Late Events
TPR,SARS-CoV-2 activates/modulates innate and adaptive immune responses
TRAF1,Regulation of TNFR1 signaling
TRAF1,TNFR1-induced NF-kappa-B signaling pathway
TRAF1,TNF signaling
TRAF2,TNFR1-induced proapoptotic signaling
TRAF2,Regulation of TNFR1 signaling
TRAF2,TNFR1-induced NF-kappa-B signaling pathway
TRAF2,TNF signaling
TRAF2,Diseases of programmed cell death
TRAF6,p75NTR signals via NF-kB
TRAF6,p75 NTR receptor-mediated signalling
TRAF6,Negative regulation of the PI3K/AKT network
TRAF6,"Cell death signalling via NRAGE, NRIF and NADE"
TRAF6,NRIF signals cell death from the nucleus
TRAF6,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
TRAF6,SARS-CoV-1-host interactions
TRAF6,SARS-CoV-1 activates/modulates innate immune responses
C3AR1,Peptide ligand-binding receptors
C3AR1,Purinergic signaling in leishmaniasis infection
C3AR1,Cell recruitment (pro-inflammatory response)
TRIO,NRAGE signals death through JNK
TRIO,p75 NTR receptor-mediated signalling
TRIO,"Cell death signalling via NRAGE, NRIF and NADE"
TRIO,G alpha (12/13) signalling events
TRIO,RHOA GTPase cycle
TRIO,RAC2 GTPase cycle
TRIO,RHOG GTPase cycle
TRIO,RHOJ GTPase cycle
TRIO,RAC3 GTPase cycle
TRPC6,Effects of PIP2 hydrolysis
TSC1,MTOR signalling
TSC1,Energy dependent regulation of mTOR by LKB1-AMPK
TSC2,MTOR signalling
TSC2,AKT phosphorylates targets in the cytosol
TSC2,PI3K/AKT Signaling in Cancer
TSC2,Energy dependent regulation of mTOR by LKB1-AMPK
TSC2,Constitutive Signaling by AKT1 E17K in Cancer
TSG101,Budding and maturation of HIV virion
TSG101,Assembly Of The HIV Virion
TSG101,HCMV Infection
TSG101,HCMV Late Events
TUBA4A,Hedgehog 'off' state
TUBA4A,RHO GTPases activate IQGAPs
TUBA4A,RHO GTPases Activate Formins
TUBA4A,HCMV Infection
TUBA4A,HCMV Early Events
TUBA3C,Hedgehog 'off' state
TUBA3C,RHO GTPases activate IQGAPs
TUBA3C,RHO GTPases Activate Formins
TUBA3C,HCMV Infection
TUBA3C,HCMV Early Events
TUBB2A,Hedgehog 'off' state
TUBB2A,RHO GTPases activate IQGAPs
TUBB2A,RHO GTPases Activate Formins
TUBB2A,HCMV Infection
TUBB2A,HCMV Early Events
TUFM,SARS-CoV-2 modulates autophagy
TULP3,Hedgehog 'off' state
TWIST1,Signaling by ALK in cancer
TWIST1,Signaling by ALK fusions and activated point mutants
TWIST1,Nuclear events stimulated by ALK signaling in cancer
CCR2,Peptide ligand-binding receptors
CCR2,Chemokine receptors bind chemokines
SFTPA2,Diseases of metabolism
TXN,Purinergic signaling in leishmaniasis infection
TXN,Cell recruitment (pro-inflammatory response)
TXNRD1,Uptake and actions of bacterial toxins
TXNRD1,Bacterial Infection Pathways
TYK2,Potential therapeutics for SARS
TYK2,Signaling by ALK in cancer
TYK2,Signaling by ALK fusions and activated point mutants
UBE2D1,Signaling by TGF-beta Receptor Complex
UBE2D1,Signaling by BMP
UBE2D1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
UBE2D1,Downregulation of SMAD2/3:SMAD4 transcriptional activity
UBE2D1,Diseases of mitotic cell cycle
UBE2D1,Aberrant regulation of mitotic exit in cancer due to RB1 defects
UBE2D1,Aberrant regulation of mitotic cell cycle due to RB1 defects
UBE2D3,Signaling by TGF-beta Receptor Complex
UBE2D3,Signaling by BMP
UBE2D3,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
UBE2D3,Downregulation of SMAD2/3:SMAD4 transcriptional activity
UBE2E1,Diseases of mitotic cell cycle
UBE2E1,Aberrant regulation of mitotic exit in cancer due to RB1 defects
UBE2E1,Aberrant regulation of mitotic cell cycle due to RB1 defects
UBE2I,Maturation of nucleoprotein
UBE2I,Translation of Structural Proteins
UBE2I,SARS-CoV-1-host interactions
UBE2I,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
UBE2I,Late SARS-CoV-2 Infection Events
UBE2N,SARS-CoV-2 activates/modulates innate and adaptive immune responses
USP4,TNFR1-induced proapoptotic signaling
USP4,Regulation of TNFR1 signaling
USP4,TNFR1-induced NF-kappa-B signaling pathway
USP4,TNF signaling
NR1H2,NR1H2 and NR1H3-mediated signaling
NR1H2,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
USF1,Estrogen-dependent gene expression
USF2,Estrogen-dependent gene expression
UVRAG,Translation of Replicase and Assembly of the Replication Transcription Complex
UVRAG,SARS-CoV-2 modulates autophagy
UVRAG,Early SARS-CoV-2 Infection Events
VAV1,Signaling by SCF-KIT
VAV1,NRAGE signals death through JNK
VAV1,p75 NTR receptor-mediated signalling
VAV1,Signaling by VEGF
VAV1,Negative regulation of the PI3K/AKT network
VAV1,"Cell death signalling via NRAGE, NRIF and NADE"
VAV1,PI3K/AKT Signaling in Cancer
VAV1,Constitutive Signaling by Aberrant PI3K in Cancer
VAV1,G alpha (12/13) signalling events
VAV1,VEGFA-VEGFR2 Pathway
VAV1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
VAV1,RHOA GTPase cycle
VAV1,Signaling by Erythropoietin
VAV1,RAC2 GTPase cycle
VAV1,RHOG GTPase cycle
VAV1,Parasite infection
VAV1,Leishmania phagocytosis
VAV1,FCGR3A-mediated phagocytosis
VAV1,Potential therapeutics for SARS
VAV2,NRAGE signals death through JNK
VAV2,p75 NTR receptor-mediated signalling
VAV2,Signaling by VEGF
VAV2,"Cell death signalling via NRAGE, NRIF and NADE"
VAV2,G alpha (12/13) signalling events
VAV2,VEGFA-VEGFR2 Pathway
VAV2,RHOA GTPase cycle
VAV2,RHOB GTPase cycle
VAV2,RHOC GTPase cycle
VAV2,RAC2 GTPase cycle
VAV2,RHOG GTPase cycle
VAV2,RAC3 GTPase cycle
VAV2,Parasite infection
VAV2,Leishmania phagocytosis
VAV2,FCGR3A-mediated phagocytosis
VCL,MAP2K and MAPK activation
VCL,Signaling by moderate kinase activity BRAF mutants
VCL,Signaling by high-kinase activity BRAF mutants
VCL,Signaling by RAS mutants
VCL,Signaling by BRAF and RAF1 fusions
VCL,Paradoxical activation of RAF signaling by kinase inactive BRAF
VCL,Oncogenic MAPK signaling
VCL,Signaling downstream of RAS mutants
VCL,Signaling by RAF1 mutants
VCP,Hedgehog ligand biogenesis
VCP,Hh mutants are degraded by ERAD
VCP,Hh mutants abrogate ligand secretion
VCP,ABC transporter disorders
VCP,Disorders of transmembrane transporters
VCP,Defective CFTR causes cystic fibrosis
VCP,RHOH GTPase cycle
VCP,Early SARS-CoV-2 Infection Events
VEGFA,Signaling by VEGF
VEGFB,Signaling by VEGF
VEGFC,Signaling by VEGF
VGF,Signaling by NTRK1 (TRKA)
VGF,Nuclear Events (kinase and transcription factor activation)
VGF,NGF-stimulated transcription
VHL,RHOBTB3 ATPase cycle
VHL,Early SARS-CoV-2 Infection Events
VIM,RHOBTB1 GTPase cycle
VIM,RHOBTB GTPase Cycle
VIPR1,Class B/2 (Secretin family receptors)
VIPR1,G alpha (s) signalling events
VIPR1,Glucagon-type ligand receptors
VIPR2,Class B/2 (Secretin family receptors)
VIPR2,G alpha (s) signalling events
VIPR2,Glucagon-type ligand receptors
VRK2,RAC2 GTPase cycle
VRK2,RHOD GTPase cycle
VRK2,RHOG GTPase cycle
VRK2,RAC3 GTPase cycle
WAS,RHO GTPases Activate WASPs and WAVEs
WAS,RHOJ GTPase cycle
WAS,Parasite infection
WAS,Leishmania phagocytosis
WAS,FCGR3A-mediated phagocytosis
WIPF1,RHO GTPases Activate WASPs and WAVEs
WIPF1,Parasite infection
WIPF1,Leishmania phagocytosis
WIPF1,FCGR3A-mediated phagocytosis
DAGLA,Effects of PIP2 hydrolysis
WNT1,WNT ligand biogenesis and trafficking
WNT1,Class B/2 (Secretin family receptors)
WNT2,WNT ligand biogenesis and trafficking
WNT2,Class B/2 (Secretin family receptors)
WNT3,WNT ligand biogenesis and trafficking
WNT3,Class B/2 (Secretin family receptors)
WNT5A,Class B/2 (Secretin family receptors)
WNT6,WNT ligand biogenesis and trafficking
WNT6,Class B/2 (Secretin family receptors)
WNT7A,WNT ligand biogenesis and trafficking
WNT7A,Class B/2 (Secretin family receptors)
WNT7B,WNT ligand biogenesis and trafficking
WNT8A,WNT ligand biogenesis and trafficking
WNT8A,Class B/2 (Secretin family receptors)
WNT8B,WNT ligand biogenesis and trafficking
WNT8B,Class B/2 (Secretin family receptors)
WNT10B,WNT ligand biogenesis and trafficking
WNT10B,Class B/2 (Secretin family receptors)
WNT11,WNT ligand biogenesis and trafficking
WNT11,Class B/2 (Secretin family receptors)
WNT9A,WNT ligand biogenesis and trafficking
WNT9A,Class B/2 (Secretin family receptors)
WNT9B,WNT ligand biogenesis and trafficking
WNT9B,Class B/2 (Secretin family receptors)
WRN,Diseases of DNA repair
WRN,Diseases of DNA Double-Strand Break Repair
WRN,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
WRN,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
WRN,Defective homologous recombination repair (HRR) due to PALB2 loss of function
WRN,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
WRN,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
WRN,Impaired BRCA2 binding to RAD51
WRN,Impaired BRCA2 binding to PALB2
XPO1,Host Interactions of HIV factors
XPO1,Rev-mediated nuclear export of HIV RNA
XPO1,Export of Viral Ribonucleoproteins from Nucleus
XPO1,NEP/NS2 Interacts with the Cellular Export Machinery
XPO1,Signaling by TGF-beta Receptor Complex
XPO1,Interactions of Rev with host cellular proteins
XPO1,Downregulation of TGF-beta receptor signaling
XPO1,TGF-beta receptor signaling activates SMADs
XPO1,Deactivation of the beta-catenin transactivating complex
XPO1,RHO GTPases Activate Formins
XPO1,MAPK6/MAPK4 signaling
XPO1,Extra-nuclear estrogen signaling
XPO1,Estrogen-dependent nuclear events downstream of ESR-membrane signaling
XPO1,Respiratory Syncytial Virus Infection Pathway
XPO1,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
XPO1,Maturation of hRSV A proteins
XRCC2,Diseases of DNA repair
XRCC2,Diseases of DNA Double-Strand Break Repair
XRCC2,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
XRCC2,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
XRCC2,Defective homologous recombination repair (HRR) due to PALB2 loss of function
XRCC2,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
XRCC2,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
XRCC2,Impaired BRCA2 binding to PALB2
XRCC4,Early Phase of HIV Life Cycle
XRCC5,Early Phase of HIV Life Cycle
YES1,Signaling by SCF-KIT
YES1,Regulation of KIT signaling
YES1,Anti-inflammatory response favouring Leishmania parasite infection
YES1,FCGR3A-mediated IL10 synthesis
YES1,Parasite infection
YES1,Leishmania phagocytosis
YES1,FCGR3A-mediated phagocytosis
YES1,Leishmania parasite growth and survival
YES1,Signaling by KIT in disease
YES1,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
YY1,Estrogen-dependent gene expression
YWHAB,MTOR signalling
YWHAB,mTORC1-mediated signalling
YWHAB,Prolonged ERK activation events
YWHAB,Frs2-mediated activation
YWHAB,Signaling by NTRK1 (TRKA)
YWHAB,Signalling to ERKs
YWHAB,Signaling by Hippo
YWHAB,RHO GTPases activate PKNs
YWHAB,RAF activation
YWHAB,MAP2K and MAPK activation
YWHAB,Negative regulation of MAPK pathway
YWHAB,Signaling by moderate kinase activity BRAF mutants
YWHAB,Signaling by high-kinase activity BRAF mutants
YWHAB,Signaling by RAS mutants
YWHAB,Signaling by BRAF and RAF1 fusions
YWHAB,Paradoxical activation of RAF signaling by kinase inactive BRAF
YWHAB,Oncogenic MAPK signaling
YWHAB,Signaling downstream of RAS mutants
YWHAB,Signaling by RAF1 mutants
YWHAB,SARS-CoV-1-host interactions
YWHAB,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
YWHAE,p75 NTR receptor-mediated signalling
YWHAE,Signaling by Hippo
YWHAE,"Cell death signalling via NRAGE, NRIF and NADE"
YWHAE,RHO GTPases activate PKNs
YWHAE,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
YWHAE,Neurodegenerative Diseases
YWHAE,Diseases of programmed cell death
YWHAE,SARS-CoV-1-host interactions
YWHAE,Defective Intrinsic Pathway for Apoptosis
YWHAE,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
YWHAG,RHO GTPases activate PKNs
YWHAG,SARS-CoV-1-host interactions
YWHAG,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
YWHAH,RHO GTPases activate PKNs
YWHAH,SARS-CoV-1-host interactions
YWHAH,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
YWHAZ,Deactivation of the beta-catenin transactivating complex
YWHAZ,RHO GTPases activate PKNs
YWHAZ,Signaling by NOTCH4
YWHAZ,Negative regulation of NOTCH4 signaling
YWHAZ,SARS-CoV-1-host interactions
YWHAZ,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
ZAP70,RHOH GTPase cycle
ZAP70,Signaling by ALK in cancer
ZAP70,Signaling by ALK fusions and activated point mutants
ZAP70,Nuclear events stimulated by ALK signaling in cancer
CNBP,SARS-CoV-2 activates/modulates innate and adaptive immune responses
TRIM25,SARS-CoV-1-host interactions
TRIM25,SARS-CoV-1 activates/modulates innate immune responses
TRIM25,SARS-CoV-2 activates/modulates innate and adaptive immune responses
TRIM25,Respiratory Syncytial Virus Infection Pathway
TRIM25,Evasion by RSV of host interferon responses
TRIM25,RSV-host interactions
ZNF217,Estrogen-dependent gene expression
MOGS,Maturation of spike protein
MOGS,Translation of Structural Proteins
MOGS,Late SARS-CoV-2 Infection Events
TUBA1A,Hedgehog 'off' state
TUBA1A,RHO GTPases activate IQGAPs
TUBA1A,RHO GTPases Activate Formins
TUBA1A,HCMV Infection
TUBA1A,HCMV Early Events
CXCR4,Early Phase of HIV Life Cycle
CXCR4,Peptide ligand-binding receptors
CXCR4,Chemokine receptors bind chemokines
FZD5,Class B/2 (Secretin family receptors)
FZD5,Ca2+ pathway
FZD5,PCP/CE pathway
FZD5,Asymmetric localization of PCP proteins
FZD5,Disassembly of the destruction complex and recruitment of AXIN to the membrane
FZD5,Regulation of FZD by ubiquitination
FZD5,Signaling by WNT in cancer
FZD5,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"
MAPKAPK3,Signalling to RAS
MAPKAPK3,Signaling by NTRK1 (TRKA)
MAPKAPK3,Signalling to ERKs
MAPKAPK3,Signaling by VEGF
MAPKAPK3,VEGFA-VEGFR2 Pathway
RAB7A,RAC2 GTPase cycle
RAB7A,RHOD GTPase cycle
RAB7A,RHOQ GTPase cycle
RAB7A,RHOH GTPase cycle
RAB7A,RHOG GTPase cycle
RAB7A,RHOJ GTPase cycle
RAB7A,RAC3 GTPase cycle
RAB7A,RHOF GTPase cycle
RAB7A,Infection with Mycobacterium tuberculosis
RAB7A,Response of Mtb to phagocytosis
RAB7A,Bacterial Infection Pathways
NUP37,Host Interactions of HIV factors
NUP37,Rev-mediated nuclear export of HIV RNA
NUP37,Transport of Ribonucleoproteins into the Host Nucleus
NUP37,Export of Viral Ribonucleoproteins from Nucleus
NUP37,NS1 Mediated Effects on Host Pathways
NUP37,Viral Messenger RNA Synthesis
NUP37,NEP/NS2 Interacts with the Cellular Export Machinery
NUP37,Interactions of Vpr with host cellular proteins
NUP37,Interactions of Rev with host cellular proteins
NUP37,Nuclear import of Rev protein
NUP37,Vpr-mediated nuclear import of PICs
NUP37,SLC transporter disorders
NUP37,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP37,Disorders of transmembrane transporters
NUP37,RHO GTPases Activate Formins
NUP37,HCMV Infection
NUP37,HCMV Early Events
NUP37,HCMV Late Events
NUP37,SARS-CoV-2 activates/modulates innate and adaptive immune responses
MAPKAP1,Signaling by VEGF
MAPKAP1,PI3K/AKT Signaling in Cancer
MAPKAP1,VEGFA-VEGFR2 Pathway
MAPKAP1,VEGFR2 mediated vascular permeability
MAPKAP1,Constitutive Signaling by AKT1 E17K in Cancer
DERL1,ABC transporter disorders
DERL1,Disorders of transmembrane transporters
DERL1,Defective CFTR causes cystic fibrosis
EFHD2,RHOD GTPase cycle
EPM2A,Diseases of metabolism
CDC73,Formation of the beta-catenin:TCF transactivating complex
CDC73,Hedgehog 'on' state
CEP97,RHOV GTPase cycle
CHMP6,Budding and maturation of HIV virion
CHMP6,HCMV Infection
CHMP6,HCMV Late Events
CHMP6,Translation of Replicase and Assembly of the Replication Transcription Complex
CHMP6,Early SARS-CoV-2 Infection Events
DYNC2H1,Hedgehog 'off' state
PARP8,Maturation of nucleoprotein
PARP8,Translation of Structural Proteins
PARP8,Late SARS-CoV-2 Infection Events
SAP30L,Potential therapeutics for SARS
TBL1XR1,Signaling by NOTCH1
TBL1XR1,NOTCH1 Intracellular Domain Regulates Transcription
TBL1XR1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
TBL1XR1,Signaling by NOTCH1 in Cancer
TBL1XR1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
TBL1XR1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
TBL1XR1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
TBL1XR1,Loss of function of MECP2 in Rett syndrome
TBL1XR1,Pervasive developmental disorders
TBL1XR1,NR1H2 and NR1H3-mediated signaling
TBL1XR1,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
TBL1XR1,HCMV Infection
TBL1XR1,HCMV Early Events
TBL1XR1,Disorders of Developmental Biology
TBL1XR1,Disorders of Nervous System Development
VPS37B,Budding and maturation of HIV virion
VPS37B,Assembly Of The HIV Virion
VPS37B,HCMV Infection
VPS37B,HCMV Late Events
PALB2,Diseases of DNA repair
PALB2,Diseases of DNA Double-Strand Break Repair
PALB2,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
PALB2,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
PALB2,Impaired BRCA2 binding to PALB2
FZD3,Class B/2 (Secretin family receptors)
FZD3,Ca2+ pathway
FZD3,PCP/CE pathway
FZD3,Asymmetric localization of PCP proteins
GEMIN7,SARS-CoV-2 modulates host translation machinery
MYH14,RHO GTPases activate PKNs
MYH14,RHO GTPases activate CIT
MYH14,RHO GTPases Activate ROCKs
MYH14,RHO GTPases activate PAKs
TTC21B,Hedgehog 'off' state
GEMIN6,SARS-CoV-2 modulates host translation machinery
PIP4K2C,Negative regulation of the PI3K/AKT network
PIP4K2C,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
ARHGEF5,NRAGE signals death through JNK
ARHGEF5,p75 NTR receptor-mediated signalling
ARHGEF5,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF5,G alpha (12/13) signalling events
ARHGEF5,RHOA GTPase cycle
ARHGEF5,RHOB GTPase cycle
ARHGEF5,RHOC GTPase cycle
ARHGEF5,RHOG GTPase cycle
ZDHHC11,Maturation of spike protein
ZDHHC11,Translation of Structural Proteins
ZDHHC11,Late SARS-CoV-2 Infection Events
TUBAL3,RHO GTPases activate IQGAPs
TUBAL3,RHO GTPases Activate Formins
TUBAL3,HCMV Infection
TUBAL3,HCMV Early Events
CPSF7,RHOBTB1 GTPase cycle
CPSF7,RHOBTB GTPase Cycle
CBLL1,Listeria monocytogenes entry into host cells
CBLL1,Bacterial Infection Pathways
HDAC11,Signaling by NOTCH1
HDAC11,NOTCH1 Intracellular Domain Regulates Transcription
HDAC11,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC11,Signaling by NOTCH1 in Cancer
HDAC11,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC11,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC11,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
CALCR,Class B/2 (Secretin family receptors)
CALCR,G alpha (s) signalling events
NUP85,Host Interactions of HIV factors
NUP85,Rev-mediated nuclear export of HIV RNA
NUP85,Transport of Ribonucleoproteins into the Host Nucleus
NUP85,Export of Viral Ribonucleoproteins from Nucleus
NUP85,NS1 Mediated Effects on Host Pathways
NUP85,Viral Messenger RNA Synthesis
NUP85,NEP/NS2 Interacts with the Cellular Export Machinery
NUP85,Interactions of Vpr with host cellular proteins
NUP85,Interactions of Rev with host cellular proteins
NUP85,Nuclear import of Rev protein
NUP85,Vpr-mediated nuclear import of PICs
NUP85,SLC transporter disorders
NUP85,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP85,Disorders of transmembrane transporters
NUP85,RHO GTPases Activate Formins
NUP85,HCMV Infection
NUP85,HCMV Early Events
NUP85,HCMV Late Events
NUP85,SARS-CoV-2 activates/modulates innate and adaptive immune responses
WLS,WNT ligand biogenesis and trafficking
ESRP2,Signaling by FGFR
ESRP2,Signaling by FGFR2
ESRP2,FGFR2 alternative splicing
DOCK5,RHOG GTPase cycle
RMI1,Diseases of DNA repair
RMI1,Diseases of DNA Double-Strand Break Repair
RMI1,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
RMI1,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
RMI1,Defective homologous recombination repair (HRR) due to PALB2 loss of function
RMI1,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
RMI1,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
RMI1,Impaired BRCA2 binding to RAD51
RMI1,Impaired BRCA2 binding to PALB2
PHC3,Regulation of PTEN gene transcription
CALM1,Opioid Signalling
CALM1,PKA-mediated phosphorylation of CREB
CALM1,CaMK IV-mediated phosphorylation of CREB
CALM1,Calmodulin induced events
CALM1,Ca-dependent events
CALM1,CaM pathway
CALM1,G-protein mediated events
CALM1,PLC beta mediated events
CALM1,DAG and IP3 signaling
CALM1,PKA activation
CALM1,DARPP-32 events
CALM1,Signaling by VEGF
CALM1,Ca2+ pathway
CALM1,VEGFA-VEGFR2 Pathway
CALM1,VEGFR2 mediated vascular permeability
CALM1,VEGFR2 mediated cell proliferation
CALM1,Uptake and actions of bacterial toxins
CALM1,RHO GTPases activate IQGAPs
CALM1,RHO GTPases activate PAKs
CALM1,RAF activation
CALM1,Signaling by moderate kinase activity BRAF mutants
CALM1,Signaling by RAS mutants
CALM1,Signaling by BRAF and RAF1 fusions
CALM1,Paradoxical activation of RAF signaling by kinase inactive BRAF
CALM1,Oncogenic MAPK signaling
CALM1,Loss of function of MECP2 in Rett syndrome
CALM1,Pervasive developmental disorders
CALM1,Extra-nuclear estrogen signaling
CALM1,RAS processing
CALM1,Signaling downstream of RAS mutants
CALM1,Signaling by RAF1 mutants
CALM1,Anti-inflammatory response favouring Leishmania parasite infection
CALM1,FCGR3A-mediated IL10 synthesis
CALM1,Leishmania parasite growth and survival
CALM1,Disorders of Developmental Biology
CALM1,Disorders of Nervous System Development
CALM1,Bacterial Infection Pathways
BAIAP2L2,RHOF GTPase cycle
SIKE1,SARS-CoV-1-host interactions
SIKE1,SARS-CoV-1 activates/modulates innate immune responses
SIKE1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
FUZ,Hedgehog 'off' state
NUP214,Host Interactions of HIV factors
NUP214,Rev-mediated nuclear export of HIV RNA
NUP214,Transport of Ribonucleoproteins into the Host Nucleus
NUP214,Export of Viral Ribonucleoproteins from Nucleus
NUP214,NS1 Mediated Effects on Host Pathways
NUP214,Viral Messenger RNA Synthesis
NUP214,NEP/NS2 Interacts with the Cellular Export Machinery
NUP214,Interactions of Vpr with host cellular proteins
NUP214,Interactions of Rev with host cellular proteins
NUP214,Nuclear import of Rev protein
NUP214,Vpr-mediated nuclear import of PICs
NUP214,SLC transporter disorders
NUP214,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP214,Disorders of transmembrane transporters
NUP214,HCMV Infection
NUP214,HCMV Early Events
NUP214,HCMV Late Events
NUP214,SARS-CoV-2 activates/modulates innate and adaptive immune responses
PREX2,Regulation of PTEN stability and activity
PREX2,RHOA GTPase cycle
STAM,Signaling by EGFR
STAM,EGFR downregulation
STAM,Signaling by MET
STAM,Negative regulation of MET activity
STAM,InlB-mediated entry of Listeria monocytogenes into host cell
STAM,Listeria monocytogenes entry into host cells
STAM,RHOU GTPase cycle
STAM,Bacterial Infection Pathways
CUBN,Defects in vitamin and cofactor metabolism
CUBN,Diseases of metabolism
MED28,Respiratory Syncytial Virus Infection Pathway
MED28,RSV-host interactions
WNT10A,WNT ligand biogenesis and trafficking
WNT10A,Class B/2 (Secretin family receptors)
TNKS2,Degradation of AXIN
TNKS2,Signaling by WNT in cancer
TNKS2,Regulation of PTEN stability and activity
SHOC2,RAF activation
SHOC2,Oncogenic MAPK signaling
ADAM12,Signaling by EGFR
PDHX,Signaling by Retinoic Acid
FOSL1,Signaling by NTRK1 (TRKA)
FOSL1,Nuclear Events (kinase and transcription factor activation)
FOSL1,NGF-stimulated transcription
CUL5,Signaling by ERBB2
CUL5,Host Interactions of HIV factors
CUL5,Vif-mediated degradation of APOBEC3G
CUL5,Downregulation of ERBB2 signaling
CUL5,Respiratory Syncytial Virus Infection Pathway
CUL5,Evasion by RSV of host interferon responses
CUL5,RSV-host interactions
ARHGAP39,RHOA GTPase cycle
ARHGAP39,RHOB GTPase cycle
ARHGAP39,RHOC GTPase cycle
ARHGAP39,RAC2 GTPase cycle
ARHGAP39,RHOD GTPase cycle
ARHGAP39,RHOG GTPase cycle
ARHGAP39,RAC3 GTPase cycle
ARHGAP39,RHOF GTPase cycle
EEPD1,NR1H2 and NR1H3-mediated signaling
EEPD1,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
DUSP16,RAF-independent MAPK1/3 activation
DUSP16,Negative regulation of MAPK pathway
DUSP16,Oncogenic MAPK signaling
DUSP16,Infection with Mycobacterium tuberculosis
DUSP16,Response of Mtb to phagocytosis
DUSP16,Bacterial Infection Pathways
TAS1R2,Class C/3 (Metabotropic glutamate/pheromone receptors)
TAS1R1,Class C/3 (Metabotropic glutamate/pheromone receptors)
AAAS,Host Interactions of HIV factors
AAAS,Rev-mediated nuclear export of HIV RNA
AAAS,Transport of Ribonucleoproteins into the Host Nucleus
AAAS,Export of Viral Ribonucleoproteins from Nucleus
AAAS,NS1 Mediated Effects on Host Pathways
AAAS,Viral Messenger RNA Synthesis
AAAS,NEP/NS2 Interacts with the Cellular Export Machinery
AAAS,Interactions of Vpr with host cellular proteins
AAAS,Interactions of Rev with host cellular proteins
AAAS,Nuclear import of Rev protein
AAAS,Vpr-mediated nuclear import of PICs
AAAS,SLC transporter disorders
AAAS,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
AAAS,Disorders of transmembrane transporters
AAAS,RHOA GTPase cycle
AAAS,HCMV Infection
AAAS,HCMV Early Events
AAAS,HCMV Late Events
AAAS,SARS-CoV-2 activates/modulates innate and adaptive immune responses
IFT88,Hedgehog 'off' state
TUBB1,Hedgehog 'off' state
TUBB1,RHO GTPases activate IQGAPs
TUBB1,RHO GTPases Activate Formins
TUBB1,HCMV Infection
TUBB1,HCMV Early Events
WNT5B,WNT ligand biogenesis and trafficking
ZBP1,Potential therapeutics for SARS
PABPN1,NS1 Mediated Effects on Host Pathways
CAMK4,Opioid Signalling
CAMK4,CaMK IV-mediated phosphorylation of CREB
CAMK4,Calmodulin induced events
CAMK4,Ca-dependent events
CAMK4,CaM pathway
CAMK4,G-protein mediated events
CAMK4,PLC beta mediated events
CAMK4,DAG and IP3 signaling
CAMK4,Loss of function of MECP2 in Rett syndrome
CAMK4,Pervasive developmental disorders
CAMK4,Disorders of Developmental Biology
CAMK4,Disorders of Nervous System Development
TAF15,HIV Transcription Initiation
TAF15,RNA Polymerase II HIV Promoter Escape
TAF15,Transcription of the HIV genome
CAMK2A,Opioid Signalling
CAMK2A,CaMK IV-mediated phosphorylation of CREB
CAMK2A,Calmodulin induced events
CAMK2A,Ca-dependent events
CAMK2A,CaM pathway
CAMK2A,G-protein mediated events
CAMK2A,PLC beta mediated events
CAMK2A,DAG and IP3 signaling
CAMK2A,Ca2+ pathway
RND2,RND2 GTPase cycle
CAMK2B,Opioid Signalling
CAMK2B,CaMK IV-mediated phosphorylation of CREB
CAMK2B,Calmodulin induced events
CAMK2B,Ca-dependent events
CAMK2B,CaM pathway
CAMK2B,G-protein mediated events
CAMK2B,PLC beta mediated events
CAMK2B,DAG and IP3 signaling
FAM83D,Signaling by EGFR
CAB39L,MTOR signalling
CAB39L,Energy dependent regulation of mTOR by LKB1-AMPK
DIAPH3,RHO GTPases Activate Formins
DIAPH3,RHOA GTPase cycle
DIAPH3,RHOB GTPase cycle
DIAPH3,RHOC GTPase cycle
DIAPH3,RAC2 GTPase cycle
DIAPH3,RHOD GTPase cycle
DIAPH3,RHOQ GTPase cycle
DIAPH3,RHOG GTPase cycle
DIAPH3,RHOJ GTPase cycle
DIAPH3,RAC3 GTPase cycle
DIAPH3,RHOF GTPase cycle
MAP1LC3B,Translation of Replicase and Assembly of the Replication Transcription Complex
MAP1LC3B,SARS-CoV-2 modulates autophagy
MAP1LC3B,Early SARS-CoV-2 Infection Events
AMN,Defects in vitamin and cofactor metabolism
AMN,Diseases of metabolism
CAMK2D,Opioid Signalling
CAMK2D,CaMK IV-mediated phosphorylation of CREB
CAMK2D,Calmodulin induced events
CAMK2D,Ca-dependent events
CAMK2D,CaM pathway
CAMK2D,G-protein mediated events
CAMK2D,PLC beta mediated events
CAMK2D,DAG and IP3 signaling
DOCK8,RHOJ GTPase cycle
ELL,Formation of HIV elongation complex in the absence of HIV Tat
ELL,HIV Transcription Elongation
ELL,Transcription of the HIV genome
ELL,Formation of HIV-1 elongation complex containing HIV-1 Tat
ELL,Pausing and recovery of Tat-mediated HIV elongation
ELL,Tat-mediated HIV elongation arrest and recovery
ELL,Tat-mediated elongation of the HIV-1 transcript
ELL,HIV elongation arrest and recovery
ELL,Pausing and recovery of HIV elongation
TLR10,Diseases of Immune System
TLR10,Diseases associated with the TLR signaling cascade
CAMK2G,Opioid Signalling
CAMK2G,CaMK IV-mediated phosphorylation of CREB
CAMK2G,Calmodulin induced events
CAMK2G,Ca-dependent events
CAMK2G,CaM pathway
CAMK2G,G-protein mediated events
CAMK2G,PLC beta mediated events
CAMK2G,DAG and IP3 signaling
VANGL1,RHOA GTPase cycle
VANGL1,RHOB GTPase cycle
VANGL1,RHOC GTPase cycle
VANGL1,RAC2 GTPase cycle
VANGL1,RHOD GTPase cycle
VANGL1,RHOQ GTPase cycle
VANGL1,RHOH GTPase cycle
VANGL1,RHOG GTPase cycle
VANGL1,RHOJ GTPase cycle
VANGL1,RHOU GTPase cycle
VANGL1,RAC3 GTPase cycle
VANGL1,RHOV GTPase cycle
VANGL1,RHOF GTPase cycle
VANGL1,RND3 GTPase cycle
VANGL1,RND2 GTPase cycle
VANGL1,RND1 GTPase cycle
RNF146,Degradation of AXIN
RNF146,Regulation of PTEN stability and activity
MED25,Respiratory Syncytial Virus Infection Pathway
MED25,RSV-host interactions
SHARPIN,TNFR1-induced proapoptotic signaling
SHARPIN,Regulation of TNFR1 signaling
SHARPIN,TNFR1-induced NF-kappa-B signaling pathway
SHARPIN,TNF signaling
NCOA3,MAPK6/MAPK4 signaling
NCOA3,Estrogen-dependent gene expression
NRIP1,Estrogen-dependent gene expression
NRIP1,NR1H2 and NR1H3-mediated signaling
CANX,Maturation of spike protein
CANX,Translation of Structural Proteins
CANX,Late SARS-CoV-2 Infection Events
CAPN1,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CAPN1,Neurodegenerative Diseases
CAPN1,Diseases of programmed cell death
CAPN1,Defective Intrinsic Pathway for Apoptosis
USP9X,Signaling by TGF-beta Receptor Complex
USP9X,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
USP9X,Downregulation of SMAD2/3:SMAD4 transcriptional activity
USP9X,RHOU GTPase cycle
USP9X,RHOV GTPase cycle
CAPN2,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CAPN2,Neurodegenerative Diseases
CAPN2,Diseases of programmed cell death
CAPN2,Defective Intrinsic Pathway for Apoptosis
SMC1A,Estrogen-dependent gene expression
CAPNS1,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CAPNS1,Neurodegenerative Diseases
CAPNS1,Diseases of programmed cell death
CAPNS1,Defective Intrinsic Pathway for Apoptosis
TRRAP,Formation of the beta-catenin:TCF transactivating complex
PICALM,RND3 GTPase cycle
CAST,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CAST,Neurodegenerative Diseases
CAST,Diseases of programmed cell death
CAST,Defective Intrinsic Pathway for Apoptosis
AXIN1,Degradation of beta-catenin by the destruction complex
AXIN1,Degradation of AXIN
AXIN1,Disassembly of the destruction complex and recruitment of AXIN to the membrane
AXIN1,Signaling by WNT in cancer
AXIN1,Signaling by CTNNB1 phospho-site mutants
AXIN1,Signaling by APC mutants
AXIN1,Signaling by AMER1 mutants
AXIN1,CTNNB1 S33 mutants aren't phosphorylated
AXIN1,CTNNB1 S37 mutants aren't phosphorylated
AXIN1,CTNNB1 S45 mutants aren't phosphorylated
AXIN1,CTNNB1 T41 mutants aren't phosphorylated
AXIN1,APC truncation mutants have impaired AXIN binding
AXIN1,Truncations of AMER1 destabilize the destruction complex
AXIN1,Estrogen-dependent gene expression
AXIN2,Formation of the beta-catenin:TCF transactivating complex
AXIN2,Degradation of AXIN
BRAP,RAF activation
BRAP,Negative regulation of MAPK pathway
BRAP,Signaling by moderate kinase activity BRAF mutants
BRAP,Signaling by RAS mutants
BRAP,Paradoxical activation of RAF signaling by kinase inactive BRAF
BRAP,Oncogenic MAPK signaling
BRAP,Signaling downstream of RAS mutants
CAPZB,RHOD GTPase cycle
CAPZB,RHOF GTPase cycle
FZD1,Class B/2 (Secretin family receptors)
FZD1,PCP/CE pathway
FZD1,Asymmetric localization of PCP proteins
FZD1,Disassembly of the destruction complex and recruitment of AXIN to the membrane
FZD4,Class B/2 (Secretin family receptors)
FZD4,Ca2+ pathway
FZD4,PCP/CE pathway
FZD4,Asymmetric localization of PCP proteins
FZD4,Regulation of FZD by ubiquitination
FZD4,Signaling by WNT in cancer
FZD4,WNT5A-dependent internalization of FZD4
FZD6,Class B/2 (Secretin family receptors)
FZD6,Ca2+ pathway
FZD6,PCP/CE pathway
FZD6,Regulation of FZD by ubiquitination
FZD6,Signaling by WNT in cancer
FZD7,Class B/2 (Secretin family receptors)
FZD7,PCP/CE pathway
FZD7,Asymmetric localization of PCP proteins
FZD8,Class B/2 (Secretin family receptors)
FZD8,PCP/CE pathway
FZD8,Asymmetric localization of PCP proteins
FZD8,Regulation of FZD by ubiquitination
FZD8,Signaling by WNT in cancer
FZD9,Class B/2 (Secretin family receptors)
TCF7L1,Degradation of beta-catenin by the destruction complex
TCF7L1,Formation of the beta-catenin:TCF transactivating complex
TCF7L1,Deactivation of the beta-catenin transactivating complex
TCF7L1,Ca2+ pathway
TCF7L1,Repression of WNT target genes
APH1B,Signaling by ERBB4
APH1B,Nuclear signaling by ERBB4
APH1B,p75 NTR receptor-mediated signalling
APH1B,Signaling by NOTCH1
APH1B,Signaling by NOTCH2
APH1B,"Cell death signalling via NRAGE, NRIF and NADE"
APH1B,NRIF signals cell death from the nucleus
APH1B,Activated NOTCH1 Transmits Signal to the Nucleus
APH1B,Signaling by NOTCH1 PEST Domain Mutants in Cancer
APH1B,Signaling by NOTCH1 in Cancer
APH1B,Constitutive Signaling by NOTCH1 PEST Domain Mutants
APH1B,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
APH1B,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
APH1B,NOTCH2 Activation and Transmission of Signal to the Nucleus
APH1B,Signaling by NOTCH3
APH1B,NOTCH3 Activation and Transmission of Signal to the Nucleus
APH1B,Signaling by NOTCH4
APH1B,Signaling by TGFBR3
TAAR8,Amine ligand-binding receptors
TAAR8,G alpha (s) signalling events
SOX7,Deactivation of the beta-catenin transactivating complex
PARP9,Maturation of nucleoprotein
PARP9,Translation of Structural Proteins
PARP9,Late SARS-CoV-2 Infection Events
ITCH,Signaling by ERBB4
ITCH,Signaling by NOTCH1
ITCH,Activated NOTCH1 Transmits Signal to the Nucleus
ITCH,Degradation of GLI1 by the proteasome
ITCH,Hedgehog 'off' state
ITCH,Hedgehog 'on' state
ITCH,SARS-CoV-1-host interactions
ITCH,SARS-CoV-1 activates/modulates innate immune responses
TAS1R3,Class C/3 (Metabotropic glutamate/pheromone receptors)
KLF16,Signaling by TGFBR3
KLF16,TGFBR3 expression
TAF3,HIV Transcription Initiation
TAF3,RNA Polymerase II HIV Promoter Escape
TAF3,Transcription of the HIV genome
FGFBP2,Signaling by FGFR
FGFBP2,FGFR2 ligand binding and activation
FGFBP2,Signaling by FGFR2
HDAC10,Signaling by NOTCH1
HDAC10,NOTCH1 Intracellular Domain Regulates Transcription
HDAC10,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC10,Signaling by NOTCH1 in Cancer
HDAC10,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC10,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC10,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
PIP5K1A,Negative regulation of the PI3K/AKT network
PIP5K1A,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PIP5K1B,Negative regulation of the PI3K/AKT network
PIP5K1B,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PIP4K2B,Negative regulation of the PI3K/AKT network
PIP4K2B,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
OBSCN,NRAGE signals death through JNK
OBSCN,p75 NTR receptor-mediated signalling
OBSCN,"Cell death signalling via NRAGE, NRIF and NADE"
OBSCN,G alpha (12/13) signalling events
OBSCN,RHOA GTPase cycle
OBSCN,RHOQ GTPase cycle
SPOP,Hedgehog 'on' state
MAGT1,Maturation of spike protein
MAGT1,Translation of Structural Proteins
MAGT1,Late SARS-CoV-2 Infection Events
KBTBD7,Regulation of RAS by GAPs
ULK1,Regulation of TNFR1 signaling
ULK1,TNF signaling
ATRIP,Diseases of DNA repair
ATRIP,Diseases of DNA Double-Strand Break Repair
ATRIP,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
ATRIP,Impaired BRCA2 binding to RAD51
ZNRF3,Regulation of FZD by ubiquitination
PPP1R1B,Opioid Signalling
PPP1R1B,DARPP-32 events
MAF1,Regulation of PTEN gene transcription
MED10,Respiratory Syncytial Virus Infection Pathway
MED10,RSV-host interactions
LTBP4,Signaling by TGF-beta Receptor Complex
LTBP4,TGF-beta receptor signaling activates SMADs
CAMKK1,Opioid Signalling
CAMKK1,CaMK IV-mediated phosphorylation of CREB
CAMKK1,Calmodulin induced events
CAMKK1,Ca-dependent events
CAMKK1,CaM pathway
CAMKK1,G-protein mediated events
CAMKK1,PLC beta mediated events
CAMKK1,DAG and IP3 signaling
RNF135,SARS-CoV-2 activates/modulates innate and adaptive immune responses
CAPNS2,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CAPNS2,Neurodegenerative Diseases
CAPNS2,Diseases of programmed cell death
CAPNS2,Defective Intrinsic Pathway for Apoptosis
WDR83,MAP2K and MAPK activation
VPS25,HCMV Infection
VPS25,HCMV Late Events
AKT1S1,MTOR signalling
AKT1S1,mTORC1-mediated signalling
AKT1S1,AKT phosphorylates targets in the cytosol
AKT1S1,PI3K/AKT Signaling in Cancer
AKT1S1,Constitutive Signaling by AKT1 E17K in Cancer
RASAL1,Regulation of RAS by GAPs
NSMAF,TNF signaling
NCK2,Downstream signal transduction
NCK2,Signaling by PDGF
NCK2,Signaling by VEGF
NCK2,Activation of RAC1
NCK2,VEGFA-VEGFR2 Pathway
NCK2,RHOU GTPase cycle
NCK2,RHOV GTPase cycle
MAML2,Pre-NOTCH Transcription and Translation
MAML2,Pre-NOTCH Expression and Processing
MAML2,Signaling by NOTCH1
MAML2,Signaling by NOTCH2
MAML2,NOTCH1 Intracellular Domain Regulates Transcription
MAML2,NOTCH2 intracellular domain regulates transcription
MAML2,Signaling by NOTCH1 PEST Domain Mutants in Cancer
MAML2,Signaling by NOTCH1 in Cancer
MAML2,Constitutive Signaling by NOTCH1 PEST Domain Mutants
MAML2,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
MAML2,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MAML2,Signaling by NOTCH3
MAML2,NOTCH3 Intracellular Domain Regulates Transcription
MAML2,Signaling by NOTCH4
MAML2,NOTCH4 Intracellular Domain Regulates Transcription
EFCAB7,Hedgehog 'on' state
EFCAB7,Activation of SMO
CUL3,Degradation of DVL
CUL3,Hedgehog 'on' state
CUL3,Regulation of RAS by GAPs
CUL3,RHOBTB2 GTPase cycle
CUL3,RHOBTB1 GTPase cycle
CUL3,RHOBTB3 ATPase cycle
CUL3,RHOBTB GTPase Cycle
CUL1,Degradation of beta-catenin by the destruction complex
CUL1,Signaling by NOTCH1
CUL1,NOTCH1 Intracellular Domain Regulates Transcription
CUL1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
CUL1,Signaling by NOTCH1 in Cancer
CUL1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
CUL1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
CUL1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
CUL1,Degradation of GLI1 by the proteasome
CUL1,Degradation of GLI2 by the proteasome
CUL1,GLI3 is processed to GLI3R by the proteasome
CUL1,Hedgehog 'off' state
CUL1,Signaling by NOTCH4
CUL1,Negative regulation of NOTCH4 signaling
CUL1,Signaling by ALK in cancer
CUL1,Signaling by ALK fusions and activated point mutants
CUL1,Nuclear events stimulated by ALK signaling in cancer
CASR,Class C/3 (Metabotropic glutamate/pheromone receptors)
PARD6B,RHOV GTPase cycle
TUBB6,Hedgehog 'off' state
TUBB6,RHO GTPases activate IQGAPs
TUBB6,RHO GTPases Activate Formins
TUBB6,HCMV Infection
TUBB6,HCMV Early Events
HINT2,RHOD GTPase cycle
IRS4,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
IRS4,IGF1R signaling cascade
IRS4,IRS-related events triggered by IGF1R
CBX2,Regulation of PTEN gene transcription
CDC42BPA,RHOQ GTPase cycle
CDC42BPA,RHOJ GTPase cycle
TUBA1C,Hedgehog 'off' state
TUBA1C,RHO GTPases activate IQGAPs
TUBA1C,RHO GTPases Activate Formins
TUBA1C,HCMV Infection
TUBA1C,HCMV Early Events
RAE1,Host Interactions of HIV factors
RAE1,Rev-mediated nuclear export of HIV RNA
RAE1,Transport of Ribonucleoproteins into the Host Nucleus
RAE1,Export of Viral Ribonucleoproteins from Nucleus
RAE1,NS1 Mediated Effects on Host Pathways
RAE1,Viral Messenger RNA Synthesis
RAE1,NEP/NS2 Interacts with the Cellular Export Machinery
RAE1,Interactions of Vpr with host cellular proteins
RAE1,Interactions of Rev with host cellular proteins
RAE1,Nuclear import of Rev protein
RAE1,Vpr-mediated nuclear import of PICs
RAE1,SLC transporter disorders
RAE1,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
RAE1,Disorders of transmembrane transporters
RAE1,HCMV Infection
RAE1,HCMV Early Events
RAE1,HCMV Late Events
RAE1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
OFD1,Hedgehog 'off' state
IL17RC,SARS-CoV-2 activates/modulates innate and adaptive immune responses
RSPO3,Regulation of FZD by ubiquitination
PARP10,Maturation of nucleoprotein
PARP10,Translation of Structural Proteins
PARP10,Late SARS-CoV-2 Infection Events
SPPL2A,Regulation of TNFR1 signaling
SPPL2A,TNF signaling
LINGO1,p75NTR regulates axonogenesis
LINGO1,p75 NTR receptor-mediated signalling
TNS4,Signaling by MET
TNS4,MET promotes cell motility
FAM83A,Signaling by EGFR
PKP4,RND3 GTPase cycle
PKP4,RND2 GTPase cycle
PKP4,RND1 GTPase cycle
PIK3R3,Signaling by SCF-KIT
PIK3R3,Negative regulation of the PI3K/AKT network
PIK3R3,PI3K/AKT Signaling in Cancer
PIK3R3,Constitutive Signaling by Aberrant PI3K in Cancer
PIK3R3,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
PIK3R3,Extra-nuclear estrogen signaling
PIK3R3,RAC2 GTPase cycle
PIK3R3,Signaling by KIT in disease
PIK3R3,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
IKBKG,Diseases of Immune System
IKBKG,Regulation of TNFR1 signaling
IKBKG,TNFR1-induced NF-kappa-B signaling pathway
IKBKG,Diseases associated with the TLR signaling cascade
IKBKG,TNF signaling
IKBKG,SARS-CoV-2 activates/modulates innate and adaptive immune responses
DGKZ,Effects of PIP2 hydrolysis
DGKE,Effects of PIP2 hydrolysis
DGKD,Effects of PIP2 hydrolysis
COL27A1,Signaling by MET
COL27A1,MET activates PTK2 signaling
COL27A1,MET promotes cell motility
CBX4,Regulation of PTEN gene transcription
SYDE1,RAC2 GTPase cycle
SYDE1,RHOQ GTPase cycle
SYDE1,RHOJ GTPase cycle
SYDE1,RAC3 GTPase cycle
SYDE1,RHOF GTPase cycle
RHPN2,RHOA GTPase cycle
RHPN2,RHOB GTPase cycle
ZCRB1,Early SARS-CoV-2 Infection Events
DOCK7,Signaling by MET
DOCK7,MET promotes cell motility
DISP2,Hedgehog ligand biogenesis
LGR5,Regulation of FZD by ubiquitination
MAPKAPK5,MAPK6/MAPK4 signaling
CDC14B,MAPK6/MAPK4 signaling
CDC14A,MAPK6/MAPK4 signaling
MADD,Regulation of TNFR1 signaling
MADD,TNF signaling
CAV1,Signaling by VEGF
CAV1,VEGFA-VEGFR2 Pathway
CAV1,Disassembly of the destruction complex and recruitment of AXIN to the membrane
CAV1,VEGFR2 mediated vascular permeability
CAV1,RHOA GTPase cycle
CAV1,Extra-nuclear estrogen signaling
CAV1,RHOB GTPase cycle
CAV1,RHOC GTPase cycle
CAV1,RAC2 GTPase cycle
CAV1,RHOD GTPase cycle
CAV1,RHOQ GTPase cycle
CAV1,RHOH GTPase cycle
CAV1,RHOG GTPase cycle
CAV1,RHOJ GTPase cycle
CAV1,RAC3 GTPase cycle
CAV1,RHOF GTPase cycle
CAV1,SARS-CoV-1-host interactions
CAV1,RND3 GTPase cycle
CAV1,RND2 GTPase cycle
CAV1,RND1 GTPase cycle
CAV1,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
CAV2,Extra-nuclear estrogen signaling
RGS20,G alpha (z) signalling events
RUVBL1,Formation of the beta-catenin:TCF transactivating complex
RDH16,Signaling by Retinoic Acid
RDH16,RA biosynthesis pathway
RUNX1,Pre-NOTCH Transcription and Translation
RUNX1,Pre-NOTCH Expression and Processing
RUNX1,Estrogen-dependent gene expression
RUNX1,SARS-CoV-1-host interactions
RUNX1,SARS-CoV-1 activates/modulates innate immune responses
RUNX3,Formation of the beta-catenin:TCF transactivating complex
PTCH2,Class B/2 (Secretin family receptors)
AKR1C3,Signaling by Retinoic Acid
AKR1C3,RA biosynthesis pathway
NCOA1,Estrogen-dependent gene expression
NCOA1,NR1H2 and NR1H3-mediated signaling
NCOA1,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
CBFB,Estrogen-dependent gene expression
NUMB,Signaling by NOTCH1
NUMB,Activated NOTCH1 Transmits Signal to the Nucleus
NUMB,Degradation of GLI1 by the proteasome
NUMB,Hedgehog 'off' state
NUMB,Hedgehog 'on' state
SOCS1,Signaling by SCF-KIT
SOCS1,Regulation of KIT signaling
PDE5A,RHOBTB1 GTPase cycle
PDE5A,RHOBTB GTPase Cycle
DYNLL1,RHO GTPases Activate Formins
DYNLL1,HCMV Infection
DYNLL1,HCMV Early Events
TNKS,Degradation of AXIN
TNKS,Signaling by WNT in cancer
TNKS,Regulation of PTEN stability and activity
IRS2,Signaling by NTRK1 (TRKA)
IRS2,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
IRS2,IGF1R signaling cascade
IRS2,IRS-related events triggered by IGF1R
IRS2,Insulin receptor signalling cascade
IRS2,Signaling by Insulin receptor
IRS2,Signaling by Erythropoietin
IRS2,Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
CBL,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
CBL,Signaling by SCF-KIT
CBL,Regulation of KIT signaling
CBL,Signaling by EGFR in Cancer
CBL,Signaling by TGF-beta Receptor Complex
CBL,Signaling by EGFR
CBL,EGFR downregulation
CBL,Signaling by FGFR
CBL,TGF-beta receptor signaling activates SMADs
CBL,Constitutive Signaling by EGFRvIII
CBL,Signaling by EGFRvIII in Cancer
CBL,Signaling by Ligand-Responsive EGFR Variants in Cancer
CBL,Negative regulation of FGFR1 signaling
CBL,Negative regulation of FGFR2 signaling
CBL,Negative regulation of FGFR3 signaling
CBL,Negative regulation of FGFR4 signaling
CBL,Signaling by FGFR1
CBL,Signaling by FGFR2
CBL,Signaling by FGFR3
CBL,Signaling by FGFR4
CBL,Signaling by MET
CBL,Negative regulation of MET activity
CBL,Signaling by PTK6
CBL,InlB-mediated entry of Listeria monocytogenes into host cell
CBL,Listeria monocytogenes entry into host cells
CBL,Signaling by Non-Receptor Tyrosine Kinases
CBL,Bacterial Infection Pathways
BECN1,Translation of Replicase and Assembly of the Replication Transcription Complex
BECN1,SARS-CoV-2 activates/modulates innate and adaptive immune responses
BECN1,Early SARS-CoV-2 Infection Events
BECN1,Respiratory Syncytial Virus Infection Pathway
BECN1,RSV-host interactions
PEA15,RAF-independent MAPK1/3 activation
CDC23,Diseases of mitotic cell cycle
CDC23,Aberrant regulation of mitotic exit in cancer due to RB1 defects
CDC23,Aberrant regulation of mitotic cell cycle due to RB1 defects
ACTN1,RHOD GTPase cycle
ACTN1,RHOBTB2 GTPase cycle
ACTN1,RHOF GTPase cycle
ACTN1,RHOBTB GTPase Cycle
TRADD,TNFR1-induced proapoptotic signaling
TRADD,Regulation of TNFR1 signaling
TRADD,TNFR1-induced NF-kappa-B signaling pathway
TRADD,TNF signaling
TRADD,Diseases of programmed cell death
SNX3,WNT ligand biogenesis and trafficking
EED,Regulation of PTEN gene transcription
EED,HCMV Infection
EED,HCMV Early Events
EED,Diseases of programmed cell death
EED,Defective pyroptosis
RNMT,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
RNMT,Transcription of the HIV genome
RNGTT,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
RNGTT,Transcription of the HIV genome
RIPK1,TNFR1-induced proapoptotic signaling
RIPK1,Regulation of TNFR1 signaling
RIPK1,TNFR1-induced NF-kappa-B signaling pathway
RIPK1,TNF signaling
RIPK1,Diseases of programmed cell death
RIPK1,Potential therapeutics for SARS
RIPK2,p75NTR signals via NF-kB
RIPK2,p75 NTR receptor-mediated signalling
FADD,TNFR1-induced proapoptotic signaling
FADD,Regulation of TNFR1 signaling
FADD,TNF signaling
FADD,Diseases of programmed cell death
SNAP23,RHOA GTPase cycle
SNAP23,RHOB GTPase cycle
SNAP23,RHOQ GTPase cycle
SNAP23,RHOJ GTPase cycle
SNAP23,RAC3 GTPase cycle
SNAP23,RHOF GTPase cycle
MTMR1,RHOF GTPase cycle
DLK1,Signaling by NOTCH1
DLK1,Activated NOTCH1 Transmits Signal to the Nucleus
CCNK,Formation of HIV elongation complex in the absence of HIV Tat
CCNK,Transcription of the HIV genome
CCNK,HIV elongation arrest and recovery
CCNK,Pausing and recovery of HIV elongation
CCNK,Signaling by TGF-beta Receptor Complex
CCNK,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
CCNK,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
DPM1,Diseases of glycosylation
DPM1,Diseases of metabolism
BANF1,Early Phase of HIV Life Cycle
BANF1,Host Interactions of HIV factors
BANF1,Interactions of Vpr with host cellular proteins
BANF1,Vpr-mediated nuclear import of PICs
FGF18,PI3K Cascade
FGF18,IRS-mediated signalling
FGF18,Signaling by FGFR in disease
FGF18,FGFR2 mutant receptor activation
FGF18,Signaling by FGFR
FGF18,FGFR2 ligand binding and activation
FGF18,FGFR4 ligand binding and activation
FGF18,Negative regulation of the PI3K/AKT network
FGF18,Activated point mutants of FGFR2
FGF18,PI3K/AKT Signaling in Cancer
FGF18,Constitutive Signaling by Aberrant PI3K in Cancer
FGF18,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF18,IGF1R signaling cascade
FGF18,IRS-related events triggered by IGF1R
FGF18,Phospholipase C-mediated cascade; FGFR2
FGF18,Phospholipase C-mediated cascade; FGFR4
FGF18,PI-3K cascade:FGFR2
FGF18,Downstream signaling of activated FGFR2
FGF18,SHC-mediated cascade:FGFR2
FGF18,FRS-mediated FGFR2 signaling
FGF18,FRS-mediated FGFR3 signaling
FGF18,Downstream signaling of activated FGFR3
FGF18,FRS-mediated FGFR4 signaling
FGF18,Downstream signaling of activated FGFR4
FGF18,SHC-mediated cascade:FGFR4
FGF18,PI-3K cascade:FGFR4
FGF18,Negative regulation of FGFR2 signaling
FGF18,Negative regulation of FGFR3 signaling
FGF18,Negative regulation of FGFR4 signaling
FGF18,Signaling by FGFR1
FGF18,Signaling by FGFR2
FGF18,Signaling by FGFR3
FGF18,Signaling by FGFR4
FGF18,Signaling by FGFR2 in disease
FGF18,Signaling by FGFR3 in disease
FGF18,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF18,Insulin receptor signalling cascade
FGF18,Signaling by Insulin receptor
DPM2,Diseases of glycosylation
DPM2,Diseases of metabolism
SAP30,Potential therapeutics for SARS
FGF16,PI3K Cascade
FGF16,IRS-mediated signalling
FGF16,Signaling by FGFR in disease
FGF16,FGFR2 mutant receptor activation
FGF16,Signaling by FGFR
FGF16,FGFR2 ligand binding and activation
FGF16,FGFR4 ligand binding and activation
FGF16,Negative regulation of the PI3K/AKT network
FGF16,Activated point mutants of FGFR2
FGF16,PI3K/AKT Signaling in Cancer
FGF16,Constitutive Signaling by Aberrant PI3K in Cancer
FGF16,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF16,IGF1R signaling cascade
FGF16,IRS-related events triggered by IGF1R
FGF16,Phospholipase C-mediated cascade; FGFR2
FGF16,Phospholipase C-mediated cascade; FGFR4
FGF16,PI-3K cascade:FGFR2
FGF16,Downstream signaling of activated FGFR2
FGF16,SHC-mediated cascade:FGFR2
FGF16,FRS-mediated FGFR2 signaling
FGF16,FRS-mediated FGFR3 signaling
FGF16,Downstream signaling of activated FGFR3
FGF16,FRS-mediated FGFR4 signaling
FGF16,Downstream signaling of activated FGFR4
FGF16,SHC-mediated cascade:FGFR4
FGF16,PI-3K cascade:FGFR4
FGF16,Negative regulation of FGFR2 signaling
FGF16,Negative regulation of FGFR3 signaling
FGF16,Negative regulation of FGFR4 signaling
FGF16,Signaling by FGFR2
FGF16,Signaling by FGFR3
FGF16,Signaling by FGFR4
FGF16,Signaling by FGFR2 in disease
FGF16,Signaling by FGFR3 in disease
FGF16,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF16,Insulin receptor signalling cascade
FGF16,Signaling by Insulin receptor
IQGAP1,RHO GTPases activate IQGAPs
IQGAP1,MAP2K and MAPK activation
IQGAP1,Signaling by moderate kinase activity BRAF mutants
IQGAP1,Signaling by high-kinase activity BRAF mutants
IQGAP1,Signaling by RAS mutants
IQGAP1,Signaling by BRAF and RAF1 fusions
IQGAP1,Paradoxical activation of RAF signaling by kinase inactive BRAF
IQGAP1,Oncogenic MAPK signaling
IQGAP1,RHOA GTPase cycle
IQGAP1,RHOC GTPase cycle
IQGAP1,RAC2 GTPase cycle
IQGAP1,RHOQ GTPase cycle
IQGAP1,RHOU GTPase cycle
IQGAP1,RHOV GTPase cycle
IQGAP1,Signaling downstream of RAS mutants
IQGAP1,Signaling by RAF1 mutants
NRP2,Signaling by VEGF
NRP1,Signaling by VEGF
NRP1,Early SARS-CoV-2 Infection Events
SYNGAP1,Regulation of RAS by GAPs
HDAC3,p75 NTR receptor-mediated signalling
HDAC3,Signaling by NOTCH1
HDAC3,Signaling by ALK
HDAC3,NOTCH1 Intracellular Domain Regulates Transcription
HDAC3,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC3,Signaling by NOTCH1 in Cancer
HDAC3,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC3,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC3,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HDAC3,Regulation of PTEN gene transcription
HDAC3,Loss of function of MECP2 in Rett syndrome
HDAC3,Pervasive developmental disorders
HDAC3,NR1H2 and NR1H3-mediated signaling
HDAC3,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
HDAC3,HCMV Infection
HDAC3,HCMV Early Events
HDAC3,Disorders of Developmental Biology
HDAC3,Disorders of Nervous System Development
HDAC3,STAT3 nuclear events downstream of ALK signaling
KSR1,RAF activation
KSR1,Negative regulation of MAPK pathway
KSR1,Signaling by moderate kinase activity BRAF mutants
KSR1,Signaling by RAS mutants
KSR1,Paradoxical activation of RAF signaling by kinase inactive BRAF
KSR1,Oncogenic MAPK signaling
KSR1,Signaling downstream of RAS mutants
KAT2B,Pre-NOTCH Transcription and Translation
KAT2B,Pre-NOTCH Expression and Processing
KAT2B,Signaling by NOTCH1
KAT2B,NOTCH1 Intracellular Domain Regulates Transcription
KAT2B,Signaling by NOTCH1 PEST Domain Mutants in Cancer
KAT2B,Signaling by NOTCH1 in Cancer
KAT2B,Constitutive Signaling by NOTCH1 PEST Domain Mutants
KAT2B,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
KAT2B,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
KAT2B,Signaling by NOTCH3
KAT2B,NOTCH3 Intracellular Domain Regulates Transcription
KAT2B,Signaling by NOTCH4
KAT2B,NOTCH4 Intracellular Domain Regulates Transcription
KAT2B,Estrogen-dependent gene expression
ALDH1A2,Signaling by Retinoic Acid
ALDH1A2,RA biosynthesis pathway
IER3,Negative regulation of the PI3K/AKT network
IER3,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
ARHGEF7,Signaling by EGFR
ARHGEF7,EGFR downregulation
ARHGEF7,NRAGE signals death through JNK
ARHGEF7,p75 NTR receptor-mediated signalling
ARHGEF7,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF7,G alpha (12/13) signalling events
ARHGEF7,RHOA GTPase cycle
ARHGEF7,RHOQ GTPase cycle
ARHGEF7,RHOJ GTPase cycle
ARHGEF7,RHOU GTPase cycle
ARHGEF7,RHOV GTPase cycle
SPHK1,Signaling by VEGF
SPHK1,VEGFA-VEGFR2 Pathway
SPHK1,VEGFR2 mediated cell proliferation
SPHK1,Extra-nuclear estrogen signaling
SQSTM1,p75NTR signals via NF-kB
SQSTM1,p75 NTR receptor-mediated signalling
SQSTM1,"Cell death signalling via NRAGE, NRIF and NADE"
SQSTM1,NRIF signals cell death from the nucleus
CDC16,Diseases of mitotic cell cycle
CDC16,Aberrant regulation of mitotic exit in cancer due to RB1 defects
CDC16,Aberrant regulation of mitotic cell cycle due to RB1 defects
TAX1BP1,Regulation of TNFR1 signaling
TAX1BP1,TNF signaling
AP1S2,Host Interactions of HIV factors
AP1S2,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP1S2,The role of Nef in HIV-1 replication and disease pathogenesis
AP1M1,Host Interactions of HIV factors
AP1M1,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
AP1M1,The role of Nef in HIV-1 replication and disease pathogenesis
CCNB1,Signaling by ALK in cancer
CCNB1,Signaling by ALK fusions and activated point mutants
CCNB1,Nuclear events stimulated by ALK signaling in cancer
TRIM4,SARS-CoV-2 activates/modulates innate and adaptive immune responses
CCNC,Signaling by TGF-beta Receptor Complex
CCNC,Signaling by NOTCH1
CCNC,NOTCH1 Intracellular Domain Regulates Transcription
CCNC,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
CCNC,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
CCNC,Signaling by NOTCH1 PEST Domain Mutants in Cancer
CCNC,Signaling by NOTCH1 in Cancer
CCNC,Constitutive Signaling by NOTCH1 PEST Domain Mutants
CCNC,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
CCNC,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
CCNC,Respiratory Syncytial Virus Infection Pathway
CCNC,RSV-host interactions
FOXH1,Signaling by Activin
WASF1,Signaling by VEGF
WASF1,VEGFA-VEGFR2 Pathway
WASF1,RHO GTPases Activate WASPs and WAVEs
WASF1,RAC3 GTPase cycle
WASF1,Parasite infection
WASF1,Leishmania phagocytosis
WASF1,FCGR3A-mediated phagocytosis
CCND2,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
CCND2,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
CCND2,Diseases of mitotic cell cycle
CCND2,Aberrant regulation of mitotic cell cycle due to RB1 defects
BTRC,Host Interactions of HIV factors
BTRC,Vpu mediated degradation of CD4
BTRC,Degradation of beta-catenin by the destruction complex
BTRC,Deactivation of the beta-catenin transactivating complex
BTRC,Degradation of GLI1 by the proteasome
BTRC,Degradation of GLI2 by the proteasome
BTRC,GLI3 is processed to GLI3R by the proteasome
BTRC,Hedgehog 'off' state
CCND3,MAPK6/MAPK4 signaling
CCND3,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
CCND3,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
CCND3,Diseases of mitotic cell cycle
CCND3,Aberrant regulation of mitotic cell cycle due to RB1 defects
USP13,Regulation of PTEN stability and activity
WASL,RHOQ GTPase cycle
WASL,RHOV GTPase cycle
WNT3A,WNT ligand biogenesis and trafficking
WNT3A,Class B/2 (Secretin family receptors)
CCNE1,Signaling by PTK6
CCNE1,Signaling by Non-Receptor Tyrosine Kinases
CCNE1,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
CCNE1,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
CCNE1,Diseases of mitotic cell cycle
CCNE1,Aberrant regulation of mitotic cell cycle due to RB1 defects
CCNE1,RHOBTB3 ATPase cycle
FGD3,NRAGE signals death through JNK
FGD3,p75 NTR receptor-mediated signalling
FGD3,"Cell death signalling via NRAGE, NRIF and NADE"
FGD3,G alpha (12/13) signalling events
STBD1,RHOA GTPase cycle
STBD1,RAC2 GTPase cycle
STBD1,RHOD GTPase cycle
STBD1,RHOG GTPase cycle
STBD1,RAC3 GTPase cycle
ATP6V0E1,Signaling by Insulin receptor
ATP6V0E1,Insulin receptor recycling
KLC4,RHO GTPases activate KTN1
KALRN,NRAGE signals death through JNK
KALRN,p75 NTR receptor-mediated signalling
KALRN,"Cell death signalling via NRAGE, NRIF and NADE"
KALRN,G alpha (12/13) signalling events
KALRN,MAPK6/MAPK4 signaling
KALRN,RHOA GTPase cycle
KALRN,RHOG GTPase cycle
CCNH,Formation of HIV elongation complex in the absence of HIV Tat
CCNH,Formation of the HIV-1 Early Elongation Complex
CCNH,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
CCNH,HIV Transcription Initiation
CCNH,RNA Polymerase II HIV Promoter Escape
CCNH,HIV Transcription Elongation
CCNH,Transcription of the HIV genome
CCNH,Formation of HIV-1 elongation complex containing HIV-1 Tat
CCNH,Tat-mediated elongation of the HIV-1 transcript
SOCS3,Signaling by PTK6
SOCS3,Signaling by Non-Receptor Tyrosine Kinases
UCN2,Class B/2 (Secretin family receptors)
CCRL2,Peptide ligand-binding receptors
CCRL2,Chemokine receptors bind chemokines
TAAR5,Amine ligand-binding receptors
TAAR5,G alpha (s) signalling events
MED30,Respiratory Syncytial Virus Infection Pathway
MED30,RSV-host interactions
CCNT1,Host Interactions of HIV factors
CCNT1,Formation of HIV elongation complex in the absence of HIV Tat
CCNT1,HIV Transcription Elongation
CCNT1,Transcription of the HIV genome
CCNT1,Formation of HIV-1 elongation complex containing HIV-1 Tat
CCNT1,Pausing and recovery of Tat-mediated HIV elongation
CCNT1,Tat-mediated HIV elongation arrest and recovery
CCNT1,Tat-mediated elongation of the HIV-1 transcript
CCNT1,HIV elongation arrest and recovery
CCNT1,Pausing and recovery of HIV elongation
CCNT1,Signaling by TGF-beta Receptor Complex
CCNT1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
CCNT1,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
CCNT1,Estrogen-dependent gene expression
ATP6V1E2,Signaling by Insulin receptor
ATP6V1E2,Insulin receptor recycling
RPL14,Viral mRNA Translation
SH2D2A,Signaling by VEGF
SH2D2A,VEGFA-VEGFR2 Pathway
CCNT2,Formation of HIV elongation complex in the absence of HIV Tat
CCNT2,Transcription of the HIV genome
CCNT2,HIV elongation arrest and recovery
CCNT2,Pausing and recovery of HIV elongation
CCNT2,Signaling by TGF-beta Receptor Complex
CCNT2,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
CCNT2,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
PSTPIP1,Purinergic signaling in leishmaniasis infection
PSTPIP1,Cell recruitment (pro-inflammatory response)
PRC1,RHO GTPases activate CIT
STARD13,RHOA GTPase cycle
STARD13,RHOB GTPase cycle
STARD13,RHOC GTPase cycle
ASH2L,Formation of the beta-catenin:TCF transactivating complex
ASH2L,Deactivation of the beta-catenin transactivating complex
SEC11C,Respiratory Syncytial Virus Infection Pathway
SEC11C,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
SEC11C,Maturation of hRSV A proteins
PYGO2,Formation of the beta-catenin:TCF transactivating complex
PYGO2,Deactivation of the beta-catenin transactivating complex
CCT6A,RHOBTB2 GTPase cycle
CCT6A,RHOBTB GTPase Cycle
IL33,Negative regulation of the PI3K/AKT network
IL33,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
USP2,TNFR1-induced proapoptotic signaling
USP2,Regulation of TNFR1 signaling
USP2,TNFR1-induced NF-kappa-B signaling pathway
USP2,TNF signaling
ACVR1B,Signaling by Activin
USP8,Signaling by ERBB2
USP8,Regulation of FZD by ubiquitination
USP8,Signaling by MET
USP8,Negative regulation of MET activity
USP8,Downregulation of ERBB2 signaling
FMNL3,RHO GTPases Activate Formins
FMNL3,RHOA GTPase cycle
FMNL3,RHOC GTPase cycle
FMNL3,RHOJ GTPase cycle
MTMR4,Signaling by TGF-beta Receptor Complex
MTMR4,Downregulation of TGF-beta receptor signaling
MTMR4,TGF-beta receptor signaling activates SMADs
NMI,SARS-CoV-1-host interactions
NMI,SARS-CoV-1 activates/modulates innate immune responses
MTA1,Regulation of PTEN gene transcription
MTA1,Potential therapeutics for SARS
LATS1,Signaling by Hippo
ATP6V0D1,Signaling by Insulin receptor
ATP6V0D1,Insulin receptor recycling
SMC3,Estrogen-dependent gene expression
DERL3,ABC transporter disorders
DERL3,Disorders of transmembrane transporters
DERL3,Defective CFTR causes cystic fibrosis
CCNE2,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects
CCNE2,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"
CCNE2,Diseases of mitotic cell cycle
CCNE2,Aberrant regulation of mitotic cell cycle due to RB1 defects
ARHGEF1,NRAGE signals death through JNK
ARHGEF1,p75 NTR receptor-mediated signalling
ARHGEF1,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF1,G alpha (12/13) signalling events
ARHGEF1,RHOA GTPase cycle
ARHGEF1,RHOB GTPase cycle
ARHGEF1,RHOC GTPase cycle
RNF185,ABC transporter disorders
RNF185,Disorders of transmembrane transporters
RNF185,Defective CFTR causes cystic fibrosis
ACBD5,RHOA GTPase cycle
ACBD5,RHOC GTPase cycle
HGS,Signaling by EGFR
HGS,EGFR downregulation
HGS,Signaling by MET
HGS,Negative regulation of MET activity
HGS,InlB-mediated entry of Listeria monocytogenes into host cell
HGS,Listeria monocytogenes entry into host cells
HGS,RHOU GTPase cycle
HGS,Infection with Mycobacterium tuberculosis
HGS,Response of Mtb to phagocytosis
HGS,RHOBTB3 ATPase cycle
HGS,Bacterial Infection Pathways
CTDP1,Formation of HIV elongation complex in the absence of HIV Tat
CTDP1,Formation of the HIV-1 Early Elongation Complex
CTDP1,HIV Transcription Elongation
CTDP1,Transcription of the HIV genome
CTDP1,Formation of HIV-1 elongation complex containing HIV-1 Tat
CTDP1,Pausing and recovery of Tat-mediated HIV elongation
CTDP1,Abortive elongation of HIV-1 transcript in the absence of Tat
CTDP1,Tat-mediated HIV elongation arrest and recovery
CTDP1,Tat-mediated elongation of the HIV-1 transcript
CTDP1,HIV elongation arrest and recovery
CTDP1,Pausing and recovery of HIV elongation
UBXN11,RND3 GTPase cycle
UBXN11,RND2 GTPase cycle
UBXN11,RND1 GTPase cycle
EXO1,Diseases of DNA repair
EXO1,Diseases of DNA Double-Strand Break Repair
EXO1,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
EXO1,Defective homologous recombination repair (HRR) due to BRCA1 loss of function
EXO1,Defective homologous recombination repair (HRR) due to PALB2 loss of function
EXO1,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
EXO1,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
EXO1,Impaired BRCA2 binding to RAD51
EXO1,Impaired BRCA2 binding to PALB2
DGKI,Effects of PIP2 hydrolysis
BOC,Hedgehog 'on' state
BOC,Activation of SMO
EBAG9,Estrogen-dependent gene expression
NLRP12,SARS-CoV-2 activates/modulates innate and adaptive immune responses
CD3G,Anti-inflammatory response favouring Leishmania parasite infection
CD3G,FCGR3A-mediated IL10 synthesis
CD3G,Parasite infection
CD3G,Leishmania phagocytosis
CD3G,FCGR3A-mediated phagocytosis
CD3G,Leishmania parasite growth and survival
IL1RL1,Negative regulation of the PI3K/AKT network
IL1RL1,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
CHMP7,Budding and maturation of HIV virion
CHMP7,HCMV Infection
CHMP7,HCMV Late Events
CHMP7,Translation of Replicase and Assembly of the Replication Transcription Complex
CHMP7,Early SARS-CoV-2 Infection Events
ARHGEF2,NRAGE signals death through JNK
ARHGEF2,p75 NTR receptor-mediated signalling
ARHGEF2,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF2,G alpha (12/13) signalling events
ARHGEF2,RHOA GTPase cycle
ARHGEF2,RHOB GTPase cycle
CHRDL1,Signaling by BMP
ACVR2A,Signaling by Activin
ACVR2A,Signaling by BMP
ACVR2A,Signaling by TGFBR3
CD4,Early Phase of HIV Life Cycle
CD4,Host Interactions of HIV factors
CD4,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
CD4,The role of Nef in HIV-1 replication and disease pathogenesis
CD4,Vpu mediated degradation of CD4
VAPB,RHOA GTPase cycle
VAPB,RHOC GTPase cycle
VAPB,RAC2 GTPase cycle
VAPB,RHOD GTPase cycle
VAPB,RHOG GTPase cycle
MTA2,Regulation of PTEN gene transcription
MTA2,Potential therapeutics for SARS
DLG5,RHOU GTPase cycle
DLG5,RHOV GTPase cycle
DLG5,RND3 GTPase cycle
DLG5,RND2 GTPase cycle
DLG5,RND1 GTPase cycle
STRADA,MTOR signalling
STRADA,Energy dependent regulation of mTOR by LKB1-AMPK
IL32,RAC3 GTPase cycle
NOG,Signaling by BMP
CHMP4C,Budding and maturation of HIV virion
CHMP4C,HCMV Infection
CHMP4C,HCMV Late Events
CHMP4C,Translation of Replicase and Assembly of the Replication Transcription Complex
CHMP4C,Early SARS-CoV-2 Infection Events
UBE2L6,Respiratory Syncytial Virus Infection Pathway
UBE2L6,RSV-host interactions
DHRS3,Signaling by Retinoic Acid
DHRS3,RA biosynthesis pathway
RPS6KA5,Signaling by NTRK1 (TRKA)
RPS6KA5,Nuclear Events (kinase and transcription factor activation)
RPS6KA5,ERK/MAPK targets
CD8B,Host Interactions of HIV factors
CD8B,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
CD8B,The role of Nef in HIV-1 replication and disease pathogenesis
MAPKAPK2,Signalling to RAS
MAPKAPK2,Signaling by NTRK1 (TRKA)
MAPKAPK2,Signalling to ERKs
MAPKAPK2,Signaling by VEGF
MAPKAPK2,VEGFA-VEGFR2 Pathway
DNER,Signaling by NOTCH1
DNER,Activated NOTCH1 Transmits Signal to the Nucleus
CD9,Uptake and actions of bacterial toxins
CD9,Bacterial Infection Pathways
MED14,Respiratory Syncytial Virus Infection Pathway
MED14,RSV-host interactions
TAAR2,Amine ligand-binding receptors
TAAR2,G alpha (s) signalling events
ATP6V1F,Signaling by Insulin receptor
ATP6V1F,Insulin receptor recycling
ACVR2B,Signaling by Activin
ACVR2B,Signaling by BMP
SOCS6,Signaling by SCF-KIT
SOCS6,Regulation of KIT signaling
COPS2,RHOBTB1 GTPase cycle
COPS2,RHOBTB GTPase Cycle
TRIP10,RHOQ GTPase cycle
CD163,Anti-inflammatory response favouring Leishmania parasite infection
CD163,Leishmania parasite growth and survival
GLP2R,Class B/2 (Secretin family receptors)
GLP2R,G alpha (s) signalling events
GLP2R,Glucagon-type ligand receptors
VAMP3,RHOA GTPase cycle
VAMP3,RHOB GTPase cycle
VAMP3,RHOC GTPase cycle
VAMP3,RAC2 GTPase cycle
VAMP3,RHOD GTPase cycle
VAMP3,RHOQ GTPase cycle
VAMP3,RHOH GTPase cycle
VAMP3,RHOG GTPase cycle
VAMP3,RHOJ GTPase cycle
VAMP3,RAC3 GTPase cycle
VAMP3,RHOF GTPase cycle
RPL23,Viral mRNA Translation
CER1,Signaling by BMP
TXNL1,RHOBTB2 GTPase cycle
TXNL1,RHOU GTPase cycle
TXNL1,RHOBTB1 GTPase cycle
TXNL1,RHOV GTPase cycle
TXNL1,RND3 GTPase cycle
TXNL1,RND2 GTPase cycle
TXNL1,RND1 GTPase cycle
TXNL1,RHOBTB GTPase Cycle
SLIT2,Activation of RAC1
PPIG,SARS-CoV-1-host interactions
PPIG,SARS-CoV-1 activates/modulates innate immune responses
ARHGAP18,RHOA GTPase cycle
ARHGAP18,RHOC GTPase cycle
RAB9A,RHOBTB3 ATPase cycle
NMT2,Assembly Of The HIV Virion
ACVRL1,Signaling by BMP
CD28,Host Interactions of HIV factors
CD28,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
CD28,The role of Nef in HIV-1 replication and disease pathogenesis
GRAP2,Signaling by SCF-KIT
MUC16,Diseases of glycosylation
MUC16,Diseases associated with O-glycosylation of proteins
MUC16,Defective GALNT3 causes HFTC
MUC16,Defective GALNT12 causes CRCS1
MUC16,Diseases of metabolism
CD80,Negative regulation of the PI3K/AKT network
CD80,PI3K/AKT Signaling in Cancer
CD80,Constitutive Signaling by Aberrant PI3K in Cancer
CD80,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
MED21,Respiratory Syncytial Virus Infection Pathway
MED21,RSV-host interactions
ARHGAP12,RHOD GTPase cycle
ARHGAP12,RHOV GTPase cycle
ARHGAP12,RHOF GTPase cycle
TJP2,Signaling by Hippo
TJP2,RHOA GTPase cycle
TJP2,RHOB GTPase cycle
TJP2,RHOC GTPase cycle
CD86,Negative regulation of the PI3K/AKT network
CD86,PI3K/AKT Signaling in Cancer
CD86,Constitutive Signaling by Aberrant PI3K in Cancer
CD86,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
GNG8,Opioid Signalling
GNG8,G-protein activation
GNG8,Class B/2 (Secretin family receptors)
GNG8,G beta:gamma signalling through PI3Kgamma
GNG8,G-protein beta:gamma signalling
GNG8,Ca2+ pathway
GNG8,G alpha (12/13) signalling events
GNG8,G beta:gamma signalling through PLC beta
GNG8,G alpha (s) signalling events
GNG8,G alpha (z) signalling events
GNG8,Glucagon-type ligand receptors
GNG8,G beta:gamma signalling through BTK
GNG8,G beta:gamma signalling through CDC42
GNG8,Extra-nuclear estrogen signaling
GNG8,GPER1 signaling
GNG8,ADORA2B mediated anti-inflammatory cytokines production
GNG8,Anti-inflammatory response favouring Leishmania parasite infection
GNG8,Leishmania parasite growth and survival
EPSTI1,RND1 GTPase cycle
PPP1R14A,RHO GTPases activate PKNs
MED23,Respiratory Syncytial Virus Infection Pathway
MED23,RSV-host interactions
MED17,Respiratory Syncytial Virus Infection Pathway
MED17,RSV-host interactions
MED26,Respiratory Syncytial Virus Infection Pathway
MED26,RSV-host interactions
MED27,Respiratory Syncytial Virus Infection Pathway
MED27,RSV-host interactions
MED7,Respiratory Syncytial Virus Infection Pathway
MED7,RSV-host interactions
ARHGEF6,NRAGE signals death through JNK
ARHGEF6,p75 NTR receptor-mediated signalling
ARHGEF6,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF6,G-protein beta:gamma signalling
ARHGEF6,G alpha (12/13) signalling events
ARHGEF6,G beta:gamma signalling through CDC42
ARHGEF6,RHOU GTPase cycle
RASAL2,Regulation of RAS by GAPs
RASAL2,RND3 GTPase cycle
RASAL2,RND1 GTPase cycle
ROCK2,Signaling by VEGF
ROCK2,G alpha (12/13) signalling events
ROCK2,VEGFA-VEGFR2 Pathway
ROCK2,RHO GTPases Activate ROCKs
ROCK2,RHOA GTPase cycle
ROCK2,RHOB GTPase cycle
ROCK2,RHOC GTPase cycle
ROCK2,RHOH GTPase cycle
ROCK2,RHOBTB1 GTPase cycle
ROCK2,Potential therapeutics for SARS
ROCK2,RHOBTB GTPase Cycle
MED20,Respiratory Syncytial Virus Infection Pathway
MED20,RSV-host interactions
SLC4A7,RHOD GTPase cycle
SLC4A7,RHOQ GTPase cycle
SLC4A7,RHOH GTPase cycle
SLC4A7,RHOJ GTPase cycle
SLC4A7,RHOF GTPase cycle
MAGED1,NRAGE signals death through JNK
MAGED1,p75 NTR receptor-mediated signalling
MAGED1,"Cell death signalling via NRAGE, NRIF and NADE"
VPS4B,Budding and maturation of HIV virion
TMEM59,RHOH GTPase cycle
TMEM59,RND1 GTPase cycle
ENTPD1,Purinergic signaling in leishmaniasis infection
ENTPD1,Cell recruitment (pro-inflammatory response)
BAG4,TNF signaling
NRG2,Signaling by ERBB2
NRG2,Signaling by ERBB2 in Cancer
NRG2,Signaling by ERBB4
NRG2,Nuclear signaling by ERBB4
NRG2,Negative regulation of the PI3K/AKT network
NRG2,PI3K/AKT Signaling in Cancer
NRG2,Constitutive Signaling by Aberrant PI3K in Cancer
NRG2,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
NRG2,Signaling by PTK6
NRG2,Downregulation of ERBB2 signaling
NRG2,Signaling by Non-Receptor Tyrosine Kinases
NRG2,Signaling by ERBB2 KD Mutants
NRG2,Signaling by ERBB2 TMD/JMD mutants
ATP6V1G1,Signaling by Insulin receptor
ATP6V1G1,Insulin receptor recycling
VPS26A,WNT ligand biogenesis and trafficking
BCAR1,Downstream signal transduction
BCAR1,Signaling by PDGF
BCAR1,Signaling by VEGF
BCAR1,Integrin signaling
BCAR1,p130Cas linkage to MAPK signaling for integrins
BCAR1,VEGFA-VEGFR2 Pathway
BCAR1,Signaling by PTK6
BCAR1,Signaling by Non-Receptor Tyrosine Kinases
GABBR2,Class C/3 (Metabotropic glutamate/pheromone receptors)
ENTPD5,Purinergic signaling in leishmaniasis infection
ENTPD5,Cell recruitment (pro-inflammatory response)
CDC42BPB,RHOQ GTPase cycle
CDC42BPB,RHOJ GTPase cycle
SOX13,Deactivation of the beta-catenin transactivating complex
AKAP12,RHOD GTPase cycle
AKAP12,RHOF GTPase cycle
NCOR1,Signaling by ERBB4
NCOR1,Nuclear signaling by ERBB4
NCOR1,Signaling by TGF-beta Receptor Complex
NCOR1,Signaling by NOTCH1
NCOR1,NOTCH1 Intracellular Domain Regulates Transcription
NCOR1,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
NCOR1,Downregulation of SMAD2/3:SMAD4 transcriptional activity
NCOR1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
NCOR1,Signaling by NOTCH1 in Cancer
NCOR1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
NCOR1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
NCOR1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
NCOR1,Loss of function of MECP2 in Rett syndrome
NCOR1,Pervasive developmental disorders
NCOR1,NR1H2 and NR1H3-mediated signaling
NCOR1,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
NCOR1,HCMV Infection
NCOR1,HCMV Early Events
NCOR1,Disorders of Developmental Biology
NCOR1,Disorders of Nervous System Development
NCOR2,Signaling by TGF-beta Receptor Complex
NCOR2,Signaling by NOTCH1
NCOR2,NOTCH1 Intracellular Domain Regulates Transcription
NCOR2,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
NCOR2,Downregulation of SMAD2/3:SMAD4 transcriptional activity
NCOR2,Signaling by NOTCH1 PEST Domain Mutants in Cancer
NCOR2,Signaling by NOTCH1 in Cancer
NCOR2,Constitutive Signaling by NOTCH1 PEST Domain Mutants
NCOR2,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
NCOR2,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
NCOR2,Loss of function of MECP2 in Rett syndrome
NCOR2,Pervasive developmental disorders
NCOR2,NR1H2 and NR1H3-mediated signaling
NCOR2,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
NCOR2,HCMV Infection
NCOR2,HCMV Early Events
NCOR2,Disorders of Developmental Biology
NCOR2,Disorders of Nervous System Development
ABCG1,NR1H2 and NR1H3-mediated signaling
ABCG1,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
GNA14,Opioid Signalling
GNA14,G-protein mediated events
GNA14,PLC beta mediated events
GNA14,G-protein activation
NUP155,Host Interactions of HIV factors
NUP155,Rev-mediated nuclear export of HIV RNA
NUP155,Transport of Ribonucleoproteins into the Host Nucleus
NUP155,Export of Viral Ribonucleoproteins from Nucleus
NUP155,NS1 Mediated Effects on Host Pathways
NUP155,Viral Messenger RNA Synthesis
NUP155,NEP/NS2 Interacts with the Cellular Export Machinery
NUP155,Interactions of Vpr with host cellular proteins
NUP155,Interactions of Rev with host cellular proteins
NUP155,Nuclear import of Rev protein
NUP155,Vpr-mediated nuclear import of PICs
NUP155,SLC transporter disorders
NUP155,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP155,Disorders of transmembrane transporters
NUP155,HCMV Infection
NUP155,HCMV Early Events
NUP155,HCMV Late Events
NUP155,SARS-CoV-2 activates/modulates innate and adaptive immune responses
SEC24C,SARS-CoV-2 activates/modulates innate and adaptive immune responses
ISG15,NS1 Mediated Effects on Host Pathways
ISG15,SARS-CoV-2 activates/modulates innate and adaptive immune responses
ISG15,Respiratory Syncytial Virus Infection Pathway
ISG15,RSV-host interactions
ARHGEF10,NRAGE signals death through JNK
ARHGEF10,p75 NTR receptor-mediated signalling
ARHGEF10,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF10,G alpha (12/13) signalling events
ARHGEF10,RHOA GTPase cycle
ARHGEF10,RHOB GTPase cycle
ARHGEF10,RHOC GTPase cycle
IKBKE,Regulation of TNFR1 signaling
IKBKE,TNF signaling
IKBKE,SARS-CoV-1-host interactions
IKBKE,SARS-CoV-1 activates/modulates innate immune responses
IKBKE,SARS-CoV-2 activates/modulates innate and adaptive immune responses
KDM4A,NR1H2 and NR1H3-mediated signaling
KDM4A,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
GREB1,Estrogen-dependent gene expression
NUP93,Host Interactions of HIV factors
NUP93,Rev-mediated nuclear export of HIV RNA
NUP93,Transport of Ribonucleoproteins into the Host Nucleus
NUP93,Export of Viral Ribonucleoproteins from Nucleus
NUP93,NS1 Mediated Effects on Host Pathways
NUP93,Viral Messenger RNA Synthesis
NUP93,NEP/NS2 Interacts with the Cellular Export Machinery
NUP93,Interactions of Vpr with host cellular proteins
NUP93,Interactions of Rev with host cellular proteins
NUP93,Nuclear import of Rev protein
NUP93,Vpr-mediated nuclear import of PICs
NUP93,SLC transporter disorders
NUP93,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP93,Disorders of transmembrane transporters
NUP93,HCMV Infection
NUP93,HCMV Early Events
NUP93,HCMV Late Events
NUP93,SARS-CoV-2 activates/modulates innate and adaptive immune responses
DOCK4,RAC2 GTPase cycle
DOCK4,RHOG GTPase cycle
HDAC9,Signaling by NOTCH1
HDAC9,NOTCH1 Intracellular Domain Regulates Transcription
HDAC9,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC9,Signaling by NOTCH1 in Cancer
HDAC9,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC9,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC9,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
IFT140,Hedgehog 'off' state
ARHGAP32,RHOA GTPase cycle
ARHGAP32,RHOB GTPase cycle
ARHGAP32,RHOC GTPase cycle
ARHGAP32,RAC2 GTPase cycle
ARHGAP32,RHOD GTPase cycle
ARHGAP32,RHOQ GTPase cycle
ARHGAP32,RHOG GTPase cycle
ARHGAP32,RHOJ GTPase cycle
ARHGAP32,RAC3 GTPase cycle
ARHGAP32,RHOF GTPase cycle
SLK,RHOA GTPase cycle
SLK,RHOB GTPase cycle
SLK,RHOC GTPase cycle
STARD8,RHOA GTPase cycle
STARD8,RHOB GTPase cycle
HDAC4,Signaling by NOTCH1
HDAC4,NOTCH1 Intracellular Domain Regulates Transcription
HDAC4,Signaling by NOTCH1 PEST Domain Mutants in Cancer
HDAC4,Signaling by NOTCH1 in Cancer
HDAC4,Constitutive Signaling by NOTCH1 PEST Domain Mutants
HDAC4,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
HDAC4,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
ZFYVE16,Signaling by BMP
DLGAP5,Signaling by NOTCH3
DLGAP5,NOTCH3 Intracellular Domain Regulates Transcription
SPCS2,Respiratory Syncytial Virus Infection Pathway
SPCS2,"Respiratory syncytial virus (RSV) genome replication, transcription and translation"
SPCS2,Maturation of hRSV A proteins
MAML1,Pre-NOTCH Transcription and Translation
MAML1,Pre-NOTCH Expression and Processing
MAML1,Signaling by NOTCH1
MAML1,Signaling by NOTCH2
MAML1,NOTCH1 Intracellular Domain Regulates Transcription
MAML1,NOTCH2 intracellular domain regulates transcription
MAML1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
MAML1,Signaling by NOTCH1 in Cancer
MAML1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
MAML1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
MAML1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MAML1,Signaling by NOTCH3
MAML1,NOTCH3 Intracellular Domain Regulates Transcription
MAML1,Signaling by NOTCH4
MAML1,NOTCH4 Intracellular Domain Regulates Transcription
GIT2,RAC2 GTPase cycle
GIT2,RHOQ GTPase cycle
GIT2,RHOJ GTPase cycle
GIT2,RHOU GTPase cycle
GIT2,RAC3 GTPase cycle
GIT2,RHOV GTPase cycle
KEAP1,Potential therapeutics for SARS
SPATA2,TNFR1-induced proapoptotic signaling
SPATA2,Regulation of TNFR1 signaling
SPATA2,TNFR1-induced NF-kappa-B signaling pathway
SPATA2,TNF signaling
ARHGEF11,NRAGE signals death through JNK
ARHGEF11,p75 NTR receptor-mediated signalling
ARHGEF11,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF11,G alpha (12/13) signalling events
ARHGEF11,RHOA GTPase cycle
ARHGEF11,RHOB GTPase cycle
ARHGEF11,RHOC GTPase cycle
ARHGEF17,NRAGE signals death through JNK
ARHGEF17,p75 NTR receptor-mediated signalling
ARHGEF17,"Cell death signalling via NRAGE, NRIF and NADE"
ARHGEF17,G alpha (12/13) signalling events
ARHGEF17,RHOA GTPase cycle
ARHGEF17,RHOB GTPase cycle
ARHGEF17,RHOC GTPase cycle
HEPH,SLC transporter disorders
HEPH,Disorders of transmembrane transporters
ELMO1,Host Interactions of HIV factors
ELMO1,The role of Nef in HIV-1 replication and disease pathogenesis
ELMO1,Signaling by VEGF
ELMO1,VEGFA-VEGFR2 Pathway
ELMO1,Signaling by PTK6
ELMO1,Signaling by Non-Receptor Tyrosine Kinases
ELMO1,Parasite infection
ELMO1,Leishmania phagocytosis
ELMO1,FCGR3A-mediated phagocytosis
GAB2,Signaling by FGFR in disease
GAB2,Signaling by SCF-KIT
GAB2,FGFR1 mutant receptor activation
GAB2,Signaling by FGFR1 in disease
GAB2,FLT3 signaling in disease
GAB2,Signaling by FLT3 ITD and TKD mutants
PSMD6,Host Interactions of HIV factors
PSMD6,Vpu mediated degradation of CD4
PSMD6,Vif-mediated degradation of APOBEC3G
PSMD6,Degradation of beta-catenin by the destruction complex
PSMD6,PCP/CE pathway
PSMD6,Asymmetric localization of PCP proteins
PSMD6,Degradation of AXIN
PSMD6,Degradation of DVL
PSMD6,Hedgehog ligand biogenesis
PSMD6,Hh mutants are degraded by ERAD
PSMD6,Hh mutants abrogate ligand secretion
PSMD6,Degradation of GLI1 by the proteasome
PSMD6,Degradation of GLI2 by the proteasome
PSMD6,GLI3 is processed to GLI3R by the proteasome
PSMD6,Hedgehog 'off' state
PSMD6,ABC transporter disorders
PSMD6,Disorders of transmembrane transporters
PSMD6,Hedgehog 'on' state
PSMD6,Regulation of RAS by GAPs
PSMD6,Defective CFTR causes cystic fibrosis
PSMD6,MAPK6/MAPK4 signaling
PSMD6,Regulation of PTEN stability and activity
PSMD6,Signaling by NOTCH4
PSMD6,Negative regulation of NOTCH4 signaling
MED24,Respiratory Syncytial Virus Infection Pathway
MED24,RSV-host interactions
SEC24D,SARS-CoV-2 activates/modulates innate and adaptive immune responses
POM121,Host Interactions of HIV factors
POM121,Rev-mediated nuclear export of HIV RNA
POM121,Transport of Ribonucleoproteins into the Host Nucleus
POM121,Export of Viral Ribonucleoproteins from Nucleus
POM121,NS1 Mediated Effects on Host Pathways
POM121,Viral Messenger RNA Synthesis
POM121,NEP/NS2 Interacts with the Cellular Export Machinery
POM121,Interactions of Vpr with host cellular proteins
POM121,Interactions of Rev with host cellular proteins
POM121,Nuclear import of Rev protein
POM121,Vpr-mediated nuclear import of PICs
POM121,SLC transporter disorders
POM121,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
POM121,Disorders of transmembrane transporters
POM121,HCMV Infection
POM121,HCMV Early Events
POM121,HCMV Late Events
POM121,SARS-CoV-2 activates/modulates innate and adaptive immune responses
RHOBTB1,RHOBTB1 GTPase cycle
RHOBTB1,RHOBTB GTPase Cycle
SV2B,Neurotoxicity of clostridium toxins
SV2B,Uptake and actions of bacterial toxins
SV2B,Bacterial Infection Pathways
SV2A,Neurotoxicity of clostridium toxins
SV2A,Uptake and actions of bacterial toxins
SV2A,Bacterial Infection Pathways
G3BP2,SARS-CoV-2 activates/modulates innate and adaptive immune responses
KIF14,RHO GTPases activate CIT
KIF14,RND2 GTPase cycle
KIF14,RND1 GTPase cycle
CDC25A,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDC25A,Neurodegenerative Diseases
CDC25A,Diseases of programmed cell death
CDC25A,Defective Intrinsic Pathway for Apoptosis
P2RY14,P2Y receptors
P2RY14,Nucleotide-like (purinergic) receptors
CDC25B,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDC25B,Neurodegenerative Diseases
CDC25B,Diseases of programmed cell death
CDC25B,Defective Intrinsic Pathway for Apoptosis
CDC25C,RHO GTPases activate PKNs
CDC25C,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
CDC25C,Neurodegenerative Diseases
CDC25C,Diseases of programmed cell death
CDC25C,Defective Intrinsic Pathway for Apoptosis
USP15,Signaling by TGF-beta Receptor Complex
USP15,Downregulation of TGF-beta receptor signaling
USP15,TGF-beta receptor signaling activates SMADs
CDC27,Diseases of mitotic cell cycle
CDC27,Aberrant regulation of mitotic exit in cancer due to RB1 defects
CDC27,Aberrant regulation of mitotic cell cycle due to RB1 defects
FGF19,PI3K Cascade
FGF19,IRS-mediated signalling
FGF19,Signaling by FGFR
FGF19,FGFR4 ligand binding and activation
FGF19,Negative regulation of the PI3K/AKT network
FGF19,PI3K/AKT Signaling in Cancer
FGF19,Constitutive Signaling by Aberrant PI3K in Cancer
FGF19,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGF19,IGF1R signaling cascade
FGF19,IRS-related events triggered by IGF1R
FGF19,Phospholipase C-mediated cascade; FGFR4
FGF19,FRS-mediated FGFR4 signaling
FGF19,Downstream signaling of activated FGFR4
FGF19,SHC-mediated cascade:FGFR4
FGF19,PI-3K cascade:FGFR4
FGF19,Negative regulation of FGFR4 signaling
FGF19,Signaling by FGFR4
FGF19,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"
FGF19,Insulin receptor signalling cascade
FGF19,Signaling by Insulin receptor
MED12,Respiratory Syncytial Virus Infection Pathway
MED12,RSV-host interactions
MED13,Respiratory Syncytial Virus Infection Pathway
MED13,RSV-host interactions
NUP153,Host Interactions of HIV factors
NUP153,Rev-mediated nuclear export of HIV RNA
NUP153,Transport of Ribonucleoproteins into the Host Nucleus
NUP153,Export of Viral Ribonucleoproteins from Nucleus
NUP153,NS1 Mediated Effects on Host Pathways
NUP153,Viral Messenger RNA Synthesis
NUP153,NEP/NS2 Interacts with the Cellular Export Machinery
NUP153,Interactions of Vpr with host cellular proteins
NUP153,Interactions of Rev with host cellular proteins
NUP153,Nuclear import of Rev protein
NUP153,Vpr-mediated nuclear import of PICs
NUP153,SLC transporter disorders
NUP153,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
NUP153,Disorders of transmembrane transporters
NUP153,HCMV Infection
NUP153,HCMV Early Events
NUP153,HCMV Late Events
NUP153,SARS-CoV-2 activates/modulates innate and adaptive immune responses
RBX1,Host Interactions of HIV factors
RBX1,Vif-mediated degradation of APOBEC3G
RBX1,Degradation of beta-catenin by the destruction complex
RBX1,Signaling by NOTCH1
RBX1,NOTCH1 Intracellular Domain Regulates Transcription
RBX1,Signaling by NOTCH1 PEST Domain Mutants in Cancer
RBX1,Signaling by NOTCH1 in Cancer
RBX1,Constitutive Signaling by NOTCH1 PEST Domain Mutants
RBX1,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
RBX1,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
RBX1,Degradation of DVL
RBX1,Degradation of GLI1 by the proteasome
RBX1,Degradation of GLI2 by the proteasome
RBX1,GLI3 is processed to GLI3R by the proteasome
RBX1,Hedgehog 'off' state
RBX1,Hedgehog 'on' state
RBX1,Regulation of RAS by GAPs
RBX1,Signaling by NOTCH4
RBX1,Negative regulation of NOTCH4 signaling
RBX1,Potential therapeutics for SARS
RBX1,Signaling by ALK in cancer
RBX1,Signaling by ALK fusions and activated point mutants
RBX1,Nuclear events stimulated by ALK signaling in cancer
RBX1,Respiratory Syncytial Virus Infection Pathway
RBX1,Evasion by RSV of host interferon responses
RBX1,RSV-host interactions
CDC42,Signaling by EGFR
CDC42,EGFR downregulation
CDC42,Signaling by VEGF
CDC42,G-protein beta:gamma signalling
CDC42,VEGFA-VEGFR2 Pathway
CDC42,RHO GTPases activate KTN1
CDC42,RHO GTPases activate IQGAPs
CDC42,RHO GTPases activate PAKs
CDC42,RHO GTPases Activate WASPs and WAVEs
CDC42,RHO GTPases Activate Formins
CDC42,MAPK6/MAPK4 signaling
CDC42,G beta:gamma signalling through CDC42
CDC42,RAC2 GTPase cycle
CDC42,RHOQ GTPase cycle
CDC42,RHOG GTPase cycle
CDC42,RHOJ GTPase cycle
CDC42,RHOU GTPase cycle
CDC42,RAC3 GTPase cycle
CDC42,RHOV GTPase cycle
CDC42,Parasite infection
CDC42,Leishmania phagocytosis
CDC42,FCGR3A-mediated phagocytosis
FGFBP1,Signaling by FGFR
FGFBP1,FGFR2 ligand binding and activation
FGFBP1,Signaling by FGFR2
RCE1,RAS processing
SREBF1,NR1H2 and NR1H3-mediated signaling
NOTCH3,Pre-NOTCH Transcription and Translation
NOTCH3,Pre-NOTCH Expression and Processing
MMP2,MAPK6/MAPK4 signaling
PLTP,NR1H2 and NR1H3-mediated signaling
PLTP,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
FCER2,Signaling by NOTCH2
FCER2,NOTCH2 intracellular domain regulates transcription
SERPINE1,Downregulation of SMAD2/3:SMAD4 transcriptional activity
SERPINE1,SARS-CoV-1-host interactions
SERPINE1,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
CXCL12,Signaling by ERBB4
CXCL12,Nuclear signaling by ERBB4
CXCL12,Estrogen-dependent gene expression
PTCH2,Hedgehog 'on' state
TF,Signaling by NTRK1 (TRKA)
TF,Nuclear Events (kinase and transcription factor activation)
TF,NGF-stimulated transcription
FASLG,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
FASLG,Neurodegenerative Diseases
FASLG,Diseases of programmed cell death
FASLG,Defective Intrinsic Pathway for Apoptosis
CTSD,Estrogen-dependent gene expression
GPAM,Estrogen-dependent gene expression
NOTCH2,Pre-NOTCH Transcription and Translation
NOTCH2,Pre-NOTCH Expression and Processing
MYC,Degradation of beta-catenin by the destruction complex
MYC,Ca2+ pathway
MYC,Repression of WNT target genes
APP,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
APP,Neurodegenerative Diseases
APP,Diseases of programmed cell death
APP,Defective Intrinsic Pathway for Apoptosis
NOTCH1,Pre-NOTCH Transcription and Translation
NOTCH1,Pre-NOTCH Expression and Processing
NOTCH1,Signaling by ALK in cancer
NOTCH1,Signaling by ALK fusions and activated point mutants
NOTCH1,Nuclear events stimulated by ALK signaling in cancer
TGFA,Estrogen-dependent gene expression
COL1A2,Signaling by TGF-beta Receptor Complex
COL1A2,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
COL1A2,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
MMP10,MAPK6/MAPK4 signaling
AXIN2,Degradation of beta-catenin by the destruction complex
AXIN2,Ca2+ pathway
AXIN2,Repression of WNT target genes
PTEN,Regulation of PTEN gene transcription
BDNF,Loss of function of MECP2 in Rett syndrome
BDNF,Pervasive developmental disorders
BDNF,Disorders of Developmental Biology
BDNF,Disorders of Nervous System Development
CDK5R1,Signaling by NTRK1 (TRKA)
CDK5R1,Nuclear Events (kinase and transcription factor activation)
CDK5R1,NGF-stimulated transcription
ERBB4,Signaling by ERBB4
ERBB4,Nuclear signaling by ERBB4
ANAPC7,Diseases of mitotic cell cycle
ANAPC7,Aberrant regulation of mitotic exit in cancer due to RB1 defects
ANAPC7,Aberrant regulation of mitotic cell cycle due to RB1 defects
TCF4,Formation of the beta-catenin:TCF transactivating complex
hsa-mir-449a,Pre-NOTCH Transcription and Translation
hsa-mir-449a,Pre-NOTCH Expression and Processing
hsa-mir-21,Regulation of PTEN mRNA translation
hsa-let-7a-1,Signaling by TGFBR3
hsa-let-7a-1,TGFBR3 expression
NOTCH4,Pre-NOTCH Transcription and Translation
NOTCH4,Pre-NOTCH Expression and Processing
hsa-mir-34c,Pre-NOTCH Transcription and Translation
hsa-mir-34c,Pre-NOTCH Expression and Processing
hsa-mir-34c,MAPK6/MAPK4 signaling
hsa-mir-23b,Signaling by TGFBR3
hsa-mir-23b,TGFBR3 expression
hsa-mir-206,Pre-NOTCH Transcription and Translation
hsa-mir-206,Pre-NOTCH Expression and Processing
hsa-mir-181c,Pre-NOTCH Transcription and Translation
hsa-mir-181c,Pre-NOTCH Expression and Processing
hsa-mir-200c,Pre-NOTCH Transcription and Translation
hsa-mir-200c,Pre-NOTCH Expression and Processing
hsa-mir-449b,Pre-NOTCH Transcription and Translation
hsa-mir-449b,Pre-NOTCH Expression and Processing
hsa-mir-200b,Pre-NOTCH Transcription and Translation
hsa-mir-200b,Pre-NOTCH Expression and Processing
hsa-mir-150,Pre-NOTCH Transcription and Translation
hsa-mir-150,Pre-NOTCH Expression and Processing
hsa-mir-34b,Pre-NOTCH Transcription and Translation
hsa-mir-34b,Pre-NOTCH Expression and Processing
hsa-mir-34b,MAPK6/MAPK4 signaling
hsa-mir-27b,Signaling by TGFBR3
hsa-mir-27b,TGFBR3 expression
hsa-mir-34a,Pre-NOTCH Transcription and Translation
hsa-mir-34a,Pre-NOTCH Expression and Processing
hsa-mir-302a,Pre-NOTCH Transcription and Translation
hsa-mir-302a,Pre-NOTCH Expression and Processing
TUBA4B,RHO GTPases activate IQGAPs
TUBA4B,RHO GTPases Activate Formins
TUBA4B,HCMV Infection
TUBA4B,HCMV Early Events
hsa-mir-449c,Pre-NOTCH Transcription and Translation
hsa-mir-449c,Pre-NOTCH Expression and Processing
POM121C,Host Interactions of HIV factors
POM121C,Rev-mediated nuclear export of HIV RNA
POM121C,Transport of Ribonucleoproteins into the Host Nucleus
POM121C,Export of Viral Ribonucleoproteins from Nucleus
POM121C,NS1 Mediated Effects on Host Pathways
POM121C,Viral Messenger RNA Synthesis
POM121C,NEP/NS2 Interacts with the Cellular Export Machinery
POM121C,Interactions of Vpr with host cellular proteins
POM121C,Interactions of Rev with host cellular proteins
POM121C,Nuclear import of Rev protein
POM121C,Vpr-mediated nuclear import of PICs
POM121C,SLC transporter disorders
POM121C,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
POM121C,Disorders of transmembrane transporters
POM121C,HCMV Infection
POM121C,HCMV Early Events
POM121C,HCMV Late Events
POM121C,SARS-CoV-2 activates/modulates innate and adaptive immune responses
hsa-mir-21,Signaling by ALK in cancer
hsa-mir-21,Signaling by ALK fusions and activated point mutants
hsa-mir-21,Nuclear events stimulated by ALK signaling in cancer
CNOT6L,Regulation of PTEN mRNA translation
CNOT6L,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
VAPA,Regulation of PTEN mRNA translation
VAPA,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
hsa-mir-17,Regulation of PTEN mRNA translation
hsa-mir-17,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
hsa-mir-19a,Regulation of PTEN mRNA translation
hsa-mir-19a,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
hsa-mir-20a,Regulation of PTEN mRNA translation
hsa-mir-20a,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
hsa-mir-22,Regulation of PTEN mRNA translation
hsa-mir-25,Regulation of PTEN mRNA translation
hsa-mir-26b,Estrogen-dependent gene expression
hsa-mir-26b,NR1H2 and NR1H3-mediated signaling
hsa-mir-26b,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
hsa-mir-33a,NR1H2 and NR1H3-mediated signaling
hsa-mir-33a,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
hsa-mir-93,Regulation of PTEN mRNA translation
hsa-mir-106a,Regulation of PTEN mRNA translation
hsa-mir-106a,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
hsa-mir-205,Regulation of PTEN mRNA translation
hsa-mir-214,Regulation of PTEN mRNA translation
hsa-mir-144,NR1H2 and NR1H3-mediated signaling
hsa-mir-144,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
hsa-mir-106b,Regulation of PTEN mRNA translation
hsa-mir-106b,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
hsa-mir-20b,Regulation of PTEN mRNA translation
hsa-mir-20b,Competing endogenous RNAs (ceRNAs) regulate PTEN translation
hsa-mir-92b,Ca2+ pathway
hsa-mir-33b,NR1H2 and NR1H3-mediated signaling
hsa-mir-33b,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
